<SEC-DOCUMENT>0001493152-24-012859.txt : 20240402
<SEC-HEADER>0001493152-24-012859.hdr.sgml : 20240402
<ACCEPTANCE-DATETIME>20240402172203
ACCESSION NUMBER:		0001493152-24-012859
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20240402
FILED AS OF DATE:		20240402
DATE AS OF CHANGE:		20240402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			bioAffinity Technologies, Inc.
		CENTRAL INDEX KEY:			0001712762
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				465211056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41463
		FILM NUMBER:		24815671

	BUSINESS ADDRESS:	
		STREET 1:		22211 WEST INTERSTATE-10
		STREET 2:		SUITE 1206
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78257
		BUSINESS PHONE:		210-698-5334

	MAIL ADDRESS:	
		STREET 1:		22211 WEST INTERSTATE-10
		STREET 2:		SUITE 1206
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78257
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>formpre14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Amendment
No. &nbsp;&nbsp;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ba_logo1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22211
West Interstate 10, Suite 1206</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>San
Antonio, Texas 78257</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
[&#9679;], 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
am pleased to invite you to attend the Annual Meeting of Stockholders of bioAffinity Technologies, Inc. on Tuesday, June 4, 2024, at
8:00 a.m. Central Time. The Annual Meeting will be held in person at the Company&rsquo;s principal office at 22211 West Interstate 10,
Suite 1206, San Antonio, Texas 78257.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies is committed to developing noninvasive diagnostics for lung cancer and other diseases of the lung. Our team of scientists
and business professionals is driven by its mission to increase detection of cancer at early stage when accurate diagnosis leads to longer
lives, fewer unnecessary invasive procedures, reduced patient anxiety, and lower medical costs. As President and Chief Executive Officer
of bioAffinity Technologies, I am greatly encouraged by the growing adoption and use by physicians of our first test, CyPath<SUP>&reg;
</SUP>Lung, a noninvasive test for lung cancer, and of the technological advancements that our team continues to make in its fight to
address the urgent need for noninvasive, early-stage diagnosis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not you plan to attend the Annual Meeting, <B>your vote matters.</B> We encourage you to promptly vote your shares by proxy over the
internet, via telephone or by mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
trust in our team and belief in our technology are invaluable. On behalf of our Board of Directors, our executive leadership team, and
our dedicated team of scientists and businesspeople, we extend our sincerest gratitude for your continued support of and investment in
bioAffinity Technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formpre14a_002.jpg" ALT="" STYLE="height: 39px; width: 135px">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maria
    Zannes</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>President
    and Chief Executive Officer</I></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ba_logo1.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE HELD ON JUNE 4, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
is hereby given that bioAffinity Technologies, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;) will host its Annual Meeting of Stockholders
on Tuesday, June 4, 2024, at 8:00 a.m. Central Time (the &ldquo;<B><I>Annual Meeting</I></B>&rdquo;). The Annual Meeting will be held
in person at the Company&rsquo;s principal office at 22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257. The Annual Meeting
is being held for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect the eight director nominees listed in the accompanying Proxy Statement to serve until the next Annual Meeting of Stockholders
    and until their successors are duly elected and qualified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    consider and approve the bioAffinity Technologies, Inc. 2024 Incentive Compensation Plan (the &ldquo;<B><I>2024 Plan</I></B>&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    consider and approve an amendment to the Company&rsquo;s Amended and Restated Certificate of Incorporation to increase the number
    of shares of common stock authorized for issuance from 25,000,000 shares to 100,000,000 shares (&ldquo;<B><I>Increase In Authorized
    Shares Proposal</I></B>&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of WithumSmith+Brown, PC as the Company&rsquo;s independent registered public accounting firm for the fiscal
    year ending December 31, 2024; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, pursuant to Nasdaq listing rules, the issuance of up to an aggregate of 1,632,000 shares of our common stock upon the exercise
    of our common stock purchase warrants issued to institutional investors and designees of the placement agent in connection with our
    private placement offering that closed on March 8, 2024, that may be equal to or exceed 20% of our common stock outstanding before
    such offering (the &ldquo;<B><I>Warrant Exercise Proposal</I></B>&rdquo;); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and
    vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Increase
    In Authorized Shares Proposal and the Warrant Exercise Proposal (the &ldquo;<B><I>Adjournment Proposal</I></B>&rdquo;); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact such other business as may lawfully come before the meeting or any adjournment thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of record at the close of business on April 8, 2024, are entitled to notice of and to vote at the Annual Meeting and any postponements
or adjournments thereof. A list of stockholders of record at the close of business on April 8, 2024, will be available for inspection
by any stockholder for a period of ten days prior to the Annual Meeting at our principal office at 22211 West Interstate 10, Suite 1206,
San Antonio, Texas 78257.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Notice of Internet Availability of Proxy Materials will be mailed to our stockholders on or about </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
[&#9679;], 2024<FONT STYLE="background-color: white">. If you previously requested electronic or paper delivery of the proxy materials,
you will be sent the proxy statement, the accompanying proxy card and our 2023 Annual Report to Stockholders on or about April </FONT>[&#9679;],
2024<FONT STYLE="background-color: white">. The Notice of Internet Availability of Proxy Materials contains instructions on how to access
an electronic copy of our proxy materials.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Your
vote is very important.</B> Whether or not you plan to attend the Annual Meeting, we encourage you to read the accompanying Proxy Statement
and to submit your proxy or voting instructions as soon as possible. In order to ensure the representation of a quorum at the Annual
Meeting, stockholders who do not expect to attend the Annual Meeting are urged to vote as soon as possible. For information on how to
vote your shares, please refer to the section of the Proxy Statement entitled &ldquo;Questions and Answers About the Proxy Materials
and the Annual Meeting&rdquo; and to the instructions provided in your proxy card or Notice <FONT STYLE="background-color: white">of
Internet Availability of Proxy Materials</FONT> or by your broker, bank, or other nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formpre14a_004.jpg" ALT="" STYLE="height: 39px; width: 135px">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maria
    Zannes</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>President
    and Chief Executive Officer</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    April [&#9679;], 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Notice Regarding the Availability of Proxy Materials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for
the Stockholder Meeting to Be Held on June 4, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
proxy statement and the 2023 Annual Report to Stockholders are available at www.proxyvote.com.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ba_logo1.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22211
W Interstate 10, Suite 1206</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>San
Antonio, Texas 78257</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 4, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENERAL
INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) of bioAffinity Technologies, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;),
is soliciting proxies to be used at the 2024 Annual Meeting of Stockholders to be held on Tuesday, June 4, 2024, at 8:00 a.m. Central
Time (the &ldquo;<B><I>Annual Meeting</I></B>&rdquo;) at the Company&rsquo;s principal office at 22211 West Interstate 10, Suite 1206,
San Antonio, Texas 78257. <FONT STYLE="background-color: white">This proxy statement (</FONT>this &ldquo;<B><I>Proxy Statement</I></B>&rdquo;)
<FONT STYLE="background-color: white">and the 2023 Annual Report to Stockholders are posted on the internet at </FONT>www.proxyvote.com,
<FONT STYLE="background-color: white">and the Notice of Internet Availability of Proxy Materials (the &ldquo;<B><I>Notice</I></B>&rdquo;)
will be mailed to our stockholders on or about April </FONT>[&#9679;]<FONT STYLE="background-color: white">, 2024. If you previously
requested electronic or paper delivery of the proxy materials, you will be sent the proxy statement, the accompanying proxy card, and
the 2023 Annual Report to Stockholders on or about April </FONT>[&#9679;]<FONT STYLE="background-color: white">, 2024.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Matters and the Board&rsquo;s Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; width: 60%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agenda
    Item</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
    Vote<BR>
 Recommendation</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page
    Reference</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of eight directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
    each Director Nominee</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    of the bioAffinity Technologies, Inc. 2024 Incentive Compensation Plan </FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    of charter amendment to increase authorized shares from 25,000,000 shares to 100,000,000 shares </FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratification
    of WithumSmith+Brown, PC as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December
    31, 2024</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    of the issuance of up to an aggregate of 1,632,000 shares of our common stock upon the exercise of our common stock purchase warrants
    issued or issuable in connection with our private placement offering that closed on March 8, 2024 </FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    of the Adjournment Proposal</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to these matters, stockholders may be asked to vote on such other business as may properly come before the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Even
if you plan to attend the Annual Meeting, please vote in advance so that your vote will be counted if you later decide not to attend
the Annual Meeting.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUESTIONS
AND ANSWERS ABOUT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PROXY MATERIALS AND THE ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
is soliciting my vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of bioAffinity Technologies, Inc. is soliciting your proxy to be used at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
did I receive a one-page Notice in the mail regarding the internet availability of proxy materials this year instead of a full set of
proxy materials?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #414042"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to rules adopted by the Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;), we have elected to mail to our stockholders
a Notice of Internet Availability of Proxy Materials instead of a paper copy of the proxy materials. All stockholders receiving the Notice
will have the ability to access the proxy materials over the internet and receive a paper copy of the proxy materials by mail on request.
Instructions on how to access the proxy materials over the internet or to request a paper copy may be found in the Notice. In addition,
the Notice contains instructions on how you may access proxy materials in printed form by mail or electronically on an ongoing basis.
This process has allowed us to expedite our stockholders&rsquo; receipt of proxy materials, lower the costs of distribution, and reduce
the environmental impact of our Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>When
and where will the Annual Meeting be held?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Annual Meeting will be held on Tuesday, June 4, 2024, at 8:00 a.m. Central Time, at the Company&rsquo;s principal office at 22211 West
Interstate 10, Suite 1206, San Antonio, Texas 78257.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
    do I need to do if I would like to attend the Annual Meeting?</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you wish to attend the Annual Meeting in person, you must present a valid form of photo identification, such as a driver&rsquo;s license.
If you are a beneficial owner of common stock that is held of record by a bank, broker, or other nominee, you will also need proof of
ownership to be admitted. In this regard, a recent brokerage statement or a letter from your bank or broker are examples of proof of
ownership. The Company reserves the right to prohibit cameras, recording equipment, or electronic devices in the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
am I voting on at the Annual Meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Annual Meeting is to vote on the following items described in this Proxy Statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 1:</B> To elect the eight director nominees listed in the accompanying Proxy Statement to serve until the next Annual Meeting
    of Stockholders and until their successors are duly elected and qualified.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 2:</B> To consider and approve the bioAffinity Technologies, Inc. 2014 Incentive Compensation Plan (the &ldquo;<B><I>2024 Plan</I></B>&rdquo;)
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 3:</B> To consider and approve an amendment to the Company&rsquo;s Amended and Restated Certificate of Incorporation, as amended
    (the &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;) to increase the number of shares of common stock authorized for issuance
    from 25,000,000 shares to 100,000,000 shares (the &ldquo;<B><I>Increase In Authorized Shares Proposal</I></B>&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 4:</B> To ratify the appointment of WithumSmith+Brown, PC as the Company&rsquo;s independent
                                            registered public accounting firm for the fiscal year ending December 31, 2024.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 5</B>: To consider and approve the issuance of up to an aggregate of 1,632,000 shares of our common stock upon the exercise of
    our common stock purchase warrants issued or issuable to institutional investors and designees of the placement agent in connection
    with our private placement offering that closed on March 8, 2024, that may be equal to or exceed 20% of our common stock outstanding
    before such offering (the &ldquo;<B><I>Warrant Exercise Proposal</I></B>&rdquo;).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 6</B>: To consider and approve the adjournment of the Annual Meeting to a later date, if necessary or appropriate, to permit
    further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the
    approval of the Increase In Authorized Shares Proposal and the Warrant Exercise Proposal (the &ldquo;<B><I>Adjournment Proposal</I></B>&rdquo;).</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the proxies, at their discretion and if designated as such, are authorized to vote upon such other business as may properly come before
the Annual Meeting or any continuation, postponement, or adjournment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
is entitled to vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
as of the close of business on the record date of April 8, 2024 (the &ldquo;<B><I>Record Date</I></B>&rdquo;), are entitled to vote at
the Annual Meeting or any postponement or adjournment thereof. As of the Record Date, there were [&#9679;] shares of the Company&rsquo;s
common stock, par value $0.007 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
many votes per share of Common Stock held are stockholders entitled to?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
have one vote per share on all matters presented at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
is the difference between holding shares of Common Stock as a &ldquo;stockholder of record&rdquo; and holding shares in &ldquo;street
name&rdquo;?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
held as a &ldquo;stockholder of record&rdquo; (also called a &ldquo;registered holder&rdquo;) are shares held directly in your name.
Shares held in &ldquo;street name&rdquo; are shares held for you in an account with a broker, bank, or other nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
do I vote my shares?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a <I>registered holder</I>, you may vote:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    internet.</I></B> Via the Internet at <I><U>www.proxyvote.com</U></I>.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    telephone</I></B>. If you are located within the United States and Canada, call 1-800-690-6903 (toll-free) from a touch-tone telephone;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><B><I>By mail.</I></B> By returning a properly executed
    proxy card it in the postage-paid envelope provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY
    11717; or</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
person. </I></B>You may vote in person at the Annual Meeting.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.85pt; text-align: justify; text-indent: -0.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.85pt; text-align: justify; text-indent: -0.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
vote online or via telephone, you will need your unique control number. You can find the control number on your proxy card or Notice.
<FONT STYLE="background-color: white">Be sure to have your proxy card or your Notice in hand and follow the instructions.</FONT> Internet
and telephone voting facilities will close at 11:59 p.m. Eastern Time on June 3, 2024, for the voting of shares held by stockholders
of record as of the Record Date. Proxy cards with respect to shares held of record must be received no later than June 3, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares in <I>street name</I>, you may vote:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    internet*.</I></B> Via the Internet at <I><U>www.proxyvote.com</U></I>. To vote online, you will need your unique control number;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    telephone*.</I></B> If you are located within the United States and Canada, call 1-800-454-8683 (toll-free) from a touch-tone telephone;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
mail:</I></B> By returning a properly executed voting instruction form by mail, depending upon the method(s) your broker, bank or other
nominee makes available; or</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><B><I>In person:</I></B> To do so,
    you must request a legal proxy from your broker, bank, or other nominee and present it at the Annual Meeting.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*Not
all street name holders may be able to vote at the web address and phone number provided above. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in street name, please check the voting instruction form or Notice provided to you by your broker, bank, or
other nominee for internet or telephone voting availability. If internet and/or telephone voting are available to a street name
holder, </FONT>such facilities will close at 11:59 p.m. Eastern Time on June 3, 2024. To vote online or via telephone, you will need
your unique control number. You can find the control number on your voting instruction form or Notice. <FONT STYLE="background-color: white">Be
sure to have your voting instruction form or your Notice in hand and follow the instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
if I return a proxy card or otherwise submit a proxy but do not make specific choices?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
shares held by recordholders entitled to vote, represented by a properly executed and unrevoked proxy received in time for the Annual
Meeting, will be voted in accordance with the instructions given. In the absence of such instructions, shares will be voted as recommended
by the Board. The persons named as proxies will also be authorized to vote in their discretion upon such other matters as may properly
come before the Annual Meeting or any adjournment or postponement thereof. If any nominee for director is unable to serve, which is not
now contemplated, the proxies will be voted for such substitute nominee(s) as the Board recommends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
are &ldquo;broker non-votes&rdquo;?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks,
brokers, and other agents acting as nominees are permitted to use discretionary voting authority to vote for proposals that are deemed
&ldquo;routine&rdquo; by the New York Stock Exchange, which means that they can submit a proxy or cast a ballot on behalf of stockholders
who do not provide a specific voting instruction. Brokers, banks, or other nominees are not permitted to use discretionary voting authority
to vote for proposals that are deemed &ldquo;non-routine&rdquo; by the New York Stock Exchange. Under the rules and interpretations of
the New York Stock Exchange, &ldquo;non-routine&rdquo; matters are matters that may substantially affect the rights or privileges of
stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation, and certain
corporate governance proposals, even if management supported. We believe that Proposals 3, 4 and 6 will be treated by the New York Stock
Exchange as routine matters and Proposals 1, 2 and 5 will be treated by the New York Stock Exchange as non-routine matters. The determination
of which proposals are deemed &ldquo;routine&rdquo; versus &ldquo;non-routine&rdquo; may not be made by the New York Stock Exchange until
after the date on which this proxy statement has been distributed. As such, it is important that you provide voting instructions to your
broker, bank, or other nominee as to how to vote your shares, if you wish to ensure that your shares are present and voted at the Annual
Meeting on all matters and if you wish to direct the voting of your shares on &ldquo;routine&rdquo; matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
there is at least one &ldquo;routine&rdquo; matter to be considered at a meeting, a &ldquo;broker non-vote&rdquo; occurs when a proposal
is deemed &ldquo;non-routine&rdquo; and a nominee holding shares for a beneficial owner does not have discretionary voting authority
with respect to the &ldquo;non-routine&rdquo; matter being considered and has not received instructions from the beneficial owner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
constitutes a quorum?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum for the transaction of business at the Annual Meeting requires representation, in person or by proxy, of the holders of a majority
of the Company&rsquo;s issued and outstanding shares of Common Stock. Abstentions and broker non-votes will be counted as shares that
are present for purposes of determining the presence of a quorum for the transaction of business at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
is the voting requirement to approve each of the proposals?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
    Required</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
    Options</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
                                            of &ldquo;Abstain&rdquo;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
    of Broker Non-Votes</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 1:</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of Directors</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    nominee must receive a majority of the votes cast at the Annual Meeting in favor of the nominee&rsquo;s election in order for the
    nominee to be elected to the Board. With respect to each director nominee, a majority of the votes cast means that the number of
    shares voted &ldquo;FOR&rdquo; the nominee must exceed the number of shares voted &ldquo;AGAINST&rdquo; such nominee&rsquo;s election.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 2:</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    of the 2024 Incentive Compensation Plan</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the matter is required.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counts
    as a vote &ldquo;AGAINST&rdquo; this proposal.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 3:</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    In Authorized Shares Proposal</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    votes cast in favor of such proposal must exceed the votes cast against such proposal.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 4:</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratification
    of Appointment of Independent Registered Public Accounting Firm</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the matter is required.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counts
    as a vote &ldquo;AGAINST&rdquo; this proposal.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 5:</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Exercise Proposal</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the matter is required.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counts
    as a vote &ldquo;AGAINST&rdquo; this proposal.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
                                            No. 6: </B>Adjournment Proposal</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the matter is required.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FOR&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGAINST&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ABSTAIN&rdquo;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counts
    as a vote &ldquo;AGAINST&rdquo; this proposal.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
does the Board recommend that I vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends that you vote your shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the eight director nominees for election to the Board (Proposal No. 1);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the approval of the Company&rsquo;s 2024 Incentive Compensation Plan (Proposal No. 2);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the approval of the Increase in Authorized Shares Proposal (Proposal No. 3); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the ratification of the approval of WithumSmith+Brown, PC as the Company&rsquo;s independent registered public accounting firm for
    the fiscal year ended December 31, 2024 (Proposal No. 4);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the Warrant Exercise Proposal (Proposal No. 5); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;
    the Adjournment Proposal (Proposal No. 6).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
will count the vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
or more inspectors of election at the Annual Meeting will tabulate and certify the votes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
does it mean if I receive more than one set of Proxy Materials?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
means that your shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your
shares. To ensure that all of your shares are voted, please submit your proxy for each set of Proxy Materials via the internet, telephone
or by signing, dating, and returning the enclosed proxy card in the enclosed envelope.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>May
I change my vote or revoke my proxy?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Whether you have voted by internet, telephone or mail, if you are a stockholder of record, you may change your vote and revoke your proxy
by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sending
    a written statement to that effect to the attention of the Company&rsquo;s Secretary at the Company&rsquo;s principal office at 22211
    West Interstate 10, Suite 1206, San Antonio, Texas 78257, at any time prior to the voting of the proxy, provided such statement is
    received no later than 11:59 p.m. Eastern Time on June 3, 2024;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
    again by internet or telephone at a later time before the closing of those voting facilities at 11:59 p.m. Eastern Time on June 3,
    2024;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submitting
    a properly signed proxy card to the attention of the Company&rsquo;s Secretary at the Company&rsquo;s principal office at 22211 West
    Interstate 10, Suite 1206, San Antonio, Texas 78257, with a later date that is received no later than 11:59 p.m. Eastern Time on
    June 3, 2024; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attending
    and voting at the Annual Meeting on June 4, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
last vote is the one that is counted. Your attendance at the Annual Meeting by itself will not revoke your proxy unless you give written
notice of revocation to the Company before your proxy is voted or you vote at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold shares in street name, please refer to information from your bank, broker, or other intermediary on how to revoke or submit
new voting instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
will pay for the cost of this proxy solicitation?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay for the cost of soliciting proxies. Some of the Company&rsquo;s directors, officers, or employees may (for no additional
compensation) solicit proxies in person or by telephone, email, or facsimile transmission. Brokers and other nominees will be requested
to solicit proxies or authorizations from beneficial owners and will be reimbursed for their reasonable expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS AND CERTAIN CORPORATE GOVERNANCE MATTERS</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is committed to implementing sound corporate governance practices, adhering to a robust corporate ethics policy, and equipping
the Board and executive team with the tools and training necessary to manage the Company for the long-term benefit of the Company&rsquo;s
stockholders and the Company&rsquo;s long-term sustainability. The Board has implemented a number of enhancements to the Company&rsquo;s
corporate governance practices, including adopting a majority vote standard for director elections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Common Stock is listed on the Nasdaq Capital Market (&ldquo;<B><I>Nasdaq</I></B>&rdquo;). The Nasdaq Stock Market LLC
Rules (the &ldquo;<B><I>Nasdaq Rules</I></B>&rdquo;) require that a majority of the Board be &ldquo;independent directors,&rdquo; as
defined in Nasdaq Rule 5605(a)(2). The Nasdaq listing standards subject members of the Company&rsquo;s Audit Committee and Compensation
Committee to additional independence requirements. The Board has affirmatively determined that each of the Company&rsquo;s non-employee
directors, which include Messrs. Robert Anderson, Stuart Diamond, Peter Knight, Gary Rubin, and Jamie Platt are independent directors
under the Nasdaq Rules and listing standards, including with respect to each director&rsquo;s committee service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leadership
Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
Zannes has served as the Company&rsquo;s President and Chief Executive Officer (&ldquo;<B><I>CEO</I></B>&rdquo;) since the Company&rsquo;s
inception in March 2014. Steven Girgenti has served as the Company&rsquo;s Executive Chairman since November 2014. In addition to the
roles of the President, CEO, and Executive Chairman, the Company&rsquo;s By-laws require the Board to elect or appoint a Chief Financial
Officer, a Treasurer, and a Secretary, who collectively serve as the officers of the Company. Any two or more offices may be held by
the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board does not have a policy regarding whether the roles of the Executive Chairman and CEO should be separate or combined. The Board
believes that it should retain flexibility in deciding from time to time which leadership structure is in the best interests of the Company
and its stockholders. At this time, the Board believes that separating the Executive Chairman and CEO roles best serves the needs of
the Company&rsquo;s business, enabling the Company to benefit from Mr. Girgenti&rsquo;s extensive experience in healthcare marketing
strategies, financing, and business diversification through merger and acquisition opportunities along with his skill in building emerging
growth companies into multi-national corporations, while leveraging Ms. Zannes&rsquo; legal and regulatory background, experience in
project management and team leadership, long-standing relationships with the team of award-winning scientists and business leaders that
she has built to advance the Company&rsquo;s objectives, and passion for defining and advancing the Company&rsquo;s strategic goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Communications
with the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may communicate directly with the Board. All communications should be in writing and directed to the Company Secretary, Timothy P. Zannes,
at bioAffinity Technologies, Inc., 22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257, and should prominently indicate on
the outside of the envelope that it is intended for the Board. The Company Secretary has the authority to disregard any inappropriate
communications or to take other appropriate actions with respect to any such inappropriate communications. If deemed appropriate, the
Company Secretary will forward correspondence to the Chairman of the Board or any specific director or Committee to whom the correspondence
is directed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Committees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board directs and oversees the management of the Company&rsquo;s business and affairs and has three standing committees, consisting of
the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. Each committee operates under
a Board-approved charter, a copy of which is available on the Investor Relations section of the Company&rsquo;s website at <I>ir.bioaffinitytech.com
</I>and can be accessed through the &ldquo;Governance Documents&rdquo; hyperlink under the &ldquo;Governance&rdquo; tab.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee consists of Stuart Diamond (Chairman), Robert Anderson, and Gary Rubin, all of whom have been deemed independent by the
Board in accordance with the requirements of Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange
Act</I></B>&rdquo;), and applicable Nasdaq Rules. The Board has also determined that Stuart Diamond and Gary Rubin are &ldquo;Audit Committee
financial experts&rdquo; as defined in Item 407(d)(5)(ii) of Regulation S-K. All members of the Audit Committee are financially literate,
as determined by the Board, and can read and understand fundamental financial statements, including the Company&rsquo;s balance sheet,
income statement, and cash flow statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
responsibilities and duties of the Audit Committee are set forth in its charter and include assisting the Board in overseeing the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selecting,
    retaining, compensating, overseeing, and determining the retention of an independent registered public accounting firm to audit the
    Company&rsquo;s annual financial statements, books, records, accounts, and internal controls over financial reporting and any other
    registered public accounting firm engaged to prepare or issue an audit report or to perform other audit, review, or attest services
    for the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing the results of a report prepared by the Company&rsquo;s independent auditors concerning the accounting firm&rsquo;s
    internal quality-control procedures; any material issues raised by the most recent internal quality-control review, peer review,
    or review by the Public Company Accounting Oversight Board (the &ldquo;<B><I>PCAOB</I></B>&rdquo;), and all relationships between
    the firm and the Company or any of its subsidiaries;</FONT></TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with the Company&rsquo;s independent auditors the responsibilities of the auditors under generally accepted auditing
    standards; any significant risks identified during the auditors&rsquo; risk-assessment procedures; the scope, timing and results
    of the Company&rsquo;s annual audit; and all critical accounting policies and practices to be used in the audit;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    approving, and overseeing any transaction between the Company and any related person (as defined in Item 404 of Regulation S-K) on
    an ongoing basis; informing the Company&rsquo;s independent auditors of the Company&rsquo;s significant relationships and related-party
    transactions; and reviewing and discussing with the Company&rsquo;s independent auditors the auditors&rsquo; evaluation of the Company&rsquo;s
    identification of, accounting for, and disclosure of its related-party relationships and transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to the Board that the audited financial statements be included in the Company&rsquo;s annual report on Form 10-K and producing the
    Audit Committee Report required to be included in this Proxy Statement;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    the Company&rsquo;s hiring policies for employees or former employees of the Company&rsquo;s independent auditors that participated
    in any capacity in any Company audit;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    the Company&rsquo;s compliance with, investigating any alleged breach of, and enforcing the Company&rsquo;s Code of Business Conduct
    and Ethics;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">reviewing
and discussing the Company&rsquo;s policies regarding information technology security and protection from cyber risks;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">reviewing
    with the Company&rsquo;s general counsel and outside legal counsel any legal and regulatory matters that could impact the Company&rsquo;s
    financial statements; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
    regularly to the Board on the Audit Committee&rsquo;s discussion and actions, including any significant issues or concerns that arise
    at the Audit Committee meetings.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional information on the Audit Committee&rsquo;s role and its oversight of the independent auditor during 2023, see &ldquo;Report
of the Audit Committee.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nominating
and Corporate Governance Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee consists of Gary Rubin (Chairman), Peter Knight, and Robert Anderson, each of whom has
been deemed independent by the Board in accordance with the applicable Nasdaq Rules. The Nominating and Corporate Governance Committee
is primarily responsible for identifying qualified candidates for nomination to the Board and for developing and maintaining the Company&rsquo;s
corporate governance policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
responsibilities and duties of the Nominating and Corporate Governance Committee are set forth in its charter and include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
    and screening individuals qualified to become members of the Board, consistent with Board-approved criteria;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">making
    recommendations to the Board concerning the selection and approval of director-nominees to be submitted to a stockholder vote at
    the Annual Meeting, subject to the Board&rsquo;s approval;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    and recommending for the Board&rsquo;s approval standards for assessing whether a director has a relationship with the Company that
    would impair director independence; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
    regularly to the Board regarding the Nominating and Corporate Governance Committee&rsquo;s actions and making recommendations to
    the Board as appropriate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information concerning the Nominating and Corporate Governance Committee&rsquo;s process of making director nominations and the
current director nominees, see Proposal No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee consists of Peter Knight (Chairman), Stuart Diamond, and Jamie Platt. The Board has determined that each Compensation
Committee member is independent according to the applicable Nasdaq Rules and the Company&rsquo;s independence guidelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
responsibilities and duties of the Compensation Committee are set forth in its charter and include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving annually the corporate goals and objectives applicable to the CEO&rsquo;s compensation, evaluating the CEO&rsquo;s
    performance in light of those goals and objectives, and determining and approving the CEO&rsquo;s compensation level based on the
    Compensation Committee&rsquo;s evaluation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving the compensation of all of the Company&rsquo;s other executive officers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing,
    making recommendations to the Board regarding, and administering the Company&rsquo;s incentive-compensation plans and equity-based
    plans, including designating the recipients, amounts, and terms and conditions applicable to the awards to be granted under each
    plan;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing at least annually the relationship between compensation and risk-management policies and practices;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    at least annually all director compensation and benefits for service on the Board and Board committees and recommending any changes
    to the Board as necessary; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
    regularly to the Board regarding the Compensation Committee&rsquo;s actions and making recommendations to the Board as appropriate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Attendance
at Board Meetings and Executive Sessions </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, the Board held five meetings, the Audit Committee held four meetings, the Compensation Committee held two meetings, and the Nominating
and Corporate Governance Committee held one meeting. All of the directors attended at least 75% of the total number of Board meetings
and, to the extent applicable, of the total number of meetings held by all Board committees on which such director served. The Board
also took action on a number of occasions as needed without a physical meeting in the form of unanimous written consents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
Meeting Attendance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company does not have a formal policy regarding director attendance at annual stockholder meetings, directors are encouraged to attend
annual stockholder meetings. Two directors attended the 2023 annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Ethics and Business Conduct</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a Code of Ethics and Business Conduct applicable to all of the Company&rsquo;s directors, officers, and employees.
A copy of the Code of Ethics and Business Conduct is available on the Investor Relations section of the Company&rsquo;s website at <I>ir.bioaffinitytech.com
</I>and can be accessed through the &ldquo;Governance Documents&rdquo; hyperlink under the &ldquo;Governance&rdquo; tab.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insider
Trading Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains a policy on insider trading that applies to any and all transactions in the Company&rsquo;s securities held by any
director, officer, or employee. The policy prohibits all directors, officers, and employees of the Company from trading in the Company&rsquo;s
securities while in possession of material nonpublic information (&ldquo;<B><I>MNPI</I></B>&rdquo;) about the Company and from giving
MNPI to others who may trade on the basis of such information. Under the policy, Timothy Zannes, the Company&rsquo;s Executive Vice President,
Secretary, and General Counsel, is designated as the Company&rsquo;s Insider Trading Compliance Officer (the &ldquo;<B><I>Compliance
Officer</I></B>&rdquo;). Prior to engaging in transfers of Company securities intended to comply with the affirmative defense provided
under Rule 10b5-1 promulgated under the Exchange Act, employees, officers, and directors must receive the Compliance Officer&rsquo;s
approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibition
against Short Sales and Hedging </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Insider Trading Policy, we prohibit our employees, officers and directors from trading in any interest or position relating to
the future price of Company securities, such as a put, call or short sale (including a short sale &ldquo;against the box&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Role
of the Board in Risk Oversight</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the key functions of the Board is informed oversight of the Company&rsquo;s risk management process. The Board does not have a standing
risk management committee but rather administers its oversight function directly through the Board as a whole and through its standing
committees that address risks inherent in their respective oversight areas. In particular, the Board is responsible for monitoring and
assessing strategic risk exposure. The Audit Committee has the responsibility to consider and discuss (i) the Company&rsquo;s major financial
risk exposures and the steps management has taken to monitor and control these exposures, which includes establishing guidelines and
policies to govern the process by which risk assessment and management is undertaken and (ii) policies regarding information technology
security and protection from cyber risks The Audit Committee also monitors compliance with legal and regulatory requirements, in addition
to oversight of the performance of the Company&rsquo;s external audit function.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee monitors the effectiveness of the Company&rsquo;s corporate governance guidelines. The
Compensation Committee assesses and monitors whether any of the Company&rsquo;s compensation policies and programs has the potential
to encourage excessive risk-taking. While each committee is responsible for evaluating certain risks and overseeing the management of
such risks, the full Board is regularly informed of such risks through committee reports and otherwise. While the Board oversees the
Company&rsquo;s overall risk management, the day-to-day management processes are executed by the Company&rsquo;s management team. The
Company believes that division of responsibilities enables the Company to address risks most effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Role
of the Board in Human Capital Oversight</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company places significant emphasis on the recruitment, development, and retention of its employees who include award-winning scientists
dedicated to advancing scientific discovery from bench to bedside. Of our nine employees engaged in research and development, all of
whom are employed full-time, one holds an M.D. and six hold Ph.Ds in biology or medicinal chemistry. Of the 53 employees at PPLS, nearly
half have worked at our clinical laboratory for more than five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Executive Vice President and Chief Medical and Science Officer, Vivienne Rebel, holds an M.D. and Ph.D. Business development is led by
our Chief Operating Officer, Xavier Reveles, who has 25 years of experience as a clinical geneticist skilled in the creation and management
of clinical laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 <B><I>(&ldquo;CLIA&rdquo;</I></B>), coding,
and Current Procedural Terminology (<B><I>&ldquo;CPT&rdquo;) </I></B>reimbursement valuations. Mr. Reveles is board certified by the
American Society of Clinical Pathology as a clinical specialist in cytogenetics who has successfully launched multiple diagnostics and
commercial laboratories. We have recently attracted experienced salespeople with a proven record in the pulmonary field. In November
2023, we hired Dallas Coleman as National Sales Director who has more than 15 years of experience in medical sales and marketing, most
recently as Executive Account Manager for the respiratory portfolio of Olympus America&rsquo;s therapeutic solutions division. In February
2024, Cole Koeppen joined us as Pulmonary Sales Executive for CyPath<SUP>&reg;</SUP> Lung in North Texas. Previously, he was Territory
Sales Associate for Pulmonx Corporation, a provider of treatments for patients with COPD. Our innovative and collaborative culture is
in part responsible for our ability to attract and retain highly skilled professionals seeking professional advancement. Outside partnerships
and collaborations that advance business and scientific research are encouraged, allowing us to multiply workforce efforts without expending
significant capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, led by the Compensation Committee, oversees employee compensation and incentivization programs. The Company&rsquo;s compensation
systems reflect the Company&rsquo;s emphasis on retention and development. The Board also oversees the Company&rsquo;s efforts to provide
pay, benefits, and services that help meet the varying needs of its employees. Compensation and benefits include market-competitive pay,
retirement programs, broad-based bonuses, stock options, health and welfare benefits, financial counseling, paid time off, and family
leave.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL&thinsp;NO.
1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Composition and Election</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s By-laws require the Board to consist of at least five but not more than eight directors. Currently, the Board consists
of eight directors. Each of the Company&rsquo;s current directors is being nominated for re-election to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected annually and hold office until their respective successors are duly elected and qualified. Each director nominee currently
serves as a director of the Company. <FONT STYLE="background-color: white">Proxies solicited by the Board will, unless otherwise directed,
be voted to elect the eight nominees named below to constitute the entire Board.</FONT> A<FONT STYLE="background-color: white">ll nominees
have consented to be named and have indicated their intent to serve if elected. In the event any of the nominees shall be unable or unwilling
to serve as a director, the persons named in the proxy intend to vote &ldquo;FOR&rdquo; the election of any person as may be nominated
by the Board in substitution. The Company has no reason to believe that any of the nominees named below will be unable to serve as a
director if elected.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Nominations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has established a Nominating and Corporate Governance Committee that operates pursuant to a charter adopted by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee Charter sets forth criteria that the Committee may consider, among other criteria deemed
appropriate by the committee, in recommending candidates for election to the Board. The Board has no formal policy regarding diversity,
but diversity is considered when evaluating nominees because the Board believes that gender and minority representation is a key component
in attaining the diverse array of viewpoints sought by the Board among its members. The Company also does not have formal stock ownership
guidelines for directors, but ownership of the Company&rsquo;s Common Stock by directors is encouraged and, in part, facilitated by grants
of stock options and restricted stock awards to directors as described below under &ldquo;Director and Executive Compensation &ndash;
Director Compensation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are not restricted to term limits, but the Board considers each director&rsquo;s tenure, level of involvement on the Board, and other
attributes and qualities to determine whether to approve a director as a nominee for re-election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders if provided with the following:
(i) the written consent of the candidate(s) for nomination as a director and verification as to the accuracy of the biographical and
other information submitted in support of the candidate; (ii) a resume or other written statement of the qualifications of the candidate(s)
for nomination as a director; and (iii) all information regarding the candidate(s) and the submitting stockholder that would be required
to be disclosed in a proxy statement filed with the SEC if the candidate(s) were nominated for election to the Board. Any recommendations
received from stockholders will be evaluated in the same manner that other potential nominees are evaluated. Any stockholder that wishes
to present a director candidate for consideration should submit the information identified above pursuant to the procedures set forth
above under &ldquo;Communications with the Board of Directors.&rdquo; With respect to the timing of stockholder nominations for the 2025
annual meeting of stockholders (the &ldquo;<B><I>2025 Annual Meeting</I></B>&rdquo;), please see the discussion set forth below under
&ldquo;Stockholder Proposals For 2025 Annual Meeting.&rdquo; The Company received no nominations of board candidates from any stockholders
for this year&rsquo;s Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Nominee Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information concerning each director nominee as of April 8, 2024, is set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
    Nominee</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
    Since</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
    Company Position(s)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes, JD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    CEO, and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Girgenti</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Anderson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <SUP>(1) (2) (3)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart
    Diamond</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <SUP>(1*) (2)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Knight</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <SUP>(2*) (3)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Rubin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <SUP>(1) (3*)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roby
    Joyce, MD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamie
    Platt, PhD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <SUP>(2)</SUP></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Audit Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Compensation Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Nominating and Corporate Governance Committee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committee
    Chairman</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
business experience, qualifications, attributes, and skills that led the Nominating and Corporate Governance Committee to nominate each
director nominee are provided below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Qualifications and Experience</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining which director nominees to nominate for election to the Board, the Board considered an array of factors related to each nominee&rsquo;s
primary experience, qualifications, attributes, and skills. Among such factors, the Board evaluated each nominee&rsquo;s professional
standing in the nominee&rsquo;s chosen field, experience in financial services or related industries, experience reviewing financial
statements and financial matters, civic and community involvement, qualification for director independence, leadership and team building
skills, diversity by race, gender, or culture, degree of collegiality and insightfulness, and stock ownership in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Biographical Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biographical information of each director nominee is included in this Proxy Statement under &ldquo;Directors and Executive Officers &ndash;
Biographical Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a quorum exists, the nominees for director receiving a majority of the votes cast (i.e., the number of shares voted &ldquo;for&rdquo;
a director nominee exceeds the number of votes cast &ldquo;against&rdquo; that nominee), will be elected as directors. Abstentions and
broker non-votes are not votes cast and will have no effect on the outcome of this vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD RECOMMENDS A VOTE &ldquo;FOR&rdquo; EACH OF THE NAMED DIRECTOR NOMINEES TO BE ELECTED TO THE BOARD OF DIRECTORS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL&thinsp;NO.
2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE BIOAFFINITY 2024 INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2014 Equity Incentive Plan terminated on the tenth anniversary of its date of adoption by the Board of Directors and our stockholders.
Therefore, we no longer have an active plan pursuant to which we can issue equity awards to our employees or directors and are requesting
approval of a new plan pursuant to which we can issue equity awards to officer, directors and certain consultants. The 2024 Incentive
Compensation Plan (the &ldquo;<B><I>2024 Plan</I></B>&rdquo;) was approved and adopted on March 27, 2024 by our Board of Directors. The
principal provisions of the 2024 Plan are summarized below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Proposed 2024 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors recommends that stockholders vote &ldquo;<B>FOR</B>&rdquo; the adoption of the 2024 Plan. In making such recommendation,
the Board of Directors considered a number of factors, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-based
compensation awards are a critical element of our overall compensation program. We believe that our long-term incentive compensation
program aligns the interests of management, employees, and stockholders to create long-term stockholder value. The 2024 Plan will allow
us to continue to attract, motivate, and retain our officers, key employees, non-employee directors, and consultants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the expiration of the 2014 Equity Incentive Plan (the &ldquo;<B><I>2014 Plan</I></B>&rdquo;), we no longer have any shares remaining
available for grant under the prior plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are asked to approve the 2024 Plan to satisfy Nasdaq requirements relating to stockholder approval of equity compensation and to qualify
certain stock options authorized under the 2024 Plan for treatment as incentive stock options under Section 422 of the Internal Revenue
Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2024 Plan vests broad powers in a committee to administer and interpret the 2024 Plan. Our Board has initially designated the Compensation
Committee to administer the 2024 Plan. Except when limited by the terms of the 2024 Plan, the Compensation Committee has the authority
to, among other things: select the persons to be granted awards; determine the type, size and term of awards; establish performance objectives
and conditions for earning awards; determine whether such performance objectives and conditions have been met; and accelerate the vesting
or exercisability of an award. In its discretion, the Compensation Committee may delegate all or part of its authority and duties with
respect to granting awards to one or more of our officers, subject to certain limitations and provided applicable law so permits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may amend, alter or discontinue the 2024 Plan and the Compensation Committee may amend any outstanding award at any time; provided,
however, that no such amendment or termination may adversely affect awards then outstanding without the holder&rsquo;s permission. In
addition, any amendments seeking to increase the total number of shares reserved for issuance under the 2024 Plan or modifying the classes
of participants eligible to receive awards under the 2024 Plan will require ratification by our stockholders in accordance with applicable
law. Additionally, as described more fully below, neither the Compensation Committee nor the Board is permitted to reprice outstanding
options or stock appreciation rights without stockholder consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of our employees, directors, consultants, and other service providers, or those of our affiliates, are eligible to participate in the
2024 Plan and may be selected by the Compensation Committee to receive an award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee determines the vesting conditions for awards. These conditions may include the continued employment or service
of the participant, the attainment of specific individual or corporate performance goals, or other factors as determined in the Compensation
Committee&rsquo;s discretion (collectively, &ldquo;<B><I>Vesting Conditions</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
of Stock Available for Issuance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain adjustments, the maximum number of shares of Common Stock that may be issued under the 2024 Plan in connection with awards
is 2,000,000 shares. All available shares may be utilized toward the grant of any type of award under the 2024 Plan. The 2024 Plan imposes
a $250,000 limitation on the total grant date fair value of awards granted to any non-employee director in his or her capacity as a non-employee
director in any single calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, split up, spin-off, combination
of shares, exchange of shares, stock dividend, dividend in kind, or other like change in capital structure (other than ordinary cash
dividends), or other similar corporate event or transaction that affects our Common Stock, the Compensation Committee shall make adjustments
to the number and kind of shares authorized by the 2024 Plan and covered under outstanding 2024 Plan awards as it determines appropriate
and equitable. Shares subject to 2024 Plan awards that expire without being fully exercised or that are otherwise forfeited, cancelled,
or terminated may again be made available for issuance under the 2024 Plan. However, shares withheld in settlement of a tax withholding
obligation, or in satisfaction of the exercise price payable upon exercise of an option, will not again become available for issuance
under the 2024 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Types
of Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following types of awards may be granted to participants under the 2024 Plan: (i) incentive stock options (&ldquo;<B><I>ISOs</I></B>&rdquo;);
(ii) nonqualified stock options (&ldquo;<B><I>NQOs</I></B>&rdquo;) and together with ISOs, options, (iii) stock appreciation rights,
(iv) restricted stock, or (v) restricted stock units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Options. </I>An option entitles the holder to purchase from us a stated number of shares of Common Stock. An ISO may only be granted
to an employee of ours or our eligible affiliates. The Compensation Committee will specify the number of shares of Common Stock subject
to each option and the exercise price for such option, provided that the exercise price may not be less than the fair market value of
a share of Common Stock on the date the option is granted. Notwithstanding the foregoing, if ISOs are granted to any 10% stockholder,
the exercise price shall not be less than 110% of the fair market value of Common Stock on the date the option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
options may be exercised in whole or in part through a cash payment. The Compensation Committee may, in its sole discretion, permit payment
of the exercise price of an option in the form of previously acquired shares based on the fair market value of the shares on the date
the option is exercised, through means of &ldquo;net settlement,&rdquo; which involves the cancellation of a portion of the option to
cover the cost of exercising the balance of the option or by such other means as it deems acceptable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
options shall be or become exercisable in accordance with the terms of the applicable award agreement. The maximum term of an option
shall be determined by the Compensation Committee on the date of grant but shall not exceed 10 years (five years in the case of ISOs
granted to any 10% stockholder). In the case of ISOs, the aggregate fair market value (determined as of the date of grant) of Common
Stock with respect to which such ISOs become exercisable for the first time during any calendar year cannot exceed $100,000. ISOs granted
in excess of this limitation will be treated as non-qualified stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the closing price of our Common Stock was $2.02 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Appreciation Rights. </I>A stock appreciation right represents the right to receive, upon exercise, any appreciation in a share of Common
Stock over a particular time period. The base price of a stock appreciation right shall not be less than the fair market value of a share
of Common Stock on the date the stock appreciation right is granted. This award is intended to mirror the benefit the participant would
have received if the Compensation Committee had granted the participant an option. The maximum term of a stock appreciation right shall
be determined by the Compensation Committee on the date of grant but shall not exceed 10 years. Distributions with respect to stock appreciation
rights may be made in cash, shares of Common Stock, or a combination of both, at the Compensation Committee&rsquo;s discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise provided in an award agreement or determined by the Compensation Committee, if a participant terminates employment with us
(or our affiliates) due to death or disability, the participant&rsquo;s unexercised options and stock appreciation rights may be exercised,
to the extent they were exercisable on the termination date, for a period of 12 months from the termination date or until the expiration
of the original award term, whichever period is shorter. If the participant terminates employment with us (or our affiliates) for cause,
(i) all unexercised options and stock appreciation rights (whether vested or unvested) shall terminate and be forfeited on the termination
date, and (ii) any shares in respect of exercised options or stock appreciation rights for which we have not yet delivered share certificates
will be forfeited and we will refund to the participant the option exercise price paid for those shares, if any. If the participant&rsquo;s
employment terminates for any other reason, any vested but unexercised options and stock appreciation rights may be exercised by the
participant, to the extent exercisable at the time of termination, for a period of 90 days from the termination date (or such time as
specified by the Compensation Committee at or after grant) or until the expiration of the original option or stock appreciation right
term, whichever period is shorter. Unless otherwise provided by the Compensation Committee, any options and stock appreciation rights
that are not exercisable at the time of termination of employment shall terminate and be forfeited on the termination date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock. </I>A restricted stock award is a grant of shares of Common Stock, which are subject to forfeiture restrictions during a restriction
period. The Compensation Committee will determine the price, if any, to be paid by the participant for each share of Common Stock subject
to a restricted stock award. The restricted stock may be subject to Vesting Conditions. If the specified Vesting Conditions are not attained,
the participant will forfeit the portion of the restricted stock award with respect to which those conditions are not attained, and the
underlying Common Stock will be forfeited to us. At the end of the restriction period, if the Vesting Conditions have been satisfied,
the restrictions imposed will lapse with respect to the applicable number of shares. Unless otherwise provided in an award agreement
or determined by the Compensation Committee, upon termination a participant will forfeit all restricted stock that then remains subject
to forfeiture restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Units. </I>Restricted stock units are granted in reference to a specified number of shares of Common Stock and entitle the holder
to receive, on the achievement of applicable Vesting Conditions, shares of Common Stock. Unless otherwise provided in an award agreement
or determined by the Compensation Committee, upon termination a participant will forfeit all restricted stock units that then remain
subject to forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
in Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a change in control, the Compensation Committee may, on a participant-by-participant basis: (i) cause any or all outstanding
awards to become vested and immediately exercisable (as applicable), in whole or in part; (ii) cause any outstanding option or stock
appreciation right to become fully vested and immediately exercisable for a reasonable period in advance of the change in control and,
to the extent not exercised prior to that change in control, cancel that option or stock appreciation right upon closing of the change
in control; (iii) cancel any unvested award or unvested portion thereof, with or without consideration; (iv) cancel any award in exchange
for a substitute award; (v) redeem any restricted stock or restricted stock unit for cash and/or other substitute consideration with
value equal to the fair market value of an unrestricted share on the date of the change in control; (vi) cancel any outstanding option
or stock appreciation right with respect to all Common Stock for which the award remains unexercised in exchange for a cash payment equal
to the excess (if any) of the fair market value of the Common Stock subject to the option or stock appreciation right over the exercise
price of the option or stock appreciation right; (vii) impose vesting terms on cash or substitute consideration payable upon cancellation
of an award that are substantially similar to those that applied to the cancelled award immediately prior to the change in control, and/or
earn-out, escrow, holdback, or similar arrangements, to the extent such arrangements are applicable to any consideration paid to stockholders
in connection with the change in control; (viii) take such other action as the Compensation Committee shall determine to be reasonable
under the circumstances; and/or (ix) in the case of any award subject to Section 409A of the Code, the Compensation Committee shall only
be permitted to use discretion to alter the settlement timing of the award to the extent that such discretion would be permitted under
Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Repricing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
our Board nor the Compensation Committee may, without obtaining prior approval of our stockholders: (i) implement any cancellation/re-grant
program pursuant to which outstanding options or stock appreciation rights under the 2024 Plan are cancelled and new options or stock
appreciation rights are granted in replacement with a lower exercise per share; (ii) cancel outstanding options or stock appreciation
rights under the 2024 Plan with an exercise price per share in excess of the then current fair market value per share for consideration
payable in our equity securities; or (iii) otherwise directly reduce the exercise price in effect for outstanding options or stock appreciation
rights under the 2024 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
awards granted under the 2024 Plan shall be nontransferable except by will or by the laws of descent and distribution. No participant
shall have any rights as a stockholder with respect to shares covered by options or restricted stock units, unless and until such awards
are settled in shares of Common Stock. The Company&rsquo;s obligation to issue shares or to otherwise make payments in respect of 2024
Plan awards will be conditioned on the Company&rsquo;s ability to do so in compliance with all applicable laws and exchange listing requirements.
The awards will be subject to our recoupment and stock ownership policies, as may be in effect from time to time. The 2024 Plan will
expire 10 years after it becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Federal Income Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of the general U.S. federal income tax consequences relating to the 2024 Plan. This summary is based on
U.S. federal tax laws and regulations in effect on the date of this Proxy Statement and does not purport to be a complete description
of the U.S. federal income tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Incentive
Stock Options. </I>Incentive stock options are intended to qualify for special treatment available under Section 422 of the Internal
Revenue Code. A participant who is granted an incentive stock option will not recognize ordinary income at the time of grant. A participant
will not recognize ordinary income upon the exercise of an incentive stock option provided that the participant was, without a break
in service, an employee of the Company or a subsidiary during the period beginning on the grant date of the option and ending on the
date three months prior to the date of exercise (one year prior to the date of exercise if the participant&rsquo;s employment is terminated
due to permanent and total disability).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the participant does not sell or otherwise dispose of the shares of Common Stock acquired upon the exercise of an incentive stock option
within two years from the grant date of the incentive stock option or within one year after he or she receives the shares of Common Stock,
then, upon disposition of such shares of Common Stock, any amount recognized in excess of the exercise price will be taxed to the participant
as a capital gain. The participant will generally recognize a capital loss to the extent that the amount recognized is less than the
exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing holding period requirements are not met, the participant will generally recognize ordinary income at the time of the disposition
of the shares of Common Stock in an amount equal to the lesser of (i) the excess of the fair market value of the shares of Common Stock
on the date of exercise over the exercise price or (ii) the excess, if any, of the amount recognized upon disposition of the shares of
Common Stock over the exercise price. Any amount recognized in excess of the value of the shares of Common Stock on the date of exercise
will be capital gain. If the amount recognized is less than the exercise price, the participant generally will recognize a capital loss
equal to the excess of the exercise price over the amount recognized upon the disposition of the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules described above that generally apply to incentive stock options do not apply when calculating any alternative minimum tax liability.
The rules affecting the application of the alternative minimum tax are complex, and their effect depends on individual circumstances,
including whether a participant has items of adjustment other than those derived from incentive stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nonqualified
Stock Options. </I>A participant will not recognize ordinary income when a nonqualified stock option is granted. When a nonqualified
stock option is exercised, a participant will recognize ordinary income in an amount equal to the excess, if any, of the fair market
value of the shares of Common Stock that the participant purchased over the exercise price he or she paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Appreciation Rights. </I>A participant will not recognize ordinary income when a SAR is granted. When a SAR is exercised, the participant
will recognize ordinary income equal to the cash and/or the fair market value of shares of Common Stock the participant receives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Shares. </I>A participant who has been granted restricted shares will not recognize ordinary income at the time of grant, assuming that
the underlying shares of Common Stock are not transferable and that the restrictions create a &ldquo;substantial risk of forfeiture&rdquo;
for federal income tax purposes and that the participant does not make an election under Section 83(b) of the Internal Revenue Code.
Generally, upon the vesting of restricted shares, the participant will recognize ordinary income in an amount equal to the then fair
market value of the shares of Common Stock, less any consideration paid for such shares of Common Stock. Any gains or losses recognized
by the participant upon disposition of the shares of Common Stock will be treated as capital gains or losses. However, a participant
may elect, pursuant to Section 83(b) of the Internal Revenue Code, to have income recognized at the date of grant of a restricted share
award equal to the fair market value of the shares of Common Stock on the grant date (less any amount paid for the restricted shares)
and to have the applicable capital gain holding period commence as of that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Share Units. </I>A participant generally will not recognize ordinary income when restricted share units are granted. Instead, a participant
will recognize ordinary income when the restricted share units are settled in an amount equal to the fair market value of the shares
of Common Stock or the cash he or she receives, less any consideration paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Share-Based Awards. </I>Generally, participants will recognize ordinary income equal to the fair market value of the shares of Common
Stock subject to other share-based awards when they receive the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash-Based
Awards. </I>Generally, a participant will recognize ordinary income when a cash-based award is settled in an amount equal to the cash
he or she receives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sale
of Shares. </I>When a participant sells shares of Common Stock that he or she has received under an award, the participant will generally
recognize long-term capital gain or loss if, at the time of the sale, the participant has held the shares of Common Stock for more than
one year (or, in the case of a restricted share award, more than one year from the date the restricted shares vested unless the participant
made an election pursuant to Section 83(b) of the Internal Revenue Code, described above). If the participant has held the shares of
Common Stock for one year or less, the gain or loss will be a short-term capital gain or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
409A of the Tax Code. </I>In 2004, the Internal Revenue Code was amended to add Section 409A, which created new rules for amounts deferred
under nonqualified deferred compensation plans. Section 409A includes a broad definition of nonqualified deferred compensation plans
which may extend to various types of awards granted under the 2024 Plan. If an award is subject to, but fails to comply with, Section
409A, the participant would generally be subject to accelerated income taxation, plus a 20% penalty tax and an interest charge. The Company
intends that awards granted under the 2024 Plan will either be exempt from, or will comply with, Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tax
Deductibility of Compensation Provided Under the 2024 Plan. </I>When a participant recognizes ordinary compensation income as a result
of an award granted under the 2024 Plan, the Company may be permitted to claim a federal income tax deduction for such compensation,
subject to various limitations that may apply under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
to the extent that compensation provided under the 2024 Plan may be deemed to be contingent upon a change in control of the Company,
a portion of such compensation may be non-deductible by the Company under Section 280G of the Internal Revenue Code and may be subject
to a 20% excise tax imposed on the recipient of the compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Plan Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
it is within the discretion of the Compensation Committee to determine which non-employee directors, employees and consultants will receive
awards and the amount and type of awards received, it is not presently possible to determine the number of individuals to whom awards
will be made in the future under the 2024 Plan or the amount of the awards except that (i) due to the expiration of the 2014 Plan on
March 25, 2024, none of the Company&rsquo;s directors received an April 2024 restricted stock grant in accordance with the director compensation
program then in effect, accordingly, upon approval of the 2024 Plan, each director will be granted a restricted stock award valued at
$18,750 based on the fair market value of the Company&rsquo;s Common Stock on the grant date (which shall be deemed to be the greater
of (a) the average closing price of the Company&rsquo;s Common Stock on the Nasdaq Stock Market over the 30 trading days prior to the
grant date, or (b) the closing price of the Company&rsquo;s Common Stock on the Nasdaq Stock Market on the trading date immediately prior
to the grant date) that will vest after three months of continued service by the director, and (ii) we have adopted a director compensation
policy that provides that each director will receive an annual equity grant of restricted stock on July 1 of each year with a grant date
value (which shall be equal to the closing price of a share of the Company&rsquo;s Common Stock as of the date of grant on the principal
established stock exchange or national market system on which the Company&rsquo;s Common Stock is then traded) of approximately $75,000
that will vest pro rata on a monthly basis for 12 months commencing on August 1 of each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
awards granted during 2023 under our 2014 Plan are set forth in the following table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Name and Position</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of <BR>
Stock Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of<BR>
 Restricted<BR>
 Shares/Restricted<BR>
 Stock Units</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Maria Zannes, Chief Executive Officer</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">66,437</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Steve Girgenti, Executive Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Michael Dougherty, Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current Executive Officers as a Group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">177,140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current Non-Executive Director Group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">213,162</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current Non-Executive Officer Employee Group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as of December 31, 2023, with respect to the Company&rsquo;s 2014 Incentive Compensation Plan,
which was approved by the Company&rsquo;s stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><B>Plan Category</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Number of securities<BR>
 to be issued upon<BR>
 exercise of
    <BR>
outstanding options,<BR>
 warrants and rights<BR>
 (a)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Weighted average<BR>
 exercise price of<BR>
 outstanding options,<BR>

    warrants and rights <BR>
(b)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Number of securities<BR>
 remaining available<BR>
 for future
    issuance<BR>
 under equity<BR>
 compensation plans<BR>
 (excluding securities<BR>
 reflected in column <BR>
(a)) <SUP>(2)</SUP></B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans approved by security holders <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">676,553</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">3.98</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">683,175</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,553</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.98</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">683,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    table does not include shares proposed to be authorized under the 2024 Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    number consists of shares available for issuance under the 2014 Plan as of December 31, 2023. The 2014 Plan expired on March 25,
    2024, and no further equity awards may be granted under the 2014 Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interests
of Directors and Executive Officers</B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current directors and executive officers have substantial interests in the matters set forth in this proposal since equity awards may
be granted to them under the 2024 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
with the Securities and Exchange Commission</B><I>. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
approval of the Amendment to the 2024 Plan by our stockholders, we intend to file with the SEC a Registration Statement on Form S-8 relating
to the shares reserved for issuance under the 2024 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote from the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the proposal
to approve the 2024 Plan at the Annual Meeting is required for approval of this proposal. Abstentions will have the same effect as a
vote AGAINST this proposal. Broker non-votes will have no effect on this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>The
Board unanimously recommends that you vote &ldquo;FOR&rdquo; the approval of the 2024 Plan.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL&thinsp;NO.
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF AMENDMENT TO THE COMPANY&rsquo;S CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FROM
25,000,000 TO 100,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has approved and is asking stockholders to approve an increase in the number of authorized shares of Common Stock from 25,000,000
shares to 100,000,000 shares (the &ldquo;<B><I>Authorized Share Increase</I></B>&rdquo;) and a corresponding amendment to the Amended
and Restated Certificate of Incorporation to effect the Authorized Share Increase (the &ldquo;<B><I>Charter Amendment</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purpose
of the Authorized Share Increase</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Authorized Share Increase is so that the Company will have shares of Common Stock available to provide additional flexibility
to promptly and appropriately use its Common Stock for business and financial purposes in the future, as well as to have sufficient shares
available to provide appropriate equity incentives for our employees and other eligible service providers. Under its Amended and Restated
Certificate of Incorporation, the Company is currently authorized to issue up to 25,000,000 shares of Common Stock and 5,000,000 shares
of Preferred Stock. As of the close of business on the Record Date, there were 11,514,354 shares of Common Stock issued and outstanding
and no shares of Preferred Stock issued and outstanding. There are also 11,450,422 shares of Common Stock reserved for issuance pursuant
to: (i) outstanding stock options, (ii) outstanding warrants, and (iii) assuming Proposal 2 is approved, future awards which may be made
under the Company&rsquo;s 2024 Plan, leaving a balance of 2,035,224 shares of Common Stock available for issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the above outstanding securities and agreements to which the Company is or may become subject, and the nominal amount of shares remaining
available for issuance after giving effect to the foregoing, the Board believes it to be in the best interest of the Company to increase
the number of shares of Common Stock the Company is authorized to issue in order to enable the Company to have greater flexibility in
addressing its future general corporate needs, including, but not limited to, the offer and sale of Common Stock in one or more registered
public offerings, the grant of awards under incentive compensation plans, and the issuance of shares of capital stock in strategic transactions
or to raise capital. The Board believes that additional authorized shares of capital stock will also enable the Company to take timely
advantage of market conditions and favorable acquisition opportunities that may become available to the Company. Subject to reserve requirements
under outstanding derivative securities, the authorized but unissued shares of Common Stock will be issued at the direction of the Board,
without stockholder approval unless required by applicable law or Nasdaq Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Programs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have historically compensated our employees with restricted stock awards and/or stock options in addition to salaries and other forms
of cash compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
non-employee directors receive compensation for their service as directors and members of committees of the Board, which has historically
consisted of cash and restricted stock awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
approved by the stockholders, the Charter Amendment will enable the Company to continue to compensate its employees and directors in
equity awards under its compensation programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
of Additional Authorized Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Charter Amendment will not affect the rights of current holders of Common Stock, none of whom have preemptive or similar rights to acquire
the newly authorized shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Adverse Effects of the Charter Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has no current plans to issue any additional shares of Common Stock following the effectiveness of the Charter Amendment, other
than issuances upon exercise or conversion of currently outstanding securities. Adoption of the Charter Amendment alone will not have
any immediate dilutive effect on the proportionate voting power or other rights of the Company&rsquo;s existing stockholders. However,
any issuance of Common Stock at the direction of the Board or otherwise in the future, generally without obtaining stockholder approval
(unless specifically required by applicable law or Nasdaq Rules) may, among other things, result in dilution to our stockholders at the
time such additional shares are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
an increase in the number of authorized shares of Common Stock may make it more difficult to, or discourage an attempt to, obtain control
of the Company by means of a takeover bid that the Board determines is not in the best interest of the Company and its stockholders.
However, the Board does not deem the proposed increase in the number of authorized shares of Common Stock pursuant to the Charter Amendment
as an anti-takeover measure and is not aware of any attempt or plan by a third party to obtain control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
at this time we do not have any plans, commitments, proposals, arrangements, understandings or agreements regarding the issuance of Common
Stock other than issuances upon exercise or conversion of currently outstanding securities, we anticipate seeking future equity financing
opportunities and will evaluate opportunities that are presented to us. We believe that the Charter Amendment will help ensure that we
have sufficient authorized shares available for issuance to allow us to pursue equity financings if the Board determines that it would
be in our best interests based on our working capital needs and prevailing market conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interests
of Directors and Executive Officers</B><I>. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Girgenti, the Cranye Girgenti Testamentary Trust, Gary Rubin, The Harvey Sandler Revocable Trust, a trust of which Mr. Rubin is a co-trustee,
Ms. Zannes and Dr. Joyce have substantial interests in the matters set forth in this proposal as each has entered into a warrant amendment
which provides that certain warrants owned by each are not exercisable until the date that we file a certificate of amendment to our
certificate of incorporation with the State of Delaware which increases the number of shares of our authorized Common Stock to allow
for sufficient authorized and unissued shares of Common Stock for the full exercise of all of the outstanding Pre-IPO Warrants, Tradeable
Warrants and Non-Tradeable Warrants of the Company and the issuance of all of the shares of Common Stock underlying such warrants. For
further information, see &ldquo;Certain Relationships and Related Party Transactions &ndash; Amendment to Warrants.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of this proposal requires that the votes cast in favor of this proposal exceed the votes cast against this proposal from the
holders entitled to vote thereon. Abstentions are not votes cast and will have no effect on the outcome of this vote and broker non-votes
are not expected for this proposal because we believe this matter is a routine matter. If there were to be any broker non-votes they
would have no effect on this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THE CHARTER AMENDMENT TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON
STOCK.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
&thinsp;NO. 4 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFICATION
OF APPOINTMENT OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee appoints and determines whether to re-engage the Company&rsquo;s independent registered public accounting firm based
on its qualifications, performance, and independence. When evaluating the Company&rsquo;s independent registered public accounting firm,
the Audit Committee considers the quality, proficiency, and cost-effectiveness of the firm&rsquo;s services, the industry knowledge,
experience in auditing public company financials, performance, and responsiveness of the lead audit partner and the audit team assigned
to the Company&rsquo;s account, and the firm&rsquo;s overall reputation and knowledge of the Company&rsquo;s operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent registered public accounting firm for the 2023 fiscal year was the firm of WithumSmith+Brown, PC (&ldquo;<B><I>Withum</I></B>&rdquo;).
After considering the factors listed above, among others, the Audit Committee has re-appointed Withum to serve as the Company&rsquo;s
independent registered public accounting firm for the 2024 fiscal year. Representatives of Withum are expected to be present at the Annual
Meeting with the opportunity to make a statement if they desire to do so and are expected to be available to respond to appropriate questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ratification of the appointment of the Company&rsquo;s independent auditor is not a matter that is required to be submitted to a vote
of stockholders, but as a matter of good corporate governance, the Board considers it appropriate for the stockholders to express whether
they ratify the appointment. If stockholder ratification is not obtained, the Board would consider an alternative appointment for the
succeeding fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ratification of the appointment of WithumSmith+Brown, PC as the Company&rsquo;s independent registered public accounting firm requires
the affirmative vote of a majority of the shares present and entitled to vote thereon. Abstentions will have the same effect as a vote
AGAINST this proposal. Broker non-votes are not expected for this proposal because we believe this matter is a routine matter. If there
were to be any broker non-votes they would have no effect on this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD RECOMMENDS A VOTE &ldquo;FOR&rdquo; RATIFYING THE APPOINTMENT OF </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WITHUMSMITH+BROWN,
PC AS THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTING
FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEPENDENT
REGISTERED PUBLIC ACCOUNTANT FEE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below shows the aggregate fees billed for professional services for the audits and audit-related fees of the Company&rsquo;s annual
financial statements included in its Annual Report on Form 10-K for the years ended December 31, 2023 and 2022, respectively, by Withum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">277,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">135,983</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,043</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees<SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,266</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">410,200</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">185,292</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Audit Fees&rdquo; consist of fees billed for professional services rendered in connection with the audit of the Company&rsquo;s consolidated financial statements and review of interim condensed consolidated financial statements included in the Company&rsquo;s quarterly reports and services normally provided in connection with statutory and regulatory filings or engagements.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Audit-Related Fees&rdquo; consist of fees generally related to accounting advice, reviews of registration statements and prospectuses, and comfort letter and consent services performed in connection with the Company&rsquo;s equity offerings.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;All Other Fees&rdquo; consist of fees for all other services other than those reported above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Pre-Approval
Policies and Procedures of the Audit Committee</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter of the Audit Committee requires the Audit Committee to
pre-approve all audit and permitted non-audit and tax services that may be provided by the Company&rsquo;s independent registered public
accounting firm and to establish policies and procedures for the Audit Committee&rsquo;s pre-approval of permitted services by the Company&rsquo;s
independent registered public accounting firm on an on-going basis. The Audit Committee is also authorized to delegate any of its responsibilities
and the authority to act in relation to such responsibilities to one or more subcommittees as the Audit Committee deems appropriate in
its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and permissible non-audit services performed by the Company&rsquo;s independent registered public
accounting firm in order to assure that the provision of such services and related fees do not impair the independent registered public
accounting firm&rsquo;s independence. The independent registered public accounting firm must provide the Audit Committee with an engagement
letter outlining the scope of the audit services proposed to be performed during the applicable calendar year and the proposed fees for
such audit services. If agreed to by the Audit Committee, the engagement letter will be formally accepted by the Audit Committee as evidenced
by the execution of the engagement letter by the chairperson of the Audit Committee. The Audit Committee approves, if necessary, any
changes in terms, conditions, and fees resulting from changes in audit scope, Company structure, or other matters. The Audit Committee
may grant pre-approval for those permissible non-audit services that it believes are services that would not impair the independence
of the independent registered public accounting firm. The Audit Committee may not grant approval for any services categorized as &ldquo;Prohibited
Non-Audit Services&rdquo; by the SEC. Certain non-audit services have been pre-approved by the Audit Committee, and all other non-audit
services must be separately approved by the Audit Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of Withum&rsquo;s services and fees in fiscal years 2023 and 2022 were pre-approved by the Audit Committee in accordance with its pre-approval
policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Audit
Committee Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee is responsible for providing objective and independent oversight of the Company&rsquo;s accounting functions and internal
controls and is primarily responsible for overseeing the Company&rsquo;s financial reporting and disclosure process. A brief description
of the Audit Committee&rsquo;s principal functions is provided in this Proxy Statement under the discussion of &ldquo;Board Committees
&ndash; <I>Audit Committee</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Audit Committee&rsquo;s Board-approved charter, the tasks of the Audit Committee include but are not limited to: (i) selecting and
retaining the Company&rsquo;s independent registered public accounting firm to act as the Company&rsquo;s independent auditor; (ii) approving
all audit engagement fees and terms; (iii) pre-approving all audit and permitted non-audit and tax services that may be provided by the
Company&rsquo;s independent auditor or other registered public accounting firms; (iv) evaluating the qualifications, performance, and
independence of the Company&rsquo;s independent auditor; (v) reviewing and discussing with the Company&rsquo;s independent auditor all
critical accounting policies and practices to be used in the Company&rsquo;s audit; (vi) reviewing the internal quality control procedures
of the Company&rsquo;s independent auditor and any material issues raised by the most recent internal quality control review, peer review,
or Public Company Accounting Oversight Board (&ldquo;<B><I>PCAOB</I></B>&rdquo;) review or inspection of the firm; (vii) reviewing all
related-party transactions; and (viii) monitoring the Company&rsquo;s compliance with all legal and regulatory requirements. A copy of
the charter of the Audit Committee is available on the Investor Relations section of the Company&rsquo;s website at <I>ir.bioaffinitytech.com
</I>and can be accessed through the &ldquo;Governance Documents&rdquo; hyperlink under the &ldquo;Governance&rdquo; tab.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has reviewed and discussed the Company&rsquo;s audited financial statements for the fiscal year ended December 31, 2023,
with the Company&rsquo;s management. The Audit Committee has discussed with the Company&rsquo;s independent registered public accounting
firm, WithumSmith+Brown, PC, the matters required to be discussed by the applicable requirements of PCAOB and the SEC. The Audit Committee
has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable
PCAOB requirements regarding the independent accountants&rsquo; communications with the Audit Committee concerning independence and has
discussed with the independent registered public accounting firm its independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the review and discussions with management and the Company&rsquo;s independent auditor referenced above, the Audit Committee has recommended
to the Board that the audited consolidated financial statements be included in the Company&rsquo;s Annual Report on Form 10-K for the
year ended December 31, 2023, filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report by the Audit Committee shall not be deemed incorporated by reference by any general statement incorporating by reference this
Proxy Statement into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the
Company specifically incorporates this information by reference and shall not otherwise be deemed filed under such acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Submitted
by the Audit Committee of the Board of Directors:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Stuart Diamond (Chairman)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Gary Rubin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Robert Anderson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
&thinsp;NO. 5 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
WARRANT EXERCISE PROPOSAL </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking stockholder approval for the issuance of up to 1,632,000 shares of our Common Stock upon the exercise of common stock purchase
warrants that were issued in connection with our private placement offering (the &ldquo;<B><I>Private Placement</I></B>&rdquo;) that
closed on March 8, 2024, as contemplated by Nasdaq Listing Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2024, we entered into a securities purchase agreement (the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;) with institutional
investors pursuant to which we issued <FONT STYLE="background-color: white">(i) in a registered direct offering, 1,600,000 shares of
our Common Stock and (ii) in a concurrent private placement, warrants to purchase an aggregate of 1,600,000 shares of our Common Stock
(the &ldquo;<B><I>Common Warrants</I></B>&rdquo;) with an exercise price of $1.64. We also issued to the placement agent, warrants to
purchase up to 32,000 shares of our Common Stock with an exercise price of $1.64 (the &ldquo;<B><I>Placement Agent Warrants</I></B>&rdquo;).
The Common Warrants and Placement Agent Warrants are collectively referred to as the &ldquo;<B><I>Warrants</I></B>.&rdquo; Such registered
direct offering and concurrent private placement are referred to herein as the &ldquo;<B><I>Transactions</I></B>.&rdquo; </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants will be exercisable commencing on the effective date of stockholder approval for the issuance of the shares of Common
Stock issuable upon exercise of the Common Warrants (the &ldquo;<B><I>Stockholder Approval Date</I></B>&rdquo;) and will expire on the
fifth anniversary of the Stockholder Approval Date. If at any time after 90 days from the Stockholder Approval Date there is no effective
registration statement under the Securities Act for the resale of the Warrant Shares, the holder may, in its sole discretion, elect to
exercise the Common Warrants through a cashless exercise, in which case the holder would receive upon such exercise the net number of
shares of Common Stock determined according to the formula set forth in the Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price of the Common Warrants, and the number of Common Warrant Shares, are subject to adjustment in the event of any stock dividend
or split, reverse stock split, recapitalization, reorganization, or similar transaction, as described in the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder will not have the right to exercise any portion of the Common Warrants if the holder (together with its affiliates) would beneficially
own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of shares of our Common Stock outstanding immediately after
giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Common Warrants. However,
any holder may increase or decrease such percentage, provided that any increase will not be effective until the 61st day after such election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a Fundamental Transaction (as such term is defined in the Common Warrant), then the successor entity will succeed to, and
be substituted for the Company, and may exercise every right and power that the Company may exercise and will assume all of its obligations
under the Common Warrants with the same effect as if such successor entity had been named in the warrant itself. If holders of Common
Stock are given a choice as to the securities, cash, or property to be received in a Fundamental Transaction, then the holder shall be
given the same choice as to the consideration it receives upon any exercise of the Common Warrants following such Fundamental Transaction.
In addition, the successor entity, at the request of holders of Common Warrants, will be obligated to purchase any unexercised portion
of the Common Warrants in accordance with the terms thereof. Notwithstanding the foregoing, in the event of a Fundamental Transaction,
the holders of the Common Warrants have the right to require the Company or a successor entity to redeem the Common Warrants for cash
in the amount of the Black Scholes Value (as defined in the Common Warrant) of the unexercised portion of the Common Warrants concurrently
with or within 30 days following the consummation of a Fundamental Transaction. However, in the event of a Fundamental Transaction which
is not in our control, including a Fundamental Transaction not approved by the Company&rsquo;s Board, the holders of the Common Warrants
will only be entitled to receive from the Company or its successor entity, as of the date of consummation of such Fundamental Transaction,
the same type or form of consideration (and in the same proportion), at the Black-Scholes Value of the unexercised portion of the Common
Warrant that is being offered and paid to the holders of Common Stock in connection with the Fundamental Transaction, whether that consideration
is in the form of cash, stock or any combination of cash, and stock, or whether the holders of our Common Stock are given the choice
to receive alternative forms of consideration in connection with the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to hold a meeting of stockholders at the earliest practicable date after the date of the Purchase Agreement, but in no event later
than 90 days after March 8, 2024 for the purpose of obtaining Stockholder Approval (as defined below), if required to effect the purpose
thereof, with the recommendation of the Board that such proposal be approved, and the Company shall solicit proxies from its stockholders
in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders
shall vote their proxies in favor of such proposal. We agreed to use our reasonable best efforts to obtain such Stockholder Approval,
and request that our officers and directors cast their proxies in favor of such proposal. In fact, three of our board members have entered
into support agreements agreeing to vote in favor of the Warrant Exercise Proposal. If we do not obtain Stockholder Approval at the first
meeting, we are required to call a meeting every three months thereafter to seek Stockholder Approval until the earlier of the date Stockholder
Approval is obtained or the Common Stock Warrants are no longer outstanding. Stockholder Approval means such approval as may be required
by the applicable rules and regulations of The Nasdaq Stock Market LLC (or any successor entity) from the stockholders of the Company
to consent to any exercise of the Common Stock Warrants and issuance of Common Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent Warrants will be exercisable, in whole or in part, on or after September 8, 2024 and will expire on March 8, 2029. In
addition, the Placement Agent Warrants may be exercised in a &ldquo;cashless&rdquo; manner if at any time after December 7, 2024, there
is no effective registration statement under the Securities Act for the resale of the shares of Common Stock issuable upon exercise of
the Placement Agent Warrants (the &ldquo;<B><I>Placement Agent Warrant Shares</I></B>&rdquo; and together with the Common Warrant Shares,
the &ldquo;<B><I>Warrant Shares</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to file a registration statement to register the resale of the Warrant Shares within 30 days of March 6, 2024, and to use commercially
reasonable efforts to keep such registration statement effective at all times until no holder owns any Warrants or Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Warrant Exercise Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on The Nasdaq Capital Stock Market (&ldquo;<B><I>Nasdaq</I></B>&rdquo;) and trades under the ticker symbol &ldquo;BIAF.&rdquo;
Nasdaq Listing Rule 5635(d) requires stockholder approval of transactions other than public offerings of greater than 20% of the outstanding
common stock or voting power of an issuer prior to a private placement for less than the applicable Minimum Price. Under Rule 5635(d),
the &ldquo;<B><I>Minimum Price</I></B>&rdquo; means a price that is the lower of: (i) the closing price immediately preceding the signing
of the binding agreement; or (ii) the average closing price of the common stock for the five trading days immediately preceding the signing
of the binding agreement. The closing price of our Common Stock on Nasdaq on March 5, 2024, the trading date immediately preceding the
signing of the Purchase Agreement and the Placement Agency Agreement, was $3.00 per share. In order to comply with Nasdaq Listing Rule
5635(d), the Common Stock Warrants are not exercisable until Stockholder Approval is obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking stockholder approval for the issuance of up to an aggregate of 1,632,000 shares of our Common Stock upon the exercise of
the Warrants. Effectively, stockholder approval of this Warrant Exercise Proposal is one of the conditions for us to receive up to approximately
$2.6 million in gross proceeds upon the exercise of the 1,600,000 Common Stock Warrants, if exercised for cash. Loss of these potential
funds could adversely impact our ability to fund our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is not seeking the approval of our stockholders to authorize our entry into or consummation of the Transactions, as the Transactions
have already been completed. We are only asking for approval to issue up to an aggregate of 1,632,000 Warrant Shares upon exercise of
the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Consequences if Proposal No. 5 is Not Approved</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure of our stockholders to approve this Proposal No. 5 will mean that: (i) we cannot permit the exercise of the Common Stock Warrants
and (ii) may incur substantial additional costs and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Warrant has an initial exercise price of $1.64 per share. Accordingly, we would realize an aggregate of up to approximately $2.7 million
in gross proceeds, if all the Warrants were exercised for cash, including the Placement Agent Warrants. If only the Common Stock Warrants
cannot be exercised, we will not receive up to approximately $2.6 million of such proceeds, which could adversely impact our ability
to fund our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in connection with the private placement and the issuance of the Common Stock Warrants, we have agreed to seek stockholder
approval every 90 days until our stockholders approve the issuance of the Common Warrant Shares. We are required to seek such approval
until such time as none of the Warrants are outstanding which could result in us seeking such approval every 90 days. The costs and expenses
associated with seeking such approval could materially and adversely impact our ability to fund our operations, advance our clinical
trials, <FONT STYLE="background-color: white">and develop and commercialize our diagnostic tests or therapeutic product candidate.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Adverse Effects of the Approval of Proposal No. 5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Proposal No. 5 is approved, existing stockholders will suffer dilution in their ownership interests in the future upon the issuance
of the Warrant Shares upon exercise of the Warrants. Assuming the full exercise of the Warrants, an aggregate of 1,632,000 additional
shares of Common Stock will be outstanding, and the ownership interest of our existing stockholders would be correspondingly reduced.
In addition, the sale into the public market of these shares also could materially and adversely affect the market price of our Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote from the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the Warrant
Exercise Proposal at the Annual Meeting is required for approval of this proposal. Abstentions will have the same effect as votes AGAINST
this proposal. Broker non-votes will have no effect on this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>The
Board unanimously recommends that you vote &ldquo;FOR&rdquo; the Warrant Exercise Proposal.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE ADJOURNMENT PROPOSAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
of and Rationale for the Adjournment Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors believes that if the number of shares of our Common Stock outstanding and entitled to vote at the Annual Meeting is
insufficient to approve the Increase In Authorized Shares Proposal and/or the Warrant Exercise Proposal, it is in the best interests
of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional votes to approve the Increase
In Authorized Share Proposal and/or the Warrant Exercise Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Adjournment Proposal, we are asking stockholders to authorize the holder of any proxy solicited by the Board to vote in favor of
adjourning or postponing the Annual Meeting or any adjournment or postponement thereof. If our stockholders approve this proposal, we
could adjourn or postpone the Annual Meeting, and any adjourned session of the Annual Meeting, to use the additional time to solicit
additional proxies in favor of the Increase In Authorized Share Proposal and/or the Warrant Exercise Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
approval of the Adjournment Proposal could mean that, in the event we receive proxies indicating that holders of a majority of the number
of shares present in person or represented by proxy at the Annual Meeting will vote against the Increase In Authorized Share Proposal
and/or the Warrant Exercise Proposal, we could adjourn or postpone the Annual Meeting without a vote on the Increase In Authorized Share
Proposal and/or the Warrant Exercise Proposal and use the additional time to solicit the holders of those shares to change their vote
in favor of the Increase In Authorized Share Proposal and/or the Warrant Exercise Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares present in person or represented by proxy at the Annual Meeting is required
to approve the Adjournment Proposal. Abstentions will have the same effect as a vote <B>AGAINST</B> the proposal. Broker non-votes are
not expected for this proposal because we believe this matter is a routine matter. If there were to be any broker non-votes they would
have no effect on this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTE
&ldquo;FOR&rdquo; APPROVAL OF THE ADJOURNMENT PROPOSAL.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIRECTORS
AND EXECUTIVE OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of the Company&rsquo;s directors and executive officers as of April 8, 2024. As set forth in Proposal No. 1, each
of the Company&rsquo;s current directors has been nominated for re-election to the Board and will be submitted to the vote of the Company&rsquo;s
stockholders at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position(s)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes, JD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    CEO, and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vivienne
    Rebel, MD, PhD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Science and Medical Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Dougherty</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xavier
    Reveles</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    P. Zannes, JD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President, Secretary, and General Counsel</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Girgenti</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Anderson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart
    Diamond</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Knight</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Rubin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roby
    Joyce</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamie
    Platt</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Biographical
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maria
Zannes, JD &mdash; <I>President, Chief Executive Officer, and Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Zannes has served as our President, Chief Executive Officer, and director since 2014. She brings more than 30 years of executive-level
management experience dedicated to defining and advancing company goals and overcoming obstacles impeding corporate success. Prior to
her position at bioAffinity Technologies, Ms. Zannes founded The Zannes Firm focusing on strategic solutions for private industry in
the medical, environmental, and energy fields. In her current capacity as the Company&rsquo;s CEO and President, she has built a team
of award-winning scientists and executives who are advancing breakthrough oncology-focused diagnostics and therapeutics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Zannes was President of the Energy Recovery Council, the national trade group for the $10 billion waste-to-energy industry, and General
Manager of ECOS Corporation, a subsidiary of Burlington Environmental. Ms. Zannes also served as a project manager at Wheelabrator Technologies,
Inc. where she led project teams that developed, negotiated, and financed the company&rsquo;s renewable energy generation facilities.
Ms. Zannes began her career as a journalist, working for Voice of America and the Associated Press. Before entering the business world,
she served as a legislative aide specializing in energy policy and law for Congressman Charles Wilson (D-TX). She is licensed to practice
law in New Mexico. She has been awarded Lifetime Achievement Awards by the American Society of Mechanical Engineers and the Earth Engineering
Center Award from the WTE Council of Columbia University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">She
is the co-founder of two engineering research centers at Columbia University. Ms. Zannes received her BA in Journalism from the University
of New Mexico and her JD from the University of Puget Sound in Washington State. We believe Ms. Zannes should serve as a director of
the Company because of her experience as a lawyer and business woman skilled in identifying, prioritizing and managing both the risks
and rewards of business opportunities and her proven record of assembling and motivating award-winning teams of professionals focused
on strategic corporate growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vivienne
I. Rebel, MD, PhD &mdash; <I>Executive Vice President and Chief Science and Medical Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Rebel is a cancer (stem) cell biologist, with more than 20 years of experience in scientific research, focused on understanding the molecular
events that lead to cancer development has served as our Executive Vice President and Chief Science and Medical Officer since 2016. She
received her MD and PhD from the Free University in Amsterdam, The Netherlands, and post-doctoral training at the Dana-Farber Cancer
Institute, Harvard Medical School. From 2005 to 2016, she led her own research group at The University of Texas Health Science Center
at San Antonio, where she first collaborated with bioAffinity. Dr. Rebel received the 2012 Cancer Therapy &amp; Research Center Discovery
of the Year Award. She is the (co)author of more than 50 publications in peer-reviewed journals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Michael
Dougherty &mdash; <I>Chief Financial Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Dougherty was appointed to serve as our new Vice President and Chief Financial Officer (principal financial officer and principal accounting
officer) effective May 1, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to joining the Company, Mr. Dougherty served from 2022 through April 2023 as the Chief Financial Officer of Alexa Business Domains, Amazon&rsquo;s
Alexa AI and voice division, where he was responsible for financial strategy over Alexa&rsquo;s multi-billion-dollar investments in AI-generated
customer experiences. From 2020 to 2022, Mr. Dougherty was Chief Financial Officer of TINT and Filestack, two software-as-a-service companies.
From 2017 to 2020, Mr. Dougherty served as Chief Financial Officer for Amazon Pay, where he supported Amazon&rsquo;s digital payment
wallet globally. Earlier in his career Mr. Dougherty held various finance positions at Russell Investments and Medisystems Corporation.
He is a Certified Public Accountant and a Chartered Global Management Accountant by the American Institute of Certified Public Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Xavier
Reveles- Chief Operating Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Reveles was appointed as our Chief Operating Officer on September 18, 2023. Mr. Reveles has served as our Vice President of Operations
since September 2022. He has 30 years of experience as a clinical cytogeneticist skilled in the design/concept and management of CAP/CLIA
clinical laboratories, coding, CPT reimbursement valuations, and the development of Laboratory Developed Tests (<B><I>&ldquo;LDTs&rdquo;</I></B>).
Mr. Reveles is board certified by the American Society of Clinical Pathology as a clinical specialist in cytogenetics. He joined bioAffinity
as Director of Operations in 2017. Prior to joining bioAffinity, Mr. Reveles created the Oncopath Laboratory &ndash; START Cancer Center
in San Antonio, Texas, and served as Laboratory Director. During his tenure at Oncopath, he commercialized eight LDTs, including bringing
to market a proprietary cancer specific gene oligo array he designed for the deletions and amplifications of specific oncogenes for solid
tumors. As the Director of the Cytogenetics Laboratory at UT Health San Antonio, Mr. Reveles&rsquo; research included molecular evaluation
of disease progression in prostate, breast and ovarian cancer, schizophrenia, diabetes, and other constitutional genetic syndromes. He
was a lecturer and instructor for the UT Health Graduate, Medical, and Allied Health Schools and the director of the NCI San Antonio
Cancer Institute (SACI) Genetics and Cytogenetics Core facility. After leaving academia, Mr. Reveles was a genomic specialist for CombiMatrix
Diagnostics, Irvine, CA, a diagnostic biotech company where he validated pre-natal, post-natal, and cancer gene arrays for commercialization
as LDTs. Mr. Reveles is (co)author of 20 publications and six abstracts in peer-reviewed journals and is a member of the Association
for Molecular Pathology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Timothy
P. Zannes, JD &mdash; <I>Executive Vice President, General Counsel, and Secretary</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zannes has been corporate legal counsel to both public and private biomedical firms for more than 16 years, having begun his legal career
as a sole practitioner accepting criminal, business, family, and tort litigation. Prior to receiving his JD, Mr. Zannes was a court bailiff
and ran his own private investigation firm after serving as an investigator for the Albuquerque City Attorney. He received his JD from
the University of New Mexico School of Law and attended the New England Conservatory with studies in violin and saxophone. Mr. Zannes
began his undergraduate education at The University of North Carolina where he was a student athlete on scholarship. In addition to his
duties as General Counsel and Secretary, Mr. Zannes is responsible for corporate compliance and directs human resources. Mr. Zannes and
Maria Zannes are siblings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Steven
Girgenti &mdash; <I>Executive Chairman of the Board</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Girgenti has been Executive Chairman of bioAffinity Technologies, Inc. since November 2014. Mr. Girgenti was formerly CEO and co-founder
of DermWorx Incorporated, a dermatology company that specialized in developing nanotechnology formulations to enhance the performance
of topical drugs. He was also the founder and CEO of Healthworld Corporation, a leading global healthcare marketing services network
with offices in 36 countries, until 2008. The network had more than 1,000 brand assignments from nearly 200 clients worldwide, providing
strategic marketing and communications services to many of the world&rsquo;s leading healthcare companies. Mr. Girgenti founded Healthworld
in 1986, and under his leadership the Company made numerous acquisitions to expand and diversify the business. Healthworld went public
in 1997. In 1998 and again in 1999, Business Week named Healthworld one of the &ldquo;Best Small Corporations in America.&rdquo; In 1999,
Forbes listed Healthworld as one of the &ldquo;200 Best Small Companies.&rdquo; Mr. Girgenti was recognized as &ldquo;Entrepreneur of
the Year&rdquo; by Nasdaq in 1999 and was named Med Ad News&rsquo; first &ldquo;Medical Advertising Man of the Year&rdquo; in 2000. In
2010, he was inducted into the Medical Advertising Hall of Fame. In addition, Mr. Girgenti is Vice Chairman of the Board of Governors
for the Mt. Sinai Hospital Prostate Disease and Research Center in New York City and is on the Board of Directors for the Jack Martin
Fund, a Mt. Sinai Hospital-affiliated charitable organization devoted to pediatric oncology research. He graduated from Columbia University.
We believe Mr. Girgenti should serve as Executive Chairman because of his unparalleled experience in the healthcare field, particularly
in marketing, and his skill in building emerging growth companies into multi-national corporations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
Anderson &mdash; <I>Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Anderson has more than 50 years of broad experience in the healthcare industry in which he held executive positions at CIBA Pharmaceutical
Co., Becton Dickinson and Company, Pfizer, Inc., Parke-Davis Division of Warner-Lambert Co, Schering-Plough Corp., and Centocor, Inc.
Mr. Anderson was Vice President of Marketing for the Key Pharmaceuticals Division of Schering-Plough Corp. and later at Centocor, Inc.
Subsequently, Mr. Anderson joined Physicians World Communications Group, the largest medical education company in the U.S. where he was
Chief Operating Officer. Mr. Anderson currently is a marketing consultant to several healthcare companies. Mr. Anderson received a BA
in political science from Rutgers University. We believe Mr. Anderson should serve as a director of the Company because of his experience
and skill in marketing and product positioning of medical products to bioAffinity Technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stuart
Diamond &mdash; <I>Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Diamond is the Global Chief Financial Officer for GroupM, the world&rsquo;s leading media investment company responsible for over $50
billion in media investment through agencies Mindshare, MediaCom, Wavemaker, Essence, and m/SIX, as well as the outcome-driven programmatic
audience company, Xaxis, LLC. Before joining GroupM, Mr. Diamond was a member of the WPP plc family as the CFO for Healthworld Corporation
(now called Ogilvy Health), where he took the company public and negotiated its sale to Cordiant Communications Group in 2000. He also
served as CFO for National Medical Health Card Systems, Inc., a comprehensive pharmacy benefit management company. From 2008 to 2014,
Mr. Diamond was the CFO for GroupM North America, where he established financial strategies and supervised all corporate accounting and
financial activities for GroupM and its agencies. Earlier in his career, he held the positions of Vice President and Controller for Calvin
Klein, Inc. and as Senior Vice President and CFO for Medicis Pharmaceutical Corporation. Mr. Diamond holds a BS from the State University
of New York, a Master of Science, Taxation degree from Pace University, and an MBA from Fordham University. We believe Mr. Diamond should
serve as a director of the Company because of his substantial business and financial acumen to his position as Chairman of the Audit
Committee and to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peter
S. Knight &mdash; <I>Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Knight is a Partner at Cyan Capital Partners, a fund dedicated to helping new fund managers and asset owners in the field of sustainable
investing. Prior to that, he was a Founding Partner at Generation Investment Management, where he and his partners Al Gore and David
Blood helped build a leading global sustainable investing firm with assets under management now exceeding $40 billion. Prior to his retirement
from the firm in 2018, Mr. Knight held leadership positions within Generation IM, notably developing and overseeing the firm&rsquo;s
U.S. business. Prior to Generation, Mr. Knight was a Managing Director of Met West Financial, a Los Angeles-based asset management company.
Mr. Knight started his career at the Antitrust Division of the U.S. Department of Justice. From 1977 to 1989, he served as the Chief
of Staff to Representative and later Senator Al Gore. He served as the General Counsel of Medicis Pharmaceutical and then started his
law practice where he represented the International Olympic Committee, the U.S. Olympic Committee, and numerous Fortune 500 Companies.
Mr. Knight has also served in senior positions on four Presidential campaigns including serving as the Campaign Manager for President
Clinton&rsquo;s 1996 re-election campaign. Mr. Knight has extensive board experience in both the for-profit and nonprofit sectors. He
served on a number of public company boards including Medicis Pharmaceutical, Par Pharmaceutical, EntreMed (Casi Pharmaceuticals Inc.),
Healthworld Corporation, Whitman Education, Comsat, and the Schroder Mutual Fund Board complex. Mr. Knight currently serves on the boards
of Generation Investment Management and Gratitude Railroad. His philanthropic efforts include serving as Chair of the Climate Museum
and the board of Emergent, a nonprofit intermediary to help stop deforestation in tropical forest nations. He received a BA from Cornell
University and a JD from the Georgetown Law School. We believe Mr. Knight should serve as a director of the Company because of his considerable
experience in finance and business to his position of Chairman of the Compensation Committee, as well as his expertise and skill in building
new ventures into leading global firms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gary
Rubin <I>&mdash; Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Rubin, a Certified Public Accountant, serves as a Managing Member of Masters Research Partners, LLC, an investment fund of hedge funds
that he co-founded in October 2000. Mr. Rubin began his career with Deloitte &amp; Touche and later served as Managing Partner at Schissel,
Rubin &amp; Lehman, a New York-based certified public accounting firm. He has been involved in the investment business, including hedge
funds, private equity, and investment banking, for more than 20 years. Mr. Rubin is active in numerous charities as well as his family&rsquo;s
foundation and presently serves on the board of Boca Raton Regional Hospital Foundation. He also sits on the finance committee of the
Levitz Jewish Community Center. He graduated with a BS cum laude from the State University of New York at Buffalo. We believe Mr. Rubin
should serve as a director of the Company because of his financial expertise and organizational skills to his position as Chairman of
the Nominating and Governance Committee and to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Roby
Joyce, MD <I>&mdash; Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roby
P. Joyce <FONT STYLE="background-color: white">was appointed to serve on our Board of Directors on September 14, 2023. He is board-certified
in anatomic and clinical pathology by the College of American Pathologists and is a Diplomat in the American Board of Pathology. He is
also board-certified in neurology by the American Academy of Neurology and is a Diplomat in the American Board of Psychiatry and Neurology.
Dr. Joyce founded Village Oaks in 2008. He is Medical Director and Laboratory Director of </FONT>Precision Pathology Laboratory Services
(<B><I>&ldquo;PPLS&rdquo;</I></B>) <FONT STYLE="background-color: white">and owner of Village Oaks, the medical professional association
whose pathologists provide pathology interpretation services to PPLS. In addition to his role at Village Oaks, he has served in various
capacities at Northeast Methodist Hospital in San Antonio, including Chairman of the Board of Trustees and Chief of Staff of the Methodist
Healthcare System. Throughout a career in pathology that spans more than 40 years, he has been a highly regarded speaker at medical and
scientific conferences, has served in leadership roles on dozens of professional organizations and committees, and has served as lead
or co-author of numerous scientific articles. Dr. Joyce received his medical degree from Louisiana State University, where he also received
a BS in zoology. He performed his internship at Fitzsimons Army Medical Center in Denver, his residency in neurology at the Letterman
Army Medical Center at the University of California Moffett Hospital in San Francisco, and his residency in pathology at Brooke Army
Medical Center in San Antonio. We believe Dr. Joyce should serve as a director of the Company because of his extensive experience as
a clinical pathologist, his substantial professional relationships with physician practices and hospital systems and his business acumen
in the creation and operation of a successful pathology laboratory that developed CyPath<SUP>&reg;</SUP> Lung as an LDT.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jamie
Platt, PhD <I>&mdash; Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamie
Platt has 20 years of progressive leadership in genomics and molecular diagnostics, guiding teams in developing, validating, and commercializing
more than 40 innovative, high-complexity molecular tests for U.S. and global firms, both LDTs and in-vitro diagnostic tests (&ldquo;<B><I>IVDs</I></B>&rdquo;).
Since April 2023, she has served as Managing Director and Chief Executive Officer at Pictor Ltd., an in-vitro diagnostics company using
a proprietary enzyme-linked immunosorbent assay platform to test complex and infectious diseases, and since January 2021, has served
as a member of its board of directors. From August 2021 until April 2023, Dr. Platt served as Chief Operations Officer at Personal Genome
Diagnostics, a company dedicated to advancing precision oncology acquired by Laboratory Corporation of America Holdings. Since May 2015,
Dr. Platt has served as President and Chief Executive Officer of BRIDGenomics, a private consulting and contract commercialization firm
she founded in 2015 to provide molecular and genomic-based strategies to clients. Dr. Platt has served since March 2021 as a member of
the board of directors of DxTerity Diagnostics Inc., a company pioneering the use of RNA-based immune system profiling to better understand
the root causes of immune mediated conditions. From February 2017 until January 2021, Dr. Platt served as Chief Operations Officer of
Inivata Limited, a company applying pioneering liquid biopsy technology acquired by NeoGenomics Laboratories, Inc. Dr. Platt earned her
PhD in molecular and cellular biology from Oregon State University and completed post-doctoral studies at the University of California,
Berkeley. Dr. Platt is an industry-recognized peer educator and speaker, holds multiple U.S. and international patents and has authored
numerous peer-reviewed publications. We believe Dr. Platt <FONT STYLE="background-color: white">should serve as a director of the Company
because of </FONT>her scientific background, her start-up company experience, her prior leadership and laboratory experience, her involvement
in transforming research organizations into successful commercial entities and her experience expanding product market share in the diagnostics
market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Diversity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Diversity Matrix (as of April 8, 2024)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Number of Directors</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Female</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Male</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Binary</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Did
    Not Disclose Gender</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
    I: Gender Identity</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
    II: Demographic Background</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">African
    American or Black</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alaskan
    Native or Native American</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asian</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hispanic
    or Latinx</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Native
    Hawaiian or Pacific Islander</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
    or More Races or Ethnicities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did
    Not Disclose Demographic Background</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
Zannes is the sister of Timothy P. Zannes, J.D., the Company&rsquo;s Executive Vice President, Secretary, and General Counsel. Other
than the sibling relationship between Maria Zannes and Timothy Zannes, there are no other family relationships among any of the Company&rsquo;s
director nominees or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delinquent
Section 16(a) Reports</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act and the regulations promulgated thereunder require our executive officers, directors and persons who beneficially
own more than 10% of our common stock to file forms with the SEC to report their ownership of the Company&rsquo;s shares and any changes
in ownership. We have reviewed all forms filed electronically with the SEC during, and with respect to, fiscal 2023. Based on that review
and written information given to us by all of our directors and executive officers, we believe that all of our directors, executive officers
and holders of more than 10% of our stock filed on a timely basis all reports that they were required to file under Section 16(a) during
fiscal 2023, except Maria Zannes had two late filings, one reported two late transactions and one reported three late transactions; Steven
Girgenti had two late filings, each reported two late transactions; Gary Rubin had two late filings, each reported two transactions;
Michael Dougherty had one late filing that reported one transaction; Peter Knight had two late filings, each reported two transactions;
Stuart Diamond had two late filings, each reported two transactions; Robert Anderson had two late filings, each reported two transactions;
Roby Joyce had one late filing that reported two transactions; Mohsin Meghji had one late filing that reported two transactions; and
Jamie Platt had one late filing that reported one late transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIRECTOR
AND EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
Growth Company Status</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company qualifies as an &ldquo;emerging growth company&rdquo; (an &ldquo;<B><I>EGC</I></B>&rdquo;) as defined in the Jumpstart Our Business
Startups Act of 2012. As an EGC, the Company is permitted to rely on exemptions from certain disclosure requirements that are applicable
to other non-EGC companies. In accordance with the SEC&rsquo;s disclosure rules for EGCs concerning executive compensation, the Company
has provided a Summary Compensation Table and an Outstanding Equity Awards at Fiscal Year End Table, as well as limited narrative disclosures
regarding executive compensation for the last completed fiscal year and a report of the Compensation Committee. In addition, for so long
as the Company is an EGC, it is not required to submit certain executive compensation matters to stockholder advisory votes, such as
the &ldquo;say-on-pay&rdquo; vote. Furthermore, the Company&rsquo;s reporting obligations extend only to its &ldquo;<B><I>named executive
officers</I></B>&rdquo; (the &ldquo;<B><I>NEOs</I></B>&rdquo;), which include the Company&rsquo;s Chief Executive Officer and the two
most highly compensated executive officers in respect of their service to the Company at the end of the last completed fiscal year. In
accordance with the permitted exemptions from disclosure requirements for EGCs, the Company has not provided a Compensation Discussion
and Analysis. For fiscal year 2023, the Company&rsquo;s NEOs were:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes, J.D.&mdash;President, Chief Executive Officer, and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Dougherty&mdash; Vice President and Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Girgenti&mdash;Executive Chairman and Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes all compensation awarded to, earned by, or paid to our named executive officers for all services rendered in all
capacities to us and our subsidiaries during the fiscal years noted below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and<BR>
</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal Position</B></FONT></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock Awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($) <SUP>(1)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option Awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($) </B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All Other Compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: justify">Maria Zannes</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2023</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">261,671</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">37,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">124,996</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">424,168</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>President and CEO </I><SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">253,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,944</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">351,287</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Michael Dougherty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338,919</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vice President and CFO </I><SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Steven Girgenti</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,995</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">248,745</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Executive Chairman </I><SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">153,333</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    do not reflect compensation actually received by the NEO. Instead, the amounts represent aggregate grant date fair value of the restricted
    stock award computed in accordance with ASC 718, Stock Compensation. The valuation assumptions used in determining such amounts are
    consistent with those described in Note 11 of the Company&rsquo;s Consolidated Financial Statements, included in the Company&rsquo;s
    Annual Report on Form 10-K for the year ended December 31, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            for 2023 the following amounts received by Ms. Zannes for her service to the Company as a
                                            director: (i) in the Salary column - $25,000, and (ii) in the Stock Awards column - $74,996.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Dougherty was appointed as our Chief Financial Officer effective May 1, 2023.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    for 2023 the following amounts received by Mr. Girgenti for his service to the Company as a director: (i) in the Salary column
    - $35,000, and (ii) in the Stock Awards column - $74,996.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Narrative
Disclosure to Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Base
Salaries</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses base salaries to recognize the experience, skills, knowledge, and responsibilities required of all its employees, including
the NEOs. Base salaries are reviewed annually and adjusted from time to time to realign salaries with market levels after taking into
account individual responsibilities, performance, and experience. For 2023, the annual base salaries of the Company&rsquo;s NEOs were:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Ms. Zannes: $220,000 through July 31, 2023 and $260,000 commencing August 1, 2023 (which amounts does not include $25,000 in fees
    paid to Ms. Zannes for her service as a director in 2023);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. Dougherty: $250,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. Girgenti: $60,000 (which amount does not include $35,000 in fees paid to Mr. Girgenti for his service as a director in 2023).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Bonuses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 26, 2024, the Compensation Committee approved discretionary bonuses for each of Maria Zannes, Michael Dougherty, and Steven Girgenti
for calendar year 2023 of $75,000, $100,000, and $37,500, respectively to be paid 50% in cash and 50% in shares of restricted stock.
The bonuses were paid out on January 31, 2024. The number of shares of restricted stock issued were determined by dividing the cash value
of 50% of each executive&rsquo;s bonus by the closing price of the Company&rsquo;s common stock on January 31, 2024. The restricted stock
awards granted on January 31, 2024, are not included in the Summary Compensation Table for 2023 and will appear in the Summary Compensation
Table for 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Compensation Committee adopted the bioAffinity Technologies, Inc. Management Incentive Bonus Plan (the &ldquo;<B><I>Bonus
Plan</I></B>&rdquo;). The purpose of the Bonus Plan is to align officers&rsquo; and other employees&rsquo; efforts with the strategic
goals of the Company through competitive annual incentive opportunities. The Bonus Plan is administered by the Compensation Committee.
The Compensation Committee has the power to grant awards under the Bonus Plan, determine the amount of cash and/or equity to be paid
pursuant to each award and the terms and conditions of each award. Awards may provide for payment in installments, or upon the satisfaction
of qualitative performance standards or quantitative performance standards, on an individual, divisional, or company-wide basis, as determined
by the Compensation Committee. Equity awards will be issued in accordance with, and pursuant to, any equity-related incentive plan maintained
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
participant in the Bonus Plan will be entitled to receive payment of the award for a plan year only after certification by the Compensation
Committee that the targets associated with such award have been satisfied. Final payments with respect to awards will vary based on the
level of achievement measured against the pre-determined performance measures. Except as may be approved by the Compensation Committee,
each participant must be employed full-time on the date of payment, and not under a notice of termination, to receive the amount earned
under the award. Except as otherwise provided by the Compensation Committee, awards will be paid on or before March 15 following the
end of the plan year in which payment under the award is earned. The Compensation Committee will have the discretion to reduce or eliminate
the amount otherwise payable to a participant if it determines that such a reduction or elimination is in the best interests of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Retirement
Plans</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company established a defined contribution plan for all employees aged 21 and older who have completed one month of service for payrolls
after April 1, 2022. The Company does not currently make a matching contribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employee
Benefits</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s NEOs are eligible to participate in employee benefit plans and programs, including medical and dental benefit plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion contains a summary of the terms of the NEOs employment agreements currently in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Zannes
Employment Agreement</I>. The Company entered into an employment agreement with Ms. Zannes on February 1, 2015, which sets forth the
terms and conditions of her employment (the &ldquo;<B><I>Zannes Agreement</I></B>&rdquo;). Pursuant to the Zannes Agreement, Ms. Zannes
serves as the Company&rsquo;s Chief Executive Officer and was entitled to an annual base salary of $220,000. <FONT STYLE="background-color: white">On
July 26, 2023, the Company and Ms. Zannes entered into an amendment to the Zannes Agreement to provide for the payment of an annual base
salary of $260,000 effective August 1, 2023. </FONT>The Zannes Agreement may be terminated by either party at any time, provided that
Ms. Zannes is required to give the Company at least 90 days&rsquo; advance notice of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company terminates Ms. Zannes&rsquo; employment without &ldquo;Cause&rdquo; (as defined in the Zannes Agreement) she is
entitled to receive the following payments and benefits, in addition to any accrued obligations: (i) an amount of cash equal to the sum
of 12 months of her then-current annual base salary, payable in the form of salary continuation in regular installments, in accordance
with our normal payroll practices, over a period of 12 months from the termination date, and (ii) reimbursement for her healthcare insurance
premiums for a period of up to 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dougherty
Offer Letter. </I><FONT STYLE="background-color: white">Pursuant to the terms of an offer letter dated April 11, 2023, entered into between
the Company and Mr. Dougherty, Mr. Dougherty will receive an annual base salary of $250,000. The offer letter provided that Mr. Dougherty
would receive a one-time signing bonus, comprised of both cash and equity. The cash portion of the signing bonus would equal $30,000
and the equity portion of the signing bonus would be a grant of restricted stock with the number of shares to be issued to be equal to
the quotient obtained by dividing $100,000 by the average of the closing stock price of the Company&rsquo;s common stock on each of the
30 trading days prior to the date of grant. In addition, the offer letter states that Mr. Dougherty will be eligible to receive further
equity grants under the Company&rsquo;s equity incentive plan at the discretion of the Compensation Committee and to participate in the
Company&rsquo;s health insurance and the 401K retirement plans on the same basis and at the same rates as the Company&rsquo;s similarly
situated employees. </FONT>In addition, on January 26, 2024, the Compensation Committee approved an amendment (the &ldquo;<B><I>Amendment</I></B>&rdquo;)
to Mr. Dougherty&rsquo;s offer letter to amend the terms of the restricted stock award previously granted to Mr. Dougherty pursuant to
the offer letter (the &ldquo;<B><I>Prior Restricted Stock Award</I></B>&rdquo;). The Amendment provides that upon a Change in Control
(as defined in the Company&rsquo;s Amended and Restated 2014 Equity Incentive Plan, as amended), any outstanding and unvested portion
of the Prior Restricted Stock Award shall vest in full immediately prior to such Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Girgenti
Employment Agreement. </I>The Company entered into an employment agreement with Mr. Girgenti on January 1, 2020, which sets forth the
terms and conditions of his employment (the &ldquo;<B><I>Girgenti Agreement</I></B>&rdquo;). Pursuant to the Girgenti Agreement, Mr.
Girgenti serves as the Company&rsquo;s Executive Chairman and is entitled to an annual base salary of $120,000, one-half of which is
paid in cash and one-half of which is paid in the form of restricted stock grants. The cash portion of his compensation is deferred and
credited to an unfunded bookkeeping account established on his behalf and is payable to Mr. Girgenti on the earlier of: (i) a Change
in Control of the Company (as defined in the Girgenti Agreement); (ii) his termination as Chairman of the Board; (iii) the termination
of his employment without Cause (as defined in the Girgenti Agreement); (iv) his death; or (v) the third anniversary of the payroll date
when such compensation would have been paid but for the deferral. The Girgenti Agreement may be terminated by either party at any time,
provided that Mr. Girgenti is required to give the Company at least 30 days&rsquo; advance notice of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company terminates Mr. Girgenti&rsquo;s employment without &ldquo;Cause&rdquo; or Mr. Girgenti terminates his employment
for &ldquo;Good Reason&rdquo; (as defined in the Girgenti Agreement) he is entitled to receive the following payments and benefits, in
addition to any accrued obligations: (i) all deferred payments of his cash compensation, and (ii) the immediate vesting of any unvested
shares of restricted stock granted to him under the Girgenti Agreement. In the event the Company terminates Mr. Girgenti&rsquo;s employment
for &ldquo;Cause,&rdquo; Mr. Girgenti will not be entitled to any of his deferred cash compensation or vesting of his restricted stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clawback
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted a clawback policy which requires the clawback of erroneously awarded incentive-based compensation of past or current
executive officers awarded during the three full fiscal years preceding the date on which the issuer is required to prepare an accounting
restatement due to the material noncompliance of the Company with any financial reporting requirement under the federal securities laws.
There is no fault or misconduct required to trigger a clawback.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee shall determine, in its sole discretion, the timing and method for promptly recouping such erroneously awarded
compensation, which may include without limitation: (a) seeking reimbursement of all or part of any cash or equity-based award, (b) cancelling
prior cash or equity-based awards, whether vested or unvested or paid or unpaid, (c) cancelling or offsetting against any planned future
cash or equity-based awards, (d) forfeiture of deferred compensation, subject to compliance with Section 409A of the Internal Revenue
Code and the regulations promulgated thereunder, and (e) any other method authorized by applicable law or contract. Subject to compliance
with any applicable law, the Compensation Committee may affect recovery under this policy from any amount otherwise payable to the executive
officer, including amounts payable to such individual under any otherwise applicable Company plan or program, including base salary,
bonuses or commissions and compensation previously deferred by the executive officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at December 31, 2023 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the outstanding equity awards awarded to the Company&rsquo;s NEOs during the fiscal year ended December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Option
    Awards</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Stock
    Awards</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Name</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt"><B>Grant<BR>
    Date</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Number
    of<BR>
    Securities<BR>
    Underlying<BR>
    Unexercised<BR>
    Options (#)<BR>
    Exercisable</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Number
    of<BR>
    Securities<BR>
    Underlying<BR>
    Unexercised<BR>
    Options (#)<BR>
    Unexercisable</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Option<BR>
    Exercise<BR>
    Price ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Option<BR>
    Expiration<BR>
    Date</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Number
    of<BR>
    Shares or<BR>
    Units of<BR>
    Stock That<BR>
    Have Not<BR>
    Vested (#)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Market<BR>
    Value of<BR>
    Shares of<BR>
    Units of<BR>
    Stock That<BR>
    Have Not<BR>
    Vested ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; text-align: left"><FONT STYLE="font-size: 9pt">Maria Zannes</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 9pt">4/28/2014</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 9pt">64,848</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 9pt">1.16</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">4/27/2024</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/27/2015</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4.20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2025</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/25/2016</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/24/2026</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">4/24/2027</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">4/23/2027</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">5/7/2018</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5/6/2028</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">2/25/2019</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">2,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2/24/2029</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/26/2029</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/25/2029</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">2/5/2020</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2/4/2030</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/27/2020</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2030</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/26/2021</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2031</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">12/16/2031</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4.20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">12/15/2031</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/26/2021</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">698</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">989</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">6/6/2023</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">13,092</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">18,553</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Michael Dougherty</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">6/6/2023</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">52,356</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">74,194</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">Steven Girgenti</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">4/28/2014</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">64,848</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1.16</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">4/27/2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/27/2015</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4.20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2025</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/25/2016</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/24/2026</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">4/24/2017</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,571</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">4/23/2027</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">5/7/2018</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5/6/2028</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/26/2019</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/25/2029</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">7/27/2020</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2030</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">12/16/2021</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">7,142</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4.20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">12/15/2031</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">2/19/2021</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">3,896</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">5,521</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">12/31/2021</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">14,285</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">20,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">8/9/2023</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">26,315</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">37,291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">(1)</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">The following table shows the vesting schedule for restricted stock awards in this column vest:</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Name</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Grant
    Date</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Vesting
    Schedule</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">M.
    Zannes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">7/26/2021</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    in equal monthly installments over the 36 months following the date of grant</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">6/6/2023</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    in equal monthly installments over the 12 months following the date of grant </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">M.
    Dougherty</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">6/6/2023</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    in equal monthly installments over the 36 months following the date of grant, subject to the closing price of the Company&rsquo;s
    common stock averaging at least $5.00 per share for 30 consecutive trading days</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">S.
    Girgenti</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2/19/2021</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    on third anniversary of the grant date, February 19, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">12/31/2021</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    on third anniversary of the grant date, December 31, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">8/9/2023</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Vests
    on third anniversary of the grant date, August 9, 2026</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">(2)</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">Calculated by multiplying the closing price per share of the Company&rsquo;s common stock on December
  29, 2023, $1.471 by the number of shares.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>2023
Director Compensation Program</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board adopted a compensation plan for directors on November 21, 2022, pursuant to which directors are compensated for services as a director
of the Company. Beginning on January 1, 2023, each director will receive compensation in accordance with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    director will be paid $25,000 per year in cash with payments to be made in four quarterly installments of $6,250 on each of January
    1, April 1, July 1, and October 1;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Chairman of the Board will be paid an additional $10,000 per year in cash, with payments to be made to the chairman in four quarterly
    installments of $2,500 on each of January 1, April 1, July 1, and October 1;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    chairman of the Audit Committee will be paid an additional $5,000 per year in cash, with payments to be made to the Audit Committee
    chairman in four quarterly installments of $1,250 on each of January 1, April 1, July 1, and October 1;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    chairmen of the Compensation Committee and the Nominating and Governance Committee will be paid an additional $2,500 per year in
    cash, with payments to be made to such committee chairmen in four quarterly installments of $625 on each of January 1, April 1, July
    1, and October 1; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    director will be granted a quarterly restricted stock award valued at $18,750 based on the fair market value of the Company&rsquo;s
    Common Stock on the date of grant (which shall be deemed to be the greater of (i) the average closing price of the Company&rsquo;s
    Common Stock on the Nasdaq Stock Market over the 30 trading days prior to the date of grant, or (ii) the closing price of the Company&rsquo;s
    Common Stock on the Nasdaq Stock Market on the trading date immediately prior to the date of grant) on each of January 1, April 1,
    July 1, and October 1. The restricted stock awards will vest after three months of continued service by the director.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes the compensation paid to the Company&rsquo;s non-NEO directors who served on the Board during the fiscal year
ended December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
Earned <BR>
or Paid in <BR>
Cash<BR>
($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock<BR>

Awards<BR>
($)<SUP>(1)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total<BR>
($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Robert Anderson</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">25,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">74,996</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">99,996</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stuart Diamond</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,996</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Peter Knight</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,496</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mohsin Meghji <SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,996</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gary Rubin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,496</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roby Joyce <SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamie Platt<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    do not reflect compensation actually received by the directors. Instead, the amounts represent aggregate grant date fair value of
    the restricted stock award computed in accordance with ASC 718, Stock Compensation. The valuation assumptions used in determining
    such amounts are consistent with those described in Note 11 of the Company&rsquo;s Consolidated Financial Statements, included in
    the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2023. As of December 31, 2023, the aggregate number
    of outstanding exercisable options held by each individual who served as a non-NEO director during 2023 was as follows: Robert Anderson
    &ndash; 104,129; Stuart Diamond &ndash; 7,142; Peter Knight &ndash; 28,568; Mohsin Meghji &ndash; 21,426; Gary Rubin &ndash; 32,139;
    Roby Joyce &ndash; 0; and Jamie Platt &ndash; 0.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Meghji resigned on December 1, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joyce was appointed as a director on September
    18, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platt was appointed as a director on December
    1, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Changes
to Program in Fiscal 2024</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, on the recommendation of the Compensation Committee, our Board amended the terms of the equity grants from quarterly to annually
as follows: beginning July 1, 2024, each Board member shall receive an annual equity grant of restricted stock on July 1 of each year
with a grant date value (which shall be equal to the closing price of a share of the Company&rsquo;s common stock as of the date of grant
on the principal established stock exchange or national market system on which the Company&rsquo;s common stock is then traded) of approximately
$75,000 that will vest pro rata on a monthly basis for 12 months commencing on August 1 of each year.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITY
OWNERSHIP OF MANAGEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership of shares of the Company&rsquo;s Common Stock as of April 8,
2024, by (i) each person known to the Company to beneficially own more than 5% of any class of the Company&rsquo;s outstanding voting
securities, (ii) e<FONT STYLE="background-color: white">ach director and nominee for director</FONT>, (iii) each of our named executive
officers, and (iv) all of the Company&rsquo;s directors and executive officers as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 49.5pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security
if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently
exercisable or exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage
ownership of that person or entity in the table below, all shares subject to options and warrants were deemed outstanding if such securities
are currently exercisable or will vest within 60 days of the filing of this Proxy Statement. These shares were not deemed outstanding,
however, for the purpose of computing the percentage ownership of any other person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 49.5pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentage of beneficial ownership of the Company&rsquo;s Common Stock is based on 11,514,354 shares of Common Stock outstanding as of
April 8, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 49.5pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, the Company believes that each person named in the table below has sole voting and investment power with respect
to all shares of Common Stock beneficially owned by such person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and Address<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares <BR>
of Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Percent of Class</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Directors and Executive Officers:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria Zannes<SUP>(2)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">285,928</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">2.46</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Dougherty<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">* &nbsp;</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Girgenti<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,104,742</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Anderson<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.51</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart Diamond<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.57</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jamie Platt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">* &nbsp;</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Knight<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">143,942</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.24</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary Rubin<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,720,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14.90</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roby Joyce<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">607,665</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.28</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All Directors and Current Executive Officers as a Group</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(12 Individuals):</B></FONT></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,381,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36.44</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Five Percent Holders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Harvey Sandler Revocable Trust<SUP>(10)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,584,144</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13.76</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Joyce Living Trust<SUP>(11)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">583,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.06</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    of less than 1%.</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise indicated, the address for each person is c/o bioAffinity Technologies, Inc., 22211 West Interstate 10, Suite 1206, San
    Antonio, Texas, 78257.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 39,998 shares of Common Stock owned by Ms. Zannes of record or beneficially; (ii) 124,660 shares of Common Stock issued to Ms.
    Zannes as restricted stock; and (iii) 121,270 shares of Common Stock issuable upon exercise of options that are immediately exercisable.
    Does not include the following outstanding warrants that were amended by the Warrant Amendment and therefore are not exercisable:
    (i) 23,571 shares of Common Stock underlying warrants with a term of five years having an exercise price of $6.125 per share; and
    (ii) 79,997 shares of Common Stock underlying warrants with a term of five years having an exercise price of $3.0625 per share.</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    84,203 shares issued to Mr. Dougherty as restricted stock.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 831,130 shares of Common Stock owned by Mr. Girgenti of record or beneficially; (ii) 160,528 shares of Common Stock issued to
    Mr. Girgenti as restricted stock; (iii) 8,955 shares of Common Stock owned directly by the Cranye Girgenti Testamentary Trust, for
    which Mr. Girgenti serves as trustee; and (iv) 104,129 shares of Common Stock issuable upon exercise of options that are immediately
    exercisable. Does not include the following outstanding warrants that were amended by the Warrant Amendment and therefore are not
    exercisable: (i) 345,252 shares of Common Stock underlying warrants with a term of five years having an exercise price of $6.125
    per share; (ii) 123,811 shares of Common Stock underlying warrants with a term of five years having an exercise price of $5.25 per
    share; (iii) 200,486 shares of Common Stock underlying warrants with a term of five years having an exercise price of $3.0625 per
    share; (iv) 5,952 shares of Common Stock underlying warrants having an exercise price of $6.125 per share held by the Cranye Girgenti
    Testamentary Trust; and (v) 2,380 shares of Common Stock underlying warrants having an exercise price of $5.25 per share held by
    the Cranye Girgenti Testamentary Trust.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>(5)</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>Includes
(i) 4,081 shares of Common Stock owned by Mr. Anderson of record or beneficially; (ii) 117,775 shares of Common Stock issued to Mr. Anderson
as restricted stock; (iii) 39,281 shares of Common Stock issuable upon exercise of options that are immediately exercisable; and (iv)
19,998 shares of Common Stock underlying warrants <FONT STYLE="background-color: white">with a term of five years having an exercise
price of $3.0625</FONT>.</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 4,081 shares of Common Stock owned by Mr. Diamond of record or beneficially; (ii) 52,927 shares of Common Stock issued to Mr.
    Diamond as restricted stock; (iii) 7,142 shares of Common Stock issuable upon exercise of options that are immediately exercisable;
    and (iv) 19,998 shares of Common Stock underlying warrants <FONT STYLE="background-color: white">with a term of five years having
    an exercise price of $3.0625.</FONT></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 22,448 shares of Common Stock owned directly by Mr. Knight of record; (ii) 452,927 shares of Common Stock issued to Mr. Knight
    as restricted stock; (iii) 28,568 shares of Common Stock issuable upon exercise of options that are immediately exercisable; and
    (iv) 39,999 shares of Common Stock underlying warrants with a term of five years having an exercise price of $3.0625 per share. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 51,590 shares of Common Stock owned directly by Mr. Rubin of record; (ii) 52,927 shares of Common Stock issued to Mr. Rubin as
    restricted stock, (iii) 32,139 shares of Common Stock issuable upon exercise of options that are immediately exercisable and (iv)
    1,584,144 shares of Common Stock owned by the Harvey Sandler Revocable Trust, for which Mr. Rubin serves as co-trustee. Does not
    include the following outstanding warrants that were amended by the Warrant Amendment and therefore are not exercisable: (i) 12,241
    shares of Common Stock underlying warrants with a term of five years having an exercise price $6.125 per share; (ii) 4,896 shares
    of Common Stock underlying warrants with a term of five years having an exercise price of $5.25 per share; (v) 408,125 shares of
    Common Stock underlying warrants with a term of five years having an exercise price $6.125 per share held by the Harvey Sandler Revocable
    Trust; (vi) 163,248 shares of Common Stock underlying warrants with a term of five years having an exercise price of $5.25 per share
    held by the Harvey Sandler Revocable Trust; (vii) 79,997 shares of Common Stock underlying warrants with a term of five years having
    an exercise price of $3.0625 per share held by the Harvey Sandler Revocable Trust. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 583,130 shares of Common Stock owned by the Joyce Living Trust. Dr. Joyce is co-trustee of the Joyce Living Trust, together with
    his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power over the shares held by the
    Joyce Living Trust, and (ii) 24,535 shares of Common Stock issued to Dr. Joyce as restricted stock. The Joyce Living Trust has an
    address at 1092 Madeline Street, New Braunfels, Texas 78132. Does not include 19,999 shares of Common Stock underlying warrants with
    a term of five years having an exercise price of $5.25 per share that were amended by the Warrant Amendment and therefore are not
    exercisable. </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    1,584,144 shares of Common Stock owned by the Trust either of record or beneficially. Does not include the following outstanding
    warrants that were amended by the Warrant Amendment and therefore are not exercisable: (i) 408,125 shares of Common Stock underlying
    warrants with a term of five years having an exercise price $6.125 per share; (ii) 163,248 shares of Common Stock underlying warrants
    with a term of five years having an exercise price of $5.25 per share; (iii) 79,997 shares of Common Stock underlying warrants with
    a term of five years having an exercise price of $3.0625.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    583,130 shares of Common Stock owned by the Joyce Living Trust. Dr. Joyce is co-trustee of the Joyce Living Trust, together with
    his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power over the shares held by the
    Joyce Living Trust. The Joyce Living Trust has an address at 1092 Madeline Street, New Braunfels, Texas 78132. Does not include 19,999
    shares of Common Stock underlying warrants with a term of five years having an exercise price of $5.25 per share that were amended
    by the Warrant Amendment and therefore are not exercisable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related-Party
Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the compensation arrangements with directors and executive officers described under &ldquo;Director and Executive Compensation,&rdquo;
the following is a description of each transaction since January 1, 2022, and each currently proposed transaction in which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company was or is to be a participant;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                                                              amount involved exceeds <FONT STYLE="color: #333333; background-color: white">the lesser of $120,000 or one percent of the average
                                                                              of the Company&rsquo;s total assets at year </FONT></FONT>end for the last two completed fiscal years<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;
                                                                              and</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    related person had or will have a direct or indirect material interest.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Zannes
Purchase of Bridge Note and Accompanying Bridge Warrant</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, Maria Zannes, the President, CEO, and a director of the Company, purchased a convertible promissory note (a &ldquo;<B><I>Bridge
Note</I></B>&rdquo;) in the principal amount of $99,000, which accrued interest at a rate of 6% per year. Originally, all principal and
unpaid interest on the Bridge Note was due, if not settled prior, on May 31, 2022. Upon the closing of the Company&rsquo;s Initial Public
Offering (<B><I>&ldquo;IPO&rdquo;</I></B>) on September 6, 2022, the Bridge Note automatically converted into 23,672 shares of Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with her Bridge Note purchase, Ms. Zannes was issued an accompanying warrant (a &ldquo;<B><I>Bridge Warrant</I></B>&rdquo;)
to purchase one share of the Company&rsquo;s Common Stock for each conversion share based on the principal balance of the Bridge Note
at an exercise price equal to $5.25 per share. The Bridge Warrant issued to Ms. Zannes entitled her to purchase 23,571 shares of Common
Stock at an exercise price of $5.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Girgenti
Purchase of Bridge Note and Accompanying Bridge Warrant</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-align: justify; text-indent: -24.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, Steven Girgenti, the Executive Chairman and a director of the Company, purchased a Bridge Note in the principal amount of
$150,000. Upon the IPO closing, Mr. Girgenti&rsquo;s Bridge Note automatically converted into 35,866 shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his Bridge Note purchase, Mr. Girgenti received a Bridge Warrant to purchase 35,714 shares of Common Stock at an exercise
price of $5.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>PPLS
Acquisition of the Laboratory</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2023 the Company&rsquo;s wholly owned subsidiary, PPLS, consummated the acquisition of the laboratory assets of Village
Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, pursuant to the terms of the Asset Purchase Agreement with Village
Oaks. As a result of the acquisition, the CAP-accredited, CLIA-certified clinical pathology laboratory is owned by PPLS. Dr. Roby Joyce
was the Medical Director and Laboratory Director of the clinical pathology laboratory prior to the acquisition, and he continues to serve
as Medical Director and Laboratory Director of PPLS after the acquisition. Founded in 2007 by Dr. Joyce, Village Oaks has provided pathology
services to physicians practicing in a variety of outpatient settings. Since September 2021, Village Oaks, under the trade name Precision
Pathology Services, had offered CyPath<SUP>&reg;</SUP> Lung for sale as an LDT for the detection of early-stage lung cancer. In addition
to CyPath<SUP>&reg;</SUP> Lung, PPLS intends to continue to offer a range of laboratory services including respiratory testing for SARS-CoV-2
and influenza, anatomical pathology, morphological stains, histological services, DNA extractions, STI testing, and women&rsquo;s and
men&rsquo;s health testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Asset Purchase Agreement, PPLS acquired the laboratory assets, which included all of the assets owned by Village
Oaks, other than medical assets, which are assets Village Oaks used in connection with its management and operation of a clinical pathology
laboratory, now owned by PPLS, and related services business, and assumed certain liabilities and obligations. The laboratory is a clinical
pathology laboratory that is CAP-accredited and CLIA-certified. Pursuant to the terms of the Asset Purchase Agreement, Village Oaks received
$3,500,000 in consideration for the assets to be purchased by PPLS, of which $1,000,000 was paid by the issuance of 564,972 shares of
our restricted Common Stock to the Joyce Trust, which share number was determined by dividing $1,000,000 by $1.77, the average of the
trading day closing prices for the 30 days prior to September 15, 2023, rounded to the nearest whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Asset Purchase Agreement contains customary representations, warranties and covenants made by PPLS and Village Oaks and consummation
of the transaction was subject to customary closing conditions, including, among other things, entry into the other ancillary agreements
described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Asset Purchase Agreement, PPLS assumed all liabilities and obligations under and obtained any and all rights, title and interest
of Village Oaks in and to (i) the Assumed Leases under the Assumption Agreement; (ii) the Assumed Contracts under the Assumption Agreement;
(iii) all accounts payable of Village Oaks as of September 18, 2023, that were incurred in the ordinary course of business consistent
with past custom and practice; and (iv) the lease of the premises used in connection with operation of the CLIA-certified and CAP-accredited
clinical pathology laboratory, pursuant to the Assignment and Assumption of Lease, which Assignment of Lease was consented to by the
landlord of the leased premises. The monthly rent is currently $10,143.83 per month, and the term of the Lease is five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Asset Purchase Agreement, PPLS entered into the Management Services Agreement with Village Oaks, pursuant to which
PPLS will provide comprehensive management and administrative services to Village Oaks in connection with the operation of Village Oaks&rsquo;
professional cytopathology, histopathology, clinical and anatomic pathology interpretation medical services practice. PPLS will provide
space, equipment, administrative, management and clinical personnel, billing and collection, and related management services to Village
Oaks in exchange for a management fee of 70% of the net revenues received by Village Oaks from the provision of the medical services.
The Management Services Agreement has an initial term of 20 years and provides that upon expiration of the initial term, it will be automatically
extended for two additional successive terms of five years each, unless either party delivers written notice of its intention not to
extend the term of the agreement not less than 90 days prior to the expiration of the preceding term. The Management Services Agreement
also provides that until the fifth anniversary of its effective date, Village Oaks will not, without the prior written approval of PPLS
own, operate, or have any financial interest in any other person or entity that operates an independent laboratory or an enterprise within
the United States that provides or promotes management or administrative services or any product or services substantially similar to
those provided by PPLS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Asset Purchase Agreement, PPLS entered into the Succession Agreement, pursuant to which Dr. Joyce, as holder of 100%
of the issued and outstanding stock of Village Oaks, and Village Oaks are restricted from disposing of their equity interests in Village
Oaks, subject to certain exceptions, without the prior written consent of the Company and Village Oaks. The Succession Agreement further
provides that the entire equity interest held by Dr. Joyce in Village Oaks will be automatically assigned and transferred to a successor
who meets the Eligibility Requirements of a Designated Physician, as such terms are defined and described in the Succession Agreement,
in the event of, among other things, the death, disability, retirement, or a court&rsquo;s determination of incompetence of Dr. Joyce,
as well as Dr. Joyce&rsquo;s failure to satisfy the eligibility requirements of a Designated Physician, exclusion or disqualification
from participation in the Medicare program, conviction of a felony or crime or moral turpitude, bankruptcy filing, or material breach
of the Succession Agreement. In the event of the automatic transfer of Dr. Joyce&rsquo;s equity interests in Village Oaks as provided
in the Succession Agreement, such agreement provides that the board of directors of Village Oaks shall nominate a group of three candidates
as the Designated Physician who satisfy the Eligibility Requirements. In the event the Company desires not to select any of such candidates,
the Company shall select and appoint a successor Designated Physician from any other physicians that satisfy the Eligibility Requirements.
Subject in all cases to the Management Services Agreement, Dr. Joyce shall not cause any voluntary interruption of the conduct of Village
Oaks&rsquo; business and operations and shall use commercially reasonable efforts to preserve (or assist us in preserving) all rights,
privileges, and franchises held by Village Oaks, including the maintenance of all contracts, copyrights, trademarks, licenses, and registrations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Asset Purchase Agreement, PPLS entered into the Professional Services Agreement with Village Oaks, pursuant to which
Village Oaks will provide pathology interpretation services as requested on behalf of PPLS based on the professional fees approved for
the CPT code for the services provided under the Medicare Physician Fee Schedule in the locality where the test is performed. The Professional
Services Agreement has an initial term of 20 years and provides that upon expiration of the initial term, it will be automatically extended
for successive terms of 12 months each, unless either party delivers written notice of its intention not to extend the term of the agreement
not less than 30 days prior to the expiration of the preceding term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Asset Purchase Agreement, the Company entered into the Executive Employment Agreement with Dr. Joyce, for a term
of three years, to serve as the Medical Director and Laboratory Director of PPLS at a base salary of $333,333.34 per year. Pursuant to
the Joyce Employment Agreement, Dr. Joyce was also appointed to serve on our Board. Dr. Joyce will be eligible to participate in or receive
benefits under our benefit plans generally made available to executives of similar status and responsibilities and will be provided use
of a company car. In the event the Joyce Employment Agreement is terminated for any reason, including by Dr. Joyce upon 60 days&rsquo;
notice, by us for cause or by reason of Dr. Joyce&rsquo;s death, Dr. Joyce (or his estate as applicable) will receive his base salary
for the remainder of the three-year employment term. However, the Joyce Employment Agreement provides that if Dr. Joyce breaches any
of the restrictive covenants set forth in the Joyce Employment Agreement, including a covenant not to compete during his term of employment
and a covenant not to knowingly disclose confidential information, such breach will be grounds for the immediate termination of Dr. Joyce
and will result in the forfeiture of all compensation and benefits otherwise due to Dr. Joyce.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the Assumed Leases is the Hologic Equipment Lease, pursuant to which PPLS leases reagent equipment from Hologic and is required to
purchase a minimum number of specified testing kits each year. The total monthly minimum purchase commitment PPLS is required to pay
Hologic, inclusive of the lease of the reagent equipment, is $16,914 per month. The term of the Hologic Equipment Lease currently expires
on December 20, 2027.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Another
of the Assumed Leases is the Leica Equipment Lease, pursuant to which PPLS leases reagent equipment from Leica and is required to purchase
a minimum number of specified testing kits. The total monthly minimum purchase commitment PPLS is required to pay to Leica, inclusive
of the lease of the reagent equipment, is $19,790 per month. The term of the Leica Equipment Lease currently expires on March 23, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the Assumed Contracts is the License Agreement. Pursuant to the License Agreement, Pathology Watch granted a license to its digital
imaging cloud-based pathology platform to facilitate remote interpretation and billing of pathology specimens by qualified professionals
to PPLS for a monthly fee of $25,000. In connection with the License Agreement, Pathology Watch also provides certain support services
and marketing vendor services to PPLS for the monthly fee of $38,000, for a total monthly fee paid by PPLS to Precision Watch of $63,000.
The License Agreement is for an initial term of 12 months, unless terminated by either party upon 90 days&rsquo; notice, and provides
that upon expiration of the initial term (or any renewal term), it will be automatically extended for successive 12-month terms, unless
either party notifies the other party of its intention not to renew the License Agreement not less than 90 days prior to the expiration
of the current term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Asset Purchase Agreement, Dr. Joyce, on behalf of Village Oaks, executed the Bill of Sale, pursuant to which all
rights, title, and interest of Village Oaks in and to the permits listed on Exhibit A attached thereto, inclusive of the CLIA-certificate
and CAP-accreditation, notwithstanding the transfer of the CLIA certificate by operation of law to PPLS upon consummation of the Acquisition,
were confirmed to have been transferred and assigned to PPLS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment
to Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2023, Mr. Girgenti, the Cranye Girgenti Testamentary Trust, Gary Rubin, The Harvey Sandler Revocable Trust, a trust of
which Mr. Rubin is a co-trustee, Ms. Zannes and Dr. Joyce consented to an amendment of the terms of the outstanding warrants that they
own. Such warrants include (i) Tradeable Warrants to purchase 98,198, 39,182, and 39,182 shares of Common Stock owned by Mr. Girgenti,
The Harvey Sandler Revocable Trust, and Ms. Zannes, respectively); (ii) Non-Tradeable Warrants to purchase 102,286, 40,813, and 40,813
shares of Common Stock owned by Mr. Girgenti, The Harvey Sandler Revocable Trust, and Ms. Zannes, respectively; and (iii) Pre-IPO Warrants
to purchase 469,063, 8,332, 571,373, 23,571, 17,137, and 14,285 shares of Common Stock owned by Mr. Girgenti, the Cranye Girgenti Testamentary
Trust, Mr. Rubin, The Harvey Sandler Revocable Trust, Ms. Zannes, and Dr. Joyce, respectively. The warrant amendment provides that such
warrants will not be exercisable until the date that we file a certificate of amendment to our certificate of incorporation with the
State of Delaware which increases the number of shares of our authorized Common Stock to allow for sufficient authorized and unissued
shares of Common Stock for the full exercise of all of the outstanding Pre-IPO Warrants, Tradeable Warrants and Non-Tradeable Warrants
of the Company and the issuance of all of the shares of Common Stock underlying such warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Timothy
Zannes Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
Zannes, brother of Maria Zannes, our Chief Executive Officer, has been employed by the Company as General Counsel and Secretary since
2014. Mr. Zanes received (i) a salary of $70,008 and an equity award valued at $9,997 in 2002 and (ii) a salary of $70,008 and a bonus
of $21,000, which was paid on January 31, 2024, <FONT STYLE="background-color: white">50% in cash and 50% in shares of restricted stock.
The number of shares of restricted stock issued was determined by dividing the cash value of 50% of Mr. Zannes bonus by the closing price
of the Company&rsquo;s common stock on January 31, 2024. Mr. Zannes is scheduled to receive an annual salary in 2024 of $80,000.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policies
and Procedures for Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted a written Code of Ethics and Business Conduct, which includes a policy on conflicts of interest that requires the Company&rsquo;s
directors and executive officers to seek determination and prior authorizations or approvals of potential conflicts of interest exclusively
from the Board. In reviewing and approving any such transactions, the Company&rsquo;s General Counsel and Board consider all relevant
facts and circumstances. The Code of Ethics and Business Conduct is available on the Investor Relations section of the Company&rsquo;s
website at <I>ir.bioaffinitytech.com</I> and can be accessed through the &ldquo;Governance Documents&rdquo; hyperlink under the &ldquo;Governance&rdquo;
tab. The Company intends to disclose any amendments to the Code of Ethics and Business Conduct, or any waivers of its requirements, on
its website to the extent required by the applicable rules and exchange requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDER
PROPOSALS FOR 2025 ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
proposals intended to be included in the Company&rsquo;s proxy statement relating to the 2025 Annual Meeting must comply with Rule 14a-8
under the Exchange Act, which requires that the notice be received at the Company&rsquo;s principal executive office not less than 120
calendar days before the one-year anniversary date of the Company&rsquo;s proxy statement released to stockholders in connection with
the previous year&rsquo;s annual meeting, and accordingly must be received in writing by the Company at its principal executive office
at the address set forth above no later than December 15, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s next annual meeting, stockholder proposals that are not submitted for inclusion in the Company&rsquo;s
proxy materials pursuant to Rule 14a-8 under the Exchange Act may be brought before an annual meeting pursuant to Article II, Section
2.12 of the Company&rsquo;s By-laws, which provides that nominations or other business at an annual meeting of stockholders may be made
(i) pursuant to the Company&rsquo;s notice of meeting, (ii) by or at the direction of the Board, or (iii) by any stockholder of the Company
who was a stockholder of record at the time of giving the notice provided for in Article II, Section 2.12 of the By-laws, who is entitled
to vote at the meeting and who complies with the notice procedures set forth in Article II, Section 2.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
nominations or other business to be properly brought before an annual meeting by a stockholder, the stockholder must have given timely
notice thereof in writing to the Corporate Secretary. To be timely, a stockholder&rsquo;s notice shall be delivered to the Secretary
of the Company at the Company&rsquo;s principal executive office at 22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257, and
not later than the close of business on the 90<SUP>th</SUP> day nor earlier than the close of business on the 120<SUP>th</SUP> day prior
to the first anniversary of the preceding year&rsquo;s annual meeting; provided, however, that in the event that the date of the annual
meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be
so delivered not earlier than the close of business on the 120<SUP>th</SUP> day prior to such annual meeting and not later than the close
of business on the later of (i) the 90<SUP>th</SUP> day prior to such annual meeting, or (ii) the 10<SUP>th</SUP> day following the day
on which public announcement of the date of such meeting is first made by the Company. The anniversary of this year&rsquo;s Annual Meeting
will be Wednesday, June 4, 2025. Thus, a stockholder notice must be received by the Company no later than March 6, 2025, and no earlier
than February 4, 2025. If the date of the 2025 Annual Meeting is changed, these dates may change. Such stockholder&rsquo;s notice is
required to set forth, as to each matter the stockholder proposes to bring before an annual meeting, certain information specified in
the By-laws and, to the extent applicable, required by Rule 14a-19 under the Exchange Act. A copy of the By-laws of the Company may be
obtained from the Secretary of the Company at the address set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to satisfying the foregoing advance notice requirements under the Company&rsquo;s By-laws, to comply with the universal-proxy
rules under the Exchange Act, stockholders who intend to solicit proxies in support of director nominees other than the Company&rsquo;s
nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act and that is postmarked or
transmitted electronically to the Company no later than April 5, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Annual
Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Annual Report on Form 10-K for the period ended December 31, 2023, (the &ldquo;<B><I>Annual Report</I></B>&rdquo;) is
being furnished with this Proxy Statement to stockholders of record as of the record date. The Company will provide stockholders with
a copy of the Company&rsquo;s Annual Report, without charge, upon written request addressed to the Secretary of the Company at the address
listed below. The Company&rsquo;s Annual Report and the exhibits filed with it are also available on the Investor Relations section of
the Company&rsquo;s website at <I>ir.bioaffinitytech.com</I> and can be accessed through the &ldquo;Annual Reports&rdquo; hyperlink under
the &ldquo;SEC Filings&rdquo; heading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22211
W Interstate 10, Suite 1206</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Antonio, Texas 78257</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(210)
698-5334</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
business other than the matters set forth in this Proxy Statement is expected to come before the Annual Meeting but should any other
matters requiring a vote of stockholders arise, including a question of adjourning the meeting, the persons named in the accompanying
proxy will vote thereon according to their best judgment in the interest of the Company. In the event that any of the nominees for director
should withdraw or otherwise become unavailable for reasons not presently known, the persons named as proxies will vote for such substitute
nominee(s) as the Board recommends, or in the absence of such recommendation, such other persons as they consider to be in the best interests
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; background-color: white"><B>Householding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that permit companies and intermediaries (<I>e.g</I>., brokers) to satisfy the delivery requirements for proxy
statements, annual reports and notices of internet availability of proxy materials with respect to two or more stockholders sharing the
same address by delivering a single copy of the applicable document(s) addressed to those stockholders. This process, which is commonly
referred to as &ldquo;householding,&rdquo; potentially means extra convenience for stockholders and cost savings for companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers
with account holders who are stockholders of the Company may be &ldquo;householding&rdquo; our proxy materials. A single proxy statement
or notice may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected
stockholders. Once you have received notice from your broker that it will be &ldquo;householding&rdquo; communications to your address,
&ldquo;householding&rdquo; will continue until you are notified otherwise or until you notify your broker or the Company that you no
longer wish to participate in &ldquo;householding.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Street-name
stockholder who are currently receiving householded materials may revoke their consent, and street-name shareholders who are not currently
receiving householded materials may request householding of our future materials, by contacting Broadridge Financial Services, Inc.,
either by calling toll free at (866) 540-7095 or by writing to Broadridge Householding Department, 51 Mercedes Way, Edgewood, New York
11717. If you revoke your consent you will be removed from the &ldquo;householding&rdquo; program within 30 days of Broadridge&rsquo;s
receipt of your revocation, and each stockholder at your address will receive individual copies of our future materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formpre14a_006.jpg" ALT="" STYLE="height: 39px; width: 135px">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maria
    Zannes</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>President
    and Chief Executive Officer</I></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPENDIX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2024
EQUITY INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1. Establishment and Purpose</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the bioAffinity Technologies, Inc. 2024 Equity Incentive Compensation Plan (the &ldquo;<U>Plan</U>&rdquo;), is to provide
a means whereby eligible employees, officers, non-employee directors and other individual service providers of bioAffinity Technologies,
Inc. (the &ldquo;<U>Company</U>&rdquo;) and its subsidiaries may develop a sense of proprietorship and personal involvement in the development
and financial success of the Company and to encourage them to devote their best efforts to the business of the Company, thereby advancing
the interests of the Company and its stockholders. The Company, by means of the Plan, seeks to retain the services of such eligible persons
and to provide incentives for such persons to exert maximum efforts for the success of the Company and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Stock Units,
Performance Shares, Performance Units and Other Stock-Based Awards. This Plan shall become effective upon the date set forth in Section&nbsp;17.1
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2. Definitions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wherever
the following capitalized terms are used in the Plan, they shall have the meanings specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
&ldquo;<U>Affiliate</U>&rdquo; means, with respect to a Person, a Person that directly or indirectly Controls, or is Controlled by, or
is under common Control with, such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
&ldquo;<U>Applicable Law</U>&rdquo; means the requirements relating to the administration of equity-based awards or equity compensation
plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which
the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted
under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
&ldquo;<U>Award</U>&rdquo; means an award of a Stock Option, Stock Appreciation Right, Restricted Stock, Stock Unit, Performance Share, Performance
Unit, and/or Other Stock-Based Award granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
&ldquo;<U>Award Agreement</U>&rdquo; means either (i)&nbsp;a written or electronic agreement entered into between the Company and a Participant
setting forth the terms and conditions of an Award including any amendment or modification thereof, or (ii)&nbsp;a written or electronic
statement issued by the Company to a Participant describing the terms and provisions of such Award, including any amendment or modification
thereof. The Committee may provide for the use of electronic, internet or other non-paper Award Agreements, and the use of electronic,
internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant. Each Award Agreement shall be subject
to the terms and conditions of the Plan and need not be identical.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
&ldquo;<U>Board</U>&rdquo; means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
&ldquo;<U>Cause</U>&rdquo; means: (a) conviction of any crime (whether or not involving the Company) constituting a felony in the jurisdiction
involved; (b) engaging in any substantiated act involving moral turpitude; (c) engaging in any act which, in each case, subjects, or
if generally known would subject, the Company to public ridicule or embarrassment; (d) material violation of the Company&rsquo;s policies,
including, without limitation, those relating to sexual harassment or the disclosure or misuse of confidential information; (e) serious
neglect or misconduct in the performance of the grantee&rsquo;s duties for the Company or a subsidiary or willful or repeated failure
or refusal to perform such duties; in each case as determined by the Committee, which determination shall be final, binding and conclusive.
Notwithstanding the foregoing, if a Participant and the Company (or any of its Affiliates) have entered into an employment agreement,
consulting agreement or other similar agreement that specifically defines &ldquo;cause,&rdquo; then with respect to such Participant,
&ldquo;Cause&rdquo; shall have the meaning defined in that employment agreement, consulting agreement or other agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
&ldquo;<U>Change in Control</U>&rdquo; shall be deemed to have occurred if any one of the following events shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"></P>

<!-- Field: Page; Sequence: 53; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any Person becomes the beneficial owner (as defined in Rule 13(d)-3 under the Exchange Act) of shares of Common Stock representing more
than 50% of the total number of votes that may be cast for the election of directors of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The consummation of any merger or other business combination of the Company, sale of all or substantially all of the Company&rsquo;s
assets or combination of the foregoing transactions (a &ldquo;<U>Transaction</U>&rdquo;), other than a Transaction involving only the
Company and one or more of its subsidiaries, or a Transaction immediately following which the shareholders of the Company immediately
prior to the Transaction continue to have a majority of the voting power in the resulting entity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Within any 12-month period beginning on or after the Effective Date, the persons who were directors of the Company immediately before
the beginning of such period (the &ldquo;<U>Incumbent Directors</U>&rdquo;) shall cease (for any reason other than death) to constitute
at least a majority of the Board (or the board of directors of any successor to the Company); provided that any director who was not
a director as of the date hereof shall be deemed to be an Incumbent Director if such director was elected to the Board by, or on the
recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually
or by prior operation of the foregoing unless such election, recommendation or approval was the result of an actual or threatened election
contest of the type contemplated by Rule 14a-11 promulgated under the Exchange Act or any successor provision; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, no event or condition shall constitute a Change in Control to the extent that, if it were, a penalty tax would be imposed
under Section 409A of the Code; provided that, in such a case, the event or condition shall continue to constitute a Change in Control
to the maximum extent possible (e.g., if applicable, in respect of vesting without an acceleration of distribution) without causing the
imposition of such penalty tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
&ldquo;<U>Code</U>&rdquo; means the Internal Revenue Code of 1986, as amended. For purposes of this Plan, references to sections of the
Code shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
&ldquo;<U>Committee</U>&rdquo; means the committee of the Board delegated with the authority to administer the Plan, or the full Board,
as provided in Section&nbsp;3 of the Plan. With respect to any decision relating to a Reporting Person, the Committee shall consist solely
of two or more directors who are non-employee&nbsp;directors&rdquo; as defined under Rule 16b-3 promulgated under the Exchange Act, as
amended from time to time, or any successor provision. The fact that a Committee member shall fail to qualify under any of these requirements
shall not invalidate an Award if the Award is otherwise validly made under the Plan. The Board may at any time appoint additional members
to the Committee, remove and replace members of the Committee with or without Cause, and fill vacancies on the Committee however caused.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<U>&ldquo;Common Stock</U>&rdquo; means the Company&rsquo;s Common Stock, par value $0.007 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
&ldquo;<U>Company</U>&rdquo; means bioAffinity Technologies, Inc., and any successor thereto as provided in Section&nbsp;15.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
&ldquo;<U>Control</U>&rdquo; means, as to any Person, the power to direct or cause the direction of the management and policies of such
Person, or the power to appoint directors of the Company, whether through the ownership of voting securities, by contract or otherwise
(the terms &ldquo;<U>Controlled by</U>&rdquo; and &ldquo;<U>under common Control with</U>&rdquo; shall have correlative meanings).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
&ldquo;<U>Date of Grant</U>&rdquo; means the date on which an Award under the Plan is granted by the Committee, or such later date as
the Committee may specify to be the effective date of an Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
&ldquo;<U>Disability</U>&rdquo; means a Participant being considered &ldquo;disabled&rdquo; within the meaning of Section&nbsp;409A of
the Code and Treasury Regulation 1.409A-3(i)(4), as well as any successor regulation or interpretation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
&ldquo;<U>Effective Date</U>&rdquo; means the date set forth in Section&nbsp;17.1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16
&ldquo;<U>Eligible Person</U>&rdquo; means any person who is an employee, officer, director, consultant, advisor or other individual
service provider of the Company or any Subsidiary, or any person who is determined by the Committee to be a prospective employee, officer,
director, consultant, advisor or other individual service provider of the Company or any Subsidiary; provided that the Award Agreement
for any grant of an Award to a prospective employee, officer, director, consultant, advisor or other individual service provider will
contain appropriate forfeiture provisions in the event such individual does not become employed or engaged by the Company or applicable
Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17
<U>&ldquo;Exchange Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18
&ldquo;<U>Fair Market Value</U>&rdquo; of a share of Common Stock shall be, as applied to a specific date (i)&nbsp;the closing price
of a share of Common Stock as of such date on the principal established stock exchange or national market system on which the Common
Stock is then traded (or, if there is no trading in the Common Stock as of such date, the closing price of a share of Common Stock on
the most recent date preceding such date on which trades of the Common Stock were recorded), or (ii)&nbsp;if the shares of Common Stock
are not then traded on an established stock exchange or national market system but are then traded in an over-the-counter market, the
average of the closing bid and asked prices for the shares of Common Stock in such over-the-counter market as of such date (or, if there
are no closing bid and asked prices for the shares of Common Stock as of such date, the average of the closing bid and the asked prices
for the shares of Common Stock on the most recent date preceding such date on which such closing bid and asked prices are available on
such over-the-counter market), or (iii)&nbsp;if the shares of Common Stock are not then listed on a national securities exchange or national
market system or traded in an over-the-counter market, the price of a share of Common Stock as determined by the Committee in its discretion
in a manner consistent with Section&nbsp;409A of the Code and Treasury Regulation 1.409A-1(b)(5)(iv), as well as any successor regulation
or interpretation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19
[Intentionally Omitted].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
&ldquo;<U>Incentive Stock Option</U>&rdquo; means a Stock Option granted under Section&nbsp;6 hereof that is intended to meet the requirements
of Section 422 of the Code and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21
&ldquo;<U>Nonqualified Stock Option</U>&rdquo; means a Stock Option granted under Section&nbsp;6 hereof that is not an Incentive Stock
Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22
[Intentionally Omitted].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23
<U>&ldquo;Other Stock-Based Award</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;13 representing
a notional unit interest equal in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions
as are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24
&ldquo;<U>Participant</U>&rdquo; means any Eligible Person who holds an outstanding Award under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25
<U>&ldquo;Performance Shares</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;10 hereof representing
a notional unit interest equal in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions,
as are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26
&ldquo;<U>Performance Unit</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;11 hereof representing
a notional dollar interest as determined by the Committee to be paid and distributed at such times, and subject to such conditions, as
are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27
<U>&ldquo;Person</U>&rdquo; shall mean any individual, partnership, firm, trust, corporation, limited liability company or other similar
entity. When two or more Persons act as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding
or disposing of Common Stock, such partnership, limited partnership, syndicate or group shall be deemed a &ldquo;Person&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28
<U>&ldquo;Plan</U>&rdquo; means the bioAffinity Technologies, Inc. 2024 Equity Incentive Compensation Plan, as set forth herein and as
may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29
&ldquo;<U>Reporting Person</U>&rdquo; means an officer, director or greater than ten percent stockholder of the Company within the meaning of
Rule 16a-2 under the Exchange Act, who is required to file reports pursuant to Rule 16a-3 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30
&ldquo;<U>Restricted Stock Award</U>&rdquo; means a grant of shares of Common Stock to an Eligible Person under Section&nbsp;8 hereof
that are issued subject to such vesting and transfer restrictions and such other conditions as are set forth in the Plan and the applicable
Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31
&ldquo;<U>Securities Act</U>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32
&ldquo;<U>Service</U>&rdquo; means a Participant&rsquo;s employment or other service relationship with the Company or any Subsidiary.
A change in the capacity in which a Participant renders service to the Company or a Subsidiary as an employee, director or consultant
or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the
Participant&rsquo;s Service with the Company or a Subsidiary, will not terminate a Participant&rsquo;s Service; provided, however, that
if the entity for which a Participant is rendering services ceases to qualify as a Subsidiary, as determined by the Committee in its
sole discretion, such Participant&rsquo;s Service will be considered to have terminated on the date such entity ceases to qualify as
a Subsidiary. For example, a change in status from an employee of the Company to a consultant to or director of the Company will not
constitute an interruption of Service. To the extent permitted by Applicable Law, the Committee or the chief executive officer of the
Company, in that party&rsquo;s sole discretion, may determine whether a Participant&rsquo;s Service will be considered interrupted in
the case of (i) any leave of absence approved by the Company or chief executive officer, including sick leave, military leave or any
other personal leave, or (ii) transfers between the Company, a Subsidiary, or their successors. Notwithstanding the foregoing, a leave
of absence will be treated as Service for purposes of vesting in an Award only to such extent as may be provided in the Company&rsquo;s
(or a Subsidiary&rsquo;s) leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the
Participant, or as otherwise required by Applicable Law. Unless the Committee provides otherwise, in its discretion, or as otherwise
required by Applicable Law, vesting of Options shall be tolled during any unpaid leave of absence by a Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33
&ldquo;<U>Stock Appreciation Right</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;7 hereof entitling
such Eligible Person to receive a payment, upon the exercise of such right, in such amount and at such time, and subject to such conditions,
as are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34
&ldquo;<U>Stock Option</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;6 hereof to purchase shares of
Common Stock at such time and price, and subject to such conditions, as are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35
&ldquo;<U>Stock Unit Award</U>&rdquo; means a contractual right granted to an Eligible Person under Section&nbsp;9 hereof representing notional
unit interests equal in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions, as
are set forth in the Plan and the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36
&ldquo;<U>Subsidiary</U>&rdquo; means an entity (whether or not a corporation) that is wholly or majority owned or Controlled, directly
or indirectly, by the Company; provided, however, that with respect to Incentive Stock Options, the term &ldquo;Subsidiary&rdquo; shall
include only an entity that qualifies under Section 424(f) of the Code as a &ldquo;subsidiary corporation&rdquo; with respect to the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3. Administration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Committee Members</U>. The Plan shall be administered by the Committee; provided that the entire Board may act in lieu of the Committee
on any matter, subject to the requirements of Section 2.9 of the Plan with respect to an Award to a Reporting Person. If and to the extent
permitted by Applicable Law, the Committee may authorize one or more Reporting Persons (or other officers) to make Awards to Eligible
Persons who are not Reporting Persons (or other officers whom the Committee has specifically authorized to make Awards). Subject to Applicable
Law and the restrictions set forth in the Plan, the Committee may delegate administrative functions to individuals who are Reporting
Persons, officers, or employees of the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Committee Authority</U>. The Committee shall have such powers and authority as may be necessary or appropriate for the Committee to
carry out its functions as described in the Plan. Subject to the express limitations of the Plan, the Committee shall have authority
in its discretion to determine the Eligible Persons to whom, and the time or times at which, Awards may be granted, the number of shares,
units or other rights subject to each Award, the exercise, base or purchase price of an Award (if any), the time or times at which an
Award will become vested, exercisable or payable, the performance criteria, performance goals and other conditions of an Award, the duration
of the Award, and all other terms of the Award. Subject to the terms of the Plan, the Committee shall have the authority to amend the
terms of an Award in any manner that is not inconsistent with the Plan (including to extend the post-termination exercisability period
of Stock Options and Stock Appreciation Rights), provided that no such action (except an action relating to a Change in Control) shall
materially impair the rights of a Participant with respect to an outstanding Award without the Participant&rsquo;s consent. For purposes
of the foregoing, any action of the Committee that alters or affects the tax treatment of any Award shall not be considered to materially
impair any rights of any Participant. The Committee shall also have discretionary authority to interpret the Plan, to make all factual
determinations under the Plan, and to make all other determinations necessary or advisable for Plan administration, including, without
limitation, to correct any defect, to supply any omission or to reconcile any inconsistency in the Plan or any Award Agreement hereunder.
The Committee may prescribe, amend, and rescind rules and regulations relating to the Plan. The Committee&rsquo;s determinations under
the Plan need not be uniform and may be made by the Committee selectively among Participants and Eligible Persons, whether or not such
persons are similarly situated. The Committee shall, in its discretion, consider such factors as it deems relevant in making its interpretations,
determinations and actions under the Plan including, without limitation, the recommendations or advice of any officer or employee of
the Company or such attorneys, consultants, accountants or other advisors as it may select. All interpretations, determinations, and
actions by the Committee shall be final, conclusive, and binding upon all parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>No Liability; Indemnification</U>. Neither the Board nor any Committee member, nor any Person acting at the direction of the Board
or the Committee, shall be liable for any act, omission, interpretation, construction or determination made in good faith with respect
to the Plan, any Award or any Award Agreement. The Company and its Subsidiaries shall pay or reimburse any member of the Committee, as
well as any other Person who takes action on behalf of the Plan, for all reasonable expenses incurred with respect to the Plan, and to
the full extent allowable under Applicable Law shall indemnify each and every one of them for any claims, liabilities, and costs (including
reasonable attorney&rsquo;s fees) arising out of their good faith performance of duties on behalf of the Company with respect to the
Plan. The Company and its Subsidiaries may, but shall not be required to, obtain liability insurance for this purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Shares Subject to the Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Share Limitation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to adjustment pursuant to Section&nbsp;4.2 hereof, the maximum aggregate number of shares of Common Stock which may be issued
under all Awards granted to Participants under the Plan shall be 2,000,000 shares, all of which may, but need not, be issued in respect
of Incentive Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Shares of Common Stock issued under the Plan may be either authorized but unissued shares or shares held in the Company&rsquo;s treasury.
Any shares of Common Stock subject to Awards that are settled in Common Stock shall be counted against the maximum share limitations
of this Section&nbsp;4.1(a) as one share of Common Stock for every share of Common Stock subject thereto. To the extent that any Award
under the Plan payable in shares of Common Stock is forfeited, cancelled, returned to or repurchased by the Company for failure to satisfy
vesting requirements or upon the occurrence of other forfeiture events, or otherwise terminates without payment being made thereunder,
the shares of Common Stock covered thereby will no longer be counted against the foregoing maximum share limitations and may again be
made subject to Awards under the Plan pursuant to such limitations. Shares of Common Stock that otherwise would have been issued upon
the exercise of a Stock Option or Stock Appreciation Right or in payment with respect to any other form of Award, that are surrendered
in payment or partial payment of the exercise price thereof and/or taxes withheld with respect to the exercise thereof or the making
of such payment, will no longer be counted against the foregoing maximum share limitations and may again be made subject to Awards under
the Plan pursuant to such limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Adjustments</U>. If there shall occur any change with respect to the outstanding shares of Common Stock by reason of any recapitalization,
reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split, or other distribution with respect to the
shares of Common Stock, or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any
other change affecting the Common Stock, the Committee shall, in the manner and to the extent that it deems appropriate and equitable
to the Participants and consistent with the terms of the Plan, cause an adjustment to be made in (i)&nbsp;the maximum numbers and kind
of shares provided in Section&nbsp;4.1 hereof, (ii)&nbsp;the numbers and kind of shares of Common Stock, units, or other rights subject
to then outstanding Awards, (iii)&nbsp;the price for each share or unit or other right subject to then outstanding Awards, (iv)&nbsp;the
performance measures or goals relating to the vesting of an Award, and (v)&nbsp;any other terms of an Award that are affected by the
event to prevent dilution or enlargement of a Participant&rsquo;s rights under an Award. Notwithstanding the foregoing, in the case of
Incentive Stock Options, any such adjustments shall, to the extent practicable, be made in a manner consistent with the requirements
of Section 424(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Participation and Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Designation of Participants</U>. All Eligible Persons are eligible to be designated by the Committee to receive Awards and become
Participants under the Plan. The Committee has the authority, in its discretion, to determine and designate from time to time those Eligible
Persons who are to be granted Awards, the types of Awards to be granted and the number of shares of Common Stock, units or other amounts
subject to such Awards. In selecting Eligible Persons to be Participants and in determining the type and amount of Awards to be granted
under the Plan, the Committee shall consider any and all factors that it deems relevant or appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Determination of Awards</U>. The Committee shall determine the terms and conditions of all Awards granted to Participants in accordance
with its authority under Section&nbsp;3.2 hereof. An Award may consist of one type of right or benefit hereunder or of two or more such
rights or benefits granted in tandem or in the alternative. To the extent deemed appropriate by the Committee, an Award shall be evidenced
by an Award Agreement as described in Section&nbsp;15.1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Stock Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Grants of Stock Options</U>. A Stock Option may be granted to any Eligible Person selected by the Committee. Subject to the provisions
of Section&nbsp;6.7 hereof and Section 422 of the Code, each Stock Option shall be designated, in the discretion of the Committee, as
an Incentive Stock Option or as a Nonqualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Exercise Price</U>. The exercise price per share of a Stock Option shall not be less than 100 percent of the Fair Market Value of
a share of Common Stock on the Date of Grant, subject to adjustments as provided for under Section&nbsp;4.2, provided that the Committee
may in its discretion specify for any Stock Option an exercise price per share that is higher than the Fair Market Value on the Date
of Grant and may establish an exercise price that is below Fair Market Value on the Date of Grant for Stock Options granted to Participants
who are not residents of the U.S if permitted by applicable law and any applicable rules of the principal established stock exchange
or national market system on which the Common Stock is traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Vesting of Stock Options</U>. The Committee shall in its discretion prescribe the time or times at which, or the conditions upon which,
a Stock Option or portion thereof shall become vested and/or exercisable. The requirements for vesting and exercisability of a Stock
Option may be based on the continued Service of the Participant for a specified time period (or periods) and/or on the attainment of
a specified performance goal (or goals) established by the Committee in its discretion. The Committee may, in its discretion, accelerate
the vesting or exercisability of any Stock Option at any time. The Committee in its sole discretion may allow a Participant to exercise
unvested Nonqualified Stock Options, in which case the shares of Common Stock then issued shall be Restricted Stock having analogous
vesting restrictions to the unvested Nonqualified Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Term of Stock Options</U>. The Committee shall in its discretion prescribe in an Award Agreement the period during which a vested
Stock Option may be exercised, provided that the maximum term of a Stock Option shall be ten (10)&nbsp;years from the Date of Grant.
A Stock Option may be earlier terminated as specified by the Committee and set forth in an Award Agreement upon or following the termination
of a Participant&rsquo;s Service, including by reason of voluntary resignation, death, Disability, termination for Cause or any other
reason. Except as otherwise provided in this Section&nbsp;6 or in an Award Agreement as such agreement may be amended from time to time
upon authorization of the Committee, no Stock Option may be exercised at any time during the term thereof unless the Participant is then
in Service. Notwithstanding the foregoing, unless an Award Agreement provides otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If a Participant&rsquo;s Service terminates by reason of his or her death, any Stock Option held by such Participant may, to the extent
then exercisable, be exercised by such Participant&rsquo;s estate or any person who acquires the right to exercise such Stock Option
by bequest or inheritance at any time in accordance with its terms for up to one year after the date of such Participant&rsquo;s death
(but in no event after the earlier of the expiration of the term of such Stock Option or such time as the Stock Option is otherwise canceled
or terminated in accordance with its terms). Upon expiration of such one-year period, no portion of the Stock Option held by such Participant
shall be exercisable and the Stock Option shall be deemed to be canceled, forfeited and of no further force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If a Participant&rsquo;s Service terminates by reason of his or her Disability, any Stock Option held by such Participant may, to the
extent then exercisable, be exercised by the Participant or his or her personal representative at any time in accordance with its terms
for up to one year after the date of such Participant&rsquo;s termination of Service (but in no event after the earlier of the expiration
of the term of such Stock Option or such time as the Stock Option is otherwise canceled or terminated in accordance with its terms).
Upon expiration of such one-year period, no portion of the Stock Option held by such Participant shall be exercisable and the Stock Option
shall be deemed to be canceled, forfeited and of no further force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If a Participant&rsquo;s Service terminates for any reason other than death, Disability or Cause, any Stock Option held by such Participant
may, to the extent then exercisable, be exercised by the Participant up until ninety (90) days following such termination of Service
(but in no event after the earlier of the expiration of the term of such Stock Option or such time as the Stock Option is otherwise canceled
or terminated in accordance with its terms). Upon expiration of such 90-day period, no portion of the Stock Option held by such Participant
shall be exercisable and the Stock Option shall be deemed to be canceled, forfeited and of no further force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If a Participant&rsquo;s Service terminates for Cause, any Stock Option held by such Participant, whether vested or unvested, shall be
deemed forfeited and canceled on the date of such termination of Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
To the extent that a Stock Option of a Participant whose Service terminates is not exercisable, such Stock Option shall be deemed forfeited
and canceled on the ninetieth (90th) day after such termination of Service or at such earlier time as the Committee may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5
<U>Stock Option Exercise</U>. Subject to such terms and conditions as shall be specified in an Award Agreement, a Stock Option may be
exercised in whole or in part at any time during the term thereof by notice in the form required by the Company, and payment of the aggregate
exercise price by certified or bank check, or such other means as the Committee may accept. As set forth in an Award Agreement or otherwise
determined by the Committee, in its sole discretion, at or after grant, payment in full or in part of the exercise price of an Option
may be made: (i)&nbsp;in the form of shares of Common Stock that have been held by the Participant for such period as the Committee may
deem appropriate for accounting purposes or otherwise, valued at the Fair Market Value of such shares on the date of exercise; (ii)&nbsp;by
surrendering to the Company shares of Common Stock otherwise receivable on exercise of the Option; (iii)&nbsp;by a cashless exercise
program implemented by the Committee in connection with the Plan; and/or (iv)&nbsp;by such other method as may be approved by the Committee
and set forth in an Award Agreement. Subject to any governing rules or regulations, as soon as practicable after receipt of written notification
of exercise and full payment of the exercise price and satisfaction of any applicable tax withholding pursuant to Section&nbsp;16.5,
the Company shall deliver to the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request,
Common Stock certificates in an appropriate amount based upon the number of shares of Common Stock purchased under the Option. Unless
otherwise determined by the Committee, all payments under all of the methods indicated above shall be paid in United States dollars or
shares of Common Stock, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6
<U>Reload Option</U>s. The Committee may in its discretion include in any Award Agreement with respect to an option (the &ldquo;original
option&rdquo;) a provision that an additional option (the &ldquo;additional option&rdquo;) shall be granted to any Participant who, pursuant
to Section 6.5, delivers shares of the Common Stock in partial or full payment of the exercise price of the original option. The additional
option shall be for a number of shares of the Common Stock equal to the number thus delivered, shall have an exercise price equal to
the Fair Market Value of a share of Common Stock on the date of exercise of the original option, and shall have an expiration date no
later than the expiration date of the original option. In the event that an Award Agreement provides for the grant of an additional option,
such Award Agreement shall also provide that the exercise price of the original option be no less than the Fair Market Value of a share
of Stock on its date of grant, and that any shares that are delivered pursuant to Section 6.5 in payment of such exercise price shall
have been held for at least six months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7
<U>Additional Rules for Incentive Stock Options</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Eligibility</U>. An Incentive Stock Option may only be granted to an Eligible Person who is considered an employee under Treasury
Regulation &sect;1.421-7(h) of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Annual Limits</U>. No Incentive Stock Option shall be granted to an Eligible Person as a result of which the aggregate Fair Market
Value (determined as of the Date of Grant) of the stock with respect to which Incentive Stock Options are exercisable for the first time
in any calendar year under the Plan and any other stock option plans of the Company or any Subsidiary would exceed $500,000, determined
in accordance with Section 422(d) of the Code. This limitation shall be applied by taking Incentive Stock Options into account in the
order in which granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Ten Percent Stockholders</U>. If a Stock Option granted under the Plan is intended to be an Incentive Stock Option, and if the Participant,
at the time of grant, owns stock possessing ten percent or more of the total combined voting power of all classes of Common Stock of
the Company or any Subsidiary, then (A)&nbsp;the Stock Option exercise price per share shall in no event be less than 110 percent of
the Fair Market Value of the Common Stock on the date of such grant and (B)&nbsp;such Stock Option shall not be exercisable after the
expiration of five (5)&nbsp;years following the date such Stock Option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Disqualifying Dispositions</U>. If shares of Common Stock acquired by exercise of an Incentive Stock Option are disposed of within
two (2)&nbsp;years following the Date of Grant or one (1)&nbsp;year following the transfer of such shares to the Participant upon exercise,
the Participant shall, promptly following such disposition, notify the Company in writing of the date and terms of such disposition and
provide such other information regarding the disposition as the Company may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7. Stock Appreciation Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Grant of Stock Appreciation Rights</U>. A Stock Appreciation Right may be granted to any Eligible Person selected by the Committee.
Stock Appreciation Rights may be granted on a basis that allows for the exercise of the right by the Participant or that provides for
the automatic payment of the right upon a specified date or event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Base Price</U>. The base price of a Stock Appreciation Right shall be determined by the Committee in its sole discretion; provided,
however, that the base price for any grant of a Stock Appreciation Right shall not be less than 100 percent of the Fair Market Value
of a share of Common Stock on the Date of Grant, subject to adjustments as provided for under Section&nbsp;4.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Vesting Stock Appreciation Rights</U>. The Committee shall in its discretion prescribe the time or times at which, or the conditions
upon which, a Stock Appreciation Right or portion thereof shall become vested and/or exercisable. The requirements for vesting and exercisability
of a Stock Appreciation Right may be based on the continued Service of a Participant for a specified time period (or periods) or on the
attainment of a specified performance goal (or goals) established by the Committee in its discretion. The Committee may, in its discretion,
accelerate the vesting or exercisability of any Stock Appreciation Right at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Term of Stock Appreciation Rights</U>. The Committee shall in its discretion prescribe in an Award Agreement the period during which
a vested Stock Appreciation Right may be exercised, provided that the maximum term of a Stock Appreciation Right shall be ten (10)&nbsp;years
from the Date of Grant. A Stock Appreciation Right may be earlier terminated as specified by the Committee and set forth in an Award
Agreement upon or following the termination of a Participant&rsquo;s Service, including by reason of voluntary resignation, death, Disability,
termination for Cause or any other reason. Except as otherwise provided in this Section&nbsp;7 or in an Award Agreement as such agreement
may be amended from time to time upon authorization of the Committee, no Stock Appreciation Right may be exercised at any time during
the term thereof unless the Participant is then in the Service of the Company or one of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<U>Payment of Stock Appreciation Rights</U>. Subject to such terms and conditions as shall be specified in an Award Agreement, a vested
Stock Appreciation Right may be exercised in whole or in part at any time during the term thereof by notice in the form required by the
Company and payment of any exercise price. Upon the exercise of a Stock Appreciation Right and payment of any applicable exercise price,
a Participant shall be entitled to receive an amount determined by multiplying: (i)&nbsp;the excess of the Fair Market Value of a share
of Common Stock on the date of exercise of the Stock Appreciation Right over the base price of such Stock Appreciation Right, by (ii)&nbsp;the
number of shares as to which such Stock Appreciation Right is exercised. Payment of the amount determined under the immediately preceding
sentence may be made, as approved by the Committee and set forth in the Award Agreement, in shares of Common Stock valued at their Fair
Market Value on the date of exercise, in cash, or in a combination of shares of Common Stock and cash, subject to applicable tax withholding
requirements set forth in Section&nbsp;16.5. If Stock Appreciation Rights are settled in shares of Common Stock, then as soon as practicable
following the date of settlement the Company shall deliver to the Participant evidence of book entry shares of Common Stock, or upon
the Participant&rsquo;s request, Common Stock certificates in an appropriate amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Restricted Stock Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Grant of Restricted Stock Awards</U>. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee. The
Committee may require the payment by the Participant of a specified purchase price in connection with any Restricted Stock Award. The
Committee may provide in an Award Agreement for the payment of dividends and distributions to the Participant at such times as paid to
stockholders generally or at the times of vesting or other payment of the Restricted Stock Award. If any dividends or distributions are
paid in stock while a Restricted Stock Award is subject to restrictions under Section 8.3 of the Plan, the dividends or other distributions
shares shall be subject to the same restrictions on transferability as the shares of Common Stock to which they were paid unless otherwise
set forth in the Award Agreement. The Committee may also subject the grant of any Restricted Stock Award to the execution of a voting
agreement with the Company or with any Affiliate of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Vesting Requirements</U>. The restrictions imposed on shares of Common Stock granted under a Restricted Stock Award shall lapse in
accordance with the vesting requirements specified by the Committee in the Award Agreement. Upon vesting of a Restricted Stock Award,
such Award shall be subject to the tax withholding requirement set forth in Section&nbsp;16.5. The requirements for vesting of a Restricted
Stock Award may be based on the continued Service of the Participant for a specified time period (or periods) or on the attainment of
a specified performance goal (or goals) established by the Committee in its discretion. The Committee may, in its discretion, accelerate
the vesting of a Restricted Stock Award at any time. If the vesting requirements of a Restricted Stock Award shall not be satisfied,
the Award shall be forfeited and the shares of Common Stock subject to the Award shall be returned to the Company. In the event that
the Participant paid any purchase price with respect to such forfeited shares, unless otherwise provided by the Committee in an Award
Agreement, the Company will refund to the Participant the lesser of (i)&nbsp;such purchase price and (ii)&nbsp;the Fair Market Value
of such shares on the date of forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Restrictions</U>. Shares granted under any Restricted Stock Award may not be transferred, assigned or subject to any encumbrance,
pledge, or charge until all applicable restrictions are removed or have expired, unless otherwise allowed by the Committee. The Committee
may require in an Award Agreement that certificates representing the shares granted under a Restricted Stock Award bear a legend making
appropriate reference to the restrictions imposed, and that certificates representing the shares granted or sold under a Restricted Stock
Award will remain in the physical custody of an escrow holder until all restrictions are removed or have expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Rights as Stockholder</U>. Subject to the foregoing provisions of this Section&nbsp;8 and the applicable Award Agreement, the Participant
to whom a Restricted Stock Award is made shall have all rights of a stockholder with respect to the shares granted to the Participant
under the Restricted Stock Award, including the right to vote the shares and receive all dividends and other distributions paid or made
with respect thereto, unless the Committee determines otherwise at the time the Restricted Stock Award is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Section&nbsp;83(b) Election</U>. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted
Stock Award, the Participant shall file, within 30 days following the Date of Grant, a copy of such election with the Company (directed
to the Secretary thereof) and with the Internal Revenue Service, in accordance with the regulations under Section 83 of the Code. The
Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant&rsquo;s making or refraining
from making an election with respect to the Award under Section 83(b) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Stock Unit Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Grant of Stock Unit Awards</U>. A Stock Unit Award may be granted to any Eligible Person selected by the Committee. The value of each
Stock Unit under a Stock Unit Award is equal to the Fair Market Value of the Common Stock on the applicable date or time period of determination,
as specified by the Committee. A Stock Unit Award shall be subject to such restrictions and conditions as the Committee shall determine.
A Stock Unit Award may be granted together with a dividend equivalent right with respect to the shares of Common Stock subject to the
Award, which may be accumulated and may be deemed reinvested in additional Stock Units, as determined by the Committee in its discretion.
If any dividend equivalents are paid while a Stock Unit Award is subject to restrictions under Section 9 of the Plan, the dividend equivalents
shall be subject to the same restrictions on transferability as the Stock Units to which they were paid, unless otherwise set forth in
the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Vesting of Stock Unit Awards</U>. On the Date of Grant, the Committee shall, in its discretion, determine any vesting requirements
with respect to a Stock Unit Award, which shall be set forth in the Award Agreement. The requirements for vesting of a Stock Unit Award
may be based on the continued Service of the Participant for a specified time period (or periods) or on the attainment of a specified
performance goal (or goals) established by the Committee in its discretion. The Committee may, in its discretion, accelerate the vesting
of a Stock Unit Award at any time. A Stock Unit Award may also be granted on a fully vested basis, with a deferred payment date as may
be determined by the Committee or elected by the Participant in accordance with rules established by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
<U>Payment of Stock Unit Awards</U>. A Stock Unit Award shall become payable to a Participant at the time or times determined by the
Committee and set forth in the Award Agreement, which may be upon or following the vesting of the Award. Payment of a Stock Unit Award
may be made, at the discretion of the Committee, in cash or in shares of Common Stock, or in a combination thereof as described in the
Award Agreement, subject to applicable tax withholding requirements set forth in Section&nbsp;16.5. Any cash payment of a Stock Unit
Award shall be made based upon the Fair Market Value of the Common Stock, determined on such date or over such time period as determined
by the Committee. Notwithstanding the foregoing, unless specified otherwise in the Award Agreement, any Stock Unit, whether settled in
Common Stock or cash, shall be paid no later than two and one-half months after the later of the calendar year or fiscal year in which
the Stock Units vest. If Stock Unit Awards are settled in shares of Common Stock, then as soon as practicable following the date of settlement
the Company shall deliver to the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request,
Common Stock certificates in an appropriate amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. Performance Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
<U>Grant of Performance Shares</U>. Performance Shares may be granted to any Eligible Person selected by the Committee. A Performance
Share Award shall be subject to such restrictions and condition as the Committee shall specify. A Performance Share Award may be granted
with a dividend equivalent right with respect to the shares of Common Stock subject to the Award, which may be accumulated and may be
deemed reinvested in additional Stock Units, as determined by the Committee in its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
<U>Value of Performance Shares</U>. Each Performance Share shall have an initial value equal to the Fair Market Value of a Share on the
Grant Date. The Committee shall set performance goals in its discretion that, depending on the extent to which they are met over a specified
time period, shall determine the number of Performance Shares that shall be paid to a Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
<U>Earning of Performance Shares</U>. After the applicable time period has ended, the number of Performance Shares earned by the Participant
over such time period shall be determined as a function of the extent to which the applicable corresponding performance goals have been
achieved. This determination shall be made solely by the Committee. The Committee may, in its discretion, waive any performance or vesting
conditions relating to a Performance Share Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
<U>Form and Timing of Payment of Performance Shares</U>. The Committee shall pay at the close of the applicable Performance Period, or
as soon as practicable thereafter, any earned Performance Shares in the form of cash or in shares of Common Stock or in a combination
thereof, as specified in a Participant&rsquo;s Award Agreement, subject to applicable tax withholding requirements set forth in Section&nbsp;16.5.
Notwithstanding the foregoing, unless specified otherwise in the Award Agreement, all Performance Shares shall be paid no later than
two and one-half months following the later of the calendar year or fiscal year in which such Performance Shares vest. Any shares of
Common Stock paid to a Participant under this Section&nbsp;10.4 may be subject to any restrictions deemed appropriate by the Committee.
If Performance Shares are settled in shares of Common Stock, then as soon as practicable following the date of settlement the Company
shall deliver to the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common Stock
certificates in an appropriate amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Performance Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1
<U>Grant of Performance Units</U>. Performance Units may be granted to any Eligible Person selected by the Committee. A Performance Unit
Award shall be subject to such restrictions and conditions as the Committee shall specify in a Participant&rsquo;s Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2
<U>Value of Performance Units</U>. Each Performance Unit shall have an initial notional value equal to a dollar amount determined by
the Committee, in its sole discretion. The Committee shall set performance goals in its discretion that, depending on the extent to which
they are met over a specified time period, will determine the number of Performance Units that shall be settled and paid to the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3
<U>Earning of Performance Units</U>. After the applicable time period has ended, the number of Performance Units earned by the Participant,
and the amount payable in cash, in shares or in a combination thereof, over such time period shall be determined as a function of the
extent to which the applicable corresponding performance goals have been achieved. This determination shall be made solely by the Committee.
The Committee may, in its discretion, waive any performance or vesting conditions relating to a Performance Unit Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4
<U>Form and Timing of Payment of Performance Units</U>. The Committee shall pay at the close of the applicable Performance Period, or
as soon as practicable thereafter, any earned Performance Units in the form of cash or in shares of Common Stock or in a combination
thereof, as specified in a Participant&rsquo;s Award Agreement, subject to applicable tax withholding requirements set forth in Section&nbsp;16.5.
Notwithstanding the foregoing, unless specified otherwise in the Award Agreement, all Performance Units shall be paid no later than two
and one-half months following the later of the calendar year or fiscal year in which such Performance Units vest. Any shares of Common
Stock paid to a Participant under this Section&nbsp;11.4 may be subject to any restrictions deemed appropriate by the Committee. If Performance
Units are settled in shares of Common Stock, then as soon as practicable following the date of settlement the Company shall deliver to
the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common Stock certificates in
an appropriate amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. [Intentionally Omitted]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13. Other Stock-Based Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1
<U>Other Stock-Based Awards</U>. The Committee may grant other types of equity-based or equity-related Awards not otherwise described
by the terms of this Plan (including the grant or offer for sale of unrestricted Shares) in such amounts and subject to such terms and
conditions, as the Committee shall determine. Such Awards may involve the transfer of actual shares of Common Stock to a Participant,
or payment in cash or otherwise of amounts based on the value of shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2
<U>Value of Other Stock-Based Awards</U>. Each Other Stock-Based Award shall be expressed in terms of shares of Common Stock or units
based on shares of Common Stock, as determined by the Committee, in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
Change in Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1
<U>Effect of Change in Control</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Committee may, at the time of the grant of an Award and as set forth in an Award Agreement, provide for the effect of a &ldquo;Change
in Control&rdquo; on an Award. Such provisions may include any one or more of the following: (i)&nbsp;the acceleration or extension of
time periods for purposes of exercising, vesting in, or realizing gain from any Award, (ii)&nbsp;the elimination or modification of performance
or other conditions related to the payment or other rights under an Award, (iii)&nbsp;provision for the cash settlement of an Award for
an equivalent cash value, as determined by the Committee, or (iv)&nbsp;such other modification or adjustment to an Award as the Committee
deems appropriate to maintain and protect the rights and interests of Participants upon or following a Change in Control. To the extent
necessary for compliance with Section&nbsp;409A of the Code, an Award Agreement shall provide that an Award subject to the requirements
of Section&nbsp;409A that would otherwise become payable upon a Change in Control shall only become payable to the extent that the requirements
for a &ldquo;change in control&rdquo; for purposes of Section&nbsp;409A have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding anything to the contrary set forth in the Plan, unless otherwise provided by an Award Agreement, upon or in anticipation
of any Change in Control, the Committee may, in its sole and absolute discretion and without the need for the consent of any Participant,
take one or more of the following actions contingent upon the occurrence of that Change in Control: (i)&nbsp;cause any or all outstanding
Stock Options and Stock Appreciation Rights held by Participants affected by the Change in Control to become vested and immediately exercisable,
in whole or in part; (ii)&nbsp;cause any or all outstanding Restricted Stock, Stock Units, Performance Shares, Performance Units, Incentive
Bonus Award and any other Award held by Participants affected by the Change in Control to become non-forfeitable, in whole or in part;
(iii)&nbsp;cancel any Stock Option or Stock Appreciation Right in exchange for a substitute option in a manner consistent with the requirements
of Treasury Regulation &sect;1.424-1(a) or &sect;1.409A-1(b)(5)(v)(D), as applicable (notwithstanding the fact that the original Stock
Option may never have been intended to satisfy the requirements for treatment as an Incentive Stock Option); (iv)&nbsp;cancel any Restricted
Stock, Stock Units, Performance Shares or Performance Units held by a Participant in exchange for restricted stock or performance shares
of or stock or performance units in respect of the capital stock of any successor corporation; (v)&nbsp;redeem any Restricted Stock held
by a Participant affected by the Change in Control for cash and/or other substitute consideration with a value equal to the Fair Market
Value of an unrestricted share of Common Stock on the date of the Change in Control; (vi)&nbsp;terminate any Award in exchange for an
amount of cash and/or property equal to the amount, if any, that would have been attained upon the exercise of such Award or realization
of the Participant&rsquo;s rights as of the date of the occurrence of the Change in Control (the &ldquo;Change in Control Consideration&rdquo;);
provided, however that if the Change in Control Consideration with respect to any Option or Stock Appreciation Right does not exceed
the exercise price of such Option or Stock Appreciation Right, the Committee may cancel the Option or Stock Appreciation Right without
payment of any consideration therefor. Any such Change in Control Consideration may be subject to any escrow, indemnification and similar
obligations, contingencies and encumbrances applicable in connection with the Change in Control to holders of Common Stock. Without limitation
of the foregoing, if as of the date of the occurrence of the Change in Control the Committee determines that no amount would have been
attained upon the realization of the Participant&rsquo;s rights, then such Award may be terminated by the Company without payment. The
Committee may cause the Change in Control Consideration to be subject to vesting conditions (whether or not the same as the vesting conditions
applicable to the Award prior to the Change in Control) and/or make such other modifications, adjustments or amendments to outstanding
Awards or this Plan as the Committee deems necessary or appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Committee may require a Participant to (i) represent and warrant as to the unencumbered title to the Participant&rsquo;s Awards,
(ii) bear such Participant&rsquo;s pro rata share of any post-closing indemnity obligations, and be subject to the same or similar post-closing
purchase price adjustments, escrow terms, offset rights, holdback terms and similar conditions as the other holders of Common Stock,
and (iii) execute and deliver such documents and instruments as the Committee may reasonably require for the Participant to be bound
by such obligations. The Committee will endeavor to take action under this Section 14 in a manner that does not cause a violation of
Section 409A of the Code with respect to an Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
General Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1
<U>Award Agreement</U>. To the extent deemed necessary by the Committee, an Award under the Plan shall be evidenced by an Award Agreement
in a written or electronic form approved by the Committee setting forth the number of shares of Common Stock or units subject to the
Award, the exercise price, base price, or purchase price of the Award, the time or times at which an Award will become vested, exercisable
or payable and the term of the Award. The Award Agreement may also set forth the effect on an Award of termination of Service under certain
circumstances. The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions
of the Plan and may also set forth other terms and conditions applicable to the Award as determined by the Committee consistent with
the limitations of the Plan. Award Agreements evidencing Incentive Stock Options shall contain such terms and conditions as may be necessary
to meet the applicable provisions of Section 422 of the Code. The grant of an Award under the Plan shall not confer any rights upon the
Participant holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as being applicable
to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2
<U>Forfeiture Events/Representations</U>. The Committee may specify in an Award Agreement at the time of the Award that the Participant&rsquo;s
rights, payments, and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the
occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events
shall include, but shall not be limited to, termination of Service for Cause, violation of material Company policies, breach of noncompetition,
confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental
to the business or reputation of the Company. The Committee may also specify in an Award Agreement that the Participant&rsquo;s rights,
payments and benefits with respect to an Award shall be conditioned upon the Participant making a representation regarding compliance
with noncompetition, confidentiality or other restrictive covenants that may apply to the Participant and providing that the Participant&rsquo;s
rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment on account
of a breach of such representation. Notwithstanding the foregoing, the confidentiality restrictions set forth in an Award Agreement shall
not, and shall not be interpreted to, impair a Participant from exercising any legally protected whistleblower rights (including under
Rule 21 of the Exchange Act). In addition, and without limitation of the foregoing, any amounts paid hereunder shall be subject to recoupment
in accordance with The Dodd&ndash;Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any
&ldquo;clawback&rdquo; policy adopted by the Company or as is otherwise required by applicable law or stock exchange listing condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3
<U>No Assignment or Transfer; Beneficiaries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Awards under the Plan shall not be assignable or transferable by the Participant, except by will or by the laws of descent and distribution,
and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, the Committee
may provide in an Award Agreement that the Participant shall have the right to designate a beneficiary or beneficiaries who shall be
entitled to any rights, payments or other benefits specified under an Award following the Participant&rsquo;s death. During the lifetime
of a Participant, an Award shall be exercised only by such Participant or such Participant&rsquo;s guardian or legal representative.
In the event of a Participant&rsquo;s death, an Award may, to the extent permitted by the Award Agreement, be exercised by the Participant&rsquo;s
beneficiary as designated by the Participant in the manner prescribed by the Committee or, in the absence of an authorized beneficiary
designation, by the legatee of such Award under the Participant&rsquo;s will or by the Participant&rsquo;s estate in accordance with
the Participant&rsquo;s will or the laws of descent and distribution, in each case in the same manner and to the same extent that such
Award was exercisable by the Participant on the date of the Participant&rsquo;s death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Limited
Transferability Rights.</U>&nbsp;Notwithstanding anything else in this Section&nbsp;15.3 to the contrary, the Committee may in its discretion
provide in an Award Agreement that an Award in the form of a Nonqualified Stock Option, share-settled Stock Appreciation Right, Restricted
Stock, Performance Share or share-settled Other Stock-Based Award may be transferred, on such terms and conditions as the Committee deems
appropriate, either (i)&nbsp;by instrument to the Participant&rsquo;s &ldquo;Immediate Family&rdquo; (as defined below), (ii)&nbsp;by
instrument to an inter vivos or testamentary trust (or other entity) in which the Award is to be passed to the Participant&rsquo;s designated
beneficiaries, or (iii)&nbsp;by gift to charitable institutions. Any transferee of the Participant&rsquo;s rights shall succeed and be
subject to all of the terms of the applicable Award Agreement and the Plan. &ldquo;Immediate Family&rdquo; means any child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law, and shall include adoptive relationships.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4
<U>Rights as Stockholder</U>. A Participant shall have no rights as a holder of shares of Common Stock with respect to any unissued securities
covered by an Award until the date the Participant becomes the holder of record of such securities. Except as provided in Section&nbsp;4.2
hereof, no adjustment or other provision shall be made for dividends or other stockholder rights, except to the extent that the Award
Agreement provides for dividend payments or dividend equivalent rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.5
<U>Employment or Service</U>. Nothing in the Plan, in the grant of any Award or in any Award Agreement shall confer upon any Eligible
Person or Participant any right to continue in Service or interfere in any way with the right of the Company or any of its Subsidiaries
to terminate the employment or other service relationship of an Eligible Person or Participant for any reason at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.6
<U>Fractional Shares</U>. In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting of dividends
or dividend equivalents under an Award, the Committee shall have the discretionary authority to (i)&nbsp;disregard such fractional share
or unit, (ii)&nbsp;round such fractional share or unit to the nearest lower or higher whole share or unit, or (iii)&nbsp;convert such
fractional share or unit into a right to receive a cash payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.7
<U>Other Compensation and Benefit Plans</U>. The amount of any compensation deemed to be received by a Participant pursuant to an Award
shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under
any other compensation or benefit plan or program of the Company or any Subsidiary, including, without limitation, under any bonus, pension,
profit-sharing, life insurance, salary continuation or severance benefits plan, except to the extent specifically provided by the terms
of any such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.8
<U>Plan Binding on Transferees</U>. The Plan shall be binding upon the Company, its transferees and assigns, and the Participant, the
Participant&rsquo;s executor, administrator and permitted transferees and beneficiaries. In addition, all obligations of the Company
under this Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such
successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business
and/or assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.9
<U>Foreign Jurisdictions</U>. The Committee may adopt, amend and terminate such arrangements and grant such Awards, not inconsistent
with the intent of the Plan, as it may deem necessary or desirable to comply with any tax, securities, regulatory or other laws of other
jurisdictions with respect to Awards that may be subject to such laws. The terms and conditions of such Awards may vary from the terms
and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary for such purpose. Moreover,
the Board may approve such supplements to or amendments, restatements, or alternative versions of the Plan, not inconsistent with the
intent of the Plan, as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of the Plan as
in effect for any other purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.10
<U>Substitute Awards in Corporate Transactions</U>. Nothing contained in the Plan shall be construed to limit the right of the Committee
to grant Awards under the Plan in connection with the acquisition, whether by purchase, merger, consolidation, or other corporate transaction,
of the business or assets of any corporation or other entity. Without limiting the foregoing, the Committee may grant Awards under the
Plan to an employee or director of another corporation who becomes an Eligible Person by reason of any such corporate transaction in
substitution for Awards previously granted by such corporation or entity to such person. The terms and conditions of the substitute Awards
may vary from the terms and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary
for such purpose. Any shares of Common Stock subject to these substitute Awards shall not be counted against any of the maximum share
limitations set forth in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
16. Legal Compliance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1
<U>Securities Laws</U>. No shares of Common Stock will be issued or transferred pursuant to an Award unless and until all then applicable
requirements imposed by Federal and state securities and other laws, rules and regulations and by any regulatory agencies having jurisdiction,
and by any exchanges upon which the shares of Common Stock may be listed, have been fully met. As a condition precedent to the issuance
of shares pursuant to the grant or exercise of an Award, the Company may require the Participant to take any reasonable action to meet
such requirements. The Committee may impose such conditions on any shares of Common Stock issuable under the Plan as it may deem advisable,
including, without limitation, restrictions under the Securities Act, as amended, under the requirements of any exchange upon which such
shares of the same class are then listed, and under any blue sky or other securities laws applicable to such shares. The Committee may
also require the Participant to represent and warrant at the time of issuance or transfer that the shares of Common Stock are being acquired
only for investment purposes and without any current intention to sell or distribute such shares. All Common Stock issued pursuant to
the terms of this Plan shall constitute &ldquo;restricted securities,&rdquo; as that term is defined in Rule 144 promulgated pursuant
to the Securities Act and may not be transferred except in compliance herewith and with the registration requirements of the Securities
Act or an exemption therefrom. Certificates representing Common Stock acquired pursuant to an Award may bear such legend as the Company
may consider appropriate under the circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2
<U>Incentive Arrangement</U>. The Plan is designed to provide an ongoing, pecuniary incentive for Participants to produce their best
efforts to increase the value of the Company. The Plan is not intended to provide retirement income or to defer the receipt of payments
hereunder to the termination of a Participant&rsquo;s employment or beyond. The Plan is thus intended not to be a pension or welfare
benefit plan that is subject to Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;) and shall be construed accordingly.
All interpretations and determinations hereunder shall be made on a basis consistent with the Plan&rsquo;s status as not an employee
benefit plan subject to ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3
<U>Unfunded Plan</U>. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by the Company to discharge
its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock
pursuant to an Award, any rights of a Participant under the Plan shall be those of a general unsecured creditor of the Company, and neither
a Participant nor the Participant&rsquo;s permitted transferees or estate shall have any other interest in any assets of the Company
by virtue of the Plan. Notwithstanding the foregoing, the Company shall have the right to implement or set aside funds in a grantor trust,
subject to the claims of the Company&rsquo;s creditors or otherwise, to discharge its obligations under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4
<U>Section&nbsp;409A Compliance</U>. To the extent applicable, it is intended that the Plan and all Awards hereunder comply with the
requirements of Section&nbsp;409A of the Code or an exemption thereto, and the Plan and all Award Agreements shall be interpreted and
applied by the Committee in a manner consistent with this intent in order to avoid the imposition of any additional tax under Section&nbsp;409A
of the Code. Notwithstanding anything in the Plan to the contrary, in the event that any provision of the Plan or an Award Agreement
is determined by the Committee, in its sole discretion, to not comply with the requirements of Section&nbsp;409A of the Code or an exemption
thereto, the Committee shall, in its sole discretion, have the authority to take such actions and to make such interpretations or changes
to the Plan or an Award Agreement as the Committee deems necessary, regardless of whether such actions, interpretations or changes shall
adversely affect a Participant, subject to the limitations, if any, of applicable law. If an Award is subject to Section 409A of the
Code, any payment made to a Participant who is a &ldquo;specified employee&rdquo; of the Company or any Subsidiary shall not be made
before the date that is six months after the Participant&rsquo;s &ldquo;separation from service&rdquo; to the extent required to avoid
the adverse consequences of Section 409A of the Code. For purposes of this Section 16.4, the terms &ldquo;separation from service&rdquo;
and &ldquo;specified employee&rdquo; shall have the meanings set forth in Section 409A of the Code. In no event whatsoever shall the
Company be liable for any additional tax, interest or penalties that may be imposed on any Participant by Section&nbsp;409A of the Code
or any damages for failing to comply with Section&nbsp;409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5
<U>Tax Withholding</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall have the power and the right to deduct or withhold, or require a participant to remit to the Company, the minimum statutory
amount to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to
any taxable event arising as a result of this Plan, but in no event shall such deduction or withholding or remittance exceed the minimum
statutory withholding requirements unless permitted by the Company and such additional withholding amount will not cause adverse accounting
consequences and is permitted under Applicable Law. Notwithstanding the foregoing, if a minimum statutory amount of withholding does
not apply under the laws of any foreign jurisdiction, the Company may withhold such amount for remittance to the applicable taxing authority
of such jurisdiction as the Company determines in its discretion, uniformly applied, to be appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
A Participant may, in order to fulfill the withholding obligation, tender previously-acquired shares of Common Stock or have shares of
stock withheld from the exercise, provided that the shares have an aggregate Fair Market Value sufficient to satisfy in whole or in part
the applicable withholding taxes. The broker-assisted exercise procedure described in Section 6.5 may also be utilized to satisfy the
withholding requirements related to the exercise of a Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, a Participant may not use shares of Common Stock to satisfy the withholding requirements to the extent
that (i) there is a substantial likelihood that the use of such form of payment or the timing of such form of payment would subject the
Participant to a substantial risk of liability under Section 16 of the Exchange Act; (ii) such withholding would constitute a violation
of the provisions of any law or regulation (including the Sarbanes-Oxley Act of 2002); or (iii) such withholding would cause adverse
accounting consequences for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6
<U>No Guarantee of Tax Consequences</U>. Neither the Company, the Board, the Committee nor any other Person make any commitment or guarantee
that any federal, state, local or foreign tax treatment will apply or be available to any Participant or any other person hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7
<U>Severability</U>. If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court
of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms,
and all provisions shall remain enforceable in any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.8
<U>Stock Certificates; Book Entry Form</U>.&nbsp;<FONT STYLE="background-color: white">Notwithstanding any provision of the Plan to the
contrary, unless otherwise determined by the Committee or required by any applicable law, rule or regulation, any obligation set forth
in the Plan pertaining to the delivery or issuance of stock certificates evidencing shares of Common Stock may be satisfied by having
issuance and/or ownership of such shares recorded on the books and records of the&nbsp;</FONT>Company&nbsp;<FONT STYLE="background-color: white">(or,
as applicable, its transfer agent or stock plan administrator).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.9
<U>Governing Law</U>. The Plan and all rights hereunder shall be subject to and interpreted in accordance with the laws of the State
of Delaware, without reference to the principles of conflicts of laws, and to applicable Federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
17. Effective Date, Amendment and Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1
<U>Effective Date</U>. The effective date of the Plan shall be the date on which the Plan is approved by the Board; provided, however,
that Awards granted under the Plan subsequent to the approval of the Plan by the Board shall be valid only if the Plan is approved by
the requisite percentage of the voting stockholders of the Company, within one year of the date on which such Board approval occurs.
If such stockholder approval is not obtained within one year after the date of the Board&rsquo;s approval of the Plan, then all Awards
previously granted under the Plan shall terminate and cease to be outstanding, and no further Awards shall be granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2
<U>Amendment; Termination</U>. The Board may suspend or terminate the Plan (or any portion thereof) at any time and may amend the Plan
at any time and from time to time in such respects as the Board may deem advisable or in the best interests of the Company or any Subsidiary;
provided, however, that (a) no such amendment, suspension or termination shall materially impair any rights or materially increase any
obligations under any Award theretofore made under the Plan without the consent of the Participant affected thereby (or, after the Participant&rsquo;s
death, the person having the right to exercise the Award), (b) to the extent necessary and desirable to comply with any applicable law,
regulation, or stock exchange rule, the Company shall obtain stockholder approval of any Plan amendment in such a manner and to such
a degree as required, and (c) stockholder approval is required for any amendment to the Plan that (i) increases the number of shares
of Common Stock available for issuance under the Plan, or (ii) changes the persons or class of persons eligible to receive Awards. For
purposes of the foregoing, any action of the Board or the Committee that alters or affects the tax treatment of any Award shall not be
considered to materially impair any rights of any Participant. The Plan will continue in effect until terminated in accordance with this
Section&nbsp;17.2;&nbsp;<I>provided, however,</I>&nbsp;that no Award will be granted hereunder on or after the 10th anniversary of the
date of the adoption of the Plan by the Board (the &ldquo;<U>Expiration Date</U>&rdquo;); but provided further, that Awards granted prior
to such Expiration Date may extend beyond that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*****</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCENTIVE
STOCK OPTION GRANT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC. 2024 EQUITY INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Stock Option Grant Agreement (the &ldquo;<U>Grant Agreement</U>&rdquo;) is made and entered into effective on the Date of Grant set forth
in&nbsp;<U>Exhibit A</U>&nbsp;(the &ldquo;<U>Date of Grant</U>&rdquo;) by and between bioAffinity Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and the individual named in&nbsp;<U>Exhibit A</U>&nbsp;hereto (the &ldquo;<U>Optionee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to provide the Optionee an incentive to participate in the success and growth of the Company through the opportunity
to earn a proprietary interest in the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
to give effect to the foregoing intention, the Company desires to grant the Optionee an option pursuant to the bioAffinity Technologies,
Inc. 2024 Equity Incentive Compensation Plan (the &ldquo;<U>Plan</U>&rdquo;) to acquire the Company&rsquo;s common stock, par value $0.007
per share (the&nbsp;&rdquo;<U>Common Stock</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants hereinafter set forth and for good and valuable consideration, the parties hereto
agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Grant</U>. The Company hereby grants the Optionee a Nonqualified Stock Option (the &ldquo;<U>Option</U>&rdquo;) to purchase up to
the number of shares of Common Stock (the &ldquo;<U>Shares</U>&rdquo;) set forth in&nbsp;<U>Exhibit A</U>&nbsp;hereto at the exercise
price per Share (the &ldquo;<U>Exercise Price</U>&rdquo;) set forth in&nbsp;<U>Exhibit A</U>, and on the vesting schedule set forth in&nbsp;<U>Exhibit
A</U>, subject to the terms and conditions set forth herein and the provisions of the Plan, the terms of which are incorporated herein
by reference. Capitalized terms used but not otherwise defined in this Grant Agreement shall have the meanings as set forth in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Option is intended to qualify as an Incentive Stock Option (&ldquo;<U>ISO</U>&rdquo;) under Section 422 of the Code. However, notwithstanding
such designation, if the Optionee becomes eligible in any given year to exercise ISOs for Shares having a Fair Market Value in excess
of $100,000, those options representing the excess shall be treated as Nonqualified Stock Options. In the previous sentence, &ldquo;ISOs&rdquo;
include ISOs granted under any plan of the Company or any parent or any Subsidiary of the Company. For the purpose of deciding which
options apply to Shares that &ldquo;exceed&rdquo; the $100,000 limit, ISOs shall be taken into account in the same order as granted.
The Fair Market Value of the Shares shall be determined as of the time the Option with respect to such Shares is granted. The Optionee
hereby acknowledges that there is no assurance that the Option will, in fact, be treated as an Incentive Stock Option under Section 422
of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Exercise Period Following Termination of Service</U>. This Option shall terminate and be canceled to the extent not exercised within
three (3) months after the Optionee&rsquo;s Service terminates; provided that if such termination is due to the Optionee&rsquo;s total
and permanent disability within the meaning of Section 22(e)(3) of the Code, this Option shall terminate and be canceled one (1) year
from the date of termination of the Optionee&rsquo;s Service; and provided, further, that if Optionee&rsquo;s Service terminates (other
than for Cause) on or after a Change in Control, then the Option shall remain exercisable until the Expiration Date. Notwithstanding
the foregoing, in the event that the Optionee&rsquo;s Service is terminated for Cause, then the Option shall immediately terminate on
the date of such termination of Service and shall not be exercisable for any period following such date. In no event, however, shall
this Option be exercised later than the Expiration Date set forth in&nbsp;<U>Exhibit A</U>&nbsp;and in no event shall this Option be
exercised for more Shares than the Shares which otherwise have become exercisable as of the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Method of Exercise</U>. This Option is exercisable by delivery to the Company of an exercise notice (the &ldquo;<U>Exercise Notice</U>&rdquo;)
in a form satisfactory to the Committee or by such other form or means as the Committee may permit or require. Any Exercise Notice shall
state or provide the number of Shares with respect to which the Option is being exercised (the &ldquo;<U>Exercised Shares</U>&rdquo;),
and include such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Optionee
may elect to make payment of the exercise price in cash or by check or by delivery to the Company of certificates representing shares
of outstanding Common Stock already owned by the Optionee that are owned free and clear of any liens, claims, encumbrances or security
interests together with stock powers duly executed and with signature guaranteed. In addition, the Optionee may make payment through
a &ldquo;cashless exercise&rdquo; such that without the payment of any funds, the undersigned may exercise the Option and receive the
net number of Shares equal to (x) the number of Shares as to which the Option is being exercised, multiplied by (y) a fraction, the numerator
of which is the Fair Market Value per share (on such date as is determined by the Committee) less the Exercise Price per Share, and the
denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest
whole number). In the event payment is made by delivery of such Shares, said Shares shall be deemed to have a per Share value equal to
the Fair Market Value per Share on the date of exercise. Upon exercise of the Option by the Optionee and prior to the delivery of such
Exercised Shares, the Company shall have the right to require the Optionee to satisfy applicable Federal and state tax income tax withholding
requirements and the Optionee&rsquo;s share of applicable employment withholding taxes in a method satisfactory to the Company. Notwithstanding
the foregoing, the Optionee may not exercise the Option by tender to the Company of Common Stock to the extent such tender would violate
the provisions of any law, regulation or agreement restricting the redemption of the Company&rsquo;s Common Stock. Further, no Exercised
Shares shall be issued unless such exercise and issuance complies with the requirements relating to the administration of stock option
plans and other applicable equity plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock
exchange or quotation system on which the Common Stock is listed or quoted, and the applicable laws of any foreign country or jurisdiction
where stock grants or other applicable equity grants are made under the Plan; assuming such compliance, for income tax purposes the Exercised
Shares shall be considered transferred to the Optionee on the date the Option is exercised with respect to such Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Covenants Agreement</U>. This Option shall be subject to forfeiture at the election of the Company in the event that the Optionee
breaches any agreement between the Optionee and the Company with respect to noncompetition, nonsolicitation, assignment of inventions
and contributions and/or nondisclosure obligations of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
By executing this Grant Agreement, Optionee acknowledges and agrees that Optionee is solely responsible for the satisfaction of any applicable
taxes that may be imposed on Optionee that arise as a result of the grant, vesting or exercise of the Option, including without limitation
any taxes arising under Section 409A of the Code (regarding deferred compensation) or Section 4999 of the Code (regarding golden parachute
excise taxes), and that neither the Company nor the Committee shall have any obligation whatsoever to pay such taxes or otherwise indemnify
or hold Optionee harmless from any or all of such taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding paragraph (a) above, if any amounts or benefits provided for in this Grant Agreement, when aggregated with any other
payments or benefits payable or provided to the Optionee (the &ldquo;Total Payments&rdquo;) would (i) constitute &ldquo;parachute payments&rdquo;
within the meaning of Section 280G of the Code (which will not include any portion of payments classified as payments of reasonable compensation
for purposes of Section 280G of the Code, including without limitation amounts allocated to any restrictive covenants), and (ii) but
for this Section 5(b), would be subject to the excise tax imposed by Section 4999 of the Code (the &ldquo;Excise Tax&rdquo;), then the
Total Payments will be either: (a) provided in full, or (b) provided as to such lesser extent as would result in no portion of such Total
Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local
income and employment taxes and the Excise Tax, results in the Optionee&rsquo;s receipt on an after-tax basis of the greatest amount
of the Total Payments, notwithstanding that all or some portion of the Total Payments may be subject to the Excise Tax. To the extent
any reduction in Total Payments is required by this Section 5(b), such reduction shall occur to the payments and benefits in the order
that results in the greatest economic present value of all payments and benefits actually made to Optionee. Subject to Section 409A of
the Code, such order of reductions shall be determined by the Optionee. Unless the Company and the Optionee otherwise agree in writing,
any determination required under this Section 5(b) shall be made in writing by an independent public accounting firm mutually acceptable
to the Company and the Optionee (the &ldquo;Accountants&rdquo;) whose determination shall be conclusive and binding upon the Optionee
and the Company for all purposes. For purposes of making the calculations required by this Section 5(b), the Accountants may make reasonable
assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application
of Sections 280G and 4999 of the Code. The Company and the Optionee shall furnish to the Accountants such information and documents as
the Accountants may reasonably request in order to make a determination under this Section 5(b). The Company shall pay all fees and expenses
of the Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Non-Transferability of Option</U>. This Option may not be transferred in any manner otherwise than by will or by the laws of descent
or distribution and may be exercised during the lifetime of the Optionee only by the Optionee. The terms of the Plan and this Grant Agreement
shall be binding upon the executors, administrators, heirs, successors and assigns of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Securities Matters</U>. All Shares and Exercised Shares shall be subject to the restrictions on sale, encumbrance and other disposition
provided by Federal or state law. The Company shall not be obligated to sell or issue any Shares or Exercised Shares pursuant to this
Grant Agreement unless, on the date of sale and issuance thereof, such Shares are either registered under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), and all applicable state securities laws, or are exempt from registration thereunder.
Regardless of whether the offering and sale of Shares under the Plan have been registered under the Securities Act, or have been registered
or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other
transfer of such Shares (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions)
if, in the judgment of the Company, such restrictions are necessary in order to achieve compliance with the Securities Act or the securities
laws of any state or any other law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Investment Purpose</U>. The Optionee represents and warrants that unless the Shares are registered under the Securities Act, any and
all Shares acquired by the Optionee under this Grant Agreement will be acquired for investment for the Optionee&rsquo;s own account and
not with a view to, for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of
such Shares within the meaning of the Securities Act. The Optionee agrees not to sell, transfer or otherwise dispose of such Shares unless
they are either (1) registered under the Securities Act and all applicable state securities laws, or (2) exempt from such registration
in the opinion of Company counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Lock-Up Agreement</U>. The Optionee hereby agrees that in the event that the Optionee exercises this Option during a period in which
any directors or officers of the Company have agreed with one or more underwriters not to sell securities of the Company, then, as a
condition to such exercise, the Optionee shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to
which the Optionee shall agree to restrictions on transferability of the Shares comparable to the restrictions agreed upon by such directors
or officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Other Plans</U>. No amounts of income received by the Optionee pursuant to this Grant Agreement shall be considered compensation for
purposes of any pension or retirement plan, insurance plan or any other employee benefit plan of the Company or its subsidiaries, unless
otherwise expressly provided in such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>No Guarantee of Continued Service</U>. The Optionee acknowledges and agrees that the right to exercise the Option pursuant to the
exercise schedule hereof is earned only through continuous Service and such other requirements, if any, as are set forth in&nbsp;<U>Exhibit
A</U>&nbsp;(and not through the act of being hired, being granted an option or purchasing shares hereunder). The Optionee further acknowledges
and agrees that (i) this Grant Agreement, the transactions contemplated hereunder and the exercise schedule set forth herein do not constitute
an express or implied promise of continued employment or service for the exercise period or for any other period, and shall not interfere
with the Optionee&rsquo;s right or the right of the Company or its Subsidiaries to terminate the employment or service relationship at
any time, with or without cause, subject to the terms of any written employment agreement that the Optionee may have entered into with
the Company or any of its Subsidiaries; and (ii) the Company would not have granted this Option to the Optionee but for these acknowledgements
and agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Entire Agreement; Governing Law</U>. The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the
entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and
agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be amended to materially impair the
rights of the Optionee without the Optionee&rsquo;s consent; provided, however, that no action of the Board or the Committee that alters
or affects the tax treatment of the Option shall be considered to materially impair any rights of the Optionee. In the event of any conflict
between this Grant Agreement and the Plan, the Plan shall be controlling, except as otherwise specifically provided in the Plan. This
Grant Agreement shall be construed under the laws of the State of Delaware, without regard to conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Opportunity for Review</U>. Optionee and the Company agree that this Option is granted under and governed by the terms and conditions
of the Plan and this Grant Agreement. The Optionee has reviewed the Plan and this Grant Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to executing this Grant Agreement and fully understands all provisions of the Plan and this Grant
Agreement. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon
any questions relating to the Plan and this Grant Agreement. The Optionee further agrees to notify the Company upon any change in the
residence address indicated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&nbsp;<U>Section
409A</U>. This Option is intended to be excepted from coverage under Section 409A and shall be administered, interpreted and construed
accordingly. The Company may, in its sole discretion and without the Optionee&rsquo;s consent, modify or amend the terms of this Grant
Agreement, impose conditions on the timing and effectiveness of the exercise of the Option by Optionee, or take any other action it deems
necessary or advisable, to cause the Option to be excepted from Section 409A (or to comply therewith to the extent the Company determines
it is not excepted).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Recoupment</U>. Any amounts paid hereunder shall be subject to recoupment in accordance with The Dodd&ndash;Frank Wall Street Reform
and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company or as is otherwise
required by applicable law or stock exchange listing conditions.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have executed this Grant Agreement as of the date set forth in <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOAFFINITY
    TECHNOLOGIES, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPTIONEE</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCENTIVE
STOCK OPTION GRANT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC. 2024 EQUITY INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Optionee&rsquo;s
    Name</B>: ___________________________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of Grant</B>: ______________________________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares Subject to the Option</B>: ______________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
    Price</B>: $______&nbsp;<B>per Share</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiration
    Date</B>: _____________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting
    Schedule</B>:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything contained herein to the contrary, if a &ldquo;Change in Control&rdquo; (as defined in the Plan) occurs prior to the cessation
of the Optionee&rsquo;s &ldquo;Service&rdquo; (as defined in the Plan), then the Option, to the extent not then vested, shall become
fully (100%) vested immediately prior to the date of such Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optionee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NONQUALIFIED
STOCK OPTION GRANT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC. 2024 EQUITY INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Stock Option Grant Agreement (the &ldquo;<U>Grant Agreement</U>&rdquo;) is made and entered into effective on the Date of Grant set forth
in&nbsp;<U>Exhibit A</U>&nbsp;(the &ldquo;<U>Date of Grant</U>&rdquo;) by and between bioAffinity Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and the individual named in&nbsp;<U>Exhibit A</U>&nbsp;hereto (the &ldquo;<U>Optionee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to provide the Optionee an incentive to participate in the success and growth of the Company through the opportunity
to earn a proprietary interest in the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
to give effect to the foregoing intention, the Company desires to grant the Optionee an option pursuant to the bioAffinity Technologies,
Inc. 2024 Equity Incentive Compensation Plan (the &ldquo;<U>Plan</U>&rdquo;) to acquire the Company&rsquo;s common stock, par value $0.007
per share (the&nbsp;&rdquo;<U>Common Stock</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants hereinafter set forth and for good and valuable consideration, the parties hereto
agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Grant</U>. The Company hereby grants the Optionee a Nonqualified Stock Option (the &ldquo;<U>Option</U>&rdquo;) to purchase up to
the number of shares of Common Stock (the &ldquo;<U>Shares</U>&rdquo;) set forth in&nbsp;<U>Exhibit A</U>&nbsp;hereto at the exercise
price per Share (the &ldquo;<U>Exercise Price</U>&rdquo;) set forth in&nbsp;<U>Exhibit A</U>, and on the vesting schedule set forth in&nbsp;<U>Exhibit
A</U>, subject to the terms and conditions set forth herein and the provisions of the Plan, the terms of which are incorporated herein
by reference. Capitalized terms used but not otherwise defined in this Grant Agreement shall have the meanings as set forth in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Exercise Period Following Termination of Service</U>. This Option shall terminate and be canceled to the extent not exercised within
ninety (90) days after the Optionee&rsquo;s Service terminates; provided that if such termination is due to the death or Disability of
the Optionee, this Option shall terminate and be canceled twelve (12) months from the date of termination of the Optionee&rsquo;s Service;
and provided, further, that if Optionee&rsquo;s Service terminates (other than for Cause) on or after a Change in Control, then the Option
shall remain exercisable until the Expiration Date. Notwithstanding the foregoing, in the event that the Optionee&rsquo;s Service is
terminated for Cause, then the Option shall immediately terminate on the date of such termination of Service and shall not be exercisable
for any period following such date. In no event, however, shall this Option be exercised later than the Expiration Date set forth in&nbsp;<U>Exhibit
A</U>&nbsp;and in no event shall this Option be exercised for more Shares than the Shares which otherwise have become exercisable as
of the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Method of Exercise</U>. This Option is exercisable by delivery to the Company of an exercise notice (the &ldquo;<U>Exercise Notice</U>&rdquo;)
in a form satisfactory to the Committee or by such other form or means as the Committee may permit or require. Any Exercise Notice shall
state or provide the number of Shares with respect to which the Option is being exercised (the &ldquo;<U>Exercised Shares</U>&rdquo;),
and include such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Optionee
may elect to make payment of the exercise price in cash or by check or by delivery to the Company of certificates representing shares
of outstanding Common Stock already owned by the Optionee that are owned free and clear of any liens, claims, encumbrances or security
interests together with stock powers duly executed and with signature guaranteed. In addition, the Optionee may make payment through
a &ldquo;cashless exercise&rdquo; such that without the payment of any funds, the undersigned may exercise the Option and receive the
net number of Shares equal to (x) the number of Shares as to which the Option is being exercised, multiplied by (y) a fraction, the numerator
of which is the Fair Market Value per share (on such date as is determined by the Committee) less the Exercise Price per Share, and the
denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest
whole number). In the event payment is made by delivery of such Shares, said Shares shall be deemed to have a per Share value equal to
the Fair Market Value per Share on the date of exercise. Upon exercise of the Option by the Optionee and prior to the delivery of such
Exercised Shares, the Company shall have the right to require the Optionee to satisfy applicable Federal and state tax income tax withholding
requirements&nbsp;and the Optionee&rsquo;s share of applicable employment withholding taxes in a method satisfactory to the Company.
Notwithstanding the foregoing, the Optionee may not exercise the Option by tender to the Company of Common Stock to the extent such tender
would violate the provisions of any law, regulation or agreement restricting the redemption of the Company&rsquo;s Common Stock. Further,
no Exercised Shares shall be issued unless such exercise and issuance complies with the requirements relating to the administration of
stock option plans and other applicable equity plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code,
any stock exchange or quotation system on which the Common Stock is listed or quoted, and the applicable laws of any foreign country
or jurisdiction where stock grants or other applicable equity grants are made under the Plan; assuming such compliance, for income tax
purposes the Exercised Shares shall be considered transferred to the Optionee on the date the Option is exercised with respect to such
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Covenants Agreement</U>. This Option shall be subject to forfeiture at the election of the Company in the event that the Optionee
breaches any agreement between the Optionee and the Company with respect to noncompetition, nonsolicitation, assignment of inventions
and contributions and/or nondisclosure obligations of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
By executing this Grant Agreement, Optionee acknowledges and agrees that Optionee is solely responsible for the satisfaction of any applicable
taxes that may be imposed on Optionee that arise as a result of the grant, vesting or exercise of the Option, including without limitation
any taxes arising under Section 409A of the Code (regarding deferred compensation) or Section 4999 of the Code (regarding golden parachute
excise taxes), and that neither the Company nor the Committee shall have any obligation whatsoever to pay such taxes or otherwise indemnify
or hold Optionee harmless from any or all of such taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding paragraph (a) above, if any amounts or benefits provided for in this Grant Agreement, when aggregated with any other
payments or benefits payable or provided to the Optionee (the &ldquo;<U>Total Payments</U>&rdquo;) would (i) constitute &ldquo;parachute
payments&rdquo; within the meaning of Section 280G of the Code (which will not include any portion of payments classified as payments
of reasonable compensation for purposes of Section 280G of the Code, including without limitation amounts allocated to any restrictive
covenants), and (ii) but for this Section 5(b), would be subject to the excise tax imposed by Section 4999 of the Code (the &ldquo;<U>Excise
Tax</U>&rdquo;), then the Total Payments will be either: (a) provided in full, or (b) provided as to such lesser extent as would result
in no portion of such Total Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable
federal, state and local income and employment taxes and the Excise Tax, results in the Optionee&rsquo;s receipt on an after-tax basis
of the greatest amount of the Total Payments, notwithstanding that all or some portion of the Total Payments may be subject to the Excise
Tax. To the extent any reduction in Total Payments is required by this Section 5(b), such reduction shall occur to the payments and benefits
in the order that results in the greatest economic present value of all payments and benefits actually made to Optionee. Subject to Section
409A of the Code, such order of reductions shall be determined by the Optionee. Unless the Company and the Optionee otherwise agree in
writing, any determination required under this Section&nbsp;5(b) shall be made in writing by an independent public accounting firm mutually
acceptable to the Company and the Optionee (the &ldquo;<U>Accountants</U>&rdquo;) whose determination shall be conclusive and binding
upon the Optionee and the Company for all purposes. For purposes of making the calculations required by this Section 5(b), the Accountants
may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations
concerning the application of Sections 280G and 4999 of the Code. The Company and the Optionee shall furnish to the Accountants such
information and documents as the Accountants may reasonably request in order to make a determination under this Section&nbsp;5(b). The
Company shall pay all fees and expenses of the Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Non-Transferability of Option</U>. This Option may not be transferred in any manner otherwise than by will or by the laws of descent
or distribution and may be exercised during the lifetime of the Optionee only by the Optionee. The terms of the Plan and this Grant Agreement
shall be binding upon the executors, administrators, heirs, successors and assigns of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Securities Matters</U>. All Shares and Exercised Shares shall be subject to the restrictions on sale, encumbrance and other disposition
provided by Federal or state law. The Company shall not be obligated to sell or issue any Shares or Exercised Shares pursuant to this
Grant Agreement unless, on the date of sale and issuance thereof, such Shares are either registered under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities&nbsp;Act</U>&rdquo;), and all applicable state securities laws, or are exempt from registration
thereunder. Regardless of whether the offering and sale of Shares under the Plan have been registered under the Securities Act, or have
been registered or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale,
pledge or other transfer of such Shares (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer
instructions) if, in the judgment of the Company, such restrictions are necessary in order to achieve compliance with the Securities
Act or the securities laws of any state or any other law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Investment Purpose</U>. The Optionee represents and warrants that unless the Shares are registered under the Securities Act, any and
all Shares acquired by the Optionee under this Grant Agreement will be acquired for investment for the Optionee&rsquo;s own account and
not with a view to, for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of
such Shares within the meaning of the Securities Act. The Optionee agrees not to sell, transfer or otherwise dispose of such Shares unless
they are either (1) registered under the Securities Act and all applicable state securities laws, or (2) exempt from such registration
in the opinion of Company counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Lock-Up Agreement</U>. The Optionee hereby agrees that in the event that the Optionee exercises this Option during a period in which
any directors or officers of the Company have agreed with one or more underwriters not to sell securities of the Company, then, as a
condition to such exercise, the Optionee shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to
which the Optionee shall agree to restrictions on transferability of the Shares comparable to the restrictions agreed upon by such directors
or officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Other Plans</U>. No amounts of income received by the Optionee pursuant to this Grant Agreement shall be considered compensation for
purposes of any pension or retirement plan, insurance plan or any other employee benefit plan of the Company or its subsidiaries, unless
otherwise expressly provided in such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>No Guarantee of Continued Service</U>. The Optionee acknowledges and agrees that the right to exercise the Option pursuant to the
exercise schedule hereof is earned only through continuous Service and such other requirements, if any, as are set forth in&nbsp;<U>Exhibit
A</U>&nbsp;(and not through the act of being hired, being granted an option or purchasing shares hereunder). The Optionee further acknowledges
and agrees that (i) this Grant Agreement, the transactions contemplated hereunder and the exercise schedule set forth herein do not constitute
an express or implied promise of continued employment or service for the exercise period or for any other period, and shall not interfere
with the Optionee&rsquo;s right or the right of the Company or its Subsidiaries to terminate the employment or service relationship at
any time, with or without cause, subject to the terms of any written employment agreement that the Optionee may have entered into with
the Company or any of its Subsidiaries; and (ii) the Company would not have granted this Option to the Optionee but for these acknowledgements
and agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Entire Agreement; Governing Law</U>. The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the
entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and
agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be amended to materially impair the
rights of the Optionee without the Optionee&rsquo;s consent; provided, however, that no action of the Board or the Committee that alters
or affects the tax treatment of the Option shall be considered to materially impair any rights of the Optionee. In the event of any conflict
between this Grant Agreement and the Plan, the Plan shall be controlling, except as otherwise specifically provided in the Plan. This
Grant Agreement shall be construed under the laws of the State of Delaware, without regard to conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Opportunity for Review</U>. Optionee and the Company agree that this Option is granted under and governed by the terms and conditions
of the Plan and this Grant Agreement. The Optionee has reviewed the Plan and this Grant Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to executing this Grant Agreement and fully understands all provisions of the Plan and this Grant
Agreement. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon
any questions relating to the Plan and this Grant Agreement. The Optionee further agrees to notify the Company upon any change in the
residence address indicated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Section 409A</U>. This Option is intended to be excepted from coverage under Section 409A and shall be administered, interpreted and
construed accordingly. The Company may, in its sole discretion and without the Optionee&rsquo;s consent, modify or amend the terms of
this Grant Agreement, impose conditions on the timing and effectiveness of the exercise of the Option by Optionee, or take any other
action it deems necessary or advisable, to cause the Option to be excepted from Section 409A (or to comply therewith to the extent the
Company determines it is not excepted).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Recoupment</U>. Any amounts paid hereunder shall be subject to recoupment in accordance with The Dodd&ndash;Frank Wall Street Reform
and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company or as is otherwise
required by applicable law or stock exchange listing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have executed this Grant Agreement as of the date set forth in&nbsp;<U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOAFFINITY
    TECHNOLOGIES, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPTIONEE</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NONQUALIFIED
STOCK OPTION GRANT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Optionee&rsquo;s
    Name</B>: ___________________________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of Grant</B>: ______________________________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares Subject to the Option</B>: ______________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
    Price</B>: $______&nbsp;<B>per Share</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiration
    Date</B>: _____________________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting
    Schedule</B>:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything contained herein to the contrary, if a &ldquo;Change in Control&rdquo; (as defined in the Plan) occurs prior to the cessation
of the Optionee&rsquo;s &ldquo;Service&rdquo; (as defined in the Plan), then the Option, to the extent not then vested, shall become
fully (100%) vested immediately prior to the date of such Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optionee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTED
STOCK UNIT AWARD AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC. 2024 EQUITY INCENTIVE COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Restricted Stock Unit Award Agreement (the &ldquo;<U>Agreement</U>&rdquo; or &ldquo;<U>Award Agreement</U>&rdquo;), dated as of the &ldquo;Award
Date&rdquo; set forth in the attached&nbsp;<U>Exhibit A</U>, is entered into between bioAffinity Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and the individual named in&nbsp;<U>Exhibit A</U>&nbsp;hereto (the &ldquo;<U>Awardee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to provide the Awardee an incentive to participate in the success and growth of the Company through the opportunity
to earn a proprietary interest in the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
to give effect to the foregoing intention, the Company desires to award the Awardee Restricted Stock Units pursuant to the bioAffinity
Technologies, Inc. 2024 Equity Incentive Compensation Plan (the &ldquo;<U>Plan</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, the following provisions apply to this Award:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Award</U>. The Company hereby awards the Awardee the number of Restricted Stock Units (each an &ldquo;<U>RSU</U>&rdquo; and collectively
the &ldquo;<U>RSUs</U>&rdquo;) set forth in&nbsp;<U>Exhibit A</U>. Such RSUs shall be subject to the terms and conditions set forth in
this Agreement and the provisions of the Plan, the terms of which are incorporated herein by reference. Capitalized terms used but not
otherwise defined herein shall have the meanings as set forth in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Vesting</U>. Except as otherwise provided in this Agreement, the RSUs shall vest in accordance with the vesting schedule set forth
in&nbsp;<U>Exhibit A</U>, provided that the Awardee remains in Service through the applicable vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each RSU that becomes vested in accordance with this Agreement, the Company shall issue and deliver to Awardee, on or within thirty (30)
business days after becoming vested, one share of the Company&rsquo;s common stock, par value $0.007 per share (the &ldquo;<U>Common
Stock</U>&rdquo;). Except as may be provided in&nbsp;<U>Exhibit A</U>, in the event that the Awardee ceases to be in Service, any RSUs
that have not vested as of the date of such cessation of service shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Dividend Equivalent Units</U>. If and to the extent that the Company pays a cash dividend with respect to the Common Stock, Awardee
shall be credited with an additional number of RSUs (&ldquo;<U>Dividend Equivalent Units</U>&rdquo;), including a fractional Dividend
Equivalent Unit if applicable, equal to (i) the amount of such dividends as would have been paid with respect to Awardee&rsquo;s outstanding
RSUs on the record date of such dividend (the &ldquo;<U>record date</U>&rdquo;) had each such outstanding RSU been an outstanding share
of Common Stock on such record date, divided by (ii) the closing price of a share of Common Stock on such record date. Dividend Equivalent
Units shall be subject to the same vesting terms and conditions as the RSUs to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>No Rights as Stockholder</U>. The Awardee shall not be entitled to any of the rights of a stockholder with respect to any share of
Common Stock that may be acquired following vesting of an RSU unless and until such share of Common Stock is issued and delivered to
the Awardee. Without limitation of the foregoing, the Awardee shall not have the right to vote any share of Common Stock to which an
RSU relates and shall not be entitled to receive any dividend attributable to such share of Common Stock for any period prior to the
issuance and delivery of such share to Awardee (but Awardee shall have dividend equivalent rights as provided in Section 3 above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Transfer Restrictions</U>. Neither this Agreement nor the RSUs may be sold, assigned, pledged or otherwise transferred or encumbered
without the prior written consent of the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Government Regulations</U>. Notwithstanding anything contained herein to the contrary, the Company&rsquo;s obligation hereunder to
issue or deliver certificates evidencing shares of Common Stock shall be subject to the terms of all applicable laws, rules and regulations
and to such approvals by any governmental agencies or national securities exchanges as may be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Withholding Taxes</U>. The Awardee shall pay to the Company, or make provision satisfactory to the Company for payment of, the&nbsp;minimum
statutory amount required<B>&nbsp;</B>to satisfy all federal, state and local income tax withholding requirements and the Awardee&rsquo;s
share of applicable employment withholding taxes in connection with the issuance and deliverance of shares of Common Stock following
vesting of RSUs, in any manner permitted by the Plan. No shares of Common Stock shall be issued with respect to RSUs unless and until
satisfactory arrangements acceptable to the Company have been made by the Awardee with respect to the payment of any income and other
taxes which the Company determines must be withheld or collected with respect to the RSUs. Subject to the following sentence, the Committee,
in its sole discretion, may provide for the withholding of applicable taxes from the proceeds of the sale of Shares acquired upon vesting
of the RSUs, either through a voluntary sale or through a mandatory sale arranged by the Company (on Awardee&rsquo;s behalf pursuant
to this authorization). Notwithstanding the foregoing, if requested by Awardee, and if the Committee consents, the Company shall withhold
shares of Common Stock that would otherwise be issued upon vesting of the RSUs to cover applicable withholding taxes, equal to the greatest
number of whole shares of Common Stock having a Fair Market Value on the date immediately preceding the date on which the applicable
tax liability is determined not in excess of the minimum amount required to satisfy the statutory withholding tax obligations with respect
to the award. The Company may refuse to issue or deliver the shares of Common Stock unless all withholding taxes that may be due as a
result of this Award have been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Section 280G</U>. Notwithstanding anything contained herein to the contrary, if any amounts or benefits provided for in this Agreement,
when aggregated with any other payments or benefits payable or provided to the Awardee (the &ldquo;<U>Total Payments</U>&rdquo;) would
(i) constitute &ldquo;parachute payments&rdquo; within the meaning of Section 280G of the Code (which will not include any portion of
payments classified as payments of reasonable compensation for purposes of Section 280G of the Code, including without limitation amounts
allocated to any restrictive covenants), and (ii) but for this Section 8, would be subject to the excise tax imposed by Section 4999
of the Code (the &ldquo;<U>Excise Tax</U>&rdquo;), then the Total Payments will be either: (a) provided in full, or (b) provided as to
such lesser extent as would result in no portion of such Total Payments being subject to the Excise Tax, whichever of the foregoing amounts,
taking into account the applicable federal, state and local income and employment taxes and the Excise Tax, results in the Awardee&rsquo;s
receipt on an after-tax basis of the greatest amount of the Total Payments, notwithstanding that all or some portion of the Total Payments
may be subject to the Excise Tax. To the extent any reduction in Total Payments is required by this Section 8, such reduction shall occur
to the payments and benefits in the order that results in the greatest economic present value of all payments and benefits actually made
to Awardee. Subject to Section 409A of the Code, such order of reductions shall be determined by the Awardee. Unless the Company and
the Awardee otherwise agree in writing, any determination required under this Section&nbsp;8 shall be made in writing by an independent
public accounting firm mutually acceptable to the Company and the Awardee (the &ldquo;<U>Accountants</U>&rdquo;) whose determination
shall be conclusive and binding upon the Awardee and the Company for all purposes. For purposes of making the calculations required by
this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable,
good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and the Awardee shall furnish
to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this
Section&nbsp;8. The Company shall pay all fees and expenses of the Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Investment Purpose</U>. Any and all shares of Common Stock acquired by the Awardee under this Agreement will be acquired for investment
for the Awardee&rsquo;s own account and not with a view to, for resale in connection with, or with an intent of participating directly
or indirectly in, any distribution of such shares of Common Stock within the meaning of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;). The Awardee shall not sell, transfer or otherwise dispose of such shares unless they are either (1) registered under
the Securities Act and all applicable state securities laws, or (2) exempt from such registration in the opinion of Company counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Securities Law Restrictions</U>. Regardless of whether the offering and sale of shares of Common Stock issuable to Awardee pursuant
to this Agreement and the Plan have been registered under the Securities Act, or have been registered or qualified under the securities
laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such shares of Common
Stock (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the
judgment of the Company, such restrictions are necessary in order to achieve compliance with the Securities Act or the securities laws
of any state or any other law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Lock-Up Agreement</U>. The Awardee, in the event that any shares of Common Stock which become deliverable to Awardee with respect
to RSUs at a time during which any directors or officers of the Company have agreed with one or more underwriters not to sell securities
of the Company, shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to which the Awardee shall
agree to restrictions on transferability of the shares of such Common Stock comparable to the restrictions agreed upon by such directors
or officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Awardee Obligations</U>. The Awardee should review this Agreement with his or her own tax advisors to understand the federal, state,
local and foreign tax consequences of the transactions contemplated by this Agreement. The Awardee will rely solely on such advisors
and not on any statements or representations of the Company or any of its agents, if any, made to the Awardee. The Awardee (and not the
Company) shall be responsible for the Awardee&rsquo;s own tax liability arising as a result of the transactions contemplated by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>No Guarantee of Continued Service</U>. The Awardee acknowledges and agrees that (i) nothing in this Agreement or the Plan confers
on the Awardee any right to continue an employment, service or consulting relationship with the Company, nor shall it affect in any way
the Awardee&rsquo;s right or the Company&rsquo;s right to terminate the Awardee&rsquo;s employment, service, or consulting relationship
at any time, with or without cause, subject to any employment or service agreement that may have been entered into by the Company and
the Awardee; and (ii)&nbsp;the Company would not have granted this Award to the Awardee but for these acknowledgements and agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Notices</U>. Notices or communications to be made hereunder shall be in writing and shall be delivered in person, by registered mail,
by confirmed facsimile or by a reputable overnight courier service to the Company at its principal office or to the Awardee at his or
her address contained in the records of the Company. Alternatively, notices and other communications may be provided in the form and
manner of such electronic means as the Company may permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Entire Agreement; Governing Law</U>. The Plan is incorporated herein by reference. The Plan and this Award Agreement constitute the
entire Agreement with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the
Company and the Awardee with respect to the subject matter hereof, and except as provided in the Plan or in this Agreement, may not be
modified adversely to the Awardee&rsquo;s interest except by means of a writing signed by the Company and the Awardee. In the event of
any conflict between this Award Agreement and the Plan, the Plan shall be controlling. This Award Agreement shall be construed under
the laws of the State of Delaware, without regard to conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>Opportunity for Review</U>. Awardee and the Company agree that this Award is granted under and governed by the terms and conditions
of the Plan and this Award Agreement. The Awardee has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to accepting this Award Agreement and fully understands all provisions of the Plan and this Award
Agreement. The Awardee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon
any questions relating to the Plan and this Award Agreement. The Awardee further agrees to notify the Company upon any change in Awardee&rsquo;s
residence address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the Company and the Awardee and their respective
permitted successors, assigns, heirs, beneficiaries and representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Section 409A Compliance</U>. To the extent that this Agreement and the award of RSUs hereunder are or become subject to the provisions
of Section 409A of the Code, the Company and the Awardee agree that this Agreement may be amended or modified by the Company, in its
sole discretion and without the Awardee&rsquo;s consent, as appropriate to maintain compliance with the provisions of Section 409A of
the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<U>Recoupment</U>. Any amounts paid hereunder shall be subject to recoupment in accordance with The Dodd&ndash;Frank Wall Street Reform
and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company or as is otherwise
required by applicable law or stock exchange listing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date set forth in&nbsp;<U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOAFFINITY
    TECHNOLOGIES, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AWARDEE</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOAFFINITY
TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTED
STOCK UNIT AWARD AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awardee&rsquo;s
    Name: ____________________________________________</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    Date: _________________________________________________,202</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Restricted Stock Units (&ldquo;RSUs&rdquo;) Granted</B>: ___________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d).</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting
    Schedule</B>: ____________________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RSUs awarded herein shall vest as follows, provided that Awardee remains in &ldquo;Service&rdquo; (as defined in the Plan) through each
such respective vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting
    Date</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RSUs
    Vested</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything contained herein to the contrary, if a &ldquo;Change in Control&rdquo; (as defined in the Plan) occurs prior to the cessation
of the Awardee&rsquo;s &ldquo;Service&rdquo; (as defined in the Plan), then the RSUs, to the extent not then vested, shall become fully
(100%) vested immediately prior to the date of such Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awardee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______
    (Initials)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPENDIX
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF CERTIFICATE OF AMENDMENT OF<BR>
CERTIFICATE OF INCORPORATION OF<BR>
BIOAFFINITY TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies, Inc. (the &ldquo;<B>Corporation</B>&rdquo;), a corporation organized and existing under the General Corporation Law of
the State of Delaware, hereby certifies as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 0.25in">1.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Certificate of Amendment (the &ldquo;<B>Certificate of Amendment</B>&rdquo;) amends the provisions of the Corporation&rsquo;s Certificate
    of Incorporation filed with the Secretary of State on March 26, 2014, as previously amended by that Certificate of Amendment filed
    with the Secretary of State on May 31, 2016, that Certificate of Amendment filed with the Secretary of State on November 29, 2021,
    that Certificate of Amendment filed with the Secretary of State on June 23, 2022, that Certificate of Amendment filed with the Secretary
    of State on June 6, 2023 (as previously amended, the &ldquo;<B>Certificate of Incorporation</B>&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>2.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporation&rsquo;s Board adopted resolutions setting forth this amendment to the Corporation&rsquo;s Certificate of Incorporation
    declaring said amendment to be advisable and soliciting the approval of the Corporation&rsquo;s stockholders. Thereafter, the necessary
    number of shares as required by statute approved this amendment at a properly noticed and duly convened meeting of the Corporation&rsquo;s
    stockholders.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>3.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4 of the Certificate of Incorporation is hereby amended and restated in its entirety as follows:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total number of shares of Common Stock which the corporation is authorized to issue is 100,000,000, at a par value of $0.007 per
    share and the total number of shares of preferred stock which the corporation is authorized to issue is 20,000,000, at a par value
    of $0.001 per share.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    other provisions of the Certificate of Incorporation shall remain in full force and effect.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by Maria Zannes, its President and Chief Executive
Officer, this ___ day of ______ 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 85; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="proxy_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="proxy_002.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 87; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ba_logo1.jpg
<TEXT>
begin 644 ba_logo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !U 1@# 2(  A$! Q$!_\0
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M^%/Q&\,>$M!^)/P]\,V7CRQU[PB]]%X>\5>"KO7H]!O9WTN\WSZ+JFEZA)'
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MR>G4QN/QZER<LI0E"M4<Y.2D](QC3>\8JR^U/MJ%&!=8SAAAB<9*\# .<DD
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M^&/A]\(M7O-1T?Q8C>(+#59_&_BN.XL]/BTU+:*P2'0M-C2>]M4O+H7,[,R
M_P!1WQ,\>^&OACX#\8_$3Q5=7=AX7\">$_$7C'Q'<6=G<W]]%H?AC2Y]5U&2
MQMXI 9;N&VA=H+<12R3,?+AV.P<?G[^PI_P5=_9#_P""C^I_$'1/V7?&'BWQ
M5??#KP_X;U_Q7#XB\"ZWX,M;71_%>YM-:TOM68P7=RB*?M5K%Y%TA&Y;I2ZL
M #],I'8PQ2 C:4+YD#1!8UR=S)RRJD:_,#DX!SDY!_$W]E3_ (+K_LT?ME?M
MWW/[$/P'^'OQ1U>ZTCPQ\6-9UOXO>*(-*\->%H=6^$>IV6BZ_H>D^'7NK[Q#
MJD5UJ-\L=EK4JZ?8R0Q&2-9F;:OK7[9__!9[]B#]@OXRZ%\ OVBO&WC#1?B+
MK?@"S^(ME9>%_AIXE\8:8WA/4]6U'0-.U675=*\ZWLVEU33;FVFL;AY7 7(N
M5;YQ_"5_P21_;6^ '[(O_!4K7_VL_C?K>OZ9\([W0_VD[.RU+1O"FK:UJOVC
MXE^)+?4_!<:>&]-NOM&G7.J:/YD\TTXOGCA6:*\;[1LNH@#_ %(5?Y<N57)(
M&"><$^OTIX8-R#GM^@/\B#^-?C9^RQ_P7)_8'_;5^-.C_ 'X">+OB5K7Q%U'
MPKXU\=6VE:I\+/$.A6EWH/@'3(=4U]#J5^DT44XBN[9;6&,)=7=T\5K;R!Y"
MKI^RU_P7"_8,_:^^/6D_LS_!OXA^.Y/BWJW_  E7V/1O$_PN\0>"M.N[[P?=
MO8>(=%74_$%O-;-J^E7&G:M;26D<L4TEW87'[@0^29 #]E:*AMV9X@[QB)F+
MDJ&5P1O8(^Y?E/F(%?CINQU%9^IZO:Z9INH:G=RBVM-.LKB_N[F0J([>TM87
MN+BY=GP@2&!'F;<0"JGD4 :U%?D5^RM_P6I_8B_;0_:$U+]F+X!>,/'?BKXF
M:=IGBO5YR_PQ\0:-H T;PDYM=5UP>)M1,^BV^G+J)CL;"YN69-2N77R(3"=]
M% 'X,_\ !=6Y?3?V]-%U*"-);BR^#'AG4+2-XX90]U;Z]J$MJJI<%(BWVM8@
M@=U592A4AMM?J?\ \$YO^"9O@&S\(6/[1'[4'AR'XJ_M ?%9[/QO.?'ENOBC
M0_"&C7]O!'I>F^'M"OWN-(%ZL+Q27^HW<=W<VKQRV\#0V]VX?\QO^"X"1R_\
M%#/ *RQK-!=?"OP# T4A 68/XVNT>)PP.U6SMR1@[@N>#7]=_P /8[:U\,^$
M;6*".);?P9HMLL,05DM8XK2R58$* +R" ^,G(YQD&OP#@;)\KS?Q)\3,5F.%
M6+JX?&QJ0HU&OJ_-%0A&4XRYJ;:2LI2IN26M]6W_ *'>.W'>=\,_11^BYD'"
MV-GE.,XJX;QV(X@Q]*<Z.-G@>&:CP\<'A\32G0Q-*CB:N*53$8:CBZ%'$RHP
M^L4:SIPD?.GQG_8J_9F^.WA#5_!?CWX*> 9+"_B2SM]:TGP=HND:WH[HA@MM
M1TG4](M+2_TV\M)62YMYK0O;*(P;A6C4@?R>>$[?QK_P2U_X*1IX;DU?5;KP
M]H_BWP[H&MS2ZI);P_$+X)^/?)CL9M:M-GDZI/X?N6MKV"^L!->:9>Z7<Q7$
MMM!?E&_M\GDBCCG+PS$)')*2B%@549V@#(8D#A<9SP,G '\;'_!> 62_MP^"
M)=.W6NIW/PD\%37LA4QRQWUMXCO9+(3DX:-9+)8-CN2&D98_O$@>AXM9;0R+
M+<'Q5E.6X7+LRRS,\MC16&G"%7%T\1B*="I15*BJ:J*TG7=X2:4';JG\O]"G
M,<YXSXNXL\(<WQV*S7@SCKPYXY_M? YA*.+6'Q&3Y)B,]IYC16,J8U4'2C@5
M%UH2IR2]G)5(SC&1_8C!<V\MG'-!.L\%Y$IMIMX;[1%-"UPKIDDR#8Z.-N0!
MM(XP:_C<_P""3"A?^"JOB)%145/%/[3D:1HJJBQMX_U(O&B@ )&YY95 1B26
M4FO[ ? JS_\ "%>$Q?(1<2>$?">P9#LE]/X?MVN2X_A!D)&XX5B=W>OX_O\
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M"?C?6;[0=&\0V5L8VO\ 2H]6CLM>BADW6]K!IT[N@Y8_JA_P2^_X.#?V=_\
M@FU^RMX>_9UA_9-\;^//%D_B37?&OQ&^(FB_%7X<Z#;^+/%'B"_$TNI6UCK&
M=4@T^VL[:&QL[*?=Y<"H(%V2;U\'PPQ>:XS@_!8O.I>TQ6+Q&-6$E%NU/!8'
M$3H0A*-[*<H1IQC:*=HW;;9^G_3 R#A?AWQ\XOP_"&&EA\BQ^%R'-,/A$Z:6
M5YCC<IPF)SK!8BE0Y:5'$3QV(G74'2@XQJ--7>O]4W_!>7]DG4OVKO\ @FG\
M:/#VA:-%K/Q#^$EL?CMX$=8G=X]6\!/-?:G96;0))<%+SPM>:ZIM$8O>L@5(
MW8*$_(+_ (-(_P!K]/$OPR^//[%OB'7C<S?#/68OC3\)[6[E15_X5]XTG@@\
M56.C!G).DZ1XF:"[CCQYJMJLD\Q'F;FQ[W_@\(_9ZO[:[LK[]ASXBWME>VUU
M9WUHWQC^%RK=6=W#)!>6S>8J0%;B"26)@\BQD.P+ <G^;7_@F[^V1X1_9*_X
M*E?"?]I_P4;CPS\"]<^,.O\ A3Q;X,U.\T_4-0T']G_XYZOJ6CZC:Z]JVC2-
M8ZO_ ,*W;Q)IGBS3HHPR2)X<54VI&S5^A'\R'^KCXAT>S\0:7?Z#JD#3Z7J^
ME:MIFIQ!YXVEL-3ADL+R F%=S&>UN98P!(DB[_-C!,99?XI/^#@'_@DK^P1^
MQ/\ L%77QS_9J^!&G_#?XK:W^T+\)?!%SXHM_$7C#74D\.>,M4\0IXA@GTW7
M]9U#2(9M0M0T7V][)7LYEC:Q= JQR?VOZ1(LL(ECF6ZC>&%([M)8YH[Z.-3+
M!J4<L;2I)'?VDUM<HR.RMO)0C_6-_.9_P=6*[?\ !+*$< K^U1^SWD9[+J?B
M!_O'&3@CG R>,=Z /S[_ ."'?_!'W_@G9^VE^P'X5^.7[0G[/4?C[XD:O\2/
MB%H$OB%/&WC&RN!I/AS7GL]'M5;2];TNSEBM[.2..2XCMVEN57SW4,2#^\WQ
M$_X(L?\ !./XI?"C]GSX#_$#]F\:U\)OV6M \?Z'\$?##^,O&HLO!MG\9?$&
M@Z_\0;>&:RUA+_5;FZU/P!X<G2XU2><64=U,+,PF>8M\E?\ !L""/^"4GPV!
MQE?BY\74..F5\0*K8[8R#C]*_HEF^Z/]]/\ T(4 ?Y@.C_L<?L]77_!?N[_8
M?N/A];:A^S1!^U3K'PQM?AC>>(=8DMCX#M_AQ#JT6CS:PSG66CM=28W<5X-1
M-S$Y5(IT8"O[D?V?/^"*'_!-O]E;XU^&/V@?@'^SAI?@?XL^")M6N/#'B2+Q
M/XZU.+1YM8\.:QX2U5XK+6-8OM.N4FT'5[BS6*2-I=Q+NS-'BOY#?#B,W_!U
MG>D$8'[;'B@G)(/R?":"5CQU^5#@<9/'?%?Z+\0(#J>TDISQD;Y'D';'".N.
M#W!R0: /\_O_ (/''D3XY?LFA3)"#^R]\;RR(6B =?%VC,?D4J 0P!P1D<9Y
M%?W"_LK<_LO?LXDY)/[/GP<8DDDEO^%>>'SN))R6) )).3@9)Q7\/W_!Y-_R
M7O\ 93_[-B^.G_J8:17]P/[*O_)KO[./_9O?P=_]5YH% '\%?_!UC=6>F_\
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M.F:3;PZ-K&E6$L4.NZCJ5Q(Y5G99DDD=U:&OX,_^"/7['O[/W[5W_!5WQ/\
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MMI,J>-OBK=>,]!@,<T<K:DGA32K.TTK4[K3Q'ML9/LXN5G",24)Q^^O[#G[
M7PW_ &)/!FK:?X>O3XI^(7C)]-C\??$S6+,1:MJT5HN8/#^A<33V.AP.SO!
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M*.(ZTI57G/$&:XWVE7$SK3IX2=6G3RRA!33:C3P=*FIPYDJ3@DG+G5OC2?\
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A!" W! /UH"A1@# ZT44 (40G)4$^M.Z444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>formpre14a_002.jpg
<TEXT>
begin 644 formpre14a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  G (<# 2(  A$! Q$!_\0
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M[(_7K6G3N!Q.LWWBZVDF%@D<D,>$:7[+U8D<QIN)..I)XISR^)WO-,ALX)1
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$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>formpre14a_004.jpg
<TEXT>
begin 644 formpre14a_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  G (<# 2(  A$! Q$!_\0
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M=Z+*NUMO8XI6 O44A[5'#$(5(#,P+%OF.>M $5_?V^G0^;<R;%)VJ "68^@
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L"TEQ+_K9Y#EW_'L/8<444 7J6BB@ HHHH 2@,#G':BB@!:*** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>formpre14a_006.jpg
<TEXT>
begin 644 formpre14a_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  G (<# 2(  A$! Q$!_\0
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L"TEQ+_K9Y#EW/N?3V'%%% %VEHHH **** $H# YQVHHH 6BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>proxy_001.jpg
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 02 R # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\>^
M+W[0WP _9]MO#-Y\>OCE\'O@C:>-=;7PSX-NOB]\3/!?PUMO%OB1T61/#_AF
M?QGK>BQ:]K;1NDBZ3I37=^R.K"W*L"?Y_?\ @NA_P74^.?\ P2@^//[+'PD^
M%/[*^C?&?2OC/H>H>-=>U[QCJ7BO2(_'4.D^+;;PO??!GX,WOAFTO$B^*\2W
M6E:EJ6IZEI?C*WT2#QEX&1? VM-K1:+Z _X+$?\ !$;PE_P6(G_9O\7:Q\>O
M&'[.OB#X,6/C#2;VT/P_TSXEV?B#P+\3'\)ZCXF\/OX?NO&OAFQ\)^.K&Z\*
M:?%8>+[74?$>DQI)=VFN^%?%<%MHLFE@'JW_  6=_P""K5[_ ,$H?@A\*OB3
MHGP/?XU>)/B[\4C\.=(MM8\67/@+P)X;CT_PQK'BW5+WQ!XJL_#?BNZEU[4+
M'2'M/"WA>WTNW?5HD\0Z])JL-MX2N--U9/VC/VA_VR?VK/\ @D%H?[3G_!/+
MP7KW@']HOXY_"3X0?%'PKX*NY/"^H^/_  YX/\7ZCX:U?XB6/P^O_&%G8^$O
M$/B.'P5<ZW-X,U^^TVPN/$N@/%KG@S2[7QGJ/A;3T_2^U^ _PJ?X/>#_ ($>
M*_!^B?$WX:>"_"W@WPE8:!\5=)TGXA6^IV/@/3M.T[P[J'B&#Q)87MCK.MVP
MTJSOY-5N;/SVU1&OX_*G(*^MQ11011P01QPPPQI%##$BQQ111J$CCCC0!(XX
MT 5$4!54!5   H _)?\ 80T;_@I/XP_X)AZOX;_:F\3IX"_;@\2>!?C/X?\
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M+"93;3-J/BCX5?"-]>L'BGMM:TKX:V]CJ"36C2Q)_6I0&K;ULD[:?\$_,/\
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M?_P5O_:2A_X)]?MV_&>__:8^(,FLS_!SX5?!RX\1_&?X"HOQ-\::S)HGQO\
M"ZRF?P7J,CZI!I(M&GE0:MHUY8D.;5)$_P!"C]G(D_L]? @DDD_!GX7DD\DD
M^"-#R2>Y-?RH_P#!"HG_ (?Q?\'"PR<'XR D9."5^-/Q4 ./8$@>@) ZT+X7
MZ1_,'O'U?Y'[ _M*?\%F/A=^RWJ7_!+C0_B/\ ?CG9^(_P#@J3J/A'1? OAB
M[LO#6@>(_@;KOBF\^ FGS:!\:=$\0ZSIVHZ9KGAS4/C[HVGZ_I>BV^IWEAJ'
MAKQ#9S1)*EJ)O<O^"I?_  4J^&G_  2I_9FL_P!I[XK_  \\>_$SPM>_$WPK
M\+U\._#F3P[%K\6J>+-*\2ZK9ZG(WB;5='T\Z=;IX9N+>X6*YDNS-=VQBMWC
M$SQ_@G_P<N_\I%O^#<3_ +/@UW_U?_[!=>N?\'B\C1?\$C]%E3 >/]KCX+R*
M2,@,GA7XJ,N1W&0..]"2;7G?]0;=GY?\#_,]A^-G_!Q79IK.N:%^P/\ \$Y/
MVT?^"D4?P\N;/1_C'\1/@%X(\07?P/\ A_XR?2-)U76?AQ8_%'P;X+^*L7C+
MQ[X1&JI;^)M.TKP_:Z$A6.[T+Q'KU@UU=67W+_P2?_X+&?LS_P#!6WX>^.=>
M^#VD>,OAI\4?A'>Z+IWQ>^"/Q(@T]/%?A(^((;W^QM?TC5='NKO2/%7@[5M0
MTC7]'M-6@;3-<L=4T&^M/$_A?PY)<Z.-4^J_^"?OP1^'O[.'[$'[*/P3^%NA
M6'A[P5X#^ WPUL-/M+"QL]/_ +0U/4?#-AKOBGQ1JD-A#;V]QXE\:>*]4UOQ
MAXLU0Q"XUOQ1KNKZQ>O+>7]Q*_\ ,S^PUX6T'X5?\'?_ /P5&\'^ ]+M?#?A
M?QE^R,GC_7-"TN-[;3;SQCX]TC]AGXF^,/$ES:I+Y$VL:_X_\4^+_%%[?O&9
MFU+Q9KKIL_M"X:0LM?+S\[#N]//R\KG[R?$S_@J9\*_AA_P5._9Z_P""4VJ_
M#7XB:C\6/VBO@]K'QE\-_$W3Y?#(^'.@Z+HWA[X[>(I]*UR&YUB'Q.VJ36_P
M$\06T#:?H]W:?:-9TDRSQQ+=O#_+'_P=X_MP7?Q0^$-Y^P[<?LI_M+>#;+X)
M_M8?";QU:?M5>,?A[+8?LP_$*>X_9V^)\X\,> OB([F+4?%Z#XESPKID4#.Z
M>"_&K>:HTIXW^V_VML_\1D/_  3 YS_Q@KXWP,YP/^%8_P#!1[@^G.3CT.>]
M;O\ P>@?\HK/@[_V?/\ #'/O_P 6"_:;_/GG]::6L?-/]1/9^3_R_P S[%_9
MY_X+KZK\3/AW\=-9OO\ @E[_ ,%$OA-I7[,/[)WC#]I/5]3^,WPJT[X<Z-\0
M/#?PHN? ]GXG\'?#[7O$FHZ?I&M>/I_"_B+5_&_A_P .O<V]WXAT7P?K5OI<
M<VHR6EJ_Z:_\$W_V_P#X1_\ !3/]D_P3^UG\&=*\0>&/#?BS6_&OAC5?!/B^
M?0I_&'@GQ+X'\4:EX=O]&\2CPWJFLZ/%=:C8VFE^+=)6VU&9I_"_B70;VX2U
MN+J6U@^O_#%K:ZCX%\/66H6T%_97_A/2;6^M+R&.ZM;RUNM'MX;FVN[>=7BN
M(+B)WBGAF1XYHW=)%96(/\BW_! :UNO^"<?_  5&_P""IO\ P1BU^XOK/X?V
M_BFV_:W_ &4(-5U));>Z^'^H6_AK3+FWM]1OX[:Y\5^*]4^$7C#X&6&L2Z:)
MEMM5^#WQ%,X9M,O_ +!*V^X9^Y'_  4V_P""K'PI_P""9L?[->A>*_A=\3?C
MK\6/VLOBN_PD^"GP;^$0\-_\)IXIUJ :-8W5_;OXJUC1-*^Q6_BCQA\/O"9B
M%X;N75O'.CF.)H([IX_U+0N40R*JR%5+JCF1%<@;E1V2-G4-D*YCC+  E%)V
MC^/_ ,&V$7_!5;_@Z \?^/)UB\1_LR?\$6?AMI_@;1Q&3J?AG5?VI=8O=?LP
M-2L+UU_LCQ5H'Q/O?B/-'J6EQM_Q-OV4?")F<B1U;^P*FQA1112 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYS?\ @JO_ ,IF
M_P#@WB_[*1^W?_ZJGX-U_1E7\YO_  57_P"4S?\ P;Q?]E(_;O\ _54_!N@J
M.[_PS_\ 26?T94444$GS5^V?_P F>?M7_P#9M7QU_P#57>*:^!O^#?C_ )0W
M?L&?]DGUC_U8_C>OOG]L_P#Y,\_:O_[-J^.O_JKO%-? W_!OQ_RAN_8,_P"R
M3ZQ_ZL?QO06O@?\ CC_Z3(_8ZBOSN_X*=?M'?'C]CW]FJ+]JCX,>'?#_ (V\
M)_ GXF?#SQM^U)X'U/PUJWB/Q/KO[(ZZ]%I/QVU?X7G2=<T&/1?B-\//#.I)
M\2[#6->GU'PS;^&O"'BJ'5-%U":XL3;_ )9#_@KI^U)X[U;X._'7X6:9\'Q^
MQO\ M0?\%J/@?_P3K_9IU'6/!7B74?%GQ#_9MTKPC\7M#^/_ .T#8^++;Q[8
MZ7J)^)'QJ^'FH:9\&;D>%])3P9X:\(ZO;>)] \5:AJL-]:A*3:NO3YVO^5W\
MC^EZOQS_ &]/AW_P6;TO]H?P]\=/^":_Q@_99UWX4GX-Z!X!\?\ [*7[5FE^
M+D\,:A\0-!\:>/M<7XK^#_$'@JPM->36]8\/>,=&\-:MI:?$+X?:6;+P7I]U
MJB^+K@Z1:Z%\-?L<?\%!_P#@I7^V'J'QBM/"^O\ A+1O$.F>(/VUO WPAT&Z
M_P"":7[1D?[/]_XO^">K_$[P5\&%\6_MXR?M+3?")4U'Q=X<\+3>.]!L_AS;
MZS<2Q^(_ >F2:1KSVNOV/C/@;_@X]\9>)_'/[,WQ-USX/Z=X6_8G\&^ /@[\
M/_\ @J%\4KSP;XU7Q+^S/^V1\>M(^*NF:'\/] T^YU>*[@\"?#3XC_".'2?&
MNL7FA^)KB+0?B?X:CU:30?$EQX8T[Q(%*,K[)VT:=G^O7IK>^VIZK_P2\_X(
ME?&OX<_M'?MI_MB_\%#K?]FH>)_VS_A'\4O@5XC_ &7_ -F72]:L/@I8?#CX
MZ:_X/U_XN6^M_;-,T&73I=>/@31]%T_0=!O_ !+,]GJ7B;Q3XI^('B3Q=XCE
M?2/F[X5_\$E/^"W?_!*SQM\2?"G_  2P_:>^ ?Q:_9/\?^*;GQ3I/PQ_:9>X
MM/$NAZI<00V-KJOB+18_!4VB+XLTW0;32O#VM>.OAO\ $#PC8?$QM)M-9\2_
M"O0VT_0=-TC]/9/V]_VQ?#G_  0^^*7_  4I^(_ACX8>#?CUJWP9\=?M-?"C
MX:OX5UR\\(> /A7XCUI]8^!'ACQO:KXR36?&/B.3X477AKQ%XRU&#4O"4A\0
MZ]>:-'H^G+H^^[^9OA5_P69_;A^)_P"UI^P5^SGXT_8M7]G#1?'?Q4\1? +]
MLCQG\1X+C5-,\0_'C3O@9XU^,FF^'/V2[W3O&*1ZO\+Y_!'A_P *?%>3XEZM
M!XVLKWPY\4_!/A:TFM[BR;Q-XQ"N:;N_=:V::5O=6EDWT5[=61^)_P!A[_@O
M)\4_V(?V[_AY\?\ ]JS]G+XK?M$?MF:#\(OA%X#\&:-K?B'P#\#/V;O@?IVI
M_$&;X]0Z3JF@_!73[O7?%WQ@\$>-_P#A6^HPCP->ZK:1Z?I>K:E\4_%UGHFC
MV%CY_P# +_@T^_8>L/@A\+++]H[Q+\;M;^/0\!Z"WQEO_AE\89](^'$OQ%OM
M-BN/%]GX(T^\\%6UU)X1TW5KBZTC0+W4K"QU#6-'L;/4]6TRQOKVZLH>V^ ?
M_!9KXW_M4?MP_$']G+P)\1?V5OAO\&?VB_$O[2OPM_X)Y?$Y_#FI?&SQYI_Q
M _8]UCP19^,/$_QW^&V@?&?X?-J/P^_:-\-K\7_&GP&,^N_"W5)]/\$6=K&_
MB%IUEU'*T3_@HS_P4MT?]B__ (*I_M=^+OBW^R3XE/\ P3X^-_[7O[+_ (5^
M'^C?LH?$3P<GQ \<_LX>*_#'AK1?BWK?B^]_:Y\6+H/ASQ"-5O+S4/AC!X:U
M.[L 8H8_B3=>2UQ*"_>*Z7NZIV7N[^ZORVZ.]];GB_P)_P""+'_!2'X3_P#!
M+;_@HK_P3.\2>./V=?&GAGXQ^./"7C']D?Q;_P +&\>VL&FRP_$SPGJ?Q$M?
MB+8W'PNF?P%I7B?PWX \->-='T+PE!XRMK#Q[KGCN&]NI!JT6K2_I[\)_P#@
MD1X9^(O_  1O^#G_  3._;5L?"NJ>*/ O@.XL_\ A-OAIJ%QKS?#'XK6'B+Q
M=JO@_P"*'PH\3>(?#WA_48]>\.6_B)K:5KW0;"R\1:'J7B?P+XFT[5O!GB77
M]+U7XC^*_P#P5 _;[^%'[,_PY^)MWXLAD\8?%C]M_P#9"_9FM]0^*/\ P2'_
M &M_@-<>"O!?QSTWXA/X^\0_#[X'ZS^TYXV^(_[6?B73)].\-7/A/0/A-JFA
M:GK.J:1<>"-(T_7]?\?:#)HGHW[+'_!6S]JSXUZ-_P $WM4\3:3\$+SP]^UG
M^WW^UM^S%JOQ \+>#/%'A0_%3X%_ ;P/\4M8\ ?%K1_A1KOQ.\8>*_V<?B%X
MHU_P"VG^,?A;\1O$/C#7-";3[V[-GI5GKNE6M@ W.U]%KS75DTUI^FQ;_P"#
M?G_@D7^TY_P2MUS]M.']H3Q-\&O%>C?&JY^ UA\,M7^$WB'Q5J<]_IOPDO?C
MS%JVJ^*-"\3>#/#(\)2ZO9?$/PQ>Z;H]CJ_BP6TCZM87.J-_9MO=ZE_217\X
M7[%?_!;#Q)^TA_P4;UOX$^)[_P" 1_91_:"\6?M.?#O]AC6? NOG5_C-J7BK
M]CW4?"^E^*]9^+UK;^)]2L](\&_M#:-_PL[XC_ Z\U+PWX0O[S0/ 2Z7;V^N
M27XU%_IW]E+]N3]L#]HO_@CGKO[:/@KX5_#WXK?MBS:!^UROPY^%.@V>K>%_
M 7C+QI\&OV@_C5\)OAQI(TF\\4W>M7 O=%\ Z!>:MH5MXQTV_P#%NL"]TG2-
M<\,RZU976EA,N9N\MW;5Z;Z+\M3Q7_@@)_P3"_:6_P""9?@#]J3PS^TEJ?PC
MU+4OC)\5_#'C7P@WPF\7^)?%UI#HVD>';_2KN/79O$G@3P-)87YN;F(PV]G!
MJ<,D6]VNHV4(WS[^U;_P1K_;?^!G[<_C_P#X*+?\$;/CW\-?A5\0?CE+K6J?
MM"?L^_&U;R/X?>,?$/B;58?$/C75O#^H1>%/&FG:QI_Q#\5P0^-M8\,>)K#P
MOKGA+QO=>+O$G@OXL6.D^*K?P-H/Z!?\$C/VW/BI^UUX5^,^F?';XJ^"O$?Q
M>^#US\-K?XC?!ZZ_9)^,G[%WQ]_9Z\0^.-$\1:W>>#_CC\*/BW\3_BE9ZIIF
MH1Z6DWPP^(/@?7H]"\3Z/I?B!=2BBUW3+^RL/BC]@?\ X+9>,/C_ /MV?%?X
M*?&[QK\%M,^#7BKQEXK\&?LMZ9X0^&/C/3/&'Q*O]6^-WCSPI^S?XF^ _BFU
M^)GQ#US]J?X&_$OX"_"SQ]\6/C%^T7_PICX)_"[X1^*=.TW21J+^&=0N+O3
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M)/[$OPN^).F_M&_M[?'^'PAXT^'WA:W\.Z'%=:+H?A+1-0\8^&=$\66.K_\
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MYU/1O%5AK/CO4+"P\3^(9-=A^(VH>+M/\;ZIK.H:YXXL_$6M7#W]?8U%!D?
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M?4=)T'2[>TL8;N^NKS4M0@AAMK65E$TWEP2_%OPL_P""//Q#_:*UGP'\6?\
M@L;\<M._:^U_P&-%O?AK^Q9\.++5_!__  3Y^"=[H42V^E2-\.M1:'Q!^TIX
MJL81>PGQS\<DGBO='U[4_"6K^$=:T>PTBZB_?*B@:;2LM//KM;1]/E9^9G:/
MH^D^'M)TO0- TO3M#T+0].L='T71='L;;3-)T?2=,MHK+3=+TO3;**"ST_3M
M/LX(;2QL;2&&VM+:&*""*.*-$&C110(**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YD_;/_ &;++]L3
M]E#]H/\ 99U+Q;=> [#X^?"OQ;\+[SQE8Z1#K]YX9M_%>F2Z;+K%MHMQ?Z5#
MJ<UDLIE2SEU&R28C8;F+.X>(_%_]C[XT^(/VOX?VO/@5^T7X*^$VOZC^S[X,
M_9V\8>#_ !_^SY-\9]*UCPMX+^*WC'XJ66LZ#JEC\9?A5=^&M=NK[QG>Z5,U
MQ;^(;)(+2SO4MOM,85?LOXA?%#P)\*=,TS6OB!X@A\-Z3JVK-HMKJ-S9ZE=V
MD=W#HNL^);^YU&;3K*\71]$T7PUX=\0>)?$?B35S8^'?#/AS1-6U[Q!JFFZ3
MI]U>18>E?'7X3Z[XNM/ ^C^,;/4?$%_=W.E6?V6QU>30[GQ#:Z#+XND\'Q>+
M1IP\)MX[D\$0O\0;3P'_ &V/&5]\-S'\1;+0[CP1-#K\@%KGQ;\%_P!BO]HK
M]FSQI+X4^!?[7?AC0OV-[CXT>+/C#!^SUXU_9FT?QA\3O!5E\1_'FO\ Q2^(
M_P (/AA^T'H_Q6\$Z1H?PGU[Q[XH\0W^@6WCKX&?$WX@^"/#^LW7A3P_\0HM
M+T[PL?#E3X?_ /!-?0? /[/'_!-;X 6WQ6U*^MO^"<WQ%^%GQ!TCQ5_PAVGV
M=U\6IOAA\$OBU\&+?2=8TM-;GC\*PZO;?%>[\137=G?ZY-9W6D16*1W*7\UW
M#]<C]J'X&3:9HVMZ9XW?Q'HWB#PSH/B[2-6\'^%O&?C33;K1/%FNWGA;P>S7
MWA/P]K-M;:IXT\4Z?J'ACP5X=NY8/$/C'Q)87N@>&=*U75[6>SCOP?M)_ J>
MW\27 ^)GAN ^#=.&J>+K.^ENM.U7PM:"Y^(5I-_PD6C7]K;:MHMU93_"?XEC
M4]/U*RMM0TJ/P/XDN-2M;6WTRXE4"W]?UL?E[+_P15^&H^%G_!.GP?IWQF\5
M:)\1/^"?GCKX.ZBGQ8T7PS;:=>?'WX/_  O^/GP\_:0U+X#?$WPM;^(DTV3P
M=XC^*GPD^&7C+1-1FOM9U#X?>*_"$6M>&XFM]>\5Z3KVT?\ @E-X^@^'7B7]
MCW3_ -KS4K7_ ()L>+?''BC7]5_9DD^#5E)\;;+X7^./%NI>/O%_[*N@?M5V
MGQ(L(M._9EU?Q#K.K>&;?0KSX&:K\9=&^#FHS_"S2?CA:VMMI6O:;^DVD?M(
M?!K61?\ E>*[O2FL+Z^TI(O%?A'QKX*GUG5=+\:Z9\-=2TGPG;^,/#FA3^--
M6T_XC:[H'P_O=,\(QZW?6OCCQ#X=\)3VZ:_K^CZ?>OU']HCX6Z5XDU#PA=WO
MC,^(=-\46G@N73[3X3?%G4A=^*;W1KCQ+!HNC7FG>"+JP\078\+VEUXKN#H5
MUJ,-GX3M;GQ1>2P:!!+J*%PL?GAJW_!+CQ3XLTS]K_X.>,_VD[+4?V4?VROB
MU\8?C3XU^'7A[X,2^%_CMX"\?_$VRT*[\,^)/AA^T.GQ9U71M#USX1>/?"7A
M#XC>!=2U7X(:XO\ ;WA^"WU6UN[*4)#MWO\ P3=^)/[0-[IMO_P41_:DL_VM
M/!7@[X5_%WX6> O 7PZ^"3?LN:'<3?'GX3>,/@)\5/BW\69?#GQ;^(MWX[^,
MNL?!7Q]XX^'F@:MX(D^$'PV\&V'C_P =ZKX=^%=IKNJZ#J/A;[YLOVA_@]?I
MK]S;^, NF>&_#?B+QE>^(+O0/$^G^%=1\(>$$B;Q7XJ\*>++_1;;PUXX\-^&
M6N+*'7]<\&:KK^F:/=:GI%GJ%U;W6L:7#=MO?VBO@S9V%C?Q^-[76/[6\2_$
M?P9HFE^%=*\0>,?$GB+Q?\(/%^J^!/BAX7\,^%/">DZUXF\2^(? GB?0/$-C
MXET?0=(U'4-,M?#?B369[==$\/:UJ-B7_K^O0+'Y$?%/_@CY\<?CN-/M/C9^
MV_X3^(!^'_[/G[2'[.WPE^(<W[(.A:/\?;SPU^T9\(=?^ VH:[^T9\5;#XV_
MV5\;==\%?#;Q5K\_A^'P/\/O@)HFI?$*Z@\:^)=*U>".\\.ZA]%_!']@+]H'
MX!_&+7_B9X)_:V\#-HGQ0\*_LP^'_C;X8U/]EP7NL^(K[]G/X,Z+\&)];^&7
MBR3X[FS^&C^,]+TNXURWL/$'A+XHVWA74[Q("_B*Q@N8-0^\YOV@_@X/#T'B
MC3_'.G^)=)OM8T/P_HR^"++6/'NK^)];\1^ =-^*VBZ5X.\.>"M.U_Q%XSOK
M[X7ZM:?$=;?PII6L/!X#34/%UR(?#^DZKJ%E)9?'SX2:KJ0T_1?&$.OP&V\-
M7!\2>'-)U_Q%X"2;QG:>']0\'Z1+\1]$TJ_\ 0^)?%FF>+?".K>&O"DOB5/$
MNNZ1XM\*:MI>DW6G>)=$NK]W?](5EY_B?'7[,_[#WQ:^&W[37B3]KK]H[]HS
MP9\=/C3JOP!T7]F^VU+X3_LXZ9^S-H/B3P7I?B^U\:R>,OC3I<'Q1^+U_P#%
M;XL0:CIEAIGA+Q!:ZUX&\#_#OP[?>,](\$_#;1QXYUVYD_26O'?!OQ[^%_Q!
MU/1-'\'ZOKVLWWB'1D\2:<J> ?B#9VR>%[M=1;0_%>JZAJ/A:TT_0/"7C$Z/
MK4?P]\4Z]=:;X?\ B/-H>N0> ]1\1S:-J<=II:E\:OA3I'BG4O!&H^._#]KX
MOT?1_%&OZEX;:Z+ZQ;:1X*M?AE>^*;QK*-'FD71[;XS_  J>XAA62XD;Q[X;
MBMH9YM0CC"'8]0HKA/ _Q)\(?$B&^O?!E[J>L:39&T:#Q"WAGQ1IGA;Q!:WZ
M3266J>"_%>KZ-8>&_'NA744#3P:_X)U37]$EMY;2X2_,-]9O/W= !1110 44
M44 8WB/PYX>\8>']<\)^+M!T;Q3X5\3:3J.@>)/#/B/2['6_#_B'0M7M);#5
MM%US1M3@NM.U;2=4L;B>RU'3;^VN+.]M)I;:YAEAD=&Y/X8?!_X2?!'PV?!O
MP7^%OPY^$7A!K^XU1O"GPP\$>&? /ALZG=I#'=:B="\*:9I.EF_N8[>".XNS
M:_:)D@A221EB0+Z+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!EP:WHMU'ILMMJ^EW$6LO+'H\D&H6DT>JR003W
M,\>FO',RWSPVUK<W$JVIE:."WGE<".&1EPD^(GP_ET>V\0Q^.O!TF@7FH7.D
MVFN)XGT1]'NM4LWN8[S3;;4UOC93ZA:/97B7-G%.UQ ]I<K+&A@E"?SQ?$;_
M ()3?M->/[K]MWX0:/+X$\(_ SPE\.?VLM+_ .">%Q/XBCTK3/$FJ_\ !1?Q
M_P"#OCY^TUX'\?Z9X1L9_$7PF\.^!O%7A/QY^SCX0\6Z%9:CJ]M\!_V@O&2^
M'M+FAL9O#]S-\5/^";'COX]?!_\ ;[E\-?L,?!O]FK1OC7\'OV4_ WP%_93U
M*Z^ >IV]O\</@/JWQ;C\?_M(WMK\.;;6O@S\-_$/B;X<?%+PK\$?!^N>'/%E
M_P".->^&GP=TK_A-H_#$%QX;\%Z"%66FO;:VE_6WW=+._0_HAT_QMX,U:_M]
M*TKQ=X8U/5+NT2_M=-T_7]*O+^YL9;9+R.]M[.VNY+B:TDM)8[I+B.-H7MI$
MG5S$ZL9AXN\)M)J<(\3^'C+HMY8Z=K$0UK33)I.H:I>C3=-L=307.ZPO-1U$
MBPL;:Z$4]W>D6MNDDY\NOQS_ &<_V)O%WP3_ ."HG[4'QOM?@=<>&/@G\0]6
M\"'X+^)O NA?L66?PM\,^#O#'['W[/7P>N])OX;KP"?VR_!FMVGC/X9>*?#F
M@^$/AQX[T7X(-X?N;36=3\%MJ&IZOJU]\C_!W_@DGX[\5?MN?M6>)?VC?@=H
M5]^S=\?A_P %'/"/C[5M<\0_!JS;QE\.OVKOC9\+?'WPN'PMN?@OH&A?'J]\
M5+8^"+G7_&6H?M.^-/%D/PC\1Z'X+U3]F^'P)K+ZU*H%EWZ)].N_7I^?D?TH
MS:YHELNJM<:QI4"Z$D<FMM-J%I$NC1RVZW<4FJEYE&G)):LMS&UV85>W99E)
MC(:JMQXJ\,6EM->W7B/0;:SM[S4M.GN[C6-/AMH-0T:VO;W5[&:>2X6*.\TJ
MSTW4;O4K9W6:QMK"]GNDBBM9WC_$P?L'_M#7G_!%G]HG]G#Q9:S?$+]N[]J?
MX'_$_6_CUXB\;>,O">H:I\4OVF/B-X6M_#4MUXC\;Z?;Z5X-72-!\-:%X+^&
MO@U+"VL?#_A7X;^"/!_A>QC6QT*)W\'^$W_!,']HGP/^U?\ #+Q7K?@+P!XD
M_9G^*7_!1_\ X*2_M=?M8^ ?%>O^&_$-AIMQ\2_#/_!1'X1? 'XCZ%X4O3J.
MG>+8?VD/@/\ M5?!SX??&WP9.A;PE%\ ?AI<RZ"]YKOQ(O8@5EKKUMZ_UT/Z
M%%^)7PZ=+>1/'W@IH[N\?3K61?%6A,ESJ$:6CR6-NXORLUY&FH6#O;1EIU2]
MM&9 +F$OJ)XM\*2+JCIXF\/.FAWT6F:VZ:UIK+H^I3W0L8=/U1A<D:??37I%
MG%:79AN)+HBW2,RD)7\RWA/_ ()7_%KX:0_\$SI[7]FC3#;? 6Q_;=;X]:-\
M$M&_81O;Z/QE\:/VDOV7_''PHUSQ#:?M/^ /&?@_6M#O/AA\&=5TGQ+XP^$]
MKH?QY\*Z;I.@^&_!GCOP[;3WMA?^=^//^"+7QP\9>)_VCG\7?"/P%\2?!W[6
M'Q?^*6I^-K&;7/ACX#UOPG\*M5_X+S^"/VO/$?A+7O$?@C3O#/BOXPZ)\?/V
M-%L/B!X7U#XH>)O'_P 0?V>_&'PK\7?#;P'KG@6V^,!\'H#LK[V7?Y_UO;R/
MZJ=5\9^#]"\W^V_%?AK1O)O/[.F_M77=+T_RM0^Q6>H_89?M=U#Y=Y_9^H6%
M_P#97Q/]BOK.ZV>1<PR.[3O&/A'6-3GT72?%7AS5-9M1=FYTG3M<TR]U.W%A
M<):7QGL+:ZENH1974D=M=F2)1;W#I#-LD95/\KOB#_@F=^W;J_CJR\6_&_P'
MJGQWF\)_MI_&/Q=-XT^'FJ_L7>+/B1\7_A!I'[!_[$'[)OP=^,WBGPO^V?X(
M\<?!72O'7QEOOV:=;\1_&S08/"=KXF\%^)-7UY_AUJEEHTVB:E??M-^S+^QG
MH7P7_;:_;L_:$A^"OPH\&Z;\:]7^#$WPL\;>%O#'@>P\5ZAI]G\,--M/C#'=
M7&B:=!K^BQ>(OB18IK.OV]_-$OBS5X(O$-VE[<JEU0*RM>^O;YV]=M3]'Z*_
M*G]MD_MP_#K]D;P1XM\ >/+'XN?ME?#+XR^%/&GAS3O@A\%OCE\-/@[\:]-6
M_P#$&C>*?AE\2?AWX2\3?M5>)?#G@J?X/^(O$][:ZMXT\5:YX0D^,OACX>>(
M-VAZF= TVT_)Q=,_X*6> OAQX\F\$?&O]K_XC_%?X&>,?#WPL_927XD?"K]M
M5] _:#^"=W#^T[H6I_&[]I6)O@8NE'XD>&O#/[6'P]U#6-(\06^I>)_%GCK]
M@#X?:[H5SI4?Q$M8[D!*_5;V_P"#Z']7-%?RIW=A_P %'[3X=^)8O#OQD_;$
M7XC^ _BM_P ,U_""X\1?##]M'5K?XA?L/1_#;X[_  D\*_M6_$RX/P CT&;]
MK;P_KG[0G@[]HKX@0:KX>D\7^-O$O[(?A'PMIVM,OC/3[.!/''QD_;O^&'['
M'[5/AKQ$W[:6M?$^\N/ _P .?V?OBQHG@_\ :KL?$.D?"G]GSQ7^S5\*?AAX
MOUS4=<^!$\FB_'C]LZVU;]H+XX_%_P 76FG:I;>$XH-"\#>.M+UG5(]!TO4
M?+K:ZW2^^VOROKZ/L?U6T5_*9+I?[?VK:+XFM/!OQ _;S^$6E:)\.?\ @H5=
M_LT>&/B-H/[:OQ'\:?#_ ,>_$'Q?\ ;/]C/PS^T5\0=.^%/Q6/QAN_#?AF+]
MJ+Q)I>O^)O$?[0?AGX4P^+/ASH?B?5/B+?\ @30K&5GC.\_;]NO#FDP?!B#]
MO[X<>"])_:&\:^/-*^%/Q+O/VRO'7QDE_8NE^'_[.&A^._V1/%_QLU'X?_%F
M>\_:$^/'Q>\/_&WXJ?L^_M#2?%OQQ>?LK^!V?X?CXY^!8?B/%X:\' K>:]>V
M^_W>>^Y_5M17\K>@_&7]L?QQKO[67B[X3^._VM/&NE?LJ?'Z.#]BC1IOAA^V
MWI'A?]JBV_X:DO\ ]IC]HWX0?'+4=1^".MVMC8>%_A?K.C?\$Y/AGK_Q$L]5
M/PVU/X=>-_':QS6U['=-I>&M)_;AT/XI?!S3/&GQ,_;N^)-EHR?LQ:;XP^.F
MB^$OVZO!/PEM_AC9^ =7M_V^?!?C3X 6WPNTOQAXM^+_ ,;_ (FZOXFUC]G'
MXH:%X8\0ZE\%_#OB+X<6W@WXK_ JV^!J>'/B"#Y?-']25%?R._LJ^!OVV?@A
M=?L%^"I;[]MGP!\)_@!\-O@=X&^(.C:-\%/VS?C%IH\>_#SXU_$_4_VH_%'B
M&P\0_$KX>>&=?^"W[57P8O\ X9>%O@Q;^(_@K^U/XW^!NGV6HIX$^"G[(7C;
M0F\2^,_HSXI_$G]LCXD>*OV@_'D/P^_;Q\(:[\4O"G[*6I_"CPUX*@_:O\*?
M#_X1?!/1]3_9XUG]MK]C>'P_X8^'?AC0=)_; ^)%SX;_ &BM/^$7[;.D^"_&
M&GZ;HWCWPCH_AW]HK]GNUT07$0)JW6^_YV_X)_2M17\HEQX<_;H\2S>$I+OQ
MY_P40\&^&/#?B/P#+X"\)VT'[<Y\9>"/AGJO_!2J#Q9XJ\)?&7Q=HW@/5K?X
MY_$KP%_P35UKQ1\/K_Q9XK\1_%;3]6\6_P!GV%AXL^+OQ7\&>"OC%>_?6C_#
MG]LOQ;^P9\(/!FEZO^T=XNO_  /^V'\6F^,_A*/XI_$_X%?M:_&7]A[2OCK\
M?1\&? '@']H'XQZE\*/BAHGQ(LOAGJ_[-7B/6_&WBCXI?#CQEX\\+^!/'/@3
M7_C/8^*_%>KZS=@6\U^7]?\ !W/W!HK\EOV"_P!G[]M[P?\ $V+QQ^V5\3_'
M_B>V\,?LI? ;P+X(\/Q?&W4/$W@QOBA=>//VA]1^,%QXZ\-:+_PC^B?$3XD>
M&/A>_P"S'X+U3XM^(_"T</BSQ3H?C/Q9X1BM;CQ#X@NKKY4^ W[/?_!2+PAX
MH^#5Y\8+?]I3XI_"/PA^T[\;_%.LZ%=_M@W7P]^//CJ]\1Z-^S/=_LZ_'#]H
MV+0OVE/B/\,[OX$_"SQ7X7_:6\,_$O\ 9@_9Y^)GA;X,>/?!WB[X>?$FT_8:
MG\0W'BKX,:<!;?5:?COM]WX_?_0I4<LL5O%+//+'#!#&\LTTKK'%%%&I>266
M1RJ1QQHI=W<A54%F( )K^<'X&_LG_P#!4?QAIOA7PG^T+XC^,OPU^'_B/X^^
M'/'WQ,T'X>_MD?%VT\4>'_#-U^P[^UIX*^)_AWPE\5KS]J;XV?'*U^'%[^U_
M<?LV>(O >@:3\9K*U/AX:1\0=.^&'P6U)O'_ (!\*_4/Q"_9:_:@^)WPG_X(
MR>-/B_IOQ ^(G[0O[*WB_P"&?B3]K>S\%?'&7P$;KQEXM_8I^*/P9^)WQ!U*
MRT'XB?#SX9_$RS\*?M!^+O"7B'QG:H=9U/7?@I+\9/ 7@G0/&'A/XH>-_A7\
M2 +>?W>GR]#]@_"WBGPQXZ\,>'/&W@GQ'H/C'P9XQT'2/%/A'Q=X6U?3_$'A
MCQ3X8\0:?;ZMH'B/PYK^DW%WI6N:#KFE7=IJ>CZQIEW=:?J>GW5O>V5Q/;3Q
M2M8UW7]"\+Z5=Z[XFUO2/#NB6 A-]K.NZE9Z1I5F+FXAM+<W>HZA-;VEN)[N
MX@M8?.F3S;B:&%-TDB*W\P7@;]@O_@J+\%?V8O@S\%/A[XO^*=KX%\&_ [_@
MF]:_$_X:Z1^T5XL\1>,9?''PY_9?_:5^%O[57P_^ NLZ5^U3^R[X@^'_ (9T
M/XQK^QEXUT_P7X)_:R_9Y^$FK^'_ (>^-)O#\OBFQUOQW\+OBS^@O[2'[,GQ
MX\5Z9_P3H^(_Q*^%4/[?O_#+_@+QGI_[1OP'\4#X+>$=?^+7QC\<_!7PKX-T
MO]H[PYX*^('BC2OV;;OXE^!_$NC^/M%7PIK?C_0/#?A_PM\=/'VJ>!?%UY>:
M!I>C^(P+>:_7O_P.US]>)=>T.#6+;P]/K.DPZ_>VSWMGH<NHV<>L7=FGG[[N
MVTQYA>SVR?9KG?/% \2_9Y\N/*DVHWB#04UF/PZ^MZ0OB"6V-[%H3:E9KK,E
MFN[==QZ89A>O;+L?,ZP&(;&R_P IQ_)9\!O^"6G[3/B#7/V._P!I'6/ACH\F
M@_"?PE^P'XITCX&>,/#7A30_%_@+PYX)_P""C?[9G[1NL_L^^#_%?QK\'>&/
MC]\%;W]@WX.?'/X'V'@AO!FJ?"?PK\??#_P=O?@IXLTGQ3\/O$MKH>C_ &G^
MT_\ \$^_VBOB;_P5F\'_ +6'@WX5>&O$W@3PYJ_[%OB+1?%_C'Q)\']#\"Z=
M'\!+W]HR\^)Z^(M7LO"FM?M>^'O'-K8?$CPO!\'[#X,^(O#OPD\9>(-1U*S_
M &D=$^(/PTTVZ\':J#LKVOT?W]M_QU\KG]"]%?SF_LU?LN_\%5=2O/A5I7QP
M\8_%#X6^ F_:3\/?%;XAZ'IW[3_Q$\5ZEH?A^Q_8Y^+&D>)O"B^)O$O[3?[0
MGQ<\2?"&^_;1T;X-^(=,^'8^.=SI7B+X=WDNIR^"?A39>)OB+\,?#_'7O[,7
M_!5>X^#OPNT/0Y?VH]$^-.C?!;X@^%=<\8ZK^W>MWX<M/^"C&I#X)'0?VY?&
M"S?%;Q5!\0?V"I9-'^)4^B_LBQ>!;30?#"?VOHP_813_ (6%I?B?X> 6\U]_
M]?U^/](-QXO\)VGBS2? 5UXG\/6WCG7O#WB#Q=H?@NXUK38?%FL^$_"6I>&=
M&\5>)]*\.R7*ZQJ/AWPSK'C7P;I7B#6[.SFTW1M2\6^&;#4KFVNM>TJ*[Z*O
MYA?'W[%?_!4C6_C9\6/BCX0O?B'8?$6Q\ ?ME>"+7XN>*_VEKG7/!_Q%\$?&
M+_@I-^Q[\;?"?P^_9J^&6F?%_0_%W[-4/B'_ ()^?!3Q)\""GACQO^SC=Z7\
M7]&L-2C^)?@'Q5';?M4>+?NSQ-\(?VY6_P""?7P6^%%K_P +%^(7QDNOBU<#
MXLWFO_%/QO\ "+XU^#?@?J'CWXE>(O".D:-XO^#/[>.A^*_%/B/X;:+<?"3X
M<ZIJ&M_M_>+O%'B7X>Z5XE^(GCSQM^T#\2+2_P#AW\3@5O-?>NU_N_4_6S2/
M%_A/Q!J_BOP]H/BCP[K>O^!-4L-#\<:'I&M:;J6L>#=:U70-)\5Z7I'BO3+.
MYFO?#VJ:EX6U[0O$NGZ?J\%G=WF@:UI.LVT4FG:C9W,W15_+I\(?V+_^"N/A
M?XE1>/H_$'BWP+^T)\1[/]G+Q1\2/V@+[]H+PSK/[.5[XH\'?\$FO O[//QQ
M3XQ?LT:#J,^G_$[QWK_[8WA#P9JW@KQ5'\-/$T5EH/@N_P#$>A>*?AIH6GR>
M&?C=W5C^RY_P5\LOA?K&I?![X@?&'X7>)O[5\%> O#_PX_:+_:V_X7YXLM;[
MXJ_LX>/_ (+_ +3_ .T;>_$!]<\<:+J7@SX>_'KQ1\%_VIOV?OA7/KEOJUO9
M? 3XD>&/!_@?X#0_'X_#?PZ#Y?-=/E_7Z=#^E&BOQX_95_9^_;L^'?[>GQD\
M7?&3XL?$WQ)^SHFC>/M&^&T%_P"*+SQQ\,?&/@&>X^%%I\"]*U"+Q;^T]KFN
M^$OC;\+] T'Q;9>,?$OA?]D;X>Q?$G4=7\:^)?B7\;OC%KOB'PBWA?\ 8>@3
M5NJ?H%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!?C+\
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MFCWDMR[6GAO3(XH8E]2HHH$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M(M-U;2;)O!<_C+5-%UG0/!.N:;<^(^,Y;K3OB[\4_%/Q)\4:I\9-/^$/QX^
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M=?EU_ ^9];\7?M0^(_&'@WP+XTE^,KZ7H/QG^$%AHT>C?L_ZJVA?$WPS\/\
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MEXJ^%JZQX6\8^"M*^*&CW^KZIX.O_$FGWN-8>(OV+?$?B#X=?L]?#SP!X/\
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MH?[0%GX*OX4^(7AU_&3_ !3N_#FK:1I6OZYJ-CJ-DGEVC_M'_L7_ !A_9_\
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M_P $;FQ\0:[X<\,7]OJ+^+O"?Q UG1O!MEK'BO0/ATVP^/GP5^%'CS5?@OX
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M3_X1>STV[\ >+/A/<WR>$EU!?#$GBJ;X6^//&GPV?QQ-I$GC4^ O%6O>#_\
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MUW4-8L-,\">#M*TR_LM.\,Z+:V0&G]?UN>,?!3]J6+QKX_7X7^,OAGJ_P_\
M%.H>*OBQ;^%9=5A\#:%H]Q8_#CQU\1O %MH&FS+\1->F\;^/]*\*_#M/$?C"
MS^'2:\/#G@SQC\/]?UFP\.Z1XFEM=%^VJ\.\*?LW?!CP3J?A+5_#G@^2VO/
MVH>*=>\+I?>)_%^N:?IOC+QS<^++KQM\2I-(UW7]2TG4OBYXP;Q[XZ@\4_&#
M5;*]^)_B"P\:>+=,U;Q;=Z=XDUFUO?<:!!1110 4444 %%%% !1110 4444
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MGC_P/X8U/XW> OAQ\2K3X3CQ1X\T+2_!FO?4K?\ !0_X/Q_LL?$K]LE?"_Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?A@GP?N_!.A_ C]LF;0/$%]X<^'.@Z%X;-UIIAO;2?28-6U#GO 7['O['OP
M^*G[+_BCX/\ [2GQ&^$^O^)/A[>^"_AWX:TOXQ^$/&]C^U?X/TWXC>,OVJ_B
M!K7C+7/BGX9^(_C?XFZGXU\:_%#QE\1OB-\0_#'C71->UT>-;B[_ .$@MFU2
MRD=FC?\ !,.;P]X8\1Z#I/QWNDN_$F@_LM6-QJ4W@C7K:32]<_9$T3]FF+X:
MZEX8OO#GQ7\.^+_!^C^)?$_[/MSJWQ0\/>#_ !CH$OBC1?%&A:;HVM^%?%G@
M4?$#Q1[;XV_8^TKQO\"_!_P>TKXBZ%H>EZEIOQWT[Q1K#Z)XJ\>V/C]?VCO
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MB;PCXCE^&4?BWP]>:1K>@>&[[PCI?Q#^*%CXK OYN^_E>WI_D?+OB;_@G/\
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MK\?=)\+^$=1^(T6GRPW^O:#XB\+ZOH_A/7/A;XY2"TC\+^.[71M6M3>WRV<
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MA[1[WXVZG\/=-EU+3/V'?&&HV]MX/^&NB^(;#1/&-_K7BK7_ !U?^ [W4/&
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M6?B%XTMOJR@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/\4K'7-5N_$WKO@VU_:6\=_LWVC>.-1^(/B/QS_PU1^R3K=KI?B+06\(>/\
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M\:7_ ,1=,\-^%=#U_P"&730W'[>NN^!?%.N>&_B?\5TO;'X#_MBZKX$TR_\
MA=\.[/Q;-\8+/X=?L_\ A_\ 9XT7XAM\1_V;/A!#X@\1Z3\0[SX\>._"R^!O
MASX/^&GB(W.C>'_$M[XZ\->%(#K(%WY=CM?V>/V4_CU\,/'WP/U#XA?$3QIX
METSP)\._APFKZKIWQ8UKQ%:7OB[3_@OXQ\'?&#PE\0(/&\,WB+QMH?C?XO\
MBQOC1:^*+*8:IXX\3VG@YO&\/ABS^ ?PRT_Q'@_!O]GOXX>*_$7@+Q/XQB\7
M^#O!-A\1_'NK_%C1?$/QJ^+.H:]\:[2+QU\=-3^&VL:EH&K#3KKP]I'@S2M9
M^'^A7/@Z\GCT7QQX4UJ3X9ZI::M\(?@'\&[CQCTNN7_[:6B?'O0_ ,/C#QS-
M\(+'XE>&;7PY\4-2\%^%];N_''AN\U3X4>+OB/H?Q,L/AS^S[XATW3[:R\.Z
MGXY^&WP?\7Q7?P#\.:.\7B'5?B9XE\>^*-!\-:C=?1/[-.CZMJW[._@OX2?&
MRV^(/Q$\2:7\,=*\,_%B_P#CKX4TVY?QAJ]Q=^)_"?B[P[K-ROA3PYX5\>6M
ME?\ AO4[)]5L]'U+3?%G@R_\)>+WU[QC9>,+7Q5K@%_3^KGQ+HO[*7[8MIX:
MT"PL?%B^&]6T#PQ\!X?'C2_'CXB:DGQL\;?"SPY\9[+]H6];6XK*:_\ #UA^
MV*/'7P^\&7?CS5M-NO%_@*V\+2?&5_"$/Q3^&?PJM;STSP?\)?C1XW^ 7QNM
M-;UGXF:AJ=Y\1](\!? NPNM9\1>&?$=U\!?V?/BDLOPT3XB:%\7K?3$\0WGC
MZXM_%<'QLUK6XK'5_P!H;X-ZE8:?/XKGM=0\,:G:<3^SIX,^//P<;X4^ ?#_
M (-\7?#LRZA\%[^_\#^&OAI\.K3X&^*O!=SX(L+#]H/QW\=/B%:^$;CQGI_Q
MXTS65\06.@6>G>/M-N/$$_@_]G*'2=!UOPK?_'V];:\?:]^U@FM?%QM"N/&.
MNZ5\/O'/C_6/#'Q=U;X=?#;P>WAWPEKWAOXOR:IX8^%.A_%OX=>'[>S\7?!C
MPQ;^$M \,?%#6O$OCSX*?&_Q'J?@G6-<\6VN@ZG\9? 7AT![]/R_J_\ PQEZ
MU^S%^U&=3\2KX9TSP)X1NO&?Q2T7XW:_XG\%?$G7[62'XP:?\,OV4=&74=*O
MO&&@>*-1LOA@-6^'_P"TAHOB+1$\+_\ "P/$UMJ?P9\/Z9XJ\)>!O&WQIDT#
M+TO]C;]H+1?%/B:ST37M9\(^#Y?$_P 7?$'PZ/@CXDK8P>%/$OBK]J#]HSXZ
MW.OZTFJV5U?R>'_C+\.OB9\)OA=\0!I5A?>*]-F\$^+=#TV*RTV[\/?$H;?P
MI\8_M4_$E-2\8^$/BG\8?$?P^\+_ !N\%>&?"S:_X)^ ^G3^//!]K^W'XR^'
MGQKM_&,5A\-]/U>T'@#X"Z"-.CM+5_!_C30;%/M'C6QB^,NE:];Z;J?M??&/
M]J[X:>&OVDKKX?+X\TR3P9+\9OB;X*\6:=X"\!:GX4T#X(>&O^"=?C+5_"M]
M_P )7XPTR/P->ZM:_MN:!#-%X2\1Z[+\0FNAI\GBC3+7X"ZO;W=V!KY;?U\_
MZ[E'Q7^QY\>]&\*^+9OAM\3-0\,^);GQBJVNL:S\=_BT8C\%#^Q_HOA#QKX-
M;Q!J1\07G@W7/B'^T[I6J>._$7Q(T;3[OQIIFK:]=?'=]6UOXAVKZ+>]9X6_
M90^+ECJ=MXE'BSQC'+IEQ\ 9/!FD^,_BKK<TO@G1+#]K;XZ_$;]H7PC:>%/"
M$MU\-M&T/6OV<?BAH'PB\*:-H<6K6TGAGPCX'\ 7NLQZ;\,?!?B6TD\8^!/C
M;\:O@?X_\'ZSXA^*?B+P^_[8G[-M[\,_$/BSX?\ PU\*_$7Q/\!/#?Q+_9I\
M0?$N[\:^ _$WPLT/1;?2/#'C.S^-[V<6O_"WP[JVO>!O!^@:@EMXG\.ZO9ZU
MXOS/"%]^V;XK\=?#SP_J'B_XU>&--OO$,_\ PTKJ6H?#KX/:7X;\ >)+$^/-
M;TWPC^SCK>J?#2X?QC\&?$,<%MX?U;QKK<_CKQ38^$H/@DUKXJT+XM:M\<8Z
M U[KK^2_KU#]F3X)?'/]F<?"?3(?A]_PD7AW1/@E\'_@GXXTRX^(-EKLFB^*
MO#-[\%?AN_BGX)W]Q'9RZ'\&M,\'Z#\9?B_\1?"?CJ./5]8U\?#VX^&6DZ!X
MV^(?Q>T(<YXW^ O[0WQ4^.G[1%QX>N_&_@3P]_PT)I3V?CZX^,WQ8\*KXK^!
ME_\ L9?L_P#A?4_AA\.=+TY;$>$]+A^-=YXE^(L7B3X?7<>C:)X\\&>)KK3M
M;M_B#XV\?6^E=-\9;/\ :H\=?&[XA^!+J+5%^#-MXV^&&K>#O"]MX8?6-!\;
M?"C2M(^$6L:QKUMXFT_X3_V=X7^)>B?')O&\L]KXJ_:%@U"[^&W@F>UT_P"
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M!FM^(-'L(=-\*7OZ,4"?R^04444""BBB@ HHHH **** "BBB@ HHHH ****
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MO@#PQX!\-_$:7PSXD\)>+97_ +4O?A\^F_#O3-,TW5K?KM&_;WN=27X<O?\
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M(-1\1:U;_L^ZSH7CA9?&OPT\(:CXBT#XJSIXF\;_  ;^*-Q\//BM\'[GQO\
M#_X"?$$:UJ^E>)]-^('C/X>:-\%#\=8_%7P[^'GQ ^)'BZS^%VG^&/$B:5N>
M!OV](_B+;>'/%>B?"74O#GPJ\1^-?@1X.C^(OC_Q+<:9:Z5+\:?@9\*OCU'-
MXBT[P1X0^(L/A)XM#^-7@?P-X+N_&.L>'/"/C#XI:=XR\'>(/&/P\\WX1ZE\
M8P+>7XGRIX8_;1^)&C^,?C9J<7Q0^$7QBT"U^)6H:)H?QI\+OX]B_9\\'^%[
MWPO_ ,$H_">K>.8_"ECX^\8Z&W@/X:7/[1WQ3^)/B^.'XIWNF0R^$?%S7?Q5
M^%EEX@^)%[X2[7XB?MS_ !)N?$GQ@^'?PR^(OPEE'P__ &;]?^+4GQJ'PXTF
M\\':+JG@!_V8=5\2>+1X?3]I_7?$5W\,/&G@WXV^)O%GA#6O&/A_P%H&E:!H
MMKXET+QO\8/"6G3^(M<_8"B@5_+^M/Z^9\*_LQ_M+_$GXZ?$GXY^%=9T/P1I
MGA_X=^(_&WAG1Y]*U3PC/XC\/W?A+XG>-/ /ARZ\7^'-)^,?C+QCJ.F?%7PW
MX9M_B;X7U/6O OP@L+'29)M'T.Y^(FG7>G^-G^9/A9^U'\=M$LO#?Q9^(OC_
M ,%?$GP7IWP"_98F^-NF^#_AQXS;6Q\1/%WC7]IKPK\3AX*\(>&/'7BV#P=X
M]^&^J^&_"VE_$CP7;:'XU\2>-?$7A'6_!MGX<^&6J1:)867["T4 ?E3^S;^V
M#\6OC;\</AQH>N^*?AKH7P]G_P"&@_"&I16'ACPO+;_&3QAX7\ _LG?%+P"/
M 'BKP9^T%\:/!FC^(_#_ (?^+GQ0AO\ 0_"'Q,^,-AXDT/X9?$#6+R'0]2TV
M\L_AG^JU%% OP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBKXGOHH+O2Y8XKWQ'\4/#/AOXDZY=QJEQJWC_P /:'XROI)_$>DV&I6_IU%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#\\+WXU_LW^!Y_%GQ<\2_ [P/X4O/V@M;^*_PW^-O
MCVT\,>$YO$GQ&M?V:_B=J'[.'@/3OBEK<.@65WXYT34Y=>;2?#C^/-77PO\
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MU?4?@7X:^)OQ%G^&WA 7%U-X5UF6RN=+-]\2O!VG^-,+3K;_ ()[Z+K?PP^
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MC\*W&E^+]%T3X5IXFCU;3KFTUJ:PMKB^U?4?"UW8Z+>Z-<ZOH3V^K^#-?O\
M5K'PS\0_A_K/BC@/AI\+?V;/%'[,K:+!\2M$_:2\)_#/Q=\?/B5XB\5_#+QY
M<ZQ%-XZ^..@_%CQA\0M-MKVQ^(?BS58VO? _[2?B3_A$M(\8>/O$6M1>'/$O
M@_Q)?>)-5OWTWQ1<4K[1OV#_ (\Z!I7Q*\0?%+P-K?@CQEXH\02G0;KXV^&[
M7PX?BQ\;O@3>?#?6],NK_P />*3=V7Q#U7X#_&'4/#B^#M'\6+ISZ3XTTCQ5
M;:%>:]9^!_%.E ?)[GT7#^U)\)6U_P 9>&;RY\6Z1JG@$&'Q.-9\ ^,=,M+3
M5;7X3:-\<-;T.QO;G1EM=;U/PU\-?$WAC6M?.ARZCIUEJ6OVWA./4+CQAIVO
MZ#H^+?\ [6?P_P#L6G:KX8\.?$;QMH.H_&#P7\$H_$_A_P ':@GAE/&7BGQJ
MO@+6L:OJO]G)<Z5\._$?F:-XZU:SBN--TKQ';WWA2"[N_$FB^(],T3R3Q+H'
M[%GC7P]X^M-;_:(\,3W'AOQ?9P_&7QMI7[0N@>'/$UGXI\<^"F_9(U+0?'VN
M^&]=TBW\'WGQ,T[P1J?PV;1[&V\+72?%#P[>:QX"C\._%KPAI>L^']WX9^"?
MV>_%WPI^&OB[PIXO\3>#OAW^T%KWP_\ CQ\)_!^J^/-#M[=?B!<3_P##3']K
M>!(#>Z];W.N>*X_#6M?$+QYX8\/Z]XC\'ZSI=IX]\26VE+8:QXRU?4P/D_GZ
M%RS_ &]O@##X.M/&GB36=>TW0T\"Q>+]7\1:'X!^*7B7PDFI0_LZ0_M6ZOX1
M\,WH\ :3XM\6>(+/X"O+\1=,TVU\#6.LZYI4$NAVNC0^/[74O!6G^I^#?VE_
MAOXY^($/PKT:'Q9;_$&*QU[4/$7A;7/#%]H6J>#K30+YM.N+CQ%%JAM@]M>7
M#:?)8WV@-KNGMI_B3P3K-U=VFC>/_ VH>(OBG4_"G_!.W0]5^%OPTO/B-HY\
M ?%?X%ZG\0/AU(_Q_P!.F^$FH^%X?@=\/?V1?#GCK1O$5WX[&L7WB?XD_LZ^
M/+;P=\-]7T&\U3PAXH\->'/'GCFP%MXYBO/$^M^]ZW??L86'Q1E^)&O_ !V^
M&FG>)OAC\7[GQ?JNB:G\:/"%II/A?XZ^)OA;XY^ ]KJ6M:7=ZPFHZ5XNN?AC
MHGQ2\#:=X1FO;31]1?1_%VH7'AC4?%?@RWU;PX!9=F>HZ]^U5\'- M](DEU7
MQ'JE[XC\3>/O!?AO1]!\$>+M8U;7/%GPV^-_AG]G/Q3HUK;VFCM%9BT^,'C#
MP]X:76M9N-,\-)IE[<^-KO6K7P'H^N>)]-MW'[4'P8L_!<7CZ[\1ZG:>'F^&
M/Q:^+EU]J\(^+;;6=(\(_ J[T?3/BY!KWAR;18]?T'Q;X$UG7+/0->\":OIU
MGXSM?$$&J:(-#;4]&U2UM/"O&?[,OP&U>/P?XST'XMZCX,_X2GXAR?$7X=^(
MT^)MWJ.B2KK_ ,3[3]L;Q_9?"F&[\2V^@WA\>>+? .J?%C5[ZXB\8V<_@[3=
M4\/:CI>K_ OP]9^ =)9K'PZ_8F^+G@9?@QI_Q@\.7NE^'_#_ (O^&_BB'P-^
MT&D7CO6_#7[1VL0>$/B%X9\>>*])\5S^,]0U#XY>.-6TX:KXBN]4MO'6N?%6
M;2/$'AWQ)9?$*+3]20"WKYZ?U^9VWBG]MOX1^'SJ,&G:1\2/%6H6?C>3P'8V
M&C> /$-O)XHU;0?VCO ?[+GQ)D\'SZS::9:^([;X7_%'XC>&+'Q)-92F'5K2
M]>?P;+XF6QU0Z?WWP^^.LGQ USXJ:7H_AE-7B^'>E0WFFKX=U662^\5ZHOC/
MXN>"[W0+2/QEI7@:TT[48-4^%KV27&IW=KH3ZIJ5PL.N7'AZRM/$^J\%XR^$
M7[+*>"7\<:_XLTCPKX3\-Z]\4I;#XF?\+/32=)\(^./BO^TKX.^,?BG4;;Q'
MJ6KR^'(O$MG^TOX"\'W6@Z;K"7]II'B71X_ <>CRZ5?:EX:O4T;QU^R]\%]0
MUB]\!>*]#\3^*/&?B#X0Z5KGASPAX^T;QCXF-K\<?C786G@[Q=-H=YXH#6/A
M%O&'[3-MXLU'6+154^$?$NFSZ/;:M&_A?2KP#TN7/!O[4-_XK\*_L/>*G^&D
M]A9?MD:/I-]=30^+;&^L?A7JNL_LZ>+/V@K'0II9=*T[5/&DMW:>#M:\/6FH
M6FB:!8[+.YUG4GTNX?3- U7E_B7^V-=?#;Q]J6BWWPKU>7P-I?P2O/BW:ZOJ
M<GCOPY\2?B)X@T[P;\9O'>H?!KX-> -4^%0\%>//BS8>&OA%)K=]X$U7XR>#
MO&EOH&JZIXC'A>71?"]S>:CN^%[C]F+PU^S]^R;\0]8U;3OA5\)?A3X5\ ^+
M_@9=?%'QS:>%V\)6=Y\ ?%/@+0+#Q/K&I^)9]-UK5=,^#_C3Q9:ZO!JFN:]:
MI);WWB1[RZFT:+6(,S7M4_96U3Q3#?>)/VGM(O;[X#).M]X;U+]H70_L'@+Q
MG8/JWPH?QIXUTS^VTO9/&^DW_P 09/"$=OXWN+[1=-\;ZIX6U-?#</Q&TSPE
MK-B!\GU^^^FWW/\ X8A^%O[;O@#QE\-/B1\0O$\WA!H/A?\ &?P#\"]8O?@+
MXTU+]I#P/XG\;_%?3O@Q>?#BW^'WBSPOX(\-:SXDBUS4/CSX#\+ZF]_X)T"/
MPWXB_MR75)5\):8GBR[]5G_:>^%R>"O!/C:T'C35XOB'X^\6_"GPIX8T7P'X
MIU/QI>_$WP##\1I/'/@B[\.VNFO<Z3JOA.7X2?$:TUJ^U:2R\/077A>[6'6I
MXKO3)K[Y2\0)^S/XC_9-U_QY+\8=6^'?PW\4_M5_#?QEXP^/GCGQ9'J>K>.?
MB'\"_P!K'X;^!M+\5Q^+M \4V^AV>B?$34_@9X3\*_#[6M(O--\%^&O -YX5
MU.\\&6?AO2M1\'CLOA9XA_8U@TN?Q%8_%/2=&_X9O^,OQ$/B*R\??&?1([GP
M;\7[OXN_M+? CQ5\0?&FCQ^+[K3=*UCXZ?$GXE_&"'2GUJ'3#XOU#5/#.FV7
MAW2-:\+:/X<T #3L_P"O^#_D?3WP3^/'PY_:"\+S^,/AI>ZU>:'$WA^6*77_
M  OXA\(WMYI?B_P5X8^(W@_7K32_$VG:7J4NC>)_ WC/PUK^G7+6L<UH]]=^
M'M;M])\6Z!XD\/Z/['7R-\#%_9-\*ZUH_P -O@9\6O VH^(-(\*^"YH/ /AG
MXTZ=XNUN^\(^'/@Y\-_#?@G4]4\.)XFU75=3TFW^$\_PUUW3-6NK:2"^T_Q'
MH'C%KFY;Q/::E?\ US0#^?S"BBB@04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'Y7:-^QUX>^)7A#XW^%OAM\6]#\)^'O$W[3/Q[U[QQXA\ _ _Q+\._$'C
M76_'/B+X^Q_%'P-\3_%</CS1-(_:'L_AYXA^.&H6?@/Q$=+G\!^&/B5\,[=/
M&/AWX@ZSH&N^'M,L>'/V6?AW\?M \8)X6^.TNK_#^\\9V-U=>#?!_A'Q!X;\
M$:/H?Q3_ &=/B1IWBZZM-!U[Q9?S:5\8OC/\(?VP$^(7CGXF>$)_#/A'6OB)
M;>"/'^J?",^+6^*=OX_H1?L$^*_#FJW[^$M$^"3VFO\ CWXA>*]!U=YM5\):
MM^SCK7BK]K/XE?&X?%[X/:5H?P_U2S\5?%7Q5\-_&O@3PGXPL]6U7X?Z8NH_
M ?P'X<U#Q!XW\":SJ5GI/(ZU_P $_P#XSR>$[C1++5?A#XBGO/ ^M>$=*T_Q
M%XC\>:1HWPX\=ZI^R]^Q[\$?"'[27@VYTGPEJ-])\6_@EXE_9U^(5S\.!ID'
M@CQ5'X9^*]U<^'?C%\-=4?7M-U<'\_ZV_JY]&:=^PGH\WA_QG9>+O'<FM>*?
M'WPB_:)^$?C#QI8:3XGFU;Q/;?M">'?@3X1U'QCXBN?B;\1_BQKFH>+/#OAG
M]G[P7HUM';^(K#PE>6$-O9VOA71;'2K&T7Z.\/'P%\-?&OBVQG\9V]SXE^.7
MQC%W9Z%(8IKJS\8Q?!#2[M/"R1Z>D\EB)/AY\&=6\8PSZX;/SX$NHX)9/-TV
M"?Y(T7]CGXKV7Q:TOQ9JGQ&TJ^\#6?Q6O+:YT.PUOQ?I5^?V=_"GQ#3]IOX$
MZ)9:;#;R^'K?Q]\+OV@TNOAA<67E?\(WKW[,FN:AIL>JZ7X@L['0CO>/?V)M
M"^(O[0%WX\\4_#_X,>(/AUKOQB\$?%[QM!K6F_:O$/CY_#?[*_QV_9V'A/QM
MX7;P>^A>+K+PQJ7C[PIXN\(:EXH\4ZU;1_;_ !&+;PYX:UCP?X>U;Q2!\_/Y
M_P!?UH=_\/\ ]CKPS\/[_P#9XO[3QEKNIR?L[^ ?@KX!T1+S3]+C'B&U^"WP
M>_:*^#NF:GJ;11AK.\US2OVBM<U?4H[#9%!?>'=+MK7;:7E^K^)VG_!//P'J
MWACX4G1/'FLW^C^&/@QH7P1O=%\7:1XUTOPSXZ^"]]\//@_X(\7>&_%GA+P'
MX\^$&NR7OBS3O@OX/G.F>)=5U/P=I:7WB?2?$/PY\2Q7]@-$UOV6?V3/C!\)
M/C%>?%'XM^.8/'FNW7PRT_PEJ7C.R\;6>H:GXLU.;PG\&=,U&R\6>'M0^!&B
M^,-7M/#VM_#W6W\'>)]<^//B-[:RO+S4H_ ^CZM\0/%::;PEG^P'XM;PCI<7
MB:]\%^*/'%O:V_A?7==@\6^+?#6M:]\+C_P3M?\ 9;UKX;6?Q"3PAKVO>'-(
MU_X[R-\39Y8O#^L6-M:1:9XZN=$U?QSH>F:'&!Y7_IGUA^T-\"]*_:3N+;P#
MJWQ(@\.:?X4\)?$#5)- \-Z;IMUX]T[Q!\8_A+\6_P!GW0/&M]>ZMJ>H:?#X
M0L_"'CSXKMI6@7?@DMXD\<:)I.H1^+8=)\(^)/"OB/F]%_9(E_MCQCXN\9?$
MNY\2>-/'NN>&?$?B+4M)\(:;X9T.WU'PUXR^'?C"VL_#NA2:GK][INA!_AQI
M&B6]GJ?B#7M672W\_4]=UC68GU2X^>O W["7BN+XG_#SQC\1_#'[/=[HNG>$
M?@GHWQ%A\)Z1!HVH>)S\$U_:UM/"N@:KHOAWX6>!O!_BZUM++XR_!2^U37+?
M2OAUX2\0^)_AEK>H:)\%?AUX9F\+>#-&RM._8Z_:':+X>6_CO2_@%\5_#?PJ
M\"?LX?"X?#+QK\1/B+<^#/C=I7P*\%_M0^$KWX@?$<W_ ,)->T[P_P"(-;U?
MXS_#GXAZ-X$U#P?\7]"T7Q+X N6O/%>L>(['P%X\\(@?-?UT\_Z9].?LI? +
MP7^S]HE_X2\'^-+?QY+!X6T+X8>%_&<R^.?$7B&Q^'?P#N]<\$^&/ OC3Q9X
MC^(GCKPSJ&O> /$.N>*K?4M"\%6'PI\-6GB;4_%[:5\,?#COJEO:ZGP7_9Y\
M5?!;6M4U/0_$7PPLH?B/\3=3^(WQDT;X?_"9?A=X'U21O 5UX7L8/ /@*P\5
M>)#H'BWQ%XH3P_XV^(_Q*\6>+O&_B?Q9/H<^@ND.C7OAZ#P1\T']A_QUI1>V
MT7PU\"K_ ,'6'QM^/OQ*U3X3WNJZYX>\ _'30_C%\=E^+6CVGQ7@TGX8ZE;Z
M-J_A*TU2!GBCT+XB6>L:]\(/AU::A>7'A7Q1KFD^%<[3/^"?_B@>')9/$:^!
M-7\57?B/XA;K;2/'/CCPS)H?P:\=?LH?$OX.V'[.?@_XFVO@^]\4>'? W@?Q
MWXV\/Z9X<\0VOA<W4W@WP+X8^(=_X9?QWH>C>%K #OKO_7]?@?37Q(_99UCX
MJ_$#XMZ[XN^)EO<>"?BK\%?%?P$L]%M_!,B?$#X4^ ?'/AF'3_&-O\)_'EQX
MONO"6@ZCXL\86>C^.O%.J:[\)O$^H^(KSPIX$T'5[N[T3P)X4@TOGH_V3O'\
MOC?0O'^L?&+PIKM_=?%R;XX?$[PC?_"364^&WC+XE6/@WX6_##P)XF\/^&K/
MXP6VM>'+GX7_  Y^%EC;^!=+\8>+/BCX6LOB1X@U#XPZGX=U7QOX4^%-U\.O
M:_V=?!WQ(^'/PS\*_#_XA67PY27PKX>@L;/4OAU]FTRRGE;Q'XK,.DW?AC1?
MAU\.?"-M<:+X03P2-6\7^$O#W@W0O'OC6_\ &FK:-\'O@_X=MM"\,S^\T!=_
MU]Q\G?"[]D;P5\$?B3XM^(OPL\2^.=*D\:>$_AUX/UGP_P",/'?Q&^*&F-9>
M#_B/\7?B5XFUF.?Q_P".=<OI?%GQ"UOXPZ[/K7B2_GOKZUU2.^U^/[3JGBCQ
M5)JU3XQ?L7_"+XW^./B#\0_'.B>'=:\5>,?A/\-?A;X=UK6_!/A3Q'K'PS'P
MV\6_%GQA9>*O VL:UIMWJ>C:]JFH_%23[5+975I]FD\+Z'>V<D=XKRI]>44"
MNS\Z+K_@GMI7B+5/%FM>//B_XM\9:MXEU3X96K:EJFGOJ-]?> O!&N_M VOC
M+PSXKNO%FO>+9=6UCXS_  A_:?\ C#\%?&FJ^%V\"^#_  7X7U?0M2^!/PX^
M$.I^%]'\CWCX ?LU67P(UWQ_JD/B>X\7P^)[VX3PS>:Z_C6^\6>&?"MWXN\8
M>-!X+O\ 6?$7Q$\4>&[[0]%U7QA=6OAJ+P=X(^'(@TVU23Q-'XM\07-SX@?Z
M?HH'=GY=>$O^"?%S-\/=>L=2\93>!/$7Q$T_]J#X;^*='BTK0_&^E>%OV;_V
MBKSX8^$?#_PQ\$6PA\/Z-X;\??"#X!?L^?L__#7P5XDO(?B!\/M'U/PSXNN_
M$_@KXP1ZW8:U;^TV/[&D2>-K#Q'J_P 3-0U70/"WCOXB>./ OAI/">DV=SI-
MQ\5?VH_AW^UKXQM?$>NM?7G_  DTL7Q%^'UGH'A>^LM)\,_V+X'>PM+ZTUSQ
M;8ZAXRUS[<HH"[/CK]HW]G'Q5\=_B#X4:V\7:?X7^&M]\!/VA_@9\6K:30[;
M6M?\0>$OCCXE^ =SJFE>$[AY].N?"VOW7AOX:>)]-L_%[7VKZ1HAU4S:AX#\
M4ZD^@:IX4P[C]BVTBU33KC1/B/>:9IFH:?\ !C2_B):W'A/3+_5/$MI^SY\<
MO'7[0WPR'A75XM0TZ+P/=7OC[XC>)].^(FHW.E>+M2UWPA/9P>!+SX8>-[*+
MQ\?N&B@+L_.'PG^PI'X%^('P,72_%>N>(O ?PY\>_%[XO^,+GQ&GA."/Q5XF
M^*4_@KX@>)_#-SX:T3P]8)-_PE?[6?AC2OVP-.URUN-(T[X2>*?"T'PE^'.B
M6'P?O?"/@KX<^\_$S]GOQ9XL\5?$'Q%X$^+NH?#>W^*_@OPIX7\<VMIH>K7.
MO#4/A]/XFO/"6K>"O'?A?QOX#\8^![36O^$D;P_\3--TW5KF^U7PGI\;?";7
MO@C\1]3U[XF:M]2T4!=_U]Y\ >$?V$K3P/8:OJ7A[XG7$?Q$O/$'ACQGI7B;
M4/!ME?>&=(\5^'/VC?VD_P!HQK>7PA_;L&IZUX(OM2_:>\<> 4T#5/&DWB?3
M?"%AI&K6'CV/XC1OXY'K2_LP:=)^SWX9^ >H>.-;OX?#^LZ)KUSXS_LC0K#5
MM8U32?'2^/IYY='TVUM-!TZ/4M4\R"2UTNSM;.RM9-EA;P)'%&GU+10%V>#>
M%/@-H_A/0?B+H%IKVHSV_P 1/#/AKPQ=2O:V4+:3;^&?AGI/PSMKBPCA18WE
MN+#28M2DCE!BCNY&@B MT1:^>OB-^PE!XWTN\\/Z7\8_%_A?PUX@\!WWPW\7
M^&K:QDD\/Z[H%Y\+_!?PRM-9_L?2=>\.Z;/XS\,V?@H77@_4/%=KXP\):!#X
MP\<1CP/>:Y=^%?$W@_[^HH"[[GQMJW[(Z)K?@?QIX.^(,V@>//AEXG^('C'P
M/J>M>%K?Q'X:@UWXD^,?B'KWB4>)/#-AK7A:\U[2[CPW\5/&OA%;.U\2:'>1
M&^L/$D&IPZSID+27]:_9%\/:]^RW\,_V8;SQQXGCM?AGX2^''@S3_B;9:?X:
ML/'-WI?@[0+/P-XON;>*QTFV\-^'M3^*7PTN/&?P_P#$DWA_1M/L]+T'Q]XA
MA\/V&GQBS@A^NJ* N_U/@V3]@SP=);?%BW_X3[Q44^*?@/\ :E^&XBDT[0/L
M?@CPA^TKIOP3\.6?ASP78164-KI7AOX1^#_@-X*\+^!_#RH=.DL4G>_0B.TA
M@U/ 7[%FC>"OBGI_Q(N/'&I^)&\+_&WXC_&?P-'K*>*=2\1:*?BYIWQ\7QQX
M%O=7\0>/?$'A2'PFFM_'B\U#PVGP]^'WPTU%+#P=X<L_'5Y\0M;-YXHD^WJ*
M!7?=GPM\6_V2?^$G_9=^!_[+_AR]FOK+X>S?!;P!>>.[Z?3-*U?3?A/X4T*#
MX=_&JYA7[!J*VVN_%G]GRY^)OP7A.AZ<U]I5W\6&U+3K[P['IS>)M%K:S^Q1
M>:AK$NM67Q:DLKOPKXF\>>+O@\;KP%IM]_PC6J?%+]JOX6?MB>.[+XE&WU[3
M/^%EZ++\4/@_X4\->&8_#@^%/B#2_AG=:_IOB+Q)XQ^(=_9?$[2_O*B@=SY>
M;]F^YA^#OA7X=:?\0[X>,? _Q&_X6YX<^(NK>&=)U&WG\>GXBZQ\1;F7Q-X'
MLI]'T?5_#.LW.OZQX?UG1--O?#^I6^C:C)J'@[Q%X-\9:=X=\5Z%Y9<?L4:I
MXC^)EA\3OB!\:_$'BK5])U6QUK3((M&U2WBBF;X\?LV_M":KH@C\2^-O&6G:
M+X,TGQ/^S=HGA#X;^%O NE^"K;PUX"\2ZS)X[NOBM\3WO/BAJOWI10%V?$WQ
M@_8YF^)_[-WP_P#V;-)^+_BOP7X:\'_#U_A;KFIV5K<SMXS\)7?P@UOX/W=Q
MK&C:3XA\,Z;?Z]IUAK3>+/"UKXH_X2WX<:;XRL-+UOQ%\-O&$VCZ&-*;XG_8
MMT?68- N-'\?:EHVN^$/%WQD^('A>]O/#>CZUI*>+OBK^V1\*?VU;4^(-&\W
M3;C5O#F@?$+X1Z%X5U#3-+UKPYKNO^#=5UM[+Q5X9\6'2O$VE_;=% 7?ZGS'
MIO[.EUI7P(U#X1V_Q NKGQ+=?$/Q3\7H/B!?^'++R!\2/$/QZU;]HR*\U#PC
MI.H:/%=>%;7Q_J2V-[X=T_7M&U+4?"D,NFV_BC2M6N%UZW\P\<?L0:9XHL?#
M<VB_$SQ)X5\4>#/&7QJ^('A?6],CUG2K6W\3?&_XYR?&OQ,FI)X(\6^!?%<^
MAK]NUWP3+9:)XW\.:Q>Z'K,NI'Q#:Z_:VVH)]UT4!=GR3\/?V2?"WP]OO!E]
MI>M-:IX-^+7AKXMV.BZ-I36.@17WAK]C2P_8TM/#&GPZMJWB+7K?PY%X3T^#
MQ/9/JWB/7_$%OJ$<&E7NNZI:0O=3?6U%% @HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1-7^$W@7P3^S9XX^+WQ+3QUXS\9>*]-\.>(?%/BKQKXB^.7CP36UOX$T/3_
M'@_1?"?AFVU7Q9=CQ#XJU0*LN_5>6FGEJ^_:W6Y^@7P[_;3_ &4_BU\18?A)
M\-?CO\/O&GQ,FT/2_$G_  A&A:L;SQ#!HNN>#]'^(.CWU[8"%9-/74O!'B#0
M_%5E#??9[BXT/5M/U".%H+J)FYR__P""@G[$6EZY\5/#.J?M3_!'3/$'P0&N
M2?%S1]1\?:'8W_P]M/"OB_0_ /C#4_$]O=7,4FG:+X(\9>)_#?A[QUKD@.C^
M"=1U_1H_%=]HZ:G9/-X1\(?V1/BQ\/O^"A'[3'[5:^(/#NO?![]HSQ'X2\8:
M7::9^T%^TAHMUX;70?V8O@;\$FM-2_9NTJ]'[+'C_5]4UWX0G7;/XMZ]ILOQ
M)TKPOJ]CH-CK#V&C:=I]M\V_!#_@EIXO\)?MF?&3XN?&;Q3\*?'/P4^*]S^W
MQ;W/PHUC7/B;\4)/B)X _;0^)?@3QCJ?@V?X8?%*[N/A#\"=+\,:+X<GT3XI
M7GP)T*"[_:#DUW1U^*]U?6_AG2C= 67?2R_X*VZ'ZS:_^T/\#O"WA[XU^+O$
M7Q2\&:-X5_9PN+BS^/'B._UFW@T/X3WMGX)\/?$B]L/&^J,?L6B:A8> ?%WA
M7QA?V-U,MW8^'_$FA:G=PPVVJV,D^1X?_:G_ &;_ !7XT^%_PY\,?&_X9>(?
M'?QL^%,/QT^$?A/1O%VCZEKGQ%^#5S!;W5I\3_"-A:7,LVL^![RVNH)[+Q':
M+)IEY&[/:W$HCEV? OAC_@F_XO\ "'_!(+QC_P $\M%\:>%%^,OCOX!_$KP3
MXM^,&I7?C+7M'\6?&OXI#6]3\7?%;Q9K6O/J?C[Q#<Z]XIUNXUC5+_5IKW6#
M#Y5C;+%96=C:0?*]K_P2#_:8\$>./'_Q(^$W[07PQ\+>.[/PO^U=\"?V9O%8
MT'Q9I^H?L]_LM?$C1GL?V2?AQI<5J+\ZKJ7[)6L_$CX\:]HC1W>G6'B&/4_
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MQ3X2^!/!/PVC\"6_A_QI^S'X^L)[3P_H%]-J7AWXZ>(/$S7_ (F\166IZ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/$'AVPOKSQ!X:^*_AU[O]I^;PS\(O#FL:_XPU#P'X'O-(UW3]5^(^B>*X=%
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MI6?COX@?%+XE:4@O])U!;SQ?XC_M*?M1:-X6M/&_PZU>'XN6'@[Q-XT_L-]
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MA;V;Z4_C3X=7/B;QO+\"A^TCH_PHM]<\=>$OASH7Q UW2/$_B?Q5X)\5Z/\
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MJDD-O\)_AS%\3M?\3:SI7A33?%.I0_%'BGXY?M2? 'X>_%&RT.V^*'CGQ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YG_  __ &E_
MC+8C4+G6?#>O^+=8^)G[8O[1/[/WPV3XK>,?@[\,?@]H_AKX*^)/VNM;AUKP
MCKOPJ\+?$7XI?8;3X>?L]6VD>)%^*OAVYUV_\2W&GZKI<>D:./$<MMX]\//^
M"DWC73/@K\(/%?C+P3X-\<S^(?!7PQ\-ZAXH3XI3V7Q"\1?%/Q)^S9\#_B[=
M^+O$WP?^'_P5\0KX8^&MSX@^,.E?\)?K_@6?Q;J'A;P7?Z#XZ\*_#KQ5:^+?
M#'A*;]/F^!?P2;_A, WP=^%;#XA:QIOB'Q^&^'OA(_\ "<:_HVLW7B/1]<\8
M9T@_\)-K&D^(;Z^U[3=3UK[;>V.LWEUJEK/%?7$T[X$W[.GPHO?B%<_$C5_#
M=KKFK2>$)? FGZ-J]KIMSX3T7PM=Z.GA_4-(L?#Z:?#:7=G>:+]KTNVM=>.L
MVOAS3]?\;V7A"#P[:?$?XB0^*@=UV/C#Q%^WIHNF2>';3XW_  (M?!<FA:WX
M?^)WBN/QIKVIV3_#CX%P_$CXA?"2']IFWTKX@?##P;KZV_A'XF>&? VIZKH&
MIZ+X5\1>&?A7\7?"?Q(O;^QU>RUKP-9Z-S^WSXXT?0?"^M^)_@/X:\/WOC?Q
MW:_!+1O!<WQMENO'?A#XXR7W@;PUJ%G\9-"A^%"V_P /O@IH7C'Q-JD.L?&+
M2M2\;:K'X&N?A'XYT[X9:G)\9])\->'?OO3?AK\.=%T.V\,:/X \%:3X:LM"
MU7PM9^'M-\*Z%8:':>&==G2YUOP[;:3:V$5A!H6L7,4=QJND16Z:?J$\:2W=
MO-(BL$N_AI\.;_6/$OB&^\ >";W7_&?AYO"/C#7+OPKH5SK'BOPHT/V9O#'B
M74YK![W7?#S6Y,#:+JD]UIIA/E&V*?+0&G;\3\Z_%W[;?Q0U;4)?"7ASP1X*
M\%ZAX#^.G[*G@?XL^,;;XL6OB32UT_XP_M]ZK^RU<>'/AC%K/PGMM-\?OKMA
M\-?&N@>-IM6NOASKW@/7]>N?"OA8:Y\0?"MTUE]&?M0_&7XC?"V[_9[UKX86
M=EXMT77_ (GZW+\2/"5CH>H>)O$GCSX3:!\&/B?XT\1Z=\,SH1N]0_X3_3/[
M"T[QSX/T_3](UZ3X@7_A6/X710:*?'J>,O#/OT7PF^%D'_"$^1\-/ $'_"M+
M>YM/AP8/!WAZ%OA]:WGV'[7;^!VBTY&\)P77]EZ9]HBT Z>DQTZP,@8V=OY>
MEX3\ ^"_ WA;P1X*\)>&='T+PK\-=!T?POX!T2RLXA9^$= \/Z$GAC1M+T(2
MB26PM]/\/1KHT'DR+)_9Q>U=WBDD5@-.W?\ KY'Y]_!K]HWXY?%/Q+\"]#T7
M7_AWXI\'?M#^%]8^//AOXK^'VTJ^TK0/A'\$?&OA7PO\5?#NE:?8SR6OC/\
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MDE-G;>5TU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ-:_"33/C/K/@I#XR^(;:YXF\1>"OAC^SKIN@_M >+?3_P!L/]LZ]_9-\'>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HKY;_ &GI_P!M:#3/"!_8PTO]EO4]9;4=4'CY/VGM>^+.A:9#
MI(M+8Z(_A"3X4^'/$5U<:BU]]K75(]:BM;9+06S6DDDQE0?('V__ (+H?]"I
M_P $G/\ PX/[8'_SLZ!I7ZI>KU_)GZQT5\]>%9OVKF_9OOYO&^G?L]1?M>#P
M3XY;3--\*ZQ\2+C]F]OB.I\0?\*UAOM:U?0[;XG)X)G \+?\)S=6^@/KUJ9/
M$']@6=Z(=-\_XA^W_P#!=#_H5/\ @DY_X<']L#_YV5 )7ZI>K_+1GZQT5\8_
MLRW/_!0V?Q+XF7]LK1OV,=,\'KH=L?!TG[,OB7XWZYXEE\2F_47B>)H?BGX3
M\/:7!H:Z7N:VETNXN;]K_:DL*6^7KS?XRWG_  5KC^*'B]/V>_#O_!.F]^"Z
MWFGCP#=?&7QE^TOIGQ0FT\Z'I1U8^+[#P1X#U;PI;7B^)3K<>GKHNHW4+Z&F
ME2W+1W\EW#$!;6UUZWT_+]#]%J*_+WPA??\ !:1O%_A)?'WAC_@E[#X";Q3X
M<7QW-X0\=?M77/B^'P2VLV0\6R^$K;6OAU::-<^*8O#QU%_#EOK%W:Z3/K*V
M46IW5O8O/,GU+^T[/^V;!H7A4_L9:9^S%J?B5M:O!XWC_:=USXJZ%H47AW^S
MW-@_A6;X5>'?$6H7&M'5?+6\BU>"VL5T\N\,S7(6,@6UW7K?3YZ?H?3M%?DY
M]O\ ^"Z'_0J?\$G/_#@_M@?_ #LZ^Y?AU+^U*_[/QE^+=A\ ;;]JG_A'_'16
MP^'6K_$2]_9^_P"$J74_$0^&<9U?Q-HEA\1O^$?GT8>$F\=3#1/[1M=3D\1)
MH$%W:PZ9). U;JGZ/_@(]^HK\FUO_P#@NEM7=X4_X)-[L#=M^(/[8.W=CG;G
MX9 XSG&><=:^C_V9[G_@HM/XNU]?VQM%_8JTSP&/#A;PO-^S/XG^.>N>+I/%
MW]IV0$>OVWQ2\(^'M&A\.?V,=18SZ==3ZG_:8LH_L_V5IY% :MUB_1_\!'VK
M17YX_&^\_P""L,7Q4\6Q_LW>'O\ @GC??!%9-#_X02Z^-_C']I+2_BI+$?#&
MB-XD_P"$ML/ ?@76/"-O(GC,^(XM#_L?4KI9?#":)/?^3JLM_;Q<!H-]_P %
MM#KVA#Q1X6_X)8Q^&#K>D#Q-)H/CW]K677D\.'4;8:\^A1:A\-X=/EUM-)^U
MMI$6H30V$FHBV2\FBMFE=0+><?OU_+]3]3:*^;OVFIOVO8/"/AYOV-M._9NU
M/QX?%,:^*X?VFM:^)VA^$8_!7]C:P9I?#US\+- \0ZS-XI'B$: D<&I6L&DG
M1GUB1KD7T=E%+\6_;_\ @NA_T*G_  2<_P##@_M@?_.SH!*_5+U?_ 9^L=%>
M#?"&7]IZ3X)QR_'NQ^ UG^T;]D\7F6R^$.K?$'4?@F+Y=2U<> A'JGC/1=+\
M=FTFT<:"WB]FT@36^I/JZ:,MU:QV4DOPG'?_ /!=/8GF^$_^"3(DV+Y@C^(/
M[810/@;]A;X9!BF[.TL 2,9 - )7ZI>K_+1GZRT5\/?LUW7_  4FF\?:FG[8
M.B?L/:;\+AX/U)M&N/V:_%/QZUOQ\_CX:UX=&CPZG:?%#P?X?\.Q^#V\.GQ8
M^I7-K>R:TFM1^'8K6UDL9M2F@Y[X\W?_  51B^)VN)^S#H'_  3]O_@P+313
MX;NOCSXO_:,TGXG/?'2K4^(5URQ^'O@C6O"L5HFM_;5T5[#499I=*%J]\D5V
M98P!;6UUZWT_+?Y'Z!45^4ME?_\ !<0WMF-1\*_\$I5TXWEJ-0:R\?\ [7;W
MJV!GC%ZUFD_PU2![Q;7S3:I.Z0O.(UE=(RS#[1_:8F_:S@\#Z(W['.G?L[:G
M\23XPL5\1P?M,:S\2M#\#IX .A^(CJ4VB77PMT'Q#KTOC!?$H\)I8VU]9PZ*
M^AR>(I9[I+^'389P+;:K7ST7KH?1-%?DY]O_ ."Z'_0J?\$G/_#@_M@?_.SK
M[K^ LO[3LOPM$G[4%C\![#XU_P!H:^&M?@+JWQ!U?X6C2Q,W_"+L+_XA:-HG
MBTZA);[#KZ'31;PS%ETZ2= &(#5NJ?H_^ CWBBOR8BO_ /@NKY47G^$_^"3'
MG^6GG>5\0?VPC%YNT>9Y1?X9!S'OSL+@-MQN&<U[]^SC=?\ !3";XAW"?M<Z
M'^PMIOPH'A;56M+C]G'Q5\?M:^(9\:C4-%&B17%G\3?!N@>&U\+/I1\1-JMQ
M%?/JT>H1Z+':6TEM+?20@6\XOT?_  $?=-%?!7[0=U_P5!A^)-TG[*>@_L$Z
MA\(/[%T@V5S^T'XL_:%T?XDGQ$5N?[?2ZLOAQX+UWPP-%1_LG]D2Q7[7TBFY
M^VPQ%8MWATM__P %U/+D\GPG_P $F?.V-Y7F_$']L(1^9M.SS"GPR+;-V-VT
M;MN<<T!;SCZ7U_(_6:BO _VCI?VHX?A_;O\ LBV'P#U'XJ?\))IBW=O^T=J_
MQ#T7X?CP@;;4?[9DM[SX9:)KWB,^)%O!I(TR&2Q&F26S:B;JXCE2V5_AC[?_
M ,%T/^A4_P""3G_AP?VP/_G9T E?JEZO_@,_6.BO _V<9?VHYOA_</\ M=6'
MP"T[XJ?\))J:VEO^SCJ_Q#UKX?GP@+;3O[&DN+SXFZ)H'B,>)'O#JPU.".Q.
MF1VRZ<;6XEE>Y"?"<-__ ,%UO)B^T>$_^"2XN/*C\\0_$']L,PB;8/-$1D^&
M0<Q;]WEEP'*8W '- 6WU6G=[^FG^1^M%%?!7[/=W_P %0)OB3;)^U9H/[!6G
M_"#^Q-7-Y<_L]^+?VA=8^)(\1@6W]@I;67Q'\%:'X8;1';[9_:\LNH+?1@6W
MV*&4M*%G_:*NO^"F\/Q%"?LEZ%^PCJ/PD_X1S26-Q^T5XK_:!T;XB_\ "6FY
MU/\ MV,67PU\&:]X9_X1Q+,:,=)F-_\ VG)<MJ:WEO%$EJT@%M;77K?3\M_D
M?=U%?DQ+?_\ !=7RI?(\)_\ !)@S^6_DB7X@_MA"(R[3Y8E*?#(N(]^-Y0%@
MN=H)P*^ZOC_+^U)#\,8'_99L/@%J'QF_M;0Q<VOQ_P!6^(FD?#'^PRLO_"2O
M!??#K1=;\5'5D?R/[#CDTX6<J^;]OEA(3(%MM5KV>WKH>^T5^3GV_P#X+H?]
M"I_P2<_\.#^V!_\ .SK[@_9KF_:LF\!ZFW[8.G_L^:;\3AXKU!='@_9KUCXC
MZWX#;P.-+T4Z5+J5W\4-#\/^(4\5MK1\1+J%O:V4FD)I::));7,EW+?QP@-6
MZI^C_P" CZ#HK\GY;_\ X+F>;+Y/A7_@D^8?-E\@R_$#]KY93!O;R3*J?#1D
M64Q[3*J,R!]P5F4 GV3X W?_  5*E^)FEI^U)H'[ >G_  <.FZR=:N?@#XN_
M:)U?XF+JXLV_X1]-+L?B)X)T3PL^FOJ&T:S)=ZA'=16>YK*.6?"T!;SCZ7U_
M(^_**^'?VD[K_@I1#\0--3]C_0_V'-2^%9\':6VKW'[2?BGX]Z)\0%^(!UKQ
M(-:ATVS^%_@[Q!X<D\'+X=7P@^EW-U?1ZU)K4OB2*[M([&#3)KCY[DO_ /@N
MIY<GE>$_^"3)EV-Y0D^(/[80C,FT[/,*_#(L$W8W%06"YP"<4 E?K%>K_P"
MS]9J*\'^-<O[3L7P>>3]G2Q^ ][\?L^%_+L_C7JOQ!TOX/$->V(\:;]1\"Z-
MJ_C13%IQU)O"^W2V$]ZMBFJ_9X'N)$^%/M__  70_P"A4_X).?\ AP?VP/\
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M6/!^H>#OBAKVL>'O'$EIH.L_#*ZC\5_H=XSE_:G7]G>WF^'EA^S_ #?M9?\
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M/@7P7I_C;0]?\3:C\'M7\<?"8P:/X[TNUT^77_! FUC2-)3QMI^AWNH7MG'
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M/V2;[-87-TU ]'_*OGZ_W?1>5C]H****" HHHH **** "BBB@ HHHH ****
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MOV6;SQ-JOAKX;_$O7M&^)FKW_A34=5T&*W\,Z1>6]A8 WRVTWLN^]M?Q_P"
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M/P[%^T)^S)K"3:_H \.:-\9H_ W@!+SQDG]OR^'AX74Q^%]7:]#6GS?\8/\
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M7X_7/C2X\0F>V\0Z=^SS^T%\1O@[)X8M_"RVVI:+=Z;?7>O!M/CL7X;X-?\
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MK2\MH7\S^'7_  1FUC0OBCJ'QI\=_'GX03^._$O[:O[-O[8WC72O@1^R+;?
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MQ_=R:9J'C&6,ZK>:'I4LAME!.W3^OOZ[WZ'IU%%% @HHHH **** /SA_:_\
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M$^@_'/P=^TM^T=XU^-FMZ'XWT";]F_\ 9BM_#/B'X6_!?Q]X%T&[O?"/C_\
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M#[PCXZ?1IT5[.]UK0?B/XO\ @KXMLFOX62\MTU#X<Z&A@FC-L]_;F.]GL?\
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M9\8?#O\ 8WQ ^(^J:H/&OC2^F\*#PCHNG>'-3\77H.^E^2%O^WO_ )(^-?\
MANC_ (.6O^D)WP4_\3!^ G_T0E'_  W1_P '+7_2$[X*?^)@_ 3_ .B$K^F6
MB@7,OY(?^3?_ "1_,U_PW1_P<M?](3O@I_XF#\!/_HA*/^&Z/^#EK_I"=\%/
M_$P?@)_]$)7],M% <R_DA_Y-_P#)'\S7_#='_!RU_P!(3O@I_P")@_ 3_P"B
M$H_X;H_X.6O^D)WP4_\ $P?@)_\ 1"5_3+10',OY(?\ DW_R1_,U_P -T?\
M!RU_TA.^"G_B8/P$_P#HA*/^&Z/^#EK_ *0G?!3_ ,3!^ G_ -$)7],M% <R
M_DA_Y-_\D?S-?\-T?\'+7_2$[X*?^)@_ 3_Z(2C_ (;H_P"#EK_I"=\%/_$P
M?@)_]$)7],M% <R_DA_Y-_\ )'\S7_#='_!RU_TA.^"G_B8/P$_^B$H_X;H_
MX.6O^D)WP4_\3!^ G_T0E?TRT4!S+^2'_DW_ ,D?S-?\-T?\'+7_ $A.^"G_
M (F#\!/_ *(2C_ANC_@Y:_Z0G?!3_P 3!^ G_P!$)7],M% <R_DA_P"3?_)'
M\S7_  W1_P '+7_2$[X*?^)@_ 3_ .B$H_X;H_X.6O\ I"=\%/\ Q,'X"?\
MT0E?TRT4!S+^2'_DW_R1_,U_PW1_P<M?](3O@I_XF#\!/_HA*/\ ANC_ (.6
MO^D)WP4_\3!^ G_T0E?TRT4!S+^2'_DW_P D?S-?\-T?\'+7_2$[X*?^)@_
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M'\S7_#='_!RU_P!(3O@I_P")@_ 3_P"B$H_X;H_X.6O^D)WP4_\ $P?@)_\
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M M]>M;>+]I*/]I7QC\0] M/$/PIU#6)U^ =[X6TWQ5X.UC4;SQW>>"?!FO\
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M[AO[F[\?_$DZ+<M=VVF:;97W:^-O^"B_[5&F^'O^"K'C"W_:#\2:#KW[+/P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1Y-/U31- \0R:I8W/B33K31YKM+>$O=L9+5OZY:!.+C:]M=FFFM-]@K^9/\
MX.:_^2;?\$O?^TKG[./_ *C'Q)K^FROYD_\ @YK_ .2;?\$O?^TKG[./_J,?
M$F@=/XX_/_TB9_3911100%%%% '\QG_!P'_R=Q_P0$_[2G_!7_U<'P%K^G.O
MYC/^#@/_ ).X_P"" G_:4_X*_P#JX/@+7].=!<O@I_\ ;_\ Z4@KX0_X*-_M
M4:3^R-^S5/X_;0OACXO\>^,OB?\ "+X0_!;P7\8O%NG^!/AOXD^+_P 0_'^B
M:=X6N_&'C#5+2]L_#7ACX>6=OK/Q>\5Z[]GDO='\*?#O7=3TE7U>TL(W^[Z_
M.;_@I'\5O@/^S?\ #7X?_M3?'CX*I\9],^ GC+Q'KWAB"Z^)?P@\!0>"]5\1
M_"_QUX<USQ#HVC_'/XK?##P+\0/'NN^#+OQ)\./ ?A'3QXF\=ZMJWCF72?#5
MAI6GZKXCUNR"5O\ Y'F7[-G[?G@7]K#QO\/7\"_"WP>WP]^,'[!'PY_X*"PZ
MUJ4EG?>*M.^)UUXWE^'I\!^*;>VT^33)/$_PSN/!=KX=OO$2W4NM:/K_ (6.
MDVJP6^CVAC6T_:QM/AS_ ,$D+;_@I5X!^!?PI\+?$7QU^P_\+_VL=9^'NC6L
M?A?PIJ7BKQA\)]$^(\'A;7/$NBZ0NNWNA:+JGB[4;"VU:ZM+O4HK.6YND@%Q
M=3J_;W/['O[ 'PQ\)67[7FL?#KQ'\ ] ^%G@[QW\=M<UN3XE_'OX06_@'P5X
MB\=^)?VL?BCIWQ(^'GASX@:+H[>$;?XB^(O&'C[QC\(_%7AS5/!VG:M?:]HS
M^$DT^2?2FXS]@WX0_L<_M%?L ZGX0\"?L\?&SX6_LY?%NX^*WP*\9?LR_M'_
M !(^*.O^,? UA^S[\1_&G[,/B'X876E:Y\8?B2WPLTG0KWX37VD6'@GX>^+=
M*TG1-.M[.W^R6=_%<11 W;2RMM=?-^>O^?;K\I^!O^"ENH>._$\WP(^!'[*W
MP-\,_$;XQ_$CX!? 2\\+^,=>@T3PGX ^.GC?X5?MG>./VL_!W[0<7A/PI,WB
MR]_9UF_8K^+OPTL=$\-0L?B[XS;2-.LO$.@^$?$$'C"WQ=+_ ."J>I?";XS?
MLU_ K7?V5?@QX*M_!7[07[1W[*/[3WBGX?Z\;?P7\%K'P;\0/V'_ (?>$/B1
M\!I?^$1T8O\ #'XC^,_VX?V>_$7Q3\/>)+3P[)\-+:Q\8:;K6J^(I/AX_BW4
M?8OV6K?_ ()V_P#!1CQU^W!?^$OV:-+T;Q"W[07ABY^._C>T^-/@"W^*-[\>
M?V:O&/Q'^#'PW^)^G:+\#?CEJ_QL_9@^(&CVWPXUW7?AQX_ET?X*^,O&GA'7
MU\4Z1J.LMJNN3IX-KWQ:_P""4=]\%/VW_"]M^R#\0?'?A#]AKP%\?/A3XE\)
M[KVX\3?M(?#7]JSXXZS\'_VCO%_PS\6:_P#%.'6OBOJ?Q-_:F_9:\<^!_&'Q
M7^(WB:U^)LOQ.^#UQXKT_P 3V\NOZ3KNM@:=GTT\^^^OE\NAY/HW_!:'7]:^
M$_QZ^*#?L<?!G3-#T;PG^W;\7/ .G:A=WJ77C_X/?L\_L:_LV?\ !1_]F/Q'
MXUM)/#$$EEK_ ,7]'_:[M/$GCG2&BE'@SQ1>:GJVDRWVMZAJ%W)Z/KG_  5_
M\1> [W7/#_PH_9@^&/A'QVOC7]D?X=?%[PWH?AKXJ_$WQ'X+_:!^,/B']O;P
M%^T1X'UKP'^S;\,O%?Q1^*^J_!KXC_L77>C>#]2\"^#-9O?B7X7\7I\1;""'
MP9?:1JUUK>+OC#_P3<^+6H76@_#3]ACXH_M$:O\ M':WX6^$&D>'/ _B7PM\
M-)/B+H_[:/\ P3/N_$_BRSTU/B;\=_A-X>^']G;?L;_L2>'?@_XL\/ZOJ/@7
M6?#7BWP=HVC^'+"T\37OB'79.\^./B3_ ()9ZY^RU\0/^"E7C[]GSQSH>J_'
M+XY_"'3OB1I=[X[U;]F;X[VW[5_[._C;QQ^R)X4\/>/_ !@_QN^&7@3X/>,/
MV>_$6J?%+P=\1/B)'\4M#^'VD^$- \5^.+OQEXO\,Z9H6M7@/3JG_P '7?7L
MUVV-;0_V]OC?XU_:8^._A_3_ -D;P7\4_B'^RC\"--\3>%(M"^!?[5>A?$CX
MD^/O%_[$O@K]I+_A5/ACXW^-O@$WPK_9JU#QK\0O'5M\,=/^&OQS\6^$_C!_
M9,J7VN?#=]8NK;2;WU;PY_P4/UO0_P#@G!\6OVM].T+X,^*/B3\)O'S>&/'O
MPI\%>'_B]\([/P'\2?$'Q%\#V7C7X>_%;P%\7_"7A?XO_#SXK:#<?$>?Q%XE
MTWQ?X0TC4O$BZEH?C:*RBTGQG9RU[A\!/V1?V1OB?X3\-_M,^$?!?C?0M6_:
M ^"/@RR\17_AO]KWXM^.=*\9^#[[X$Z3\%_#U_KOBWX8?'OQ1\+OBWXCLOA!
M;:5H&@_&_3M8\5^)KUK/3?'6A^/)?%"6OB1?<-$_8<_9<T'X)^._V>;;X8MJ
M?PM^*?BV7Q]\4K'Q5XX^(WC;QA\4/'<^H^'=3E\;?$GXJ^,?%VN_%;Q]XO>7
MPAX3LSXF\6^-=8UK^Q?#'A_PZ+X:!H^GZ;;@KQOMLUI^:^?E\S\ROV?/^"B^
MC^._C]:_LHZ[^S%\)_AE=_%/_@H3^U9^S;::?IYL9]+^+7[-?P/\,?\ !0G2
MM _:#M=+BT*PL-3\8WWQJ_X)_P#COX8?$_P)J(U?_A"]+UKPCXLOKZ*Q^)7@
MBVG\<_:E_P""I_Q ^#GQ5_;M\$Z'^Q7\,/BS\._V1U_:#;4/$K:!\2H+;PUJ
M/A[]C+X5?M22^./BQXJ_X5+JWP;@\/?'#Q=\5U^!-SX6TOXCZ=\8+SQ%=Z1X
MJ_X0SQEX1O?$>H>&_P!I++]BC]ES3_'WP>^*5K\(-#3XA? #XC_M+_%OX.^+
M)-3\2W&K^!/'_P"V+K/B[Q!^TOKFE37.MS)-#\6=:\=>)M1UW0]1CO?#]C<7
MMH?#^E:.NBZ&NF[?B?\ 9-_9Z\9^"OVC_AUXG^&UAJ_@O]KG7=0\2_M%:#/K
M/B>.W^)FMZI\-O ?P@O[[4)[?6X;W13<_#CX8^!?#+V_A>YT.U6#0(KY($U:
M]U*_O02M?5777]?^ ?C?\(?VU_B%^T]H/PL_9F\ ?L>_LH67BCX@_%G]M1/#
M]_\ $VS\8:'^S['X#_8;\1?!KP;\2/B#/^SYXP^%7@WX\^ _C!J'QP^.]K\(
M)?@Q\2O!O@GQ5X3U#P+\2_BC=^(M:\)_\(19^.N?\%?\%B_'_P 2/C9\+?A]
MX-_8]\*:U;?%#PO\&A^T'X'T%OBIX[\>6VLZ_P#ME?M3?L*_M!>)M \<^ /@
MEXC^%VN_"#]F^+]E?Q#\4H_%_P =KOX.6/Q1^$A33-%OO#/B.2U\/1?K=XX_
MX)]?LB?$&]\1:QK?PFDTKQ-XG^,&M?'R]\;> /B%\4OA5\0M+^+GBGX<^'/A
M)XR\8^#?B)\+_&W@_P <?#ZX\>?#KPGH7A?XA:7X$\0>'-"^(%G:W-QXSTO7
M-0U35;N]].^$?[+7[/GP%U:TUGX-?"KPQ\-KO3_@[\-O@!80>$X[S2](L/A!
M\(M>^(/BCX=^"[+P_%>?V#:6GAWQ!\5?B%JRZE;Z;'K>IWGBB^DUK4]1$5FM
ML#;6NC\OFM=>NNI^.WP[_P""AGQK\-_"3]F7XAQ?L,_!;6?"?[6'[*?QZ_:D
M_P""?GP-_9^\77S?$CP]XO\  WP&OOC]\/\ X*>.;&_^&FF^'],\0_'7X2>)
M;ZQU7X@_"K2FM/AW\1+_ %#X9-X4^)=EXKTSQE>\9\4O^"L7PI_98_9B^$O[
M1FC> _V4_B!\?O%OCGXL_"WQSX9^'^E^+?V<==\'?!S]E'P?XD^+/Q_\#7GA
M7XY^"?"?QL\*_%?P%X7\*>%OAWX-^ GCSP_X?U37?C/\4/A#;Q:)IWASQ)'=
M6OZO^"?^"<_[&WPWN_&=YX"^#S>$W\9^!OB+\,H[;1/B)\5;+3/AM\/OBY?'
M5OB7X._9[T>/QR-)_9A\/^-=9%MKNO:;^SE9?"RWO->TW1==*KJ^AZ/>6.W\
M.?V!_P!D7X6:G8ZYX6^"^C7WB"RT;XD:)-XC\?:_XR^+/B374^,/BWPSXX^*
MNM^,/$/Q4\2>,]:\<>-?B)XD\$^";GQC\0?&-]KOCOQ!I_@OP=H&I>([CP_X
M6T'2]/ O'S\_/\_*^_<Y/X _'WPA^T7^T#^UAX L? _P[U7P9\&=2_9A\6>"
MOB3I*6FN3?$^'XM?!'2/B?X?\9WLDVG_ &47/A^SO+&P\):M9W=Y,=&6UGAN
M+7Y(EY/X'>-X/&?[4O[:O[''C#]E;X.?#'X5?"SX<?LT_$WPF='N/#7BAOC?
MX6^.OBK]IKP7<^(?B1X)T_PCI?A7PM)!JG[-LLGAOPO)?^--2?PUJ&F:SXAU
M;2=8U&?P9X6](^#_ /P3X_9-^ 7CCPC\0_@[\/?$W@'Q'X(\%^"_AYH<.B_&
M?XY'PG/X-^''PWE^$7P_T3Q/\/[WXDW?@'QQ'X(^'$J^%_"EYXU\,^(-1\/V
MEKI]UI=W:ZEIFG7MKW_Q*_93^$7Q/\2^)/&FJ67B#0?&/C>\_9D_X3SQ+X4\
M1ZCI.H^-O#7[)'QC\0?'3X/> =>BF>^TU?!4/CCQ?XRB\8:;I%AI5_XW\+>+
M=>\)>(]4OM"N8+.V!.W3:R^]+_.[/SS_ &]O^"@/P&_81_:+_8R^%M[\+O@C
M?/?06^J>-O%6OZOX1\%>(OV;?V>?$WQ6^$G[,^D^(OA;IMQI;7U]/>^-_C!:
M^)-5\+^'IM-LX_@?\$_CMKK[Y_"VG65UY;X<_P""F2Z[^TWK/[+_ (K_ &8O
MAKHL^O?MY^/OV6? 6OW-S:76D_%/]G_4A\2O^%[>.],L9=)\^Z\?^%_C+\./
M \?QS\%S0/X=?2_C5\$O%&K:G?ZCXJLDC_5OXC_L>_LT?&"^^-&I_%'X0^&?
M'FH?M!_"W1O@I\6KSQ.^K:K/XD^%GA^R\>6.C>"]/DN=1=O!^E:>GQ/^(%U"
M?!)\.7AU;Q7JVNR73ZU+'J$?.Q_L)?LF1^)?AYXS?X,Z)>>,?A3\;/&G[1GP
M_P#%NIZSXLU7Q1X=^-'Q'T&7PWX^\<0^(-3\07>KWUUXRTF1(_$FDZI>7WA[
M5[ZTTW6+W2)M8TK3;^T TMUO^M[W7]:[^OPW^PC^V;XZ_:4UO]FWP]^T+^S;
M\!_"=Q^V?^PUJ'[>OPD\5_"?Q)>>+[:+PCK"? #0/BO\-?BQX0\9>!]"UOP]
MXNCMOV@OAE!!XQTS6_%7A3XGZ=;^)M*NET&?PE90>(O,OVF?VH?VC/V=M.\,
M^)OB5^PO\ O#?C#XY_M:ZA^RSX#UG3_"/Q$_:2USQ?\ !H_!7]IGXFV?BW5/
MAU^R[\-OBK\<_$U]JGAGX >!=)NO .A>#]7AT?3?%FI:CXACTWPWX+U34+#]
M,/V;/V$_V3_V1;F74/V?_A!IW@S6G\#^&OA?!XEU7Q)XV^(?B[2_A=X->27P
MG\+= \7_ !+\3>,/$_ASX8^&YY9+K1/AWH&K:;X,TR\;[9::)%= 3#W/QU\)
M_A[\2]9^%GB'QQX;M]?UCX*?$0_%CX7WLUYJ=H_A/XA'P%X[^&!\26T6GWMI
M!?W'_""?$WQSX?\ L>KQ:AIGD:_-=_8O[1M-.O+, _'74/VT_&_C;6_%OQ2U
M7]EC]G?Q/^R[X7_;P^"W[!GQ/N?$]YK/_#0?B;XJ^)OBC\-_V8F^..D^#-6^
M'NH:!!X5\ _'#XPZ;X1\.?#/QAJ"_$+5?A)8Z_\ $B+Q/X8U.^TWX6W_ (E^
MQW_P4H_:,_;NT#QEXS^'7[$/P!\??'+X)> OV:_B!X)N+K7_ !+X!F\&:5^T
M3X^\=>%_&O@FVU/XY?#[P/XBDE\-?"_X?:MX_P!!^+/PBU#Q3\%/BN)KOP1X
M<\37&O\ AK6+1OV$U7]A+]E#6_CA%^T1JOPAT^\^)\?C?1/BE+))XF\<+\/]
M0^+GAGP_%X4\,?&C6?@Q'XG3X,Z[\;?#'ANVLM$\,_&;6O -_P#$_P /:;IN
ME6VC>++*/2=-%KTOP<_9"_9R_9^U?PYKOP<^&5AX%U3PG\&/#O[/6AW.F:YX
MJNE@^#GA#Q5XA\;^%/!-Y;:KKM_:ZQ:>&?%'B[Q9JN@:IK,%_KVCOXH\16NG
MZK;V.MZG;70.ZZ+T\NZ\[ZWV/@G_ (*!_MV_&3]C6P_9CU3PC^SGX+^(OQK_
M &@O"/Q(M?%_@9+3XH>*?%&IZ[\&OA1=?%*Q^"O@2;X(?#7XK>-/$>I^*?%N
MJZYX+\)ZI+X3UOPUH&H:W+XCO+*:TN[Y+CXANO\ @M3KWAC5_P!K7X=_$+]C
MSP-<_"+]F#X+?MA^-M3^&-E?^)O#.M:!X:_9'G^&'A;0_".N77BSX;7'P%\>
M:1XS\9?$C0?AOXID^"'BWQW#\ [^/2]7\?Z GAS6],E3^A_Q/\(_AUXS\?\
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MGQ!^)GPPU3XB>(_'EFNF:W'XX^*GQB\5^&=.T>;Q?\//'FN:!X(\"Z[X_O\
MP/\ #3PWXW\4_"CX>:A\3?#GPX\.^%="^*D'ABRTGXD:?XIT::]T^ZA^)/\
MP3M_8Y^*WB;5?&?BCX/+IGB[6?$GP[\97WB?X<>/OBA\'->7Q=\*?!OQ9^'?
M@3Q18:M\(O&O@>^TCQ#I'@/XX_%#P==ZSI,]CJ/B#PUXDBT;Q)<:O8>'_#$&
MC M/Z_X+NWYGSY^SG^T%-X__ &UOVL?V7_B-\"?A#\!HM'UCQ-XP\)^!=;^'
MWCC3?BG^TMX1\*:S\.[;3_VI]/\ &NI>!M%^"'QA\":UJ_BN6WUJT\!^)/&O
MCCX-^(3X,T;XE7VG>)/$;Z5I/IO[+'[0GQ-\>?M2?MB? +Q=\.O@_;Z+\$G^
M%OB>]^*_P*U#Q-J'A<_$/XK#QQ-?? [XE:AXG\.:!'KGQ[\!?"WPC\)OB/XV
MO_#QGBL?"/QA^'MGKFC>'!+X>N/$ONOPZ_9#^ GPM^*NI?&[PKX9\4W?Q1U'
MPOJ'@J#Q7XZ^+7Q?^*<WAKPGK=[X<U3Q+X?\ Z7\4/'GC#1/AMIGC'6/!_A7
M7/'5M\/],\,KXZU[P]H^N^+_ .VM7T^VO8_(/"/_  37_98^'%_I]W\,-(^*
M/PZL(?C9I'[0&N^%M ^._P 9M2\$>,/B)H_BS6?B&M[X@\%^,/&_BCPS;6FK
M_$G5XOB%XI'A?3/#FH^+O$NBZ,OB74M5T.*^T;4 -/RZ?\'^NQ]ZT444""BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#^73_@XU_Y+C_P0_\ ^TF?PH_]3WX4U_47
M7\NG_!QK_P EQ_X(?_\ :3/X4?\ J>_"FOZBZ"Y?!#_M[_TI!7\R?_!S7_R3
M;_@E[_VE<_9Q_P#48^)-?TV5_,G_ ,'-?_)-O^"7O_:5S]G'_P!1CXDT!3^.
M/S_](F?TV4444$!1110!_,9_P<!_\G<?\$!/^TI_P5_]7!\!:_ISK^8S_@X#
M_P"3N/\ @@)_VE/^"O\ ZN#X"U_3G07+X*?_ &__ .E(*^6OVN_V7+;]K[X2
M:U\%-;^,_P 6?A!X(\7Z;XA\.?$*'X3Z1\!]5OOB!X+\5^'M2\,Z_P"#-<E^
M.WP1^-MIHVF7VG:I<O'KG@2R\'^.=.NA'-I7BVQ7S8Y?J6O,/BY\6?#GP8\)
MP>,?%.G>*=3TNX\4>$?"@B\)^'KWQ#>6MYXP\1:?X=L]3U06P2TT;P]I<VH"
M_P!;US5[RQL+2RMWM[>6[UF[TK2=1"/0\,L_V/?"GB/X2?%;X _'/Q!?_&KX
M(^./%_A&Y\!_#G4O[>\+VGPF^%OPW\,?"K2?AS\+](\4:1XKN/'?B*X\/^*_
MAA_PLW4OB%K7BD>*_$'C?Q7K<T[V6BV^E:/9<O\ LN?L/:;^R%XGO+'X2?&+
MXES_  )U"Z_:#\;:A\%O'6HS>.[K5?C3^T;\=O\ A<_B7XDZK\3?$=_>^)Y[
M+P/IRM\./ASX1LK73U72=7\7^-OB7K_Q.^*'B[5?&A^ZJ*!W9\=_"_\ 8ZTS
MX=?&7XR?M"ZS\=/CA\6/C1\7?AUX;^#]GX\^(L?P/M+KX4_"?P7XJ^)'C?P=
MX"^'&@?##X)_#;PA=Z?X<\5_%/Q1K-OK_P 4O#WQ-\;ZM(-+LO$OBK7-,L?L
M,OQ=IW_!#']C'PYX+\.^"_!'B#X^^"([']G/6?V9_'7B'2?B1I.M^(?C-X2U
MKQO\+OB=-XP^)C^._!OB_1O^%D6OQ)^%_P#PG=IX@\ Z+X#TT^(OB)\4IKW0
M;RR\7&RT_P#3/XM?&!/A9<^ =*L_AYX]^)_B3XD>)[_POX<\+_#Z3P!:ZGY^
MD^%/$'C+5-3U"^^)7CWX=>&K32['1_#EX)#_ &_+J4]Y/9V]EIMT))Y+?(\%
M_M+_  :\9ZG:^'%\;>'O#'C74_&7Q:\%Z)\/O%WB3PMI'COQ#=_!OXD?$SX9
M^)=8T'PS%KM[J&IZ#J.I_"+QUKOA^[MT:[N_"VB:CJ5_8Z9=:/K^GZ0!=^?_
M  W]?Y'P[J/_  2*^"MC\1O'7Q:^$OQR_:4^ 7C_ ,9_M:1_MFV&M_#?5O@=
MXFM?A_\ %N^^#/QR^"WC6P\!^'/CK\!_C)X6LO _Q'T_]I#XQ^._%N@>(-$\
M27=I\2_&-WXD\%:OX0M(+;1XO9-3_P""=7P1E_98\ _LJ>&?%'Q:\$Z1\+_B
MGX:^/?@7XQ:?XLTCQI\<M)_:"\/_ !EG_: OOCAJ7B;XP>%_B9X3\8^/O&?Q
M;U/Q+XM\;)XZ\#>)_".N3^+?$&GKX5L]*FT^QT[UZ+]L3]FW5-;\.^&?"'QA
M^'7CWQ#XL\.V_C#P[I?@_P ?^!;Y=7\(S^.?!_P]'B2RUB_\2Z9X=GTY_$'C
MC1%TM$U@ZAXIA-Q%X.LO$6I"VTZZZ.?]J+]FFVCUJ6X_:#^"D4?AS7;3PMKI
M?XH^"0=*\37\GB>"P\.7J_VWNAUZ_N?!'C6SL='8?VC>7W@[Q98VUO+=^&]9
MAL@-?/\ K0Y#]E7]E'PM^R)X#T;X6_#OXA_%#Q)\./#7@;P9X.\->#?'M]X'
MU'3-!U/P]?>+M:\8_$*QN_#7@+PIK<OC?XR^)?&-[XE^)8U'5;[P=;ZCIFBV
M7PT\'_#GP]:W&B7GU+7E_BOXW_!CP)X-T#XB^-OBU\-?"7P_\5I:R^%_''B3
MQQX9T7PAXC@OO#NH^,+6XT+Q)J.IV^CZM:S>$-'UCQ<MS87EQ;CPKH^K>(VD
M71=,OKZ#R>[_ &OOA5;:5^UYX@@>\UC0_P!BVUU*3XKW'AW4_"&O:E>WV@_"
M33OC-X@TWPYHFG>)YK^*YTSPWJUGHB?\):OA0WWC&T\0:);I]ET&XU24#5ZG
MU117R_:?M9_#6RDU&P^)%IJ?P-\0^&KUQX]\.?&GQ#\+?!5UX"\,O\./B3\5
M+#XAZEK@^(VI>"_%OP^U+PC\)O'EPOB3X6>*?B#'I%UX3\;P>)K?0D^%WQ;F
M\ ]I#^TK^SK.^L)%\>?@VS>'O!L?Q$U[_BYG@Q1HG@&72_"VN)XUU9FUE5T[
MPJ-$\<^!]9DU^[,.EQ:3XU\'ZE+=)9>*-"GOP5CVRBOG6#]KC]F.?4?%VF?\
M+X^%=O-X%L_ =[XJN+[QOX?T_3](3XG6^I7?@2WGU"]OX+-K_P 2VNE7<^FZ
M?',]Y.GD!8-]Q$K;3?M-?LX"^BTP?'WX,2:E/-X2MX=.@^)_@JXOI)_'WAJ7
MQKX'C6S@UJ2X+>,/!=O=>,_#/[O&N>$+2\\4::;G0K.ZOX@#W"BBB@ HHHH
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M62V\;_&+]I#XU^&]9\ /X?\ 'WA[P=H7BSP3XI_:4U]+;7/B+\/_ (O6[?\
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MWUM+70(],TF'4]2_4VBB@3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK\>_"?PIXTF^(7C7P_HWA'Q!\1?BW\;_ ([?M%_$:3P;H&HZEK&E>"M*\?\
M[0_Q*^*?C#PWX*M]:U?4=<E\'^&]:TGPU>:Y<G6K[2[G5(X;N/ZUHH ****
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MQ?XQ\/\ @7P/\3M7T/PWXBTW6KBT^'_Q)75I? OBT3Z?/<6=QHOB:VT6\O\
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M:_HVH:UX'U.6XTS39Y+_ ,,WNEW3S:?8RM*7M+=H_6J* .:\)>#/!_@'1?\
MA'/ GA3PUX*\/#5O$>OC0?"6A:7X<T4:[XP\1:KXP\7:T-+T>UL[$:MXI\6Z
M[K?BGQ'J(@^V:YXCUG5=;U.:ZU/4;RZFQ;SX4?"W4+SXB:C?_#7P!>ZA\7M
MT_PK\6+Z[\'>';F\^*'A?2=+U71-*\-_$2YFTYYO&N@:9HNNZYI&GZ/XE?4]
M.L]+UG5=/MK>.TU&\AF[^B@#\X;#_@EK^RVO[2VL_M*^(]%'C.ZO/ FO?#;0
M/@YK'PX_9WT#X,^%O!_B7X;Z=\'-7T2ZTWX=?!#P/\0?BYI*?":TU'X:>&]
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MSPQHWVW110 5^5OA3X-_L:Z;I:>*M _: ^ ,>J_L_?'KXK?$[X^?%?POXA\
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M77+71=-UBRC6;4H;+4?[2T^UO/L%S:S?&7B#]BOXV:5\.O"OP\\+>(/$=O\
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M?M8>)OCCX6M(K#P1X&O;"3P#^T'X6M8H/!.@>%]8TSQ!X1U+Q_HOCKX3OO\
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M6K6FGZ%X$T71/!?ANTO?V?9+CXRWVH_ _P 8V'PZ\$-=^)?&GB#4_BY::_\
M%2U\'?$X>&-,TSX?Z-\/KGM_"W[#EAX?M_#45WX^MKZXT+QSI7B^ZU*P\#6V
MDZE?6>F?L<^+OV3(]%M+N3Q'JCZ;Y7_"8ZI\0=.O91J4.G//>^%DTR8:E=>(
MJZVV^&'QIO?V*/B'\(XO^$4\"_&37?A;\<O!OP\F\&WDG@S3/#,WB7_A.M/^
M"^HZI>^$H9;#PAXWT_PYJ/@R_P#B1-\-H)?!GASXAIXH/PMCE\'V7AH-Y+XX
M_9=^->HZI\5O$?A'Q8;#Q-\0K#]HK39YY/BU\1M#DUKPMXPUSX3ZG\,? L6K
MZ9#?WOPYTV#2?!OC#P[8^*_!&GG7/@;J'Q&\9^//AI9W?B?QIXR'B0#?[27]
M>7E_74J^&/V+](\1>&]=\/W_ ,7/!GBSQ7HGQ=E\3^-M9T'X6_V=9:?XX;_@
MG+H_[#]_I2Z'J7Q#\3ZEI-]+X7U33OB1YU]XGU74%\/:K!\/)Y[FTE_X2QU\
M*_\ !.S3-!UF[U/5OB)#XL6R^*UK\3O!5UK^D_$W5M4\*1ZK^UW\*OVROB'X
M6ATC7OCIKGPEMK+Q-\2OA9H]GH.M>#/A+X&U_P ,:?I_A2^U*^\7:UH.N:AX
MS\UB_9"^-ESXLT+4[.#Q%\+/AMJ7Q-^,7BFT\$_#+XM:1=^*_A9=^-M:_9RF
M^$OCQX/&7AO5? T5Y\/?"GPQ^)>@7V@>#[[Q%:_"S1O&9^#'PNM/B/\ !KQ5
MXK^S\O8_LZ_M-^.]&\>ZUX=M_$/P[&H?$;XOKXSLM<^)_BBXUG]H+PQ'_P %
M%/#_ ,5/#5FNF^-](U*TT?2]*_93\$_$+X-^%= \96$?@?6_#?QGTWX16MZ/
M@#X5T+Q5.!\_ZV_+M^1]2Q_L1/-X?_:/\$ZG\38)_!'[1G[/_B_X%ZK8:=X#
M2QU[PHGBGXF_M0>.8O$6C:K>^+=8T&ZM-*T/]IB^\+Q>&KSPCY-Q=>#M/UHZ
MK#8:I-X9L.A^%7P2N_#OQ\\4^-O%GQ?\%>+/BW/+J'Q'^(?A;P/\.KOX?:8=
M)^*'@#X6?!KP/JW]A:A\2/'^K65L\/[*NMK#K6N:WXBU#Q%=P7VD0WFF:/X.
MT?3XO+/#W[*'Q6TG7O#?BVU\8^,+Z_\ "FA_LCVG@23XA?$_4-1\0^";'PC^
MTK\8_''[1WA9K#PK91>!A%K7[/?Q)T3X0VU[8VNK7OCW2?!_A+0/&?B/5Y?
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M$2_$%?VE?^$^;3ET9E^'<GQ(5QKC3[O&B>'D<CPN/WT\8: /%GA+Q1X6-V;
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MXYIHHI+J5K>U221$>YG6":Z:&W5F#32K;6UQ<-'&&<0033%?+B=EEH ****
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M4J* N?C=)HG[8/PN\(7.H?"YOBW/X:\9?$G]J?Q[XL\,'PWX*M+WPEX6U_\
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MAR\^*5SH^D>'KOGO&WP9^+WQ/_9*_:FTC]G+X&VOPBT;XZV7Q!UOQC^S)?\
MAWXH?LT:SX7\*:?\"K[PW\.?AKX4LK7X10>!/'OQ;^+7B[3=$U[]HG7_  ?>
MQ> 5TM_^&;;+QA\3O#5A8_';4_WEHH"YS/A;6M3UFRF37-$ET'7M*?3M/U^S
MB?4+[03K5QX>T76]1'A+Q#J6C^'YO%OANQN-8?2+;Q(NAZ0+V_TW4;>?3-.O
M;.ZL;?IJ**!!1110 4444 %%%% !1110 4444 %%%% !7\R?_!S7_P DV_X)
M>_\ :5S]G'_U&/B37]-E?S)_\'-?_)-O^"7O_:5S]G'_ -1CXDT%T_CC\_\
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MOAY[GQ)KGQ5^'7QBC35[KXM>!_"?[/K^/O@!\/M TO7_  =/X'3X%?$#PO\
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M%%%% !1110 4444 %%%% !1110 4444 %?S)_P#!S7_R3;_@E[_VE<_9Q_\
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MX\-^'_$.N?'%O$GB[5Y?AMK7B>Y3P1HV@Z'JF@V6L:[<7'/_  5UCX^_ O\
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M\._'>B:%=7FKZQJ_PSUZ"XU>'PO\1-/\3?#?PYZ+\)/VF8/C%\6?'7PU\/\
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M-9M.UCJ*V9T_5;:^TNZO+*XXC2O@;X$T+7?$NNZ'/XZT4>*_$2>+M4\/Z/\
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MOV^E?M%?LM?![PQ\9O$&@>%?$7P]\-_"9_A_<_'&32/@;X]\-V?A?4KCX'>
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M-X?T'3=:\)-\1?$$UU/XDTZ]^(L^G:UH^C^(=?OO#GASP5I6@@:^?X]?\_\
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M$O%'QP^,WACXP?M#>!]=\.?$3POXX\%7MQJOC/PSI^G3:7XF\):S9:;X7O\
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M!'Q)^'_[ _@'X??$#X/^&?V=_B-^T'X&_:7_ &B/&_C#2O *Z9HOA+QQX_\
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MAX(U>3Q-X+^)G@>>^L+K1M1\6:7HMQXC\'>&_#_B3P_K'A[Q)=Z[X0!?/?\
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M^*?4O#'[-'CGP]H'[#OAO5?!'P"\0:5\ ?A%?>"/''P3OO%6K#X<Z5XTM_\
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M#VBZ'X>T[[+HFBZ586G144 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^)GQ(.G:5IP\&?%WQY+X'UC0;+X:_#OQ1\.O'.DR]SJWQG^/'Q4^(?PU\/\
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M[I'A+Q!XCTZ#7M2\$VME>W?A]0<6T][+2Z[J_H^E^Q^J?[.'CG7OB?\ L\?
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M+-:\+?VIG0?\%!_%&H7VMVNB?L\ZEKUGI(^%_AE-?TGQ;XJN_!4_Q2^)VD?
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M\%UHOP_^(^@? WXJVVD?%.RN?%MM\:_$W[0'BS]F#1M ^$^@ZUX-\.Z/\0?
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MU3P9'JD?A#7]:\+ZW;V^N>$=:U_0]3U7PCKD$.L^&KS2M3C2Z7O** "BBB@
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M *1,_ILHHHH("BBB@#^8S_@X#_Y.X_X("?\ :4_X*_\ JX/@+7].=?S&?\'
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M/^'UFGC33M$\8>#YM:F.M77A+4$\!1M<7NJ:OXPBATO7 5O+\?Z_K8\STO\
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M!/P(\%?LU_%7Q'+\)+W4?AQI'B+XJ^*]<^%_[4'@K4_#^B^)/"/PD\-1>,]
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MB36KBVT^WO+^X@TO1M.O;Z6"QM+J\EC@:.VMYYF2)@#KZ*_*75O^"I=YX/\
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M?X+^--E^R/X+\5P.=-MDB3PM\>/A_P"%?@UX,U!=,3Q)9Z?H_A'XD>%=,?\
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MC5=.N[)K1/&]YI6E?M!>(M;/@?Q9HGA'4T7Q_:ZIXS\%1:C%K=EXHNSX[O\
ML-GQS-\%/'VN>(M.UNZU_P"('P[^)L/A_P"(/B+PQ:Z/HG[97A;X@_'[Q9X7
M\>:@GB'3;N7PW\7=7^ .GPZ=HWA;[7XF_P"$CE\$>#-%BM/"?C+Q'H^K=_XJ
MTK]@O7]"UC0M8^,?P[L/#@^'O[1?B_Q=-:_'.QT[2M1^#O[7);XG_'&_U[Q
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M6_@GK6DZ5X*U:]QX:\1:)#X7\::;INJ^(_!O@_Q5X=I?'C1_V?\ 5? G@_\
M94U3XV^$_A-J7A;5OV?OB%H6C7?C=+/QK8^$?V<OB-X=^.>EPV[OXKT'Q#9S
MZUX6_9^\9G3]?O-1G=='\(>._&4VE^+-$\!>,M-4#[_/>_G]YR&I_M%?LC?$
M#1KKX::I\)+GQU8V&H:5XAU;X8ZK\%--U?2=,^+7B[]HGXE_!#1_"-Q8ZW9_
M\(3=?%'5OVC/AM\6M,U'7=+U'4/#/A]_"GBCXP^,?'.@_"Z:'XC7WSOXJ?\
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M7/VEOBK\/O@!\)O'/_!/;XD?#/PG\4_C)XMT/X;_  UUOXCZ!^T9\.O%NI^
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M=[\3?V8_V>O[!U;7-:\6?&F^L)O WP1^&ESJOP_\-:#I]EJ>K^)- \3>.-2
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M<>.-)^&\T/P?^*'@'XGR_%?PUX:^$>G?$'PD\,/PQ^%OA2V^$#6OQ+M/$^O
M6\T?K#17XE:YH'[7VN_"+]LB/Q1X+^+OARY_:[_97^-7Q0\'VOAC6U\=>(_A
ME\6-"TW7;#P7\)9_".J^$==TGP+XQ\;? ;Q?\&_@])X=\+:?#X?U'QC^SI\0
M?&-G"/BO\3=0\9>)?HZZ^$/C#X?_ !*^*?B'PMHNN>*K:+7?^"=OPP\$6NL?
M"WX876@:'\*/!'Q@\(1^/8? Z^&?AAX>N;'1?!^EZEXM^(-[!!J5WX<^&7B2
MZO\ Q=X/TOP7_9]DEB!8_2>BOS!\+ZQ^UE=>%+1OB%#XL\?7FNR?\$\_'?\
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MCCX/_;;\7Z[^T7??M:^.O^"=FG_M6Z[\>[+]KW]JO0_',7[0/B#]GI?B_/\
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M)ZQK%C^TIX2\/>'O%-U#X=TR\\67*Z#\<_C-J/A+XJ^"M+TFSL_% ->I]4^
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M=ZG=^-X/"7P*^(G[/EQ%XFU'5/&>J^*]5\:^*_"7Q"O/%OBCX@ZWXKUNYO\
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M<7M[<%?.N[N>:YG>2:5W;5V(65RJ[U5D5]HW*CE"ZJV,A7,:%E! 8HA()48
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M=/L9-(DL6TR32I+2!]-DTUX#:OI[V+1FU:Q:U)MFM&B,#0$PF,QG;446BZ/
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MAQ\,_C;?'QO\%?V[= ^(VG:O\2/@_P".K?Q_XU\(>'O'?Q*^$8\#?$25]/\
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M&7QBL+/XN> K'XG_ !&\>ZU\"?VA-7^+7C?P%XLT/XDZ!XA\$^!/$GQ#U/\
M9)U=_"'PW\7?"?0HI=)U>WTOP/X9\.7?QN\.^,^\TS0OVZ[;P_<>'O'?A'XC
M_$#Q+X_\+? &W^)GQ)L?B+>^$?\ A7/C'1/A9#<?$+3?A]X$^%_[2?P;T'QE
MI>M_%?0HK&[\4?#'5?V7X=+LOB3'=^-V^)^@> ->M;[]@:X[0_B!X+\3:_J_
MAGP[XCTW7-9T+1='\0:K!I4K7UM::3KVO>,_"^F7#:G;I)I<LLOB'X>^--'N
M+*"]EOM/OO#U]#J%M:DP><!?R7W?U_5KGY^_#GPK^U;X4_9T^.6K>-O .H:U
M\??BOXL_9XU7Q#;Z5XMT'1=2N+C5/V9OV/OA%\>?B+IMW\+O&O@]FN_AMXB\
M+?%_Q#;>#?!OC/X=Z]X[G\ CPY\.O$OAN'Q9X1\5CDO#WPY_;RFT6T\2R:[X
MVT?XC>%] \)^%_ASHOBKQSX=/PYMUNOC'^TUH.OZ[\3O".C?$/XBW'C.YM?@
M?J?[.NLZ_=^+?&_Q9\76%YX:TVY\&^+?$/Q#F^*.I^,/U2U/4M/T;3=0UC5K
MRWT_2])L;O4M2U"[E6&UL=/L8)+J\O+F9R$BM[:VBDFFE<A8XT9F( -<5\-?
MBQ\.?C#H5SXD^&GB[2?%VDV&H1:3JDFG22QWNBZK<:-H_B6TTS7M(O8K75]!
MU"_\,>(O#GBK3K+6+&QN=1\*^)/#GB:QBN-"U_2-0O +^2W[?AY?Y'P#\-?@
MI\5]7^%/[:&AWWA?X]^%]3^+GPST3PO\/YOC7\6/"&J_%'4O%*? V;0]?>#Q
M[\,O'WB"[T"UM/B5J>J6\=_/XFLK*RUMM;NOAO+:?"!?A_;VGGFJ?!O]K?PG
MX?\ B]XZ^ &F_%3PUXY^(_C<-HNE>*O'OA'Q'JMG\,K3_@F5\/O ^BW^I>&?
M&GQ-?P;K7Q;T_P#:I^&7A'P[:>,O'/B*]\>7'BG3Y$\0?$!/@%KGB75+S]@G
M8(K.0Q"*S$(CR.0H)(5$5G=L#Y416=C@*I) JIIM_!JNG6&J6L=[%;:E96M_
M;Q:EINHZ-J,<%Y!'<0QW^CZQ:V.K:5>I'(JW6FZI96>HV,XDM;VUM[F*6% +
M^G]?\,?G[<?#+XZ1_LGVEX3XJ^*OQJ^%'Q/LOCA\(_#.O6>F^"/B5JVE_#SX
MBIXDC^"=IXJ^(7QH^*EK:>(/BI\,K?QC\%-&^(GQ'^+1F7PG\2[9OB9J.EO#
MXEF'SGHO[,W[3/P>MO$V@Z9X8E^(NC^#-!TWQ3X/UWP_XI@T"RU[XN_M9^(?
M@]H_[7GQ4\.Z?I'CWP#\3],^(WPJ\2>#?VH?VG/$)T_Q%\/]5^+MK^U[=?#C
MX6_$'2_%EQXPA\/?LW10%_0_*_P;\)/VP/$?ANRC^(_B7XSZ'J$I^ _@2XLM
M)^)_AWPS<6OPSL/C5XEU#XT:H6\,_$?QI?67C?Q5\)='^'VA^(O&;_$7QK\4
M/#VE'44^$?Q'L_'>N>.?%OB/&\"^!OVU/'_Q=5?B/I/Q2^&?P,\9>/O GBOQ
M[X5T'XM2:?=>'&OOA?\ MJ1?$WPGX?\ B-:_';QG\5Y_"VB_$EOV0HK/5/A5
M;_ GPGKL]GIVJ^!_A+X6\+7?Q>M+O]::Y+QGX\\'?#O19_$'C;Q'I7AO2H+;
M6KI9]2N5CFO$\.^&=<\9ZW!I5B@DO]9O].\)^&/$7B.?3-(M;W4?[&T+5M0C
MM7M["YDC OY+[O/^K'YL_"CX.?M$W?[/?[:>B?%KPSXVO_CK\?/A)X-U';KW
MC[1]5\)>)?'NN_L/_"WX9>+M \+Z;8>-;WX=_#[4[;X[>&/B19^)+;PWIGA#
MPM+9ZAX8U.QOM0\*KH,VF4]+^&_[4G@_2/@IHGP%\#^*?AWX6T*7Q*_Q=\/>
M(]-_9P^&=GKVHZKJGAI?A?>:?X&^"&LOX5M[3PAXZMXO%/QAU?P_XBT+4M?_
M &<K/XF^#+/PS\6OBEK_ ,+])\-?JU;SQ74$%S Q>&XACGA<JZ%XID62-BDB
MJZ%D8':ZJZYPR@@@59-1MXM3L](:._-U?6&HZC#+'I6IS:8EOI=QI5M<QWFM
MQ6;Z-I]_+)K%HVG:5?W]MJ>L6\.JW>D6=]:Z'K<VG@7]-[GY >"_A?\ M_/X
M U"1_'WQB_X2RS^"G[2'B;PA9>,;GP)X,U'1_P!IZ?X>?L[Z=\&- \73K\</
MV@-+\=^%'^)*?'3QA;0_VC'\&-.ULZ[X?3PJ?@M'\+=#U+O_ !7X0_:)@\1:
M%XA^%_@SX_0> -(M?@!J&E_#3QS\49K[QCXR\4:-XV_:OF^*WA3XA_%2+X_G
MQ_X;T.S@\2_![Q+;:[J/BKXG_#.73;+2O#&G_#;QGI%QJ6DZ3^I]<?:_$#P7
M=Z9XNUI?$>FVNC> M2US2?&6KZG*VCZ7X;O/#5I%?:\=4U#5DLK2WL]*LIH[
MN\U,S'38K8M/]K,<<C(!?R1^>GP;^&?[7%[\#?VF-"^.FO\ B'Q;XZ\>_!F;
MPQ9>!]0TC1]*T%_C9/X=^)^F_$'Q/\//&U_\=?B;#<>!/B:VK_#JW\)^&X-!
M^"/P_P# FB>'=.OH/A[X8\;>*/BAHOA_A[3]DCX\_ [0;&+X$ZUXEM#JGPQ^
M-GQ%\;>$?A<GPK^#W@R'X]:CX7_9(^$O@C1OA]X#CO;;PS#XGC^#7@'XXW/P
MVM_B)KGC'X*VWQV\3:A\3/BM<J\7PZE\)_KG10%S\8/%4/[5:>.'^'W@Q?VB
M[#[;X.^/_C#]F+PWJWQ7\)7&L^#=0TG4_P!E?P]\)?&'[3VMZS\0=0\2?$#P
M7I'Q&UCX\>(T\+ZUXI^*$\WP(\0V>A?$CP+K'Q<M/ W@_P -[_BWPC^VHOA[
M6[O1M)^/FL^(K'1+_5?BIX1O?B=X?TWPI\<_C5IOBZZF\(^%_@!XG\(?&;P?
MX[^ ?P)\2^';;6H+GQ1IOB#X=W7@ZUUS]FK5_B%X,^(]_P"'?VP_AYJ_ZVV&
MMZ-JMWK=AI>K:9J5]X:U.'1?$=G87]K>76@:S<:-I/B*#2=:M[>6272M3F\/
MZ_H6NQ6%\D%W)HVM:1JB0FQU*RGFTZ OY+^OZ^_4_+'3_!?[5_BO]H#6/$?B
MWX?>)]-^&FG?&;2/%.GZ!=^-M.\0Z'86_P /?B#X_P!!\.^*?"6H>)OC;XC+
MGQW\*[CPYXYU'0?"'PR^#V@>&Y/$NE>#M7TWQ;X]\,^*]6TW]/\ 2KR?4=+T
MW4+K2[_1+F^L+.\N-%U5].DU32)[JWCGFTO4GT?4-6TE[_3Y':TO'TO5=2TY
MKB&0V6H7EL8KF2_10%[A117->-/&'AOX>>#O%GC_ ,9:I'HGA#P/X:UWQAXJ
MUJ6"[NHM(\-^&=+NM:US5);:P@NKZXCL-,LKJ[>"RM;F[F6(QV\$TS)&P(Z6
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^9/_@YK_Y)M_P2]_[2N?LX
M_P#J,?$FOZ;*_F3_ .#FO_DFW_!+W_M*Y^SC_P"HQ\2:"Z?QQ^?_ *1,_ILH
MHHH("BBB@#^8S_@X#_Y.X_X("?\ :4_X*_\ JX/@+7].=?S&?\' ?_)W'_!
M3_M*?\%?_5P? 6OZ<Z"Y?!3_ .W_ /TI!117Q3^WQXZM_ /P UO6+3X@^$_
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M8ZIXX^+^BV'@SQU/;GP!\1;3Q-I7P-\)3:!XHL0+>A^Q%%%% @HHHH ****
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M,M?>'/V8?@C?_ S3+'1+R:UA@M6_:EMOBIK6H2^(C!=>+[FYU3PA\6M0\1?
M27PYX,C Z[KUZ?I_PWD>%:A_P35^+D'@J?PHNJ_"GQQJ&J>,_@AXS^(WB_6-
M8L= \3?'B^\"?L6Z7^S+XD;XG7WQ!_9V_:1AN=2T+XA^'%^,G@77?$5I\2-1
MU'5?'_B:ZNF\&^,O#&D^,/$?UO\ M5?L_?%WQQX/TG0/A%XJ\)7OB+5?V8/V
MC/V4VN?C)\0/%/A^[EN_C?X8^&\NF_%9M;\+^"_%FH>.?&'@VX^#\MYJ/A<Z
M3X6G\26'B77]=MO&OAF30WT_6_GS7O"?[>=[K?Q&OKOQCX\MO#UY\;_']EXX
M\,:)X.NIM3O?@'/\7_&4_P #?$GP>\2Z!^TOX3B@O_#GPDM/ &B_%'P]\*[+
MX._$+6_".H>+O$5U+XF_:#T71].\>Y7B#X5?ML>'?"/Q"?P1K7Q6\7?'+7K?
M2O%-Q\3=1E^'VBZ1KGB"U_X)C_$[X5Z/XI\&_#OQ3XQ\8_#;X1>,+S]L'1O#
MFH^*/!/A13H^GW7B'PI)J>J>)_AJ=6O;8#YK2VEO1&;X?_8L^-'C&\^(WBB7
MP5\*/"2WWQA_:AN-6T_Q-XG\?66M_M2^$M=_X*0>&/CQX+\._'RW@\$7@TWX
M>VOP6^&?B+X7^!);S4_C9I5Q\._C%<6VF^#O#GPTO_$_PG\5>J> ?V#O''A[
M6;/QMJDGPOL/&>A:S\!+WX:OH>I^*M3A^!WA'PE^V_\ '_X__%3X4?"G7-4\
M-Z?>>'/!UU^SE\8M%_9NT:3PMHW@C3_'_A3PK%X,\3>$?!7PTL_#_AO2?)?V
MJ/$7Q^^"\_Q)\-6?C_XM:?HEQ8?'"V_9!L]+^,WPNC\>^+?BGJ'PP_94N?AI
M)>6?Q$\<6GQ2^-NF6WQA\5?M"^%]%^'(M?'=R'UU/#ME\/\ 6-5_X9EBT/[!
M_:WT_P#:0OM7MO\ A2\'Q$FE3X5>-1\*+CP!KWAC1/#&C_M+/K7AM/ NL?'^
M#7=8TS4=>^%EEHC:E<+I%M:>(/!4WAZW^*<?BWPYK7Q-N?V?+50&WW6W^7X_
MUMH<Y\;OV7OBMXT^.VM_%?X=Q?#72[>7P_\ "?4GN_%GBBZN?$WC+Q3\%OC?
M\'_C'X:\"1:M;_!C4_&GP:^'GBM/AUJ?AKQ;-X:^)_Q!\ 1S:A'XVC_9RU;Q
MYK'B7Q'>^*:K^P_\=O%&@?&BT\8Z3\ ?$GB/XR_!S]J;P/X:\0ZAX\^(EWJ7
M[-'BOXY?%;]L/Q[9:G\)]3U#X67MWJUOXS\*_M#_  U^'OQ4\1>'X_@MXB2P
M^$T%TMMX[TF#P=X7\*_6%CIGQV\'_L^_&Z]N]-\:?$GXN>)_BS^T!J&@Z/JG
MC2UL-2L/AUXA^-WBSP[\+7\&S^&=4T2Q\/Z3X%_9]3P;KOAOPKX8U'PKXK\0
MW.B$Z[K=G\7O%7B;Q;<?+OPM\$_MSM86^J_$#5_B9'>>$/%'P9TKP5I\OBCP
MUH>FW_P]O_V^?V@-#^+VK>)=$7XE_$#5O$%]%^P)<_!ZXB?XJ>//'WC31UDT
M[Q!I&J2?M(Z;X@U>P!?-::?T_P"O\_O'X'_!R/X-ZC\;;+1K'PQH/@/QQ\7;
M?QW\./!OA"T_LG1/!GAZX^#_ ,)/"OB#2XO#]M8:?HN@76M_$SPGX_\ '-_:
M>'XI=/U&\\6S>([Z=_$6N:XD?O5?%_["WBSXK_$3X.W?Q!^*_B^'QG<:SXHO
M?"G@S7; :(NC>)_"/PBL--^$-[\5] D\-%]!U#PM^T-\0O!'CS]HGX>ZM83W
M!G^%/Q5^'VG7)LY=*.EV'VA0)A1110 4444 %%%% !1110 4444 %%%% !7\
MR?\ P<U_\DV_X)>_]I7/V<?_ %&/B37]-E?S)_\ !S7_ ,DV_P""7O\ VE<_
M9Q_]1CXDT%T_CC\__2)G]-E%%%! 4444 ?S&?\' ?_)W'_! 3_M*?\%?_5P?
M 6OZ<Z_F,_X. _\ D[C_ (("?]I3_@K_ .K@^ M?TYT%R^"G_P!O_P#I2"BB
MB@@**** / ?C#\3?'O@/X@_LR^%O"/AGP?KFA?&3XR:U\.O'.I>)/$NM:+J_
MAO1-,^"7Q;^*D.H^$M/TOPSKEGK.K23_  U>*6'6=0T>R\C&FHXEUC^V_#OP
MMX!_X*%?$:P^!OP'N_'OP1U?Q?\ '?XH_"O]GOQY9:!X%N?%/B?3->T3XP?!
M;XG_ !,_X23Q%'\-?A7XSUKP?XK>_P#@1\4-"O? OA3P?X_\*:5K]_X#2#XD
M7'A'6?$GBOP3]C_M'?$_X5?#;4?A7?\ Q=\$:=XF\/:=KGB_X@:9XFN?#5WX
MSUCX:Z_\-_ NMZM;>+?!OA;1_#/B;Q1J?B^YTZ_U3PSIG_"'VT/B8VVNW]A8
M+?Q:E<Z==>+ZWX\_8<UO0?[)\5_!3P?/HWPN\$2W_CO0/$GP)T.33OV>?AG\
M M1^*_P^TFZ^(*7>B2Z'X+\&^#[N+XQ^'_A;9:1=ZA:>)/"M_P#$;Q'\)K'Q
M#\-9O&7B.,'\OZV_,]7^)'C6Z\!^ _#_ (R^%>@Z9X#\9_M*_%7X26.HZ[\6
M?#VNKI'@[Q'\0-&\)^#[;7/B;X5B\0^'=5M_$D?A;PKX=^&?AOP=;Z]X?.L_
M%6\\#>#KJ_L9M:O=0KG/BO\ M%^)_P!G/2+RP\2:4GQBN/AI\(OB#^T'\:?&
MBW>G_#2;1_@WX'UAFNY_"7A>*P\16OCCXDOHAU+^S/"]O?>$O"]ZWA.^NO%'
MC/P%<^)O!^EZY2^('[6'[,.I^#O%OA#XN>$O%5SH%KX9\<:I\1_AA\0_@9XK
MU.#2_AY\/_!/A7XE^*?$?CCPOJOAJ_T)? ]KX#\7^&M;AN[]KBSO=:GNOAK;
MP2?%S0=<\ :7YWK_ ,5OV#=%TW1])\2? NPM9/@2/B)XQL_!^K?LQZA_;7P9
M\)^%8?A/\9_B+\5;/0+SP:9]#\/*OQ#^#7Q)UN[\-)=^*M2\::CIEG<Z%<?%
MKP#XMT#P<!;R9T,G[;GB9/%EEIO_  HZ-/!VI?$;XF>$+3Q3-\3[!=6@\._!
MG]JC1?V2/B%XEU/PI!X1N5M]7NO'?BWPKXS^'OAC3_$&K6GB3X:CQ9>^*_%'
MP\\=:'H/P_\ &+8/VX]3_LTWFK_"G3O#EUXQT7Q+KGP-LKWQUXC\4S_$=/ _
MQ7T/X2^+M&U_2OA5\)OB/XO\*>*&U+Q/X<\1^#_#OA7PG\3[_P 0>&-2O;K6
ME\(ZCX4\:Z9X:Z:\^-G[)%G:66LW_@+2K'PTW[07C7X V?BW6?A'::%X?/Q@
MU3X_Z?IGCV/2[G7])TR[U:UU_P#:;TRQU#7_ !+X?LM3M?$7CWP_J'Q3N+C4
M-#\%>(O'6@?/OP@\2?L::?X3U+P;_P ,[V+:AXX\76&AMX!\6_!S0-:^-GQ7
M\?\ AOXV?M87GA^\\8V-MX2M/"NIW.D:W\#?C-\5O#&L:UXF>_\ "#P>,?$_
MB#_A&M1O+76O% %O)GK/A']N3Q#\0+?X=:KX,^ VI7^B?$CP=\/]2T9M9\?Z
M;X;\1#QY\5/V;/$'[1O@?P(_A[4O#N+:WDL] 3P-XG\3:WJFAGP]XB\0^'[V
M'0M8T>/Q5=>%>LTW]J?Q-\0?A_K?[0'P5\#S?$;X(:#HOB&#0K/3K'7KSQK\
M6=8NK3X+7NA>-/"5KX>TSQ%X@L? GPWN]<^.?A'XO>%-)\ >.OC'?^(_AP+?
MX6^!/&OB&&R\$>+*'PQ^+_['GBR_\"^ /@[X3LO#=M>W/@SPO\,_$6@? 6Y\
M%^'?"?C2W_9C@^)WPU\+>'G\1^ ["P\,>-O"_P"S#J%U>:)HU_H,-KX"\,:=
M=_#;Q'#H&K76G^"M6\^^'WQT_9:\(_ >7X7^)? _C.'X>>!M;^.^B^/;/QK\
M-8?$5K;^'?@9\<];\!?$G]HOXIMX3T%/!VA>'/%WQ4MK[Q[/K:Z7HMU+J$WC
M?Q?I'ABR\-_"SXE:OX& MY/^OZTM_D?4?C#]HCPYX+_9AO?VE;H^'/$6EP?"
M[3?'FD:;X/\ %?\ :GA_QGKVOZ39/X2\'>"?&.J:'H4FKCQOXIU32/"7@[6+
M_P ,Z-=:M>ZSI<USX?TZYN7TR'X_T7_@H'KFA?!>[\0:SX9\(_&_XB_"71?V
MC]2^/%_\)]>M_ OA.?1OV7;?PAXEU_Q=X#T7Q+J7C98-9^,?PG\?_#_XH?#'
MX9:CX]U73M%O/'^A^"/&WQ;TVST[Q!X]TSWWQ_\ '+]GCX,VMW\*_%'@VR'A
M#X1Z?H&J^&_ G@+X3^(_%FF^!_#?P=\):)\48=;M?"V@^"W\-^&=-^$WA_2=
M)\3>#HO#4]W>PWFAZ)X?\#65Q\1KGPGX1U)GB?XI?LOZQKGB;^T_A0/'TWC7
MQ;XB_9SU'Q19?!'_ (2_3/BKXTO]*O/#OQ$^$T.M'0[E_%^DZ7I7P]E\+_$W
M5=3W?"[1U\&:EX7\4^*8;GX?>*M,\+@>J?Y'">,/VZ=;\#^+[+X8ZE\!/%OB
MCXGZ7KOQ#@\?^'_A6?'_ ,4M'TSPU\.-"_9^\7ZE>^!-6\)?"*\U_P 5>*=9
M\*?M._"VYT'0_'/@[X2>$)=?LO'_ (?U3XD:4NA>%=4\>:<_[:?B*";Q-9M\
M%HA?7?CO4OA_\'8I/B9IXMO&^HZ)^U9;?LC:MK7C^_A\*W%M\,/#L?C?5_#G
MC;3IM(/Q.US5?ASJTIM] 7XDV<7PUON-UW]J'_@GUXHT#7?CMXA\-^ _$&G>
M ;CPA\8=6^(&M?"_0+S5])\+^/?#5Y'X.^/MMJ.IV']M7.B^)O"7P!.GZ'J%
M@;CQ_KMK\+O#/A;2?#-_JMCX+T2YV?B/^T+^PEHWA'Q3?_$7P?X,N/!FC>)?
MCUX>UQM1^%NAZS926?P0^(TGBO\ :5\9-I<6GWE]'X5^'OQ>\.?\)'XUU*]L
M+35=>^)EGX7U;PSI?BGQ9XL^'4_B8#Y/S.)^&O[?GB67Q"W@7QU\*/&FOZUH
M/BWXF7GQ1U[P;X9\9^)['X=>"[[]K[]IO]GWX96^GS> OA[XE\(:U;>!+/\
M9_UFZ^+'B#QWXR^%$MEX/TZU\9^%K+XA:]?:UX4T3Z%_9P^.OQ'^,7CWQS!X
MU\&Z9\/]$MO@U^SQ\1O"7A6Q\5Z/XZN(H/BU=_&/49M3U/Q-H^FZ7$FIS:+X
M<\,:-J_AP17NG:)K^@:S<^'-?\4^&=7TCQ/K'D/CKQA^SK\#/BS8^!O"'[)?
MA>/Q3\(+;]G-?"OB+PE\)?"^F0:3H_[5'QJ^*7@JWT3X9W/A[0'O=.U.R\8:
M+XJ\4:Y;D:!X6%YXGUKQ+K^NZ196?BW7K+K_ (&_&/\ 8A\*>,_#/PW^ WA/
MP3\.-?\ BY%X7TJ&S\%_":W^':7WB:S^%7B3XK^%?ACXOAL- T6_TSQOX7^#
MOAWQ3XE'A#Q!90M\.O#UC;Z%K/\ PC.H^)?!^A^( .E[/]#E-:_:TTCQI\0]
M6\.:1\(-*^('BCX1_%/X>K\$_$<7BWQSX>\&:[KWQ5U/XV_ *X\5/XO\4?"/
MP]I,47A"RTCQYI?C67X<Q_&W1+?2==GB\-ZGXB\46UOH[8L7[4NLZMJ7A?Q'
M\,/A/9>%C\2/&?[($?QL\7ZOXSTZ[U31M?\ B[XPTCPA=>#M+\)7&E,GC&TT
M;P3H5QX8O_'>D:CH:6]_K_AV_P! T7Q FC^.+KP=Z1X)\>_L5V_CGQ/)X5^%
M'AGPEXJU?XHW>A7/BM_@$WA*;XA?$7P9^T/XI^$&O:SH^N2^$['4/$LW@?\
M:+\2>)[74O%,VV"SUOQX?B5IM_=^&?B1IOC'Q%SNJ?$O]AU_'_@*6Q^!NF^,
M?B'HJ^%-)^&VK^&_V:;G5]3T'64UWXSW?PV\,>&O$LG@^WM?#FHQ:U\/?CKK
M>BWT6IZ;X?\ AO'!K_B3QCKW@33_ (B>'M1\8@?)_P!?U<G_ &QOVDOC#\$O
MBK\"O"7PUL?#]SH7CCP?\1_$/BV[\0>$&\1:58:EH?QJ_9*^$OA"3Q7K=O\
M$CP7JO@#X;O)^T#KC>//B!H/A?XGZIX!M8=,^(5[X)UOPKX.\3>']?S[K]O?
M6)D^+-_H?[/OCN;PO\._&/CWPG9_$#Q'I'Q=T7X?00?"3XMZM\&?B1XD^(WB
M?1O@9XLB\/:'!XGT6ZU;PE+\)+7X^7$O@EY?&WQ5A^#GAKPQ\1=1\#9%U^VA
M^R-\23\3M7^+GA#2]4^%]AI/B#X9^%?B5XG^#_BKQCX;^(WP?^*?['/P=_;+
M\=>![NSU7P%/K*)\1?AA/>ZCK_PFBTK5K7QC:_"S0]'UZTF\=W7ASP77;^"-
M:_8?^.OB+QWX"T3X*> _$6M^*+>^\9_'33-5^"6@SZ-97T'BSXB>&+N3XQ^(
MWT2Z\'7^O:SXG\-^/AIT-[KFN3^.=&O[[QKH#^(? ?B-O$U\!\MM_P"O0YCX
ME_MU^(/@]X;_ &A_&/B[P'X%\0Z5\(/B1K\/A+0/A[XS^)?B[QCXX^!?@_X"
M?#_XU^*OB/;Z5X:^!_B18=<TVU\=Z)9W!U'^P?@]HU_XET'0_$WQHT4RZ-K_
M (PB\=_MS_$'X:Z[\2O#NJ? &^^(_B+P[\1OBO;>!_"?P5E^*?Q%\4^)_@]\
M'O!WPG\0^(]>O-+\.?!?6;JT^*6L:K\7/"/A[PMX+>UM?A_>>(-<AT;6OBWH
M%CIC^)]5Y?QK\3/V2?C3J/@30=!_9J\#?$O7?V@OB7\(GU\_%/\ 9VMKH:G\
M-_BS\)/B0OA7XX^(= \1^'[/4_$.A^,_@Q\ O&/PQT>^UZ6SUOPQI.AV>B^.
M]'T[1/# \)WG6_%+XE?LQZ[XUTO2?^&;_#7Q?N?$G[5]Y\,_'^IS?"?0]9UR
M[^-'@[]F/XR:BNMZ;I]UHMWJ^O\ CO1?!OPNTGX57FN^+U\+V%M\(/&-CK$/
MBJZ^$]UI]SJH'R_'LM?U9WWP_P#VF/&/Q+_:<\+>!=.\,V&A_![5_!7[;-OI
MVHS:]IVI^*_$7C?]DW]HKX"_L^Z_?^(- .F64O@_34\5>)?B,?!L/AWQ#X\M
M?%'A.XTO7?',GP[\3C3?!C]]X?\ &GQ1^)'QS^+7AO0O%7ACP-X#^ WC/P%X
M.U+PQ=^"YO$'C'XD76O_  Z\&?%/6O%3^([GQ1IMIH'@>^TGQ_;^ _"L&E>%
MY]1M?'/@+QGK5_XGUS3V'@[2O(HOCW^PUX)\>6_Q>TOP?X6TCQ_\2/@G_P +
M?T7XJ^&?@G(_Q(^)?PI\=:K\*)-2;2I-!\+R_%SQ!_PD&IZQ\)+O4/#MUHHN
M/%&JZ59VMA::YX@^&WB:Q\)9/BC]I/\ 8A\2?$K2/$/BKP'H7B;XV>&;^+PM
MX'U36/A?X?U7X@R^(_!OQ7\-?#G6O!7A/Q=J$4B6%[\-/CI\1?#/@W4(;SQ'
MI'AZS^*?B&VL_"VHZOXACGDMP/D]OQN]?T&?#?\ ;XUGXK7?@.W\*?L\^.;:
MS^+_ (M^'MC\)/%7C%?&W@'P-XI\#_$7X;_'7XLV7B"[\4>,?A9HT5SXK\,^
M!_@-JNL>,/"7PUL_BGX;TR/XA?"M=-^(^L_\)+JC>'O._'W[67[15[\.M+LM
M$\/>"/!GQ@\8_$[QA\,+&'P_XX?4?!&A>']*_;[^&'[(8\5Z?XL\7_!/7]4;
MQ_;Z)XVDU+0WU?X7:WX&BU/S_$6N>$=>LXK7P4WTKJWB/]D[X*?$ZW\-VOPK
M\.>'?&5WXL\!>.M7\2^$_@U;PZ?X8^(7[07BCX@_"GX9Z_K_ (JTW0((-,\;
M_%KQAXF^)_@V#4K2XN-7@O/&_B6?QS<Z!I?Q'&H^)?'?AW\0/"_C;X/?LW^.
M/!G[*OPFO?BW^U%<Z[\;O#'@#Q%I.F?"_P />!]-U;Q-I/[0WB;XA>/?&?\
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M\;? 7P'^*UEXD\0>)O@!;:#;3_#_ ,:>/[:SF/PCU;XY64^H^&/%_A[Q#?\
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M/0K;Q9:37O@G6O#'@#7)M/\ %WAFWU'SK?PMXEUC0A?-HVM2VE?Q+/\ LU_
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MR=.OOB#JNF76G>//B)HFLZ7J_P 4OC;X/_:.\;:UIGB#1/%FG:]IVMZC\;/
M/A#Q]INLV6I0:GX8U+1(+'PK=:+HL]YIER!=7ZVOWUMV/&9/BI^S5>:'^S[\
M?O W[/D/Q/\ '7Q1\1:Q\)?@T_@#X?\ PCO/B/H^N^&O"_QF^(/BSPM;_$37
M/$OA_P !>%O#_AV'X??%V*;Q#:_%&+X?Z_XBNI;?P;XA\32>.M$N=?\ -9?C
MM^POXATV[\0_\,^:+K_PE^.NM>%QJ?Q>N?@A\//^%>_%3Q7XC\)Z'^TC>?\
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MC[0=6^'/@GPUX<\5>%_&%WK7AKQFMC/JOBW2=;UO5=8U*_ OZ_>?.OQ%\7?
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MND@\.7,.A>(?AYXK_9Q^)FM6?BSP]/J'B3PG8^)?"^J^%'EUN^UFUT/]1J*
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MT/@Y^P-\9/ABOP#U?[/\+;KQG\./BAI'B'QAJ/B'X@Z/XW\%'PO)I'P>\/\
MQ%\1>%_AYIO['?POM[OXM^/]+\$ZSJ&D^/IO$'A;XH>!/&^@^%?$>H_&;XD>
M$_'GQ=^&OB#]BJ* N%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]HO]F?Q'\4-.U3Q[\.]+\0^,?A'XGU70Y/CCJ7PPT4:'\#HO%'[0?QN_9O\
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MWAC5/%7I/A/]NG]C;X@Z'/XC\'^"]1\76UKX:M=>U*V\,_#?PYXMU;2?A/\
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MPT+P!H'P_P#"?A&Z\-:IJ/B<#3N^O]?YDWB#XD?L26?P>^+NAW?CKP,?A?\
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MG\0V78_"+]J7PY\:-6^&5_X3T34H_AU\9O 'CKQG\.O%6J2Z-#<ZA)\.]?\
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MWMSHNB^(OVDO$CZ5X_\ '6EZ_+I-I\0O%T'_  LK5)/$_B8>(?CWI_@8ZO\
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MRNO66O>"?%5CJMO%IOW)10%W_7W_ )GR-X=_8Y^'VDVO[0.DZQK?B3Q)X?\
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M#T3QAK^N:/$^O_$#PI8?!7X^?L]>(KKQIX@&MOXHUWXJ^.?AS^T+XMUWQ/\
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MH"_I]QXC_9/[2'_0^_!'_P -'X\_^?91_9/[2'_0^_!'_P -'X\_^?97MU%
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M ,-'X\_^?91_9/[2'_0^_!'_ ,-'X\_^?97MU% 7]/N/$?[)_:0_Z'WX(_\
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M17FES6@^(+:'-"VNZDEX='&JHUD-0.F6/KU>"_!__DH7[5/_ &7KP[_ZR_\
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M ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4 ??\ 17P!_P /8O\
M@EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(_9U_^>-0!]_T5\ ?
M\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4
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MP2R_Z26?L ?^)D?LZ_\ SQJ /O\ KP7]I#_DGOAW_LO7[*W_ *U!\'Z^>O\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJX/X@?\%#/V OC=;^ /A?\&/VY/V/?B[\2
M_%/Q\_9F3PS\._AC^TS\%O'OCGQ&^D?M%?"[7M530?"7A7QMJNOZN^F:'I>I
MZS?II^GW#6>E:=?:A<".TM)Y8P:W7K_F?IW1110(**** "BBB@ HHHH ****
M "BBB@ HHHH **** /!?V5O^37_V;_\ L@OP?_\ 5>^':]ZK\G/V=/\ @J)_
MP3.\*_L^? GPQXG_ ."BG["GAWQ)X;^#?PPT'Q#X?US]KG]G_2M:T+7-'\$Z
M'I^K:/J^EWWQ!@O=-U33+^WN++4+"\@ANK.[@FM[B*.6-T'LG_#V+_@EE_TD
ML_8 _P#$R/V=?_GC4#>[]7^;/O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/
M&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ!'W_17P!_P]B_X)9?\ 22S]@#_Q,C]G
M7_YXU'_#V+_@EE_TDL_8 _\ $R/V=?\ YXU 'W_17P!_P]B_X)9?])+/V /_
M !,C]G7_ .>-1_P]B_X)9?\ 22S]@#_Q,C]G7_YXU 'W_17P!_P]B_X)9?\
M22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\ $R/V=?\ YXU 'W_17P!_P]B_
MX)9?])+/V /_ !,C]G7_ .>-1_P]B_X)9?\ 22S]@#_Q,C]G7_YXU 'W_17P
M!_P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\ $R/V=?\ YXU
M'W_17P!_P]B_X)9?])+/V /_ !,C]G7_ .>-1_P]B_X)9?\ 22S]@#_Q,C]G
M7_YXU 'W_17P!_P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\
M$R/V=?\ YXU 'W_17P!_P]B_X)9?])+/V /_ !,C]G7_ .>-1_P]B_X)9?\
M22S]@#_Q,C]G7_YXU 'W_17P!_P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@
MEE_TDL_8 _\ $R/V=?\ YXU 'W_17P!_P]B_X)9?])+/V /_ !,C]G7_ .>-
M1_P]B_X)9?\ 22S]@#_Q,C]G7_YXU 'TAX _Y+!\?O\ L(_#;_U!;6O;Z_*3
MP5_P5)_X)CV/Q0^-.K7G_!1S]@JVTW7+_P !/H][-^V'^SNEOJ2:=X.MK*^>
MSD;XC!9UM;M6MYF3*I,K1D[E8#US_A[%_P $LO\ I)9^P!_XF1^SK_\ /&H
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M.H:)J_AO5M*U73Y=8OTM[Q(;AXB!:?:I_P"3'U_\9OA1^R7#\)O@)\8/AO\
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M (QU?P%K^J_M:^*['7?AEIVI:+X)UGPC\&/V^O .J:1X?UJ\\):AK7AF>_\
M OPF\.76L^%-9O\ P'X+O-8\+:[+J?A[5;GPOHDU_IMQ)I]NR 6G;X9]=?>[
MZ=3IO"EM^S8_[%7@SXZ>/?V<?^";7@WXL?'.S^#.@?":[^(_[#>G? +X(^$/
M'GQ;\$6'C+5[W6M7^*'C64_&_P #?"_PPOC+XCW6I> _'/P[M_B5X:^'NI>%
M/"&O6/B3Q%HVHP^A:7H'[*_C(?!OXKZ#^Q1^Q7X3_9T^+_P&\,^+_"OB"_\
MV3/AE\38M4_:"UJT^(P\0_ 3Q=\4_ VL:?X3^#VH^%-5TCP#X<T#7O%?A+5/
M#'Q3\?ZMK?PL\+>*;3X@W'A70-9\%^'?_!>3_@WK^%?]A)X+_:G\1VEIX2@D
MM/!.EZW\%?V^O&6B?#ZP?2(/#T>E_#C0?&?PG\0:-\.](L_#MO'X<TW2/!-A
MH.FZ5X=:?0=-M;32+JYLY:5Q_P %TO\ @W8NO$-AXCG_ &E=2>73-5\4>(;3
MP\/@-^W>GP]7Q5XT\2^+?&/B?QG/\+H_A"GPVO/'6J^*O'GC'Q!)XXO/"D_B
MVWU7Q'JEY9ZS;RW+, +3O\,]_P"]MVWZ'VC\'?V</A/\1?V.-<^+FG?L1_L7
M>/OCWJ?PUO/%/P[\*?\ # VC?LY^'-2\87GPVT;Q#X=\*2>$?C-XJU;5-=LI
M_%E]/:0^*7^)?@OPGKUO/;Z*?$7A==,U3QB?((O"O[.6JWG@CP)X._9,_8/U
MSQGX]M+'PA!XJ\;_ +"6G?"C3_ 'Q1O/C'XB\):XOQ)^%7B+6KCQ=IEOX)\"
M^';^+3?!A\3Z5/\ &+XD2>"[?PSX_P#!W@GXH:'XAT/RKP?_ ,%_?^"!'@/X
M=ZI\*O#'[9'Q'M/!6J64^FFSO_AO_P %%-?UG1]-FT&P\-1:?X1\8>(/AMJG
MC+P/8Z9I&F646@6G@W7]"M_#=Y$^K:!'INK3W%]+S4'_  7$_P"#<:'PS/X1
MF^/MKJFCW=A)8WTOB#]FK]MCQ)KVI7$GCM?BD?$6J>+/$'P4U/Q7J?CA/B='
M#\2(?B%?ZU<^.K?Q_;6GC.#Q%'XDM+;4X@+3[3_\FO\ F>[:EI/[*/A+X@^%
MO#ES^RK^P_\ $#P;\.=>^-UM^UWKUQ^P*OP$\4?#GPY\/+/]FE['7_"NA?%*
M2YL;O0O ND?M-^#OC#\3_'3W>L^#-=^"&F^*-=\!7!\2Z!;:#X@]&O/!?[)'
M@?X&?L[?'[XE?L-_L;+X,\;:3XZN?C:/#?[+GPXBG\'_ /"/?!KXF?%;2->\
M.R:A!=Q6UE<ZK\+V^',7AS5O[6O_ !'XJ^(7A*#3-<TR>SDL=<^5_ G_  7B
M_P"#>;X<7\^L^&OVGM7G\1WG_"4G5/%WB_X$?MW_ !%\;:\WC73/A[HGB9_$
MOC;XA_"#Q1XL\3OJ>@_";X9>'B_B#6-2>S\.> _"OA^P:UT;1K*QBEA_X+Q_
M\&Z\'P=\'_L^Q_'O0S\$_ $7PVM_!WPRD_9/_:^F\):!;?!_Q'X;\7?#.VL]
M,F^ DD9MO!OB3PAX9U;2+><S0I<Z-9B:.:)7C<"T_P"6I_Y-_G8],TGP=\,9
M]!\*^%=?_8?_ ."=>A_&KPAJ'P^^'/[1T$7[*/A74?"WA[XD_%W]L_P=^S=\
M*O$W@;P])K&FZ['X'\;?#CPU\=OBS9^&]=\17^N6MC>?!RZE\4RZ7J5X?$6O
M\+/ GP1T[4? /_"[_P!CO]ASQOI'CCXR?MG_  P:/X"_\$Z[I?$.D6G[+_QG
M\;_"?P_JLVA:9XF^.FK7$/BF'PG#K&NZHVEVFE:/>7T.CQLKWMG<GS!_^"_O
M_!O7)K7C/Q(_[1.E'7_B)XU^'?Q%\<ZR/V4?VO5U+Q3XV^$D7A:'X:>(M8NU
M^ 8FN[[P3%X*\+KX?WOY%C_8]NR0EI+DS:&B_P#!PG_P0 \.WND:EH?[34&F
M7V@:[\3/$VC75M^RW^V&LNG:_P#&3Q1J'C7XH:I;D_ 9@MUXV\5:KJ.N:VY#
M+/?7<TD:Q*0@ M/^6?\ Y-Y^?G^!6MM:^ D5K\(?%MY^P'^PU>>"]6F^&/BO
MXMZ7;?LDZ!I?C;3/A-XC^%?[6'CGXEZWX3TN>VU35+7Q?\.;;X+>$O',7@^]
M\+>)/$/B30O#WQ!^&6E:%+X^\9>#]6\*>V>+/AW^SRWP!\/?$7P9^QC^P\/%
M?B;]L/XN_ .QO+']B;PS\7=+_P"%>^ OVB_C5\+]!UW2OAWX2U[PAXE\5>)M
M0\#_  WT/4-3OM,\:6>DMJM[K/B:ST.+1([;PY!X-H'_  7V_P"#>CPOJN@Z
MWX?_ &BM/TG5O"[6#^'[^T_98_;$2XTEM+T;QMX>T\VC-\!V"&TT3XC^.=-B
MR&Q;>)M34Y,J-'@P?\%TO^#=33_A=X;^"^@?M%R>#OAIX,U[_A*/!GAKP!^S
MO^W%\/!X-U\Z[JGB7^U/".L>!_@SX?U[PQ<?VQK>KW'_ !(M4L(_(U.]T[9_
M9MS+:,#M/^6:_P# O/S]#TZP\)?"_P 4? OX@?';1OV-?^"<7A.W_9V_9J\%
M_%WXO^ O&/[)'A%M;\=_$R#X<:A\5/BIX!TW6(/$UA;? ?PQI&EZ9+\-(?$/
MB#3/C/JW@GXMQ^.K+Q#I7B:R^#E]I'Q*[7Q5\-?V>[[XN?'3]G;2OV1_V%?#
MFM_"CX9?$_XU2_%'0?V:?A+>:EJ?@.;P1I]_\/?AEX>\'>)M!UG3/#G[1'PH
MU[Q]X \3?'^7Q OQ!\+Z'\+=7^ 7C.;X>:$/VUO!^C_ OYFUC_@MG_P;;ZX/
M#$-U\<=,LM-\*>%O#7@2R\/^'OV9?VU?"GA/6_ /@N_U#5?!7P_\>^#_  Q\
M$]'\+_$[P#X*U?6-=UCP;X(^(^D>*O"OA36/$/B35O#^D:=J'B+6[F_VO%W_
M  7@_P"#?3Q7X1OO"<7[5EYX9>7Q!\4/&FB^)O#_ .RQ^U7)XF\)_$'XQ:%X
M_P##OCWX@>'Y_$?[-_B'23XHU?2OBAXXM7?7-'UK1S;:[/83:1/ID<%C&"M/
MM/\ \F_SU_I'Z_\ P]_8J_8L\1^ ? _B'5/V-_V3GU/7O!_AG6M1>#]G/X0P
MP-?:IHME?7;0PCPBPBB:XGD,<09A&A";CC)[#_AA#]A[_HS7]E/_ ,1X^$7_
M ,Q]?E9X=_X.4?\ @AWX9\/Z'X;T[]LS6&T_P]H^F:'8-=?LR?M?2W+66DV4
M%A:M<2K^S]&LDY@MXS+(L<:O)N8(@(4;'_$3;_P1(_Z/*U'_ ,1A_; _^<%0
M*U3M/_R;_,_3O_AA#]A[_HS7]E/_ ,1X^$7_ ,Q]'_#"'[#W_1FO[*?_ (CQ
M\(O_ )CZ_,3_ (B;?^")'_1Y6H_^(P_M@?\ S@J/^(FW_@B1_P!'E:C_ .(P
M_M@?_."H"U3M/_R;_,_3O_AA#]A[_HS7]E/_ ,1X^$7_ ,Q]>8?&W]D7]C/X
M;?!CXN_$70OV+?V0[O6_ /PP\?>-='M=6_9S^%4^E7.J^%?"FK:[I]OJ<%GX
M:L+N;3YKNPACO(K6^L[F2V:1(+NWE*S)\)_\1-O_  1(_P"CRM1_\1A_; _^
M<%61X@_X.3_^"%_BK0=;\,>(OVN9]8\/^)-(U+0==TB^_9=_:_ELM4T;6+.;
M3]4TZ\B_X4$/,M;ZRN)[:XCR-\4KKD9H"U3M/_R;_,]2T_X2?LY?#+7-0\%_
M&O\ 9-_X)U>//$FO_#[X8^._AAJ/@7]EWP=\%[;4M6\<>(M8\+:A\-O$GA+7
M9OV@/$$OB&9M'D\4_#B^\'7_ (BU_P")-A8_$+PYIOPYL;SX7RZ]XSY+0_$O
M[!^MVF@^)(_^"<_[+VF^$/BU#^S\?@'+XC^#WP0T'7?$-U\;/V=O%W[2VH6_
MQ-M8O!&M6/PZ'@CP)X'\31:DUC=^+9+[6-/@T_2HM0.I0S0_,MG_ ,%NO^#<
MG3]-6RLOVD-8MM436= \01^/8O@G^WXOQ@CUGPKH^O>&?#FH1_&W_A5/_"WX
MYM&\(^*_%O@BP">-UC@\!^+O%O@54_X1'Q1KVBZA&O\ P6T_X-P;;2]"T;1O
MVA[WPEIGA/PI\/?!?@VU\!? ?]O/X>CP-H?PJT;6/#'P_;P'+X'^$GA^?P-K
MWASP=X@UOP%!XM\)R:-XLO/AUJE[\/-3UN]\$SOH)!VGVG_Y-_G^'XG[*_#3
M]DG]A'XG_#GP!\2M-_8;_9Y\-Z=\0_!/A7QSI_AWQK^R_P#"7P[XRT"R\6Z%
M8:_:Z+XM\/R^%9Y="\3Z5!J$=CKVC23S2:9JL%W9/+(T!=NV_P"&$/V'O^C-
M?V4__$>/A%_\Q]?ES8?\','_  1!TVQLM.M?VS-::VT^TMK*W:\_9M_;,U&[
M,%K"D$1NM0U'X$W6H7]R8XU,][?75S>74NZ>ZGFGD>1K?_$3;_P1(_Z/*U'_
M ,1A_; _^<%0*U3M/_R;_,_3O_AA#]A[_HS7]E/_ ,1X^$7_ ,Q];OAC]CG]
MD3P3XAT?Q=X,_97_ &</"/BSP[?1:GX?\3^&/@?\,M \0Z%J4 80ZAH^M:5X
M8M-2TR^A#N(KNRN8+B,,P20!CG\I_P#B)M_X(D?]'E:C_P"(P_M@?_."H_XB
M;?\ @B1_T>5J/_B,/[8'_P X*@.6IVG_ .3?YG[ST5^#'_$3;_P1(_Z/*U'_
M ,1A_; _^<%1_P 1-O\ P1(_Z/*U'_Q&']L#_P"<%0+DG_++[F?O/17X,?\
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M;3/#VA?%/XAK\7?B-IO@[3KCX(&U\+2^-/BJEKX_U[7M(CM_%-YK6B>"K/\
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M\,(?L/?]&:_LI_\ B/'PB_\ F/H_X80_8>_Z,U_93_\ $>/A%_\ ,?7YB?\
M$3;_ ,$2/^CRM1_\1A_; _\ G!4?\1-O_!$C_H\K4?\ Q&']L#_YP5 6J=I_
M^3?YGZ=_\,(?L/?]&:_LI_\ B/'PB_\ F/H_X80_8>_Z,U_93_\ $>/A%_\
M,?7YB?\ $3;_ ,$2/^CRM1_\1A_; _\ G!4?\1-O_!$C_H\K4?\ Q&']L#_Y
MP5 6J=I_^3?YGZ=_\,(?L/?]&:_LI_\ B/'PB_\ F/H_X80_8>_Z,U_93_\
M$>/A%_\ ,?7YB?\ $3;_ ,$2/^CRM1_\1A_; _\ G!4?\1-O_!$C_H\K4?\
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M_@B1_P!'E:C_ .(P_M@?_."H_P"(FW_@B1_T>5J/_B,/[8'_ ,X*@+5.T_\
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M?_$8?VP/_G!4!R3_ )9?<S]YZ*_!C_B)M_X(D?\ 1Y6H_P#B,/[8'_S@J/\
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MPX_^9NC_ (9(_92_Z-D_9[_\,O\ #C_YFZ^A** N^[^]_P"9\]_\,D?LI?\
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MPX_^9NC_ (9(_92_Z-D_9[_\,O\ #C_YFZ^A** N^[^]_P"9\]_\,D?LI?\
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MX9T?3]!T6P261YI5LM*TJWM+&U62:22618((P\CO(P+,2=ZB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>proxy_002.jpg
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 03 R # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'W[8WB/X0?"?]HO]H;Q=^Q9:_'S2?BSIGA#X+?$_3_A3X6^)7P$\=R?#K6O
M/Q#^/MGX)\4> OA])JNKPW7B\ZE,FO7V@?!_3-5^+&N>'K;PQ'IC:MZ]J'_!
M5OX7>#?V<O@_^T1\1OV>OVUM)T'XA_#37OBAXWM?#/['_P =O$Z?!7PEX,U"
M?2?%WB[XIW-KX1CC\)^$C)8:GXI\(7%Z[Z_XS^&EM'\1M"T"[\*S#41R?A/_
M ()9R:=^R!_P4^_9/U_XPVIA_P""BW[0/[=7QGM_'>A>!FCN?A79_MB-<G2M
M+U#0;SQ+M\=:A\.S-!]NNDUCPO%XIM;5-/MSX=!2]A^+_CG_ ,$5/VG/VG;'
MX2-\=?VC/V2/'NH>%?V,]7_8\\0:)X]_9$\=_%3X;?"^XM/$?C:;PU^T_P#L
MH_#KQ=^TC;>%OA=^U'K/@;5? GA;Q5\2?&&E^/?[*UWP-I_B7PY8/X9M].^&
MUF![OHKK6[O:W:UM_P C[J^-W_!:#]B/X&Z[J'A[4+[XV_$Z_P!-_9S\ _M>
M74_P*^ 'Q3^,.DVO[+_CZ#7;Z'X[ZKK?@SP]?Z1X;^&WA;2M#&K>,O$'BJ]T
M*'1['6M $"7]YJ0M(<2#_@KIX#U_]O7X)?L>_#[X&_&_XB_#[XW_ +/.@_'O
MPG^TCX0^&WQ#UCP7K&B^.M0^$K>!O$VAV4/@M+&]^!</AWXIV5S\1OCS+XD@
M\,_#?QC%8_#SQ'I5MKE]+-:>7?#[_@D)XO\ !GA7XOZ#=_'CPYJ-[\4O^".W
MP._X)=I>P?#S4[:WT;Q1\(OAW\1?!-W\9GMI/&4\M[H.NW?CM=3@\#K<VVH6
M4&G&SD\4W,DPNE['X>?\$S_C7\$/BI_P36^+WPA^/?PQ?7_V._V)/!'_  3_
M /COHOQ$^$7B?7-$^+_P3TJ\^"^J>+O%WPIG\._%#PQJ'PM^)U[J'PDG3PW-
MXJ;XE>&+&#Q!:/JFDZB-"NK7Q&![MNM]>OW/1?UU.1_X*>?\%2/C!^P!^UG^
MQOX*TCX<^!_&O[,/CWP;\6/BG^V!XAO-'\5WWQ1^%OP9^'OC?X.?#[5_BOX"
MN]$\56VF?V'\+Y?C!:_$3XDZ3>> /&^I:CX#\+Z\^FR>&X[:\U_3NT\&?\%7
MO"_@O6O^"@FJ?M27WAKPWX!_9H_;<\#?LC?L]:9\)? GQ"\:_%?XX:]\2_A%
M\*_&WP^\!>'? ?A[4?'?B/XK_&+QOXI\=ZEIOAW2OAWX:TBSDT&P&K:AI5CI
M&C:_XCA^D/C_ /L):1^T)^V-\"?VC/&FM^'=8^&7PS_9M_:I_9Q^('P6\0>%
MI=8M?B=X<_:=A^'=AJ\=YJS:M!96FC6ND>"K_2]7T>ZT;4?[9M-;>);BT6)M
M_P"5OPC_ ." GCKX0? 37_AOHW[9M[K7Q5^'?[?WP6_;K_9,^+GC'X83>*(/
M!=[^SC\,=(^!OPE^&7QW\+-XZTF[^+>AO\%=.N/ GBC5?#/B?X;W[W-SI_B3
M3%BDT=M(U0!<MM=_GKK^'^7F?0_[3?\ P76^"/P?_9,^+/[0'PI^#7QQ^(_Q
M2^#7Q6^&7P6^*/[.'Q%^%_Q.^"'Q&^!_C+XJ:SX03PMJ'Q_TW7_ 6M:O\-?"
M?B?P?XM@\2?"GQ9-HVH>"_C5XE;1OA?X*\8)XKUN>31/8+O_ (*7_!KX=?%7
M]H3Q[\<_CKK7PA^!7P@_8S^ G[2GBKX._%K]FSQ?\-_'WP;TSXI^,_&WAK3M
M>\5^*+W5;[Q?XA\<>.=6TFP\%6'P%A^&MEXPT7Q1:Z?IVGOK>L^(X=+3YK^(
M'_!%_P"*/QW^!7_!1Q/CI^U%X0N_VN_^"C7B3]E#Q+XO^)7PS^"^J>%_@5\*
M[3]B3Q!X0\4_ +P1X.^$OB;XG^,O%^LZ1_:_AS64\>^)=>^)QUCQ!9^*0++3
MM,N/#\<VL=%^T%_P1Z^(W[8A_:MU_P#:$_:+\(^&?'W[5_['_P"RK\#=<UKX
M'?"K6=+\._#WXU_LL?''Q%^T!X3^*GACP[X^^(OBR_UKP'/XZNO"Z7GPYUKQ
M)%K.HZ%I&K:<WCO3KG6+?4M+ ]W\5=^MKZ6Z:V[GU#J/_!6/X"Z-X&^'WB77
M/@I^VSH7CWXN>+O&WA3X4?LX:Q^Q_P#&?3_VF_B-:_#?PYX2\6^/?'?A?X,S
M^'U\13?#+PEH7C?PY+KGC_4&T_PY8ZK?+X8EO!XKVZ&_M^K?MC^!OB!^P;\2
M?VV?V9?$&B^/O#&F_ +XR?%7X<:AXAT3Q%8:9=>)?A?X<\8/<^'/&OA6]?PK
MXNTB]\/>./"6H^$O'?A.]E\.>)M%U;2=;T&[DTG5K.1[?\VOVG?^"4O[3W[9
M]I^S]\5OVF?BS^Q!\3_VEOV;-;^,>@^'-!\0_LB?$G6OV2OBE\%_C#X5^'.F
M7OA_XG_"W5/VEYOB/IWQ8\,>-O ,7Q%\+?$_P#\4O#^AZ>]U+X/O/AQJ>F7$
MFJ1_H#\/OV,&\#_\$^_%G[%>FS_!CP+J7B_X0?'+P!-J'P,^$&I?"SX+^&/$
M'QN_X3N\O]4\'_"._P#B%XYUK3M$TG5?&\UW=V>H_$;5M9\37EM?:SJ&L6NH
M:S.EJ![NGKKZ77Z=?.W0_(O_ ()R?\%E?VCOV@_BO\(-$^/'BG]@OXM_!OXB
M?L6ZG^UC\</B3^QY/\2=!E_X)]:II/AC0O%=Q\-?VRKCQQ\3_B_X*\+Z[/'>
M>(O#$>CR>+?"GC/3]?\ "/B:^UGPII^B:,;J_P#TG^&?_!8+]BKXC:/X[\3Z
MEK/QB^#WA#P7\ /%'[6&E^+_ (^_L^_&+X.Z!\4OV7_!LVDPZ_\ ';X/S>,?
M"%C>_$'P7:?\)'X3EBTW2K%?'-W;^,?",]KX0FB\2:4US\F^$O\ @AYH7A&7
M]G.PTGXKZ/H?A>W_ ."7'B?_ ()9_MY:3X2\"#PW??M4?##4/A3HO@[PI\3?
M"5[!K%SI_P .?BQX4\:6FM>(3XS\3:+\1]:U7PKJR>"Y+VUM8)KRZ^<]"_X(
M36'PP_9B_:<^''QB;]E?Q'X7NOV(/B5\!M"^)W['_P"PEXQ\'_MJ^/;V/1/"
M6IV?Q(\5WUW^T1\1-&\=^/KX_#J&;4_@]\-O!7A:S^,/CC7XW;7M!2TT_1K@
M&^5^6JT2MI=WZ[[=?QN?IW\!_P#@KS^RC^T'XVOOAIX5\,_M0>%?B+8_LT^+
M_P!KZ+P'\2_V5?CAX'\8^(?V>_"NM^'-!M/B#X"\-:EX0?6/B?:>.K[Q/9Q?
M#K3OAK9^+=6\77EEK&AV-DOB73)]$$)_X+ ?LG:1\._VB/'_ ,1] _:-^!][
M^S!X"\"_%GXH_#+X[?L[?$KX2_%@_"3XF>*-2\%>!_BAX0\%^,=)TV;QGX*U
MKQ;H?B#PW=:EH%Y>7'AC6]!U+2O&%EX?OQ:6]U^)OP!_9O\ VUOV\OVI_C;<
M>,OC5\=?"WA#2O\ @CQXS_8.T#]MA_V%/C)^P/<^'?BU\2/C#\-?$>@R>#/@
MU\?O&D/Q4^)_CVRT?X;^*O$/Q[\:>"]:\!?#NTN]4TGP!\/[;X<RS:9XL\0>
MX/\ \&]WCS5/AE^V+X-/Q8_9$^#EW^UK^QO\.?V7IO#G[+G[(>N?![X8^"O$
M'P\^,MQ\11\3M5TO4OC9XV\8?%7Q;XMT)H=-\8>,O'7BV?QOKFLK:27>M/H&
M@Z)HMN"M'\GO]ZVZ_@?HSXL_X+3_ +'6@0^$+*UTK]I_5_$'Q \ >/\ XRZ+
MH/AC]DOX\^*?%OA_]FWP-XFN/![?M<^,_ VC^"+WQCX9_9G\2:ND%YX$^(VJ
M^'T'C;2;FWO=!T>]5I8XOCO]@K_@J9XS\2? S]EOXO\ [6O[0*:IK&I_\$K/
MC[^W!\<_AIX;_9VLCJ'B>R^"7Q7LM)\4_%[1/B5X1UW2]"TF;PYX;W>&++X,
M:'\/W;Q3>:HOB.'7[9[..PN/M/\ :8_8!_:!\7_MC:/^V?\ LF_M)_#OX&_$
M#Q!^R+<?L0?%C1?BM\"M1^,_AL_"=/B1J?Q2\-?$?X66.@?%3X5/X?\ B]X*
M\0Z]XAM-.M?&%QXQ^'NNZ=J=@NL^' -":WUKXZ^&O_!#'QCX ^#W@7X7O^T?
MX8U"Y\&?\$A?VK?^"8@U>+X8:M;VUWK_ .TAXVLO%NG?%];&3QW<31Z+X1AL
MH["[\&->O?ZR^^XB\2Z<)!%$ N6WS5_UZ=._7L?<?P6_X+%?L/\ QNU[Q!H^
MF>)_BE\-]/T?]FC5OVP]&\:?'3X&_%7X+^ ?B'^S7X5MM-N/'OQ<^&GB[X@>
M%]%TKQIX0\ OJ^GKKNJZ7*UMJUA.WBCP3)XM\%P3^)8K'[-?_!7;]DK]JCXM
M_"WX)?#W3/VAO#/C_P"-GP[\6_&3X3VGQ@_9P^+?P@T?XA?!?PS;Z)>:?\7?
M"'B+Q]X:T71/$?@+QQ::VESX)U31KV^N]1M[&ZFU33]&CN=';5?FWQ__ ,$A
MX?$G@?X%Z#X\^+NH:KX(^!W_  1_^-G_  3.\>:5\/? $_\ PG/CF#XG?#;X
M8>#M5^)OP[BN]=U:TTC6+.V^&MU=^'/!>H:;XC:[U35=.LI]2N8H)5N?AC_@
MG+\/_P!JCXE_\%!?V+?$7C+7?C)\4/@Q^P;^P=\5_@C=_%SXH_\ !/CXV?\
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MCZ-^SO\ $GP-^RA\7?@O\#_B+\%OVOO@MX5\+^//B-IDOP]UE?B1^T[X7O\
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MB_P7)XGTG5/#>H+<6MS<Z'XALY-%\4Z)I5^T-O+],?M;?\$\/&?[2G[1FO\
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MI7A2PT;PGXQ^,?PUUK6[+6_ 7B:ZGTA?$#6]U%(]HMKUO[%O_!'O7OV1]?\
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M$<?C"7XB:=\/_#?@[X>2_'KX=>%=>CUGP#=W<%YI7BZ637((!:7-K]F?"?\
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M^T5\.?B%\<O@A\2_@M\+?B7\,?AQI.EZQ\7]3^'OQ"^(.@:+X;\63_!NVU:
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MW\*_$'7_ !)KGA[P[X5\!VOQ+\.M<72:/\1? 7P+\&?"3X4^,;""XFMK?6O
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MXY\1?LG:MIWB6+Q0?$%K\3_A+\-_'.I> OC;J5[%J,/[3>K#3_&=QJOPGO\
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M^&VM:OJEKXFM+2]DU[2+C7/"?A:W\?\ @OXA^")/%/@3Q("TT]7?\+?J8/\
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MS5/&.D^)=$OO#^K:QK>MW/AK5M+\0:%8:7JFD:T [=/S_KR/IVBBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFGR_\*[=O$3V,-J8M':]\VV]RHH _*?_ (:,_P""OO\ TB[_ &6?_%HFK?\
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M>)/[2LH!H%]X7N?V:_@JNAV']F2W^HG7AKVJL+BS@TX:0PO6O;3A_C;\:O\
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MI_A9_%/AM?$%W:0Z2VOZ.+LZC;?I;10!\M?M-?$/]K?P!;>#9/V5/V8_A?\
MM(W6J3ZZGC>W^)7[3EW^S='X0M[./2F\/SZ/<6OP'^-__"7OK<EQK$=]"\/A
MO^Q!I=I(LFJ_VHRZ=\F?\-&?\%??^D7?[+/_ (M$U;_Z :OU8HH \%\*^,OV
MA]1_9ZNO&WB_X&>!?#'[2<?@SQCJMI\ M*^.<_BCP!<^.-+&N'P1X.E^/C_"
M?0)[;2/%WV30!K'C ?"&=O"!UJ^\OPYXD&BJ=5^(?^&C/^"OO_2+O]EG_P 6
MB:M_] -7ZL44 ?''[-7Q1_;<\>^(_$=A^U+^R)\(/V<_#%CHD-WX9\0_#?\
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M7FG7VIP^$[9?B])\+OA_-+#XFL;?2[[4;K_A6Z-X:DU*XLQ;:TVG>?>>Y44
M?E,/VC?^"OQ )_X)=?LM D D'_@J+JN1GL<?L#D9'0X)'H2.:^@?V;_BS^W?
MX[\=:IH_[4'[&?P8_9X\ 6_A/4-3TCQO\.?VR[S]HC6M2\80:QH-KI_A6[\$
MW7[,OP6&EZ7?Z+>^(=7E\4IXGU V-WH5GI)T&X&N#4-,^V** /@OX]?&3_@H
M=X-^)&IZ#^SQ^PU\"OCG\+[>PTF?2_B)X[_;FO\ X&>(M1U&YLHY=9L+GX=V
M_P"R?\6(].ATJ_,MG:WP\9WO]JP(EZ;6P:1K2+QO_AHS_@K[_P!(N_V6?_%H
MFK?_ $ U?JQ10!X'^T9XR_:)\#>!++6/V9/@7X#_ &A/B%+XFT^PO_ _Q#^.
MMQ^SWH=GX5GT_5IM1\1P>.+;X2_&5[W4K#4K;1K&#PV?"EJM_;:I=WYUNT;2
MELM1^(_^&C/^"OO_ $B[_99_\6B:M_\ 0#5^K%% '@W[.OC']H;QQX"N=9_:
M9^!O@7]GWXB1^(]1L;7P+\/?CE<?M!:%<>&(+/39--\0R^.;GX4?!Q[;4=0O
M9]5M9_#P\)SKI\&G6MY_;-VVI-:V'P^/VC?^"OQ )_X)=?LM D X/_!475<C
MV./V!R,CH<$CT)%?JNS*@R[*H+*H+$*"SL$1<D@;G=E11U9F"@$D"@N@W991
ML4.^6 VH=V&;)^53L;#' .UN>#@ ^$/@'\8O^"A?C/XCV&A?M$_L.? OX%?#
M&;3=6N-0^(?@/]N._P#CKXAL=4MK;S-'TV#X>W'[*/PECOK?5;O%M=:B?&5K
M_9<6ZY^QWQ"V[:_[1_Q9_;Q\"^.]-T;]F']C+X+_ +0WP_G\*:?J6J>./B+^
MV;>?L\:UIWB^?5M=MM1\+6O@FV_9C^-"ZCIFGZ/9Z!JL/B=O%%B;ZYUR[TL:
M';?V*;[4?L];^Q>^FTQ+VT?4K>V@O)]/6YA:^@L[F2:&VNIK0.9X[:XEMKB*
M"=XUBED@F2-V:)PJ6.HZ?J=G!J.FW]EJ&GW0W6U]8W4%W9W"F0Q!H+JWDD@F
M!E!CS&[#S 4^\"* /RR/[1O_  5^ )'_  2Z_9:8@$A1_P %1=5R2!T&[]@<
M+D]!D@9ZD#FONCXQ>+_C]X6^$$OB?X)_!3P3\7?C2L?AHQ?";Q;\:Y_A'X2E
MEO[RQB\4(WQ9C^%WQ$FBC\.6<U_>:?+_ ,*[=O$3V,-J8M':]\VV]E;4+!;^
M/2FOK-=3FM9;Z'3FN81?RV4$L4$UY'9EQ</:PSSPPRW"QF&.6:*-W#R(#,ES
M;RS3VT=Q#)<6PB-S DL;S6XG5GA,\2L7B$R*S1&15\Q59DR 30!^5O\ PT9_
MP5]_Z1=_LL_^+1-6_P#H!J^S_P!FSQQ^TOX\\(:YJ?[47[/WP^_9U\:6?B:;
M3]!\)_#G]H"?]HK2-;\+)I6E7,'B2[\6W'P>^"SZ-J$VKW.K:4_AS_A'-1$-
MOI5OJ?\ ;,HU,6=G[LVMZ,EC8ZH^KZ8FF:FU@NFZBU_:+8Z@VJM$NEK8W9E%
MO=MJ33PK8"WDD-XTT0MQ(9$!5]9TB,WZR:KIL;:5);PZH'OK5#ILUY'#-:17
MX:4&SDNHKBWEMX[CRVGCGA>(,LJ%@#\RM7_:&_X*UVVK:I;:+_P3+_9AU;1K
M;4KZWTG5;S_@IKJFDW>IZ9#=2Q6&HW.E+^PGJ(TR>^M%ANI=/&H7WV*25K8W
M=P8C,_HGP2^-7_!1_P 6?%#PMX>^/7[!7P$^#/PFU$ZT/%GQ,\$_MZ7_ ,:/
M$WA@6GAS6+_0FT[X:7'[(WPNC\2C6?$UKHWAV\_XKG16T:QU>Y\0!=2_LHZ3
M??>"ZWHSR6T*:OIC2WJ))9Q+?VC27:22/$CVR"4M.CRQR1(T0<-)&Z EE8#3
MH ^,/VDOBK^W-X#\7:)IG[+O['GP;_:*\&7?AN._U[Q9\1OVQ+W]G75M%\3M
MJ>HV\OAVR\)VW[-/QJ36M.CTJ#2]23Q"?$.F-+<ZA=::=%B&G+?7WSM_PT;_
M ,%?O^D7?[+)_P"\HNJ_U_8&K]6** .:\&7_ (IU7P?X4U/QSX=TWP?XUU'P
MUH5_XP\):-XC?QAH_A?Q3>:7:W'B#P[I7BV31/#,GBG3=$U:2[TRQ\1OX<\/
MOK=K:Q:FVB:4UT;"WZ6BB@ HHHH **_-G_@HS_P56_93_P""8_A+PAJWQZU+
MQ=XG^('Q,OI=-^$_P,^$^AV?BOXN?$F[MKW3M.O)]$T;4=6T#1-,T:PO=7TV
MTN=;\3>(-$L+K4+VTT'0WUKQ/?Z;H5[^8"_\'"OQSF59K7_@AC_P5CN+:51+
M;7"?L]^/F2>WD&^&9&A\ S1,LL1613%-+&0P,<LB8=@I1DU=+3NVE]UVKG],
MM%?S.?\ $0A\>?\ I!9_P5E_\1Y^(7_SO*/^(A#X\_\ 2"S_ (*R_P#B//Q"
M_P#G>4#Y)=E_X%'_ .2/Z8Z*_F<_XB$/CS_T@L_X*R_^(\_$+_YWE'_$0A\>
M?^D%G_!67_Q'GXA?_.\H#DEV7_@4?_DC^F.BOYG/^(A#X\_](+/^"LO_ (CS
M\0O_ )WE'_$0A\>?^D%G_!67_P 1Y^(7_P [R@.279?^!1_^2/Z8Z*_F<_XB
M$/CS_P!(+/\ @K+_ .(\_$+_ .=Y1_Q$(?'G_I!9_P %9?\ Q'GXA?\ SO*
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MY1_Q$(?'G_I!9_P5E_\ $>?B%_\ .\H#DEV7_@4?_DC^F.BOYG/^(A#X\_\
M2"S_ (*R_P#B//Q"_P#G>4?\1"'QY_Z06?\ !67_ ,1Y^(7_ ,[R@.279?\
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M_P#.\H#DEV7_ (%'_P"2/Z8Z*_F<_P"(A#X\_P#2"S_@K+_XCS\0O_G>4?\
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M%'_Y(_ICHK^9S_B(0^//_2"S_@K+_P"(\_$+_P"=Y1_Q$(?'G_I!9_P5E_\
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M$/CS_P!(+/\ @K+_ .(\_$+_ .=Y1_Q$(?'G_I!9_P %9?\ Q'GXA?\ SO*
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M3PAK_BVQ\/M\1-9\1VVA^&M:TCXW_P"(A#X\_P#2"S_@K+_XCS\0O_G>4?\
M$0A\>?\ I!9_P5E_\1Y^(7_SO*2TC;LK7>KT::\NEGH[W;WM8Y)<S=EJ[M<T
M;>GQ7MV[62VO?Z,\1_!#XK0?$2]^*?P]^%/BK2/!^H7WQ,U_]CGX.7?P.^'V
MM>%O"GQ \2^-O#5_XKM/C?H_C;0;_6/V>OAQ^TAXATN]^.6MZUH4'@#XBZ+X
M9NO$6F>(_%WPP^,[Z=\)/'_0?"CX(^,O!'Q*_:&\8^(OV7S\7X'^&_[5GB";
MX;:W\-O"W@JUG^(NO?M-M\<_AK\);3XB:M<7GA?]JP?'JZU+_A+?#GQA\46>
MJQ_L]3^ [<^)!\-/&/Q?^(7A2OE/_B(0^//_ $@L_P""LO\ XCS\0O\ YWE'
M_$0A\>?^D%G_  5E_P#$>?B%_P#.\I)65E>UG'SLU:]_YM_>LWL^EI-QDW=I
M;I_%&UT[_P VVVB:ZZZZ?IQI_P"QAX7T$_L;?""3X5?#SQ!IWPQU.Y^-OQH^
M-=K\-?!NBQZW\1?AMXOM?B[I&D>&8[;;X@^'&M?$_P#:\^(A_:<TO3O!<J>#
M]%TWX8>/_ ][;V6D^,M/T[4/TKK^9S_B(0^//_2"S_@K+_XCS\0O_G>4?\1"
M'QY_Z06?\%9?_$>?B%_\[RG^&K=ELKVT6^B226KT6K;U:Y)>NB6LHZVOJ_>W
M;;;LEY)))+^F.BOYG/\ B(0^//\ T@L_X*R_^(\_$+_YWE>\?LH?\' ?[.?Q
MU_:%\)_LF_M"_ ']I_\ 8#_:%^(\UG:_"WPA^UK\.I? 6B?$C4]9O%T_PUX:
M\/ZY>S6>LZ9XH\47Z7.F^&K;QAX2\,>'?%&NC3?"'A/Q1X@\<:[H_AB\!<DN
MWW-/\$V_P/WKHHHH)"BBB@#^6KX2Z!I/QC_X.NOVKM5^)EA:^,+C]EO]@WP"
MGP'76H4O(OAS>>(+#X&WE[JWAY)@WV+5(_\ A=WQ@MK:YB*K%;_$7Q*?+-Q=
M13P_U*U_,%^RS_RM3_\ !2[_ +,4^$G_ *9/V/*_I]H7]?>RY[Q_P0_)A111
M00%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?S>?\'4OPP\%^*/\ @DS\0_BUJ>CQ#XD_L_\ Q/\ @KXP^$?C>R9[#Q/X
M*UOQA\5O!WPU\12Z+KEH8=3LK?5/#?BN\:ZLX+J.VEUC3/#FMO$VJ^&]%NK+
M^D.OY_/^#H/_ )0J_M4?]C/^S?\ ^M+?":@J'QQ_Q+\S]O?@]XCU3QC\)/A;
MXNUR6.?6O%7PY\$>(]8FAACMXIM4USPSIFIZA+%!$J101R7=U,Z0Q*L<2D(B
MA5 'HU>.?L[?\F_? K_LCGPQ_P#4)T2O8Z"7N_5_F%%%% '\P7[+/_*U/_P4
MN_[,4^$G_ID_8\K^GVOY@OV6?^5J?_@I=_V8I\)/_3)^QY7]/M)?Y_FRY[Q_
MP0_(****9 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'YS?M<_\%5_V,/V(/BMX7^"7[0'C'XC:=\3O
M&/P^F^*>@>%OA]\!_C;\8KNZ\"VVLZOH%WKT\GPH\!>,+>Q@L]2T+4DO8KV6
MWGM+>&.\N(X[6XMYI)](_P""K?[!OB?X0_LR_'CP?\<[?QC\*OVO/VCO!G[)
MOP,\3>'?!7Q N9M<^/7CW4M:TKP[X$\4>&[KPM9^*_AO>R7F@:@-0N/B)H?A
MBUTJU-C?ZA+;V&J:;<W7X8_\%6O$'B+PU_P76_9@U'PI^W1\+/\ @G3K/_#M
MSXAV\7[3OQB\(_"CQQX+T*"?XP^-/-\+S>'_ (S^,? W@>74_$;)'-IUU<ZV
MU_;G2)UMK"[MY;TP_FE\&?%'@K7?V&?^"4.B>#-"BN%^'W_!UC\#O ?B;X\:
M?XAUO7_#'[8GB^RU[Q)KFK?M4^"O[<T70I="\*_$*+Q!9>']/\+65I)9Z!<>
M"KVP:9=0CO[2U#3D5HO75)_>IOM;[*ZM[W6S/ZVOVH/^"NG[$W[)_P 8KC]G
M?QMXN^(WQ%^/FE>&+;QQXK^#W[/'P5^*O[07CGX?^"KJWM[V/Q/\1;'X5^%/
M$EEX&LAIU]I.L'3_ !+J&G>(&T#7?#WB*/1I-!U[2=2O/JK]EK]K/]G7]M;X
M/:)\>OV7?BGX?^+OPKUZ[OM-MO$6B1:KIMWIVLZ883J/A[Q/X9\1:?HWBOP?
MXEL8KFSN[KPYXKT/1M;BT_4-,U-K#^SM4T^ZN?Y\_P#@E[\=_@1^R%_P4*_X
M+??"K]L/XH_#GX$?M$_$3]M'6/C]X;\1_&SQMX;^'L7Q,_9-\0Q>)M=^!)\(
M^)?&.IZ5I_B70_ACX6UK4UOK33;ZYC\*P^)'LYH[>2SU6&Q^'?@=^V='^S'^
MSE_P<)?\%!/V<SJ%O\$/VEOVQ4^&?_!/J?1;62&S^)_[47C&+Q+\.O&/Q?\
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MQ;ZYJ%S<ZK&KJGB32M"@ANM1\:Z%I6M <FJ5VTW)7_P[*^UWMZ[7/UR_9?\
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M6,H_X.-O^"5"D@,?V1?VQR!D9('A[6\D#J<5_,-^S?X7U[]D'_@BS\*OV\?
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M&C2ZSK6N:!I>O^+X_ _B4ZGX/\4Z5XTT:ZU?3IO[*B,=S_@J=^UY\3?VV/\
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M^&7P]\ ZA\3_ !7J/COXEW_@KP7X;\+7GQ#\<:P -6\9>.;K0]-L)_%OBO5
M -1\1:^^H:O>@ 7-Y*!7\0W[#7Q8_;K^''[(O_!P3X:^/O[6O[4WCSXU?!3_
M ()Y?L0_&WPMX@^(/QR^*FJ^+O@5\4/VC/V.OC-^T;XPLOAK=ZGXJN+GX6:U
MX9U[Q9HGAF\D\!2: GVCP%HC0DII.FM!]U?\$H?$UIXG^#M[\26^*/\ P7*U
MWXX3_P#!.#6OB+XS\5_MF^,_VH;W]B77?&^L?#SX?WOB'Q9^S[XK^*$C>$_$
M&OW'BK66\1_!77_"^M7>H7?PZ_M_Q'H5_<Z="][0-Q:ZIJZ77JD_U/ZEOAG\
M+?AE\%O!.B_#/X.?#KP)\)OAQX:_M+_A'/A_\,_"/A_P)X)T#^V=7O\ Q!K'
M]B^%/"VGZ5H.E?VKKVJZIK>I?8;"#[=J^I7^I77FWEY<321^&/A/\+/!/B_X
M@?$'P9\-? 'A'Q[\6+K0K[XI^-_#'@WP[H'B_P")=[X6L;C2_#-Y\0/$NE:;
M::SXRNO#NF7EWIVA7'B*]U*72+&ZN+33WM[>>6-OX]/^"&>I_P##3'@W]FC5
M?BU\>O\ @OYXG^.GQ,^&'QWT_P 7?$SQ7\5?VLM2_8!U"75_"OQ=\#KK>@_%
M#Q5/J_P\;Q#X;\.7%K??#W7K37;BZ\.?'[P]H5QI4\?B/18K-?3OA[^Q)XM\
M4_\ !8W]H/\ 8,U+_@I!_P %<U^"7PP_8L^&WQ[\-WMM_P %&OV@8O'3^//%
M7CS2_#>JC4=?;6WL;K0SIMY(;;3$T:%X+K,QNW4K%&!RN\E?9-O=WLTGU[]S
M^OB6**>*2">..:&:-XIH9462*6*12DD<D;@H\;H2KHP*LI*L""17D>B_L]?
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MX]\0>"!\,?\ A!/^$&U#<-2_L,:I_P )K_PF2_8_M?V+_A$[OR/M<WBW@?\
MX*Z2>,O^",=[_P %<_\ AGI=-DL_A?\ $+XD?\,]?\+:^V+(? GQ4\2_#/\
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MK_L'_!*G_@LYX-_X*>^/?CCX"MO@9XD^ -]X!T+P[\5/@P?&'BU]=U']H/\
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MM'FTU=$'B2ZULV&IVUH@.T]-5N[:QT:33]+*]_*U^A]W>/\ ]@Z;QS_P4M^
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MNL-2\'P?&:SUJYLS\/\ 6=0\5V?PYTVWM5\+>)Y]8:YUN?A_^"PG_!:C0_\
M@E=X?^#&H>&?@&?VI]<^+?A;XC?$>ZTK0_BY9_#G2O!GPK^'DGP_TIO'VK>(
MK?P!\35GTOQ1XJ^)WA/PWX7+:78V.L74^H-8:I=7-BMA<7OVD_\ @JA^TUX!
M_;IM/V#OV4O^">]O^US\2#^R7X5_:YU;4+C]K7P/^S]'I7@C7?B%J'PWU6Q6
MV\?_  RU?1;]] UX^&$$\'BM-3U5?$C/;^'H+71KZ[<!*;M\Y*[72UV[[;+>
MU['Z6_LB_LS>!OV-?V9O@I^R[\-[[6]6\&?!+P%H_@C2=:\23V]QX@\026*R
M7&K>(];>S@M;!-4\1:U=:CK=];:;:6>EV=Q?R6FEV5GI\%M;1?1E>:?!KQ/\
M1_&OPI^'WBWXO_"Y/@G\4?$7A/1M7\??"*/QQHOQ+C^'/BF]M(YM7\()\0/#
MEGI^@^,5T6[:2S'B'2;&TL-2$?VFW@CC<*/2Z"'OK_F%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\_G_!T
M'_RA5_:H_P"QG_9O_P#6EOA-7] =?S^?\'0?_*%7]JC_ +&?]F__ -:6^$U!
M4/CC_B7YG[0?L[?\F_? K_LCGPQ_]0G1*]CKQS]G;_DW[X%?]D<^&/\ ZA.B
M5['0)[OU?YL****!'\P7[+/_ "M3_P#!2[_LQ3X2?^F3]CROZ?:_F"_99_Y6
MI_\ @I=_V8I\)/\ TR?L>5_3[27^?YLN>\?\$/R"BBBF0%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\O_@?
M4/&W[>'_  77^)'QH^'7P)_:&^&WP/\ @G_P3/\ BU^QKXQ^*WQV^#WBKX6^
M&-2^-NJ_'77KV/1_ USKEOY7C.PDTGQ"NKV=[I4Y>XTW1]8U":WM-.F\-7OB
M3\PO"/Q<^.?PW_X(3>)_^"*^M_L'_MQ7_P#P4#@@^)/[.]AX&T7]F_Q_JGPI
MUNU\;_M">)/'"?%C1_CUI]A>?"J[^%^C^$_$4L,WC(^)8]$U#7-*DU2WNX?A
MO=#Q];?W>T4%\_EMRVUZQO;UW=S^4SQ]_P $X=<^-'_!0_X/?LL?'?X<^,=;
M^ VK_P#!NU9_L>_%'XN:!X+UW4?AEI'Q3T+XVZ(VGP:!X_U#0I/!UO\ $;PM
MK?AO2_B?X&TC4;M==M+K0] \2'21;QQ.WPA^SA\(_P!OWQ'X'_X.&;;]J7X!
M_&NX^/FJ_P#!.+X>_LO6?C./X9_%'4],_:J^(?[._P $_C+\"8?B/\(=<U7P
MQ#+\5M3^,6G>&_"WQ!E3P@=8FO\ 5/&Z36EG:0ZC9:?!_=%10'.^RV7?2SO^
M/4_E[_X(2>'OV=_AS=?!'PSHO[/?_!4?X9?M1Q_L;>#_  +\:M:_:>\#?MC:
M#^RO8^*=#\/_  KO?B?I/P\M/C7JDGPC\*W,OCOPNL/P^L_!OA_0Q:>%H-0T
M/PO;:=X?FETUOK;_ (*(?L;_ /!13XW?MT?LL_M._LV:C^Q9XP^$'[)OPW\4
M:K\.OA!^U=XF^/.C6&E?M/\ CV^\2:!XI^-EQX>^#7@'7;7QA?>%OA4OA70?
MA+/K_B$W7@;Q-JGCCQ#H6CZ=K-SIVL3_ +G44"YG=NRUOOKO?N_,_E$_X(I_
MM)_$S_@G;_P3-_X)Y_ 7]KSX(>/M&\0?M+?M3^+_ -FW]DWX/>#_  )KVA_M
M&Z!I_C7XH?%SQIXT^(/[4O@CXS:G\,K+P;X4\(^)T\1:_+K7@1O$DT'P@UWX
M=^)1X?U.[U+6GL/V\_X*9?M=_%?]BG]E#Q;\8O@3^S7\3OVK/C->:MI?@;X9
M_"WX9^"?%OCM8/%?B2VU.6S\9?$+2O EEJ7BZ'X:^%(=,N;_ ,0/H5D;_5K]
MM&\*Q:GX:_X2(^*M#^Q/$/PM^&7B[QI\/?B3XK^'/@3Q/\1/A)+XHG^%/C[Q
M#X0\/ZUXT^&4_CC1/^$:\:S?#WQ3J6GW.N>"Y?%_AS_B0>*)/#=_IK^(-$_X
ME6K&[L/W%=W0#=Y<S5[N[6R>OWI?,_AL\,?LR>+/VJ?^"5'_  5!^"&A?#7]
MN#X@?\%._P!K_P (^ ?VL/VG/C3^T1^R1\6?V<O!?Q=\??!CXN> _B-X:_9P
M^ =Y\0- \-Z9>Z!X&TS3]?\  WPG\(1V^F7>L/K>N:Q8:)X%\%W6B?#OP']J
M^"/C9XX_:O\ ^"AOP%_X*"^%OV2_VP_#7P5_X)K?\$T/CCJ_Q>T7Q?\ L\>/
MOAW\1_'G[1GB_P *7D>J?LE_!7P-\0M.\)7OQ6^*VA:59:BT2>%YKGPE)K\>
MEZ3<^([%_$/A2?7?ZOJ*!\[UTWO\KI)_*R22Z'\=?[!WQP^,_P"U!^WUXR_;
M:_:Y_9F_;#^'_P"VEX[\'^./V?OV"?A/XO\ V+OVC=,_8^_8<^'=WIGB&XTO
M6OB=\<?$_@/PW:Z]XZ^(5_YB?$3XDVFDZ4W]A^(/$&E:;!8:7XLT7X:?"OYM
M@_X)Y?\ !7S]DOX]_P#!+?PO/X$_9!^,/Q$T7]K/]J_]H76?V@_"#?M9_$#1
MO&?QW^-W@VUNOBW\7OVZ?'MI\)_#UOX4C\2Z6-+\+_#75_#VDZ>+W4/#NAZ#
MJ*/IVEWEU)_=-10'.]=%9JUM;)6:26JTU?J]7J?&_P"R=^VW\,_VQ_$G[4VA
M?"OPA\3-+TO]DS]I#QO^RMXU\;>--*\):9X1\;?%CX:BV7Q];?#.70_&GB/7
M]7T+PM/?Z9:WVK^)_#_A#[5<:E;II5KJ AOVLOX]_P#@K%^SS?\ Q/\ VV_^
M"H?BW]JK]GK]M"]^+^K?"GX0^%_^"56H_LC?LN>(_B%\&/CO<>$]"T[Q1I?A
MGXUZYX%^%_C/1/C1JD?Q6TKP9'\1_#'QXN-4;PUX.M-:TGPC:(^B?!RUTS^Y
M7X>_"WX9?"/1;_PY\*?AUX$^&/A[5/$6O^+]3T'X>^$?#_@O1=1\6^*M0EU;
MQ1XHO]+\-Z?IMC=^(O$FJS3:GK^MW$$FIZQJ$LM[J-S<7,C2'NZ!*7*[K\]>
MCW\[:^3MYG\_'C3P5XO_ &E?@_KW[,GQI_8_\8Z3_P %1_V@?^"#OB?P/\0_
MVS1\&_!^G? ;P]XF^*'A76_ OB;]E34OC]X>UDVNA^-;;XYZS?\ Q*U+X.^'
M=+N/ ]EX;GE\2:/KMU8&W23\SOV=M/\ B_\ MK^*O^"!_P"R]8?LQ?M0_!O5
M_P#@F1X UB;]MSQC\8?@EX]^%'A'X5:U\(_@9X?^"?@7PSH'C/Q?I&E>&OB)
MX@^+_B#P[%KFA6'@+5M=NXO"NMVGB&:(V>D>,F\+?V<44 I6OHM6WZ-IQ_)Z
M7\C^$'X&?"7]H7QK^Q?_ ,$M?^"+VI?LP?M(^$_VG/V1/^"G=G\3OVF_&NM?
M!;QMHG[/W@C]GOX6?&WXY_%?6/C1X4^/NI:99_#+QCI/B[0/B-I6G_#"/2=?
M:Z\>^(=(UFPL5MI-8\#OXN_H]_X+B^(OC_=_L'>*?V>OV7OA]X[\=_&O]M/Q
MQX(_9!T2^\&^%-?\1Z3\./"'QIU0Z)\4_B-\2=5T/3-1B\ _#W3OAK%XH\.:
ME\0M:ET[2/"&L^*="UF\O4BM75OV!HH!R;:=EHV[=+MW?RNMC^.NZ_9+_P""
MC?\ P3B_:\_X):?M4^+O#/P1^,7PE^#?AKP'_P $O/'^A?L'?!']I*\\9:5^
MR%XCTC6I-#\<_'G1]<U_XMZKK_A'X4^+].C^*^L^+- M/#L!\<65A::G::E=
M>*]-BM/KG_@L]\4?'G[;W_!,O]LSX=_![]E+]L+2_&OP,_;5^$7P8BT#QA\!
MM?@UOXQQ_"G]H3X=7^N?&3X"Z-X/O/&6M_$3X%ZEID-SK'AWXAQZ=I(OM*LK
MN_NM*T^&W=J_I;HH#F=T]+K\=6]?O9_(9I/[%O[1\?\ P6,C_8WE^$WCX?\
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M^-'A?_@@U_P5/^&GB?X.?%KPW\2O&E__ ,%39?!GPY\0?#3QMHOQ \8Q^-O
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M)[[1100%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA\.?$O2?&/B=O#NO6_P]UIO ^J^(Y_#L>LZ+KNG7.NPZ;;ZI:3:;-=(W%?\
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MZ)KTMK)!K<UGJ$#II$,,$+:Q%B:$Q [:Z#_@L!^QI^T_^T5^T%_P3?\ CO\
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M]^!8_P""D?[?O[2/PH_X*H^!?V./"/[?_P"RY_P3S^ VM?L(Z+^T3?\ Q?\
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MK_#7]K7P+^V3\./BCXO_ &7_ -JGP+\&;']GWQM:_$?X+>')O&GQ,^%OQ/\
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M^UL_#HTKV?P3_P $R/VM_P!H7XZ?\$A?B/\ \% O@C\"/B9X8_9<_9$^._P
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M75O%/B*Y-GH6@6)D(%QJFK70,%C:)F2>4;$!-?D7XQ^+'[2FC>(?C+\9+?\
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M3ME^*,_Q0^@+G]H'XX>&OVI'_8JU?XL-=^+T^-'A#]H4?$'5M(^&T'B[3O\
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MPETCX.7/B+PS\+OA1X ^+/PTG\9?#?7?&OA75/CMHWB#Q[9^-OAG>^!?#>H
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M"O4/VI_BIK.C?LV?\%3-$^#'@[XN>'- _9VB\7^+H?$W[$D'QFU31/B-->_
MK5O >O>-_@AXO\:>-?AIINJ>!?!?@W19O!&JVOAKXE:7XQ^-'@[7_'D7VO\
M\%#/"6O^*8/V24T3XP_$7X2*O[87PDTN:\\ 6OPGN&O+[7$UN#1M2O\ _A:?
MPO\ B59R7V@W]NH\/V5O;VFE7U_JTL6N:;KTB:/'8 6V5_S/O#PSXQ\*^,XM
M9G\*:_I?B"'P[XEUWP=KDNE7<=VFE>*O#-Z^F^(= OFB)$&J:/?QO::A:/B2
MWG4QN 172U^'?A'5/C#\);/XL?'?PU\=/%5MX:7_ (*RZ-\'&^ T/A7X7?\
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M4D^,OA?1/!7[0?Q:UO1[GX$_LY>!(/V;OV^-'\+:+H$MOHG[<^F?#OXLZ_\
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M]M/X;?LS_LJ^#?!5E^S5H/C#XMZIKG_!/+]CGXRWWASXB^)?%W[-7Q-T30O
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MXY?$FZTKPO\ %#6O&]]KFE?L](_@3QO'KEG\4O$&M:OQO\?_ +;FA?&GXO\
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MPH^ _P &?ACH<OBBW\;RZ-\//A?X(\%Z5)XTM+<6=IXODT[PWH>FV;^*+6T
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MKQQXJ\+Z=XDL/'7H^C?M#_MA:5X\^%7[,'Q7\:>'-+_:)_:?'[$7Q>\.^(_
M.F^%]7^'/@/PEI_P[;6O^"B'PW^%YN+"_P!5\2> O#$W[-/C<Z!\3_$Z^)+O
MPIXU_;P^ ^DMXA6T;P?HUD#L^_?:^W]+^NGZ$^,OV0_@K\3_ (S>+/B[\7?
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M8? '_!'W]EK]L*;Q/;>&/@S:Z+\2_B/\8-,_: MOCC\4/BO:^+OAYJ]MXH\
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MXAUO4-%\,7UQKA\06?BBX\7@K=+_ )^7YZ?FS],/ 7P'^!WPJ\1^-/&'PO\
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MQ;;PLWQ5^%OPY^)K>!O$5IXP\$M\0?!'AGQFW@[Q;8 K8^*/"Q\1Z9J1\/\
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M7"AB:MUO_5OZ]"2OY_/^#H/_ )0J_M4?]C/^S?\ ^M+?":OZ Z_G\_X.@_\
ME"K^U1_V,_[-_P#ZTM\)J!P^./\ B7YG[0?L[?\ )OWP*_[(Y\,?_4)T2O8Z
M\<_9V_Y-^^!7_9'/AC_ZA.B5['0)[OU?YL****!'\P7[+/\ RM3_ /!2[_LQ
M3X2?^F3]CROZ?:_F"_99_P"5J?\ X*7?]F*?"3_TR?L>5_3[27^?YLN>\?\
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M2%-+)T]4%H?)K\A?#6J_MH:O\3_@Q\!_B)\;?'/PL\+^+?BS^T9#::QIU_\
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M_;X^(4=P9((6-TL7_!+C_@I1Y:3%E)F$:&38K[@BE]H +4"MK9]KZ>C:^_\
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M[\&/$_P=7X; 6??L^OR/U]\+_"WX9>"/#_@[PGX+^'/@3PAX6^'=U<WWP_\
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M?"'A_P $>&8;_4)!+?WT6@^&=/TS2H[R^E59+RY2U6:YD >9W8 UR/@[PO\
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M-O$OPC^*=]^Q/X7\$?&_Q]\0?V)_&'Q%\*77QT^/"^!/%?Q<\!ZO\-/ FA_
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M\^N06=IXS\:Z/X7B?PS+J<,MUJ5EHR'0WN5MU^P&OQF_:N^(WCCQMX:_:O\
M%/C7]I_5_ L/PF_X*&?LD?LX>%/V:WTKX7+X#_X1/6/B5^R9K6@Z'XFM[OP9
M)\5M?^(GQNLO'UW\8?!_BW3/B!HT7AG3[[P'9V.CW/@GPS\2]*^(?W)^WE\<
M/BA\'[[1X_AYXQN/"T%Q^RO^W9\0[F.#3/#E^9O%WPB^%GA'Q#\/=<$FNZ/J
MKQR^%M7U*^OH;6,KI>H/<F+7;'5+6.&","VW=Z?E_FCZLU#]F+]FO5O!5E\-
MM5_9Z^!VI_#K3?%UWX_T[P#J'PF\!7G@K3_'E_>ZAJ5]XVLO"USH$FAVOBZ]
MU'5M4O[OQ)!81ZS<WNI:A=37KSWEQ))T_P 1?@S\'_B__P (W_PMKX4?#7XH
M_P#"':PGB'PC_P +%\"^%_&W_"*Z_&8C'KGAO_A)=+U/^P]80V\!34],^RWJ
MF&(K.#&FWXN^!NM?&CP'^T3\&?AQX^^/OC/XXZ1\>OV0_B1\;?$L/CCPU\,=
M!M?"/Q+^$7CK]G3P_/J/PR@^'G@CPC?Z+X3\::5^T+>V&L>$?$^J>,[72(?A
M]X(OM"O[/Q#JGQ%UWQS\K?&KX]_&;2?%'_!13Q_X6_:N\2Z1XK_9 _:K_9J^
M'WP;_9FT_1O@[+X1\::3\3_V?OV-?&7AWX.>+=*U?X<7OQ/\3:Q^U3\6/BW\
M0/ACX'\3:1XXLM1TSQ!J6E:;\-)M/\3>%?$MOJ8*S;W\[Z]7;^G\S]FU\#>"
M4.C%/!_A93X<\4ZYXY\/%?#^DJ=!\;>)U\3)XE\8:,1: Z7XI\0IXT\8IKGB
M"Q\C5M67Q9XF6_N[@:]J@NLCXD?";X5_&30;?PK\7_AI\/\ XJ^%[/5[+Q!:
M>&_B1X-\.>.=!M=>TU+B/3M;M]'\3Z;JFG0:OI\=W=)9:E%;K>6J7-PL$T:S
M2!OR<^ GQD_;$^,?QZF\<:5XDU]_ GAG]NC]JG]GGXJ_#S7/%/[/FD_"+2?@
M_P#!KQI\;?AMX#T3PAX'A\,-^TGH_P 8;KPIX.^$W[2#ZKXG\4ZJ?']EXT\8
MZIID&G_ SQ'\*;#P/XAX>^+/[5_A'_@G[^QS^VY\4_VIOC%X]^&>I?L@I^U]
M^VK=> /^&8_!_P :-!7Q/\$/V?\ QKIWC+X->&/$WP6L_A[XG^"'P(MK#XJ:
M_P"./A7=7FF_$;QI+X\L-8T_Q!\4=>TC1_@_XQ!V??\ /?\ KT/Z &T;2'U.
MQUI]*TUM9TO3=1T;3=6:QM6U/3M(UBXTF[U;2K&_,1NK33=4NM!T*YU&QMY8
M[6]N-%TF:YBEDTZS:'C?B+\(/A-\8-*_L+XM_"_X=_%+0]JI_8WQ%\$^&O&^
ME;$U#3M61/[.\3:9J=GM35='TG4U7R<+J&EZ=> "YLK:2+\B?$/[0OQMM?#'
MQ._:.F_:/\0^'_B'X$_X*-6O[*6C_L;#2/A&_P /KWP7%^U3X>^ _@CX3:MI
M=WX#NOC)_P ++_:7_9]U;PQ^UCX-\=O\0=.U?PI??%;P+XOL+&^_9VTG6O O
MC+?^%OQ._:$EUSX-?&;7_P!H[Q[XET_XA?\ !3C]MO\ 9:U_X/:AX<^$5M\+
M(_@K\./CI^VO\*_AEX>T4:1\-],\?V'B;P5;?!?X=^(3XQN_'FJZ]KVI:=KV
MCZY+=^&]8M]*T<"S_J_]?H?KY=>%/"U\VJ/>^&M O&US0(?"FMM=:-IUPVL>
M%K<ZF;?PUJAFMG.H:! =:U@PZ-=F;3HCJVIE+9?M]UYO*>"?@Q\'OAIH7AWP
MM\./A/\ #3X?^&?"&LZCXC\)>'?!/@3POX4T+POXAU?3]5TC5M=\.Z1H6E6&
MGZ)K.J:5KNMZ9J.J:9;VU]>Z?K.JV5S/+;:C=Q3?FC_P4E_:-\>>#+?XK>#_
M ((?$3XE_#;XB_L]_LE^-?VJ?'/BO3_&7P ^'GP@\*>%]8F\9:+\,?$_CB_^
M+WPJ^+WC+X@:[:>)O@[\0(-(\!^ O"X^'J:9)JJ?&_5](U+Q-\%6O>X_9JT_
M6M7_ &^_VC?B#JOQ-\:ZC<>+/V,?V$_%]W\/;UO J^$=-C\<^,/VQI=/@T6V
ML_!=GXUMM!\-7WAKQ(GA/[=XOU-[B\U_QJ->O_$4MGHT?AH%9VO?SM]WZ,^T
M/''CC]FRX^)/ASX-?$GQ?\#I_B_XX\(>*++PC\*?''B#P%+\2?%_@'Q'$UKX
MTM/#G@;7KMO$^O\ A#78/#CV_BB#3-+N]%U2+06AU5)TTLK!U'Q*U;X0^!?#
M'BOXC?&#4_AOX.\&:?X8ET;QSX[^)5YX8\/>&+'P9>71@GTKQ7XH\426>E6W
MABZO-1,,MCK%\FE3W5\8WB:6ZP_X _'V_O(O'O[=/Q%M8_A3_P ,T^&/^"BG
M[&?BO]HWX:>)]6L;;]L[Q7\8OA#H'[,-OX8N?@5KYL#HW@B'Q7<_#W]G";]G
MWX0>-/#OC#XP?&G2=2^(\_P5^-GP,NOBO\![SX7?H/\ M%1>';7]HC]AI_&W
MQ0N/B1\/;C]O3Q_+]F\6W7@"XT'X8?&V;]D+XS0_!7X7M_PB/ACPW%:Z3I&J
M#7=7\"6OQ,G\2>,!\8_$_@#R?$U]XIG^%]AIX.VVO])7_K^D?9'BOQ]^S'X0
M^$VJ?%7QSXU^!'A?X%^.]*\/7^M?$CQ7XC^'VB?";QEH?B/2-*T'PI>ZIXPU
MB\MO!_B+2M>T$:'HOAZYN]1O+/5-(&E:=IKSV8LX:ZW7?AK\'OBCX3O](\3>
M ?AK\1/ OC?4=&\::GI>N^%?"_B[PGXNU:S.CZCX>\67]EJ%AJ&CZ_J-J=&T
M"^T;7KB*[N8#I6CW5C=+]ALGB_$K]G*Z\,K^WO\ #RXMI_#B_LJ2_'W_ (*Q
M+^S#,[Z<O@!_VHY)/V-/^$H/PUDR-+/Q+E\2C_@K,;9M#/\ :4OAYOVB/)+6
M+^(]WT5^S5\7_!OP+_X)E?%7XO'4O%&E?"/P?\5/V^-0^"^I?":U^'EUJ%O\
M$M0_;5_:$TG]F.7X$+XVV?!"V\!2_#?4OAJG[/NI^+9[+X"Z1\,)? 6J^(]1
MTSX66=_J%L!;UZ?C^JZ_H??7P;^!P^&/BGXS_$7Q!XKD\>?$GXY>-M-\2^*O
M$C^']-\-6.D^&O"/AG3/!7PY^'?AC2K.6_OK7PQX3\/Z7/J]P=;U_7[[5OB'
MXP^(GBNUGT/1_$FF>#_#7M%_HFC:K=:)?:II&F:E?>&M3EUOPY>7]A:WEUH&
MLSZ-J_AR?5]$N+B*2;2M3F\/:_KNA2W]B\%U)HVMZOI;RM8ZE>03?FM^QK\:
M/B=9?%W]J3X-?'[XAQW4/PI?]F?4-#MO'_Q-^%?CKQGX(\3_ +0<7C'2+7X9
M^)?&'P[^&/P=T"/5O$>J^'?!VN^%O VI:/XM\26VM_$AK+P_X[UWP=X@^'WA
M#P?\_#Q5^U'XMO? _BVR_;"^)OA:+XG_ /!2G]IO]E4^%](\"_ F[\-^%?@;
MX$\??M-Z-INDZ!'K/POU+59OB/I</P@T?_A'/B%K>JZNVEP_9K+6O#?B6"+6
M#KP*WGV_+_)'ZZ:Q\&O@_P"(OB)X=^+WB#X4_#;7/BSX0TZ32/"?Q0UCP+X7
MU/XB>%])E:]>72_#OC6]TN?Q+HFG2/J6HM)9:;J=M;.U_>LT1-U.9/-OB'X3
M_9 ^#5_XR_:,^+'AK]FWX5:IK]II&C?$+X[_ !#T;X8>!K_6K&TU+1+_ $'2
MO&7Q/\2VVEW&HVEMK'AOPY>Z18ZWKDT,.I:#HES9Q+=:78O!P?[('Q'UZ^\'
M^,O!/Q/^)\GCKQ1X,_:3_: ^#7@KQ/XS?PCI'CGQSX>\!>+=<U7P]I]_9^&-
M)\+:+XA\1>$_!.W2;W4-$\.6>H:GH7A=/$GB1+[7)=>UR^\C\22>!HO^"INA
M-\='\-Q[_P!DKP%%^PHWC9K=;4_&%OB=\>A^VM'\+VU#&E_\+2D^&)_9#%^D
M1_X3B3X?KX@_X0X'PLGQ5P!UW>B>W];?U8^X/"]Y\'_B[H>F?$[P7=?#7XG^
M&_%EMX;U#1OB%X7G\+^-=#\36G@G7M1UCPA>Z9XLTEM3L-9MO"/B>ZU?5/#=
MS:7]S%H&O7&HWNEO::A-<RMJ^)?AK\.?&>A>+_"_C#P!X)\6>&?B"T3>/?#O
MB7PKH6NZ%XW:"QTS2X&\7Z1JEA=:?XE:'3-%T?3HCK-O>F.QTG3+1"+>PM8X
MOS:_:S^+OQ:E_:5^ O[.OP/\4>-O!OA7Q_\ !S]H[XLS:C\"?$/[-?AWQQX\
M\??#CQ[\*?#-WI^C:U^T-X7\9^"I=.^%DGC_ %_QUX]\*Z/X=OM=\8>*-3\)
MCQ5>P> ?#OQ#\*>//F+XI?%[]MZP^"W[6_Q2\8?M*2?#GXJ_LA?\$S/@7^TL
M_@+X,^&?A)K7P9UG]J0?!_XZ?$+XK7FOZKXP\%>,_%7C3X+^)_$7PKT;PYHO
MA+0_%_A@6G@_5/%FIV'BB?Q7?>"/%G@ ';;7?;OOIM^FQ^X_A_X>^ ?"6E>$
M]"\*^!_!_AG1/ 5F^G>!M'\/^&M%T;2O!>GRVC6$MAX3T_3K*VM/#MG)8.UD
M]KH\-G ]HS6S(824/*:-\$OAQX$T_P"))^#G@OP+\%?%7Q1?5-6\4>-?AS\/
M?!.AZWJWC2^M;^.T\=^(XH-#6P\9^)-+O=0GU.*X\76VL)=W#S1WZ7%O=744
MOY(_'*]^*?P>^+?_  5(^*7PN^/GC71OB-IWP7_9,F\&V/BC2/A=XH\'>"[[
MQOXL\=:=X;UU/"P\!:3KVJ:+X6?3/$&BZ+8:MXIGMM8L-7\96^J7NHZ]#I6L
M>'*O[:7Q_P#B[^S[X;^,VG?"CX]?'7Q-XO\ V*/@'X/^+?Q1^(WQ9\9?LH>!
M?AQXC\2?$/Q'\0M6^'/A_P 6^%[;]GV;QC\4_%GQ*/A6;X?7WA/P'X=^#7PU
MN] U3P[X8^$'Q%\*?':#7]?\$ <KZ/?U\OU:/KW]G[X#_ CX.7'Q^^*_C#XE
M?"+Q,/#5OHW@;XH#1_AY\/?@A\ /@?8_!^_UCXRZE+%X&MI]0TKPKXJNM8^(
M$?Q-^*WQ \5>+M8O=8OK#P;J2W'A[2?".BV%CV&F_%C_ ()J>./B7J/Q3T;X
MD_L.>,?C&?#-MH^K?$72?%_P%\1_$X^#-<U/1_A[::9J'BVRU"]\5GPOJVL>
M*]!\$06=S?G2;W4?$>D^'$CDN-7L[.XN_L@QPW'B3]N"&5(IX9/VT_'<,T,B
MK+'(C_!OX&+)%+&P965T8JZ."&5L,"#7QYI'C3Q!\*_A%^WUXV^'NI6WA;Q3
M8_\ !2[P]X?M];L]+T.[GM]+\:>./V2_"'BBP$&JZ=J%CC6O#FMZEI<[R6K7
M,*W:W=G+;:A!:7< '5ZO9;:;I?U^9^A]M^R1^SGI$'PET[PC\(O _P ._#OP
M4^+MY\=? W@[X:>&]%^'O@F+XH7GP\\=?#)O$^M^$?"5AI.@>(;NW\/?$'6K
MZR&K6%R+/Q58>%_%EN4U_P *Z#?6/O5_HFC:K=:)?:II&F:E?>&M3EUOPY>7
M]A:WEUH&LSZ-J_AR?5]$N+B*2;2M3F\/:_KNA2W]B\%U)HVMZOI;RM8ZE>03
M?BO=>+/VI/%%_P"'O%^G?M@_$KPI%X^_X*4?';]E6#PKI'@/X$7GAGPM\#O#
M?C7XZ>'[?3-&BUSX7:IJ]W\2=*7X>Z=>^%OB!K>KZJFD26NE6&M^&/%.EQ>)
MK/Q9Q^I?M!_M17/Q.^%?[*.F?$GXK^);6[^*O[?FA+\5?"6K?LY> ?C;\0KO
M]G/Q/\"[GX._!V_\4?%#P-_PJ>_O8/AQ\;_B;XVU.R\&>"-*^+7CC0?V9-+\
M0ZGJ.H^&--^/5WXM LWU_,_<G3O!_A+2+?PS::3X7\.Z7:^"M+&A^#;;3M$T
MRRM_"6BK8VVEKH_AF&VM8H]!TM=-LK/3AI^E+:6@L;2VM!#]G@BC3@/#G[/'
MP \':AXBU;PC\#?@]X6U7Q?XMT?Q]XMU/PY\,_!6AZAXH\=>'K^\U70/&GB*
M]TS1+6YUOQ;H>IZCJ&HZ/XCU.2YUC3+^_O+RRO(+BZGD?XE^*GQE_:0^$W_!
M.?P#X_\ B/XW\,^#OCEJ.K_LP?#;XK?'#18O!'B30?A_X0^+O[1'PK^#7Q/_
M &F+<C2;SX26&J>"O@_XS\0?&XZCJWAS7?@9X)\3Z9_:?BW0-=^$.@:U9W7@
M/Q4^*_[07PX^)_QG_9F^'O[5?CG7[#P_X\_X)@V]M\8/$OA;X,^+?BK\(]6_
M:V_:5\=_"_XV?"%-1@^&FF?#75+ZX^#G@OP=\3?AWI_C_P  ^,?&WP]USXK/
MXK\63^)_A9XD^$?@33 5O/\ /H_^"?L'\2/#7PX\7^ _%?A[XO:!X)\4?#&_
MT6\?QQH?Q(TK0M;\!WGAVQ3^T;]O%>F>)X+GP]<:+9QVGVZ\;5X'L;=+;[3,
M46'>OA?@+X^_L0_$[5M,^&OPP^-7[*OQ"USQ%JMIXMT;P!X"^(_PC\6:MKNM
M^"I++Q)8^)],\*^'M9O[S4]5\)2^$=.UZTUJUL)[O09/#%EJD-S:-HL$]MS'
M[(^N>/I?$W[8WPI\>_$GQ%\6M-^!/[3NF?#CX?\ B;QQ8>$X?&D?@3Q5^RE^
MR_\ '1O#OBJ_\'>'?"NC>))M"\8?&/QCI^B:W/X?L]9E\'KX=TSQ#=:_K6F7
MWB;6_BCQQXT\1?!_X2?\'!GQ=^&-]#X6^)GPE\7?$'QY\//%.GZ)HNK:EX5\
M7^"?^".?[%/B+PIJECINK:7J^F7\FD:O86-];:1J6EZEI=X8Q:WFF7EI<36T
MP%NGI;MK9?J?J]H7P9^#_A?Q7XB\=^&?A1\-?#OCCQ?KUMXJ\6>,M"\"^%](
M\5^*/$]EI&M>'[/Q'XB\1:?I=OJ^MZ]::#XD\1:);:QJ5Y<ZA!I&OZUIL5PE
MGJM]#/M^#OA[X!^'5MK=E\/O _A#P+9^)O$^M>-O$=IX.\-:+X8MO$'C/Q).
MESXB\7:W!HEE8Q:KXGU^YCCN-:U^_2XU759XTEOKN>158?DG^V[^VKX\^%OC
MCXY:'\(_BMI<>E>%O@A^P9J6HR:$WPTO[CX4:9^U7^VY=? KQW\=+/Q#XUTK
M5O!6AZQX<^"-[JWCSPGKGQ:'B#X*^&)O!NE>.OB)X1U?X?P>);;6LCQ/J'[?
M'A#X<^/M7\1>.OB*GP[^%'Q6U?QWK?ARP^+7[(>F_M>:G^S_ *=\ ]+U37_"
M]CXYUCX?/^S]>ZA\-?BQ=1?$"QTOQWJ?P=UGQI\//$GAZ+QE\;](TKPC?^$O
MCD#L^ZU\S]3=9\.? 3X,6WC7XP:KX3^&'PZ276I/B%X_^(<?A3P[H5]>^)9M
M'3PC-XT\3:_8Z;#J&I>(9?#\Z>&I-?OY[C5)-%D&D-=&P8V]:GC;X'_!7XE^
M%&\!_$?X0?"[X@>!F\1WGC%O!GC;X?\ A/Q7X4;Q=J.J:IK>H>*6\.Z[I-_H
MY\1WVM:YK6KWFN&S.IW.J:QJE_/=/=ZA=RS?@]^TE\>=:^.7[/O[='Q-;]KK
MQ#X6^'_P[\?_ ++_ ,,/A/\ "?5?"GPPT;PIX^^$OQQ^#/[*?Q,\,:O\0-%\
M1?#32_BM<?$[]HOQ)\:_$EMX6U[0_%'@K3? >J>'O"'@_1/!>EZGX-^.&C?$
M3WO6?VG?B;XZ_:L^#MQ\-OBM\5_"7P/^+'[9/[1?[%M_8>,O%G[.UO!X@U_X
M$_!7]I?0/B,?@A\*=-^#OB#XBV-A\./CO\#+KQ%IOQ&^*7Q$L_%.L7VF:C'=
M>#?$WP5\4>!(Y0+/O^?:Y^UMC8V6EV5GIFF6=KIVFZ=:V]CI^GV-O#:65C96
MD*6]I9V=I;I'!:VMK!''!;V\$:0PPHD<:*BJH\;TGX0_LX?!GPI<Z?H7PO\
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MTW3[FYMY9K.V>/@M!^&O[-/P!T7P_P"&_#'@'X&?!3P[K?Q&M+SPKH&@^%?
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M(_BC^VAIGQ,_: \1>)/&/PXU30O&O@_X2^'O 'PEL]=\.SV#?#"YTZ[\._\
M">Z-J(O[&2\!V>]_S?9_FS]<M,^ WP-T7X7WOP0T;X,_"C2?@MJ5AJFEZC\(
M=,^'?A"P^%]_IFMS37.M:=>^ +71XO"EU8:O<7$\^J6D^DR6]_---+=QRO([
M,7'P&^!MYXQ\%_$6[^#/PHNOB#\-M"@\+_#OQU<?#OPA/XQ\ ^&K6.YBMO#O
M@OQ/+H[:WX6T*VBO;R.#2=#OK&PACN[E([=5GE#_ (<C]K']HOXA_ #]JO\
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MT?X_^(?B'\$/AI\<?^"<=GJWQ3\<WG@77]8\!^)_VJ/B'\8OA[\3?V6O&/Q
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MQ#J6C:-97NM>);5/$7B!+;7=2FN=4@37=86*Z0:G>B?\._'_ ,1O'FD>)O\
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M>S\-^%I?%^D>*/#$&E>'/!$>N^%?$L=KJ\?B(%;?7L_6_P#P]_O/V]U;X!_
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M=7O]<U+X!^'[;XO_  ]^-7@73+32&@NM5\6?#Z7QQ\#O&5G=7%L=>NO'E_\
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MC^&/VQOB-\#/CO\ $CQ9XY\:_$C2/VE/C;\$+WPSXP^'?B#X%WO[/GPZ^/\
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MA=XKO-/\5^#M<\)1^-O 5[XT\$>/=#@A\6>"O&7B_1M=TGQAJ@*WG^>E[/\
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M2OVF/''C"W\5?LLZ/\4/$WQ2^)GAOX5Z@?V<[_2?VAOA7\)OC3^TUX.TO3_
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MZ!^U[^T5\%+WX=W_ ,-M.?XI?#?X4>//A)\*OV?]-^&WQ'\0>$-?FA^'NK_
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MKKVIZGX8U/X>Z!\1M;;6[_Q%IWA_4-5M/B'J6B:Q>>,+;2)M!U";5YNV\8_
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M#6*XE:>>+P!/%HRR^#HYYG>:9/#K:<LDKM(X9V)/:^,/!G@_XA>&M6\&>/\
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M:+J>A:I9ZYHFH+;7D4T(OM'UG3K#6-*NPGVC3]4L;/4+22&[M89D_&O0[_\
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M/1[/1;2WBTVVTN.T_P!%33X;9+1+?]RL(C^6N=\:_"GX7?$KPY8>#OB-\-O
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M$^M>&?!%[:O8WG@[P_JDNEM?:-X5N[*22SNO#VG3VVD7%J[V\MF\3,A](HH
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M)K/P[XJO=.GUW1+6:2YN9);?3;^VAD>XG=T+2R%N]HH \2_X9H_9P_X1/7_
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M6 +::SJDVNZY+J.J0".^O9=9U62YGE;4;LS;=% 'G&C_  <^$7AV+Q+!X?\
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M_P#P4N_[,4^$G_ID_8\K^GVDO\_S9<]X_P""'Y!7SO\ &']KW]DW]GG7-/\
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MYX8AUSQ(GV"WDG_<K_@CS^T-^RE8^*/^"G?[+'Q+^.7[/5G\8OBE_P %G?\
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MUW4?!7PWL3HOBR]%WX]\8:?X6\37WA;P?;^9XA\06?AW7;K2=.NX-(U![?\
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M?S_@Z#_Y0J_M4?\ 8S_LW_\ K2WPFH"'QQ_Q+\S]H/V=O^3?O@5_V1SX8_\
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M$FC^!-,O=#CU:W.C7^DV85RVWNK7?32UDUZW>G3:_E^WWP>_:8_8-^,7B]O
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M]CC2_P!G[X%?%#Q+<?M^>)?#>I^)/@[/KGPF_P"$FN/V&?#%OXL\1>-/AO\
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MT^UN[6SC!-*R>MW?>VRT_4]7E_: _9&T'0/"'Q>G^-G[.6C>%OVBM4\-^%O
M7Q0E^)'PRT[0/CKK4]O>VGA#PYX0\;/K,.G?$[5)K5=1MO#>D:-J>MW<EN+V
M'3+<QB=:QO'7BK]B;PWJMI\-_B7XC_99T#7/ \'@RPL/ 7CK6/A+I6J^#[;X
MN^(Y/#?P]LK3PMK]Q!>>'X/B?XNTZ70/!EO#8VD?C7Q'82:5HB:GJ=JT$?\
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MOOA%J_BC6]+T?4X?^$>UC3UTNZ\&7$Z?V-JEF+1_L-] )?P,T7QU^Q#\-?\
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ML_7TVC6O@9)#_P +:N];^+'Q0'Q&\3*=3@:QU[3X_"=G:R2ZW+'HR)J\=O8
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M6KM;?=;O7:_J?UU_#_XQ?LU:U\-O%_Q9^%?Q3^!NK?!_0=0\9Z_X]^)GP_\
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M3O#'PABUCP1<W-SXX^'UY9W/Q5\+6T?BV?P'<>+HOB/HVG:XOCW^Q)_%L?\
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MP\%?M#W7P?@7P_IFG3?$J3P;8_![P1X^5;GP?X^E@N=*TGP_JNJV%Q>_D/\
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M7\.^&]"EDN9I=$T#1-,T?2)9;Q0MW+)ING6MM9O)=* MR[0EIU $I8 5T5%
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M0Z$_A[2'T;7M2U.X6[U+4-9TQK,V6J7VH7:)=7UW?03W%W<(LT\DDBAAU5%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP[2\'QIM/V4_^"HGQ5_9WO=)$7]O:7^T9\"M%_9*^-/P.NM"ED5S;7U[\1?
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M6\,:3X?_ &.?AK?1^,_#2_";XQ_#_P"#-SJ?AB^TS]E3QM\,-,L?'.IKX_\
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MAL'[_P 0?%7X7^$O'/P]^&'BKXD> O#/Q+^+@\6M\*/AYX@\8>'M&\<_$Y?
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MLB?"S7O VLS:7HDXD\6_LX?#\:C=VY\0AS_1_P#\%</V0KW4?V__ -G#P_\
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MK;48?"?]K?V_)87$%XFGM;S1R-_%Q^QIJ'PG\$_"_P#X-_\ XJ?MRVO@B/\
M8>TK]B7]IOPC\%/'GQNT2/Q!^RQ\*O\ @H/K?QCU>?PEXF_:!-_+;^#M#CO/
MACIUY;?#G5?'=]I<=GXCTK5]=\)ZKHVH>%-=\0:%ZK\:/C%H_P"WU^S;8? 3
MXK6O[#GCSX91?\'"O[ O[,WBCQY^P#X0U3X>?!?]H;P3\5/!_@;3/''C#^T#
M\5OBM/X@\3:AX7\477@!O%VF>+&GATKPCIME ^-$MVA"N57U;MNVK;7:T[O3
M\NA_;$?BC\,Q\3%^"I^(O@4?&-O K?%%?A*?%WA\?$QOAFGB!/";_$5? ?\
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MS6;EMMOI/AKP]H7CF_U;7=3G8%8;#2[2ZNY6!$<3'BNK^#O[<G[%/[0_BYO
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M]7NX4T8%RJSUU4K*UK/S[_UU/ZWM*_X*6_\ !./7=+\5ZWHG[?\ ^Q-K.B^
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MJ[TGQG?ZMX/M=:M='T.YT[Q%<7%M836UXW"^)_VJ?V,HOC)H'[.?C/\ :/\
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MKKFK65]X+\6Z<?$%QIFASZ9H,.J:??\ AW5-*TD&XI).[U2:VOJY6?I9??\
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M>K:NV7^T"?@SKW[/_P#P7B^*G[$.D0Z+_P $W_&_Q_\ ^"25O\*-3\'Z'?\
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MWX^(-Q=^!=/L5UNXN!XRGN?#%M%_;<LMBWX!>)_B%^P]\=_^"K/_  2(O?\
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M.-/?_#>VM[+QUX<UCXI?!/3-5U#5YV30?##R_$/0S9^,+W2+U+#7)+<>']0
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M(>&;%M<UC^SM*MC=)_+_ /\ !/WX'?!_]O[_ ()/>-?V,7_:>_X)Q_&'Q?\
M%G_@FO\  ?PIH?PT_9V^'OA?PS^T;^SWXOT;X7^&+GPG?_M7:[I'Q]^*WB'Q
M[XJ^&WQ<L?A[)XDU:\\"_"Q6^(WA35[VY\-:-=ZO;^&]&X7]BOX[>,/^"H<W
MQ<_;#^*=GKZM_P $\/\ @D-K_P"R1KMEXOTV2V2/]O\ ^-7@CQ)K'[:7C71?
MM$:3:7K6A>$OA1\.?!VL6<TDCPZ;XZ>.2YOVD#:>!RK75Z.VMK]E][NC^D7P
M%^WE_P $Z/&T_P 0M5^&'[9O[%/BVY\'^!+GXC_%;4O 7[1/P+UZ?PM\,O!K
MZ?HUYX\^(5YX>\87<FB>!/"CZYI6E7/BCQ)):^']"?6-/L9;ZU.H6T4V-H\_
M_!.3]M_X1?&7X=_#CQO^R[\?/A+XD\$ZM\.OC='\ ?BGX%U:V@\"^,+&ZM]8
M\->*_&'P3\4V^M^%]*\0Z;IU_#=0G7=(-_965[&7>""X"_RB_LY^//AWK/\
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MT^U_,%^RS_RM3_\ !2[_ +,4^$G_ *9/V/*_I]I+_/\ -ESWC_@A^04444R
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M%TF>[\/^;_8%U-IMG+<:'Y\"VL_]D3O"TNF^=:HEM+]B:#S($6%]T:A1K44
M9BZ)HR:O)X@32-,37IK%=+FUM;"U75Y=,29;A-.DU(1"]>Q6X59UM&F-NLRK
M*(PX#4_3=)TK1K=[31],T_2K62YN;R2VTVRMK&W>\O9GN;RZ>&UCBC:YN[B1
MY[F=E,L\SO+*[NQ8Z%% &'XB\,>&O%^F2:+XL\/:'XHT::2.:72?$6DV&M:9
M++"2T,LEAJ5O<VKR1,28W:(M&22I!-/TGPYX>T!KE]"T'1=%>]CL(KQ])TNQ
MTYKN+2[1-/TR.Y:S@A,\>G6$<=E8)*76TM(TMK<1PJJ#9HH YRW\'^$K._35
M;3PMX<M=4CU35-<CU*WT33(+]-:URUCLM:UA+R*U6X75-8LHHK35-0607>H6
ML4=O=S31(J"C>?#OX?ZC'/#J'@7P=?0W6L7?B*YBO/#&B7,=QX@U"..*_P!=
MG2>Q=9M8O8H8HKO4Y U[<QQ1I-.ZHH'8T4 1000VT,-M;0Q6]O;Q1P6]O!&D
M4,$,2".*&&*,+'%%$BJD<:*J(BA5   K%D\*>%IIKBXF\-:!+/=ZM8Z_=32:
M-ITDUSKNEK$NF:U<2-;%YM6TY8(5L=2D9KRT6&(6\T8C3&_10!F#1-&&L-XA
M&D:8-?;3O[(;7!86HUAM)^T+=_V6VIB+[:=.^UHEU]B,_P!F^T*LWE>8H8/N
M])TJ_NM.OK[3-/O;W1YY;G2;R[L[:YNM+N9X'M9[C3KB:-Y;*>:VDDMY9;9X
MI)()'A=C&S*="B@#-AT71[>^U34[?2=,@U+6X[.+6M0AL+6*^U>+3X9;>PCU
M2[2);C4([&WFF@LTNY)EMH998H0B2,IYZ\^'/P]U&RTK3=0\!^#+_3M"AN+?
M1+"\\+Z)=66CP7;Q274&E6L]B\&GPW,D$#W$=I'"DSPQ-(K-&A'9T4 9*:#H
M<>BGPTFBZ2GAQM.DTAM 33K-=%.DS0-:RZ8=*$(L3ITML[V\ED8/LSP.T31&
M-BIYZU^&?PWL;74K&R^'_@BSLM9@BM=7L[7PIH-O:ZK:P3"X@MM2MXK!(;Z"
M&X GBANDECCF E15<;J[>B@#,N-$T6[U/3];N](TNZUG24NHM*U>XL+2;4],
MCO8C#>1Z??R1-=627<+&*Z2VEB6>(F.4.I(K-N_!G@_4/$-AXNO_  IX:O?%
MFE6YM-,\3W>A:7<^(=-M6,C-;6&M36KZE9VY::4F&WN8XR99"5R[9Z6B@#CM
M$^'?P_\ #-ZFI>&_ W@[P_J,<$EM'?Z)X9T72KV.VE"B6W2ZL+&WG6"0(@DB
M601N$4,IVC&AI?A+PIH>JZSKNB^&/#VD:YXCECG\0ZSI>BZ;I^JZ]/$7,4VL
MZC:6T-WJDL1DD,<E]-.Z%WVD;CGH:* .;L/!WA#2M>U3Q5I?A7PWIOB?6XE@
MUKQ'8:'IEGKVKPJZ2+#JFL6]K'J&H1*\4;K'=W$J!XT8 %%(I:?\.OA]I&JQ
MZ[I7@7P=IFN12W4\6LZ?X8T2RU6*:]BG@O9H]1MK&*[26[AN;F&ZD68/<17$
M\<I=)9 W8T4 <[X?\(>$_"<=Q%X5\+^'?#,5V8C=1^']%TW1H[DVX=8#<)IU
MM;+,85DD6(R!O+$CA-H9LV-=\-^'?%%G'I_B;0=%\16$5PEY%8Z[I=CJ]G'=
MQQRPQW4=MJ$%Q"EQ'%//$DZH)5CFE16"R.&VJ* .8T[P3X,T=-/CTCPCX8TN
M/2;VZU+2DT[0-*L4TS4;ZV:SO;_3UMK2);*]O+1FM;JZMA%/<6S-!-(\1*G5
MM=&T>QU#5-7LM)TVSU76_L7]LZG:V-K;ZAJ_]G0M;:?_ &I>Q1)<W_V"W=X+
M+[7++]EA=HH/+1BITJ* ,*V\+^&K+2[_ $.S\.Z%::+JOVXZIH]MI&GP:7J1
MU.,PZD;_ $^*W2TO/[0B)BOOM$,GVN,E)_,4D5BVGPR^&]A;ZA:6/P^\$65K
MJ]LEGJMM:>%-!M[?4[2*9;B*UU"&&P2.]MH[A$G2"Y66))D655#J&';T4 <U
MH?@SP?X9COH?#?A3PUX>BU-8EU*+0]"TO28]06%9DA6^2PM;=;M8DN+A(A<"
M01K/,J "5PRZ+X,\'^&M&N/#GAWPIX;T#P]=-=O=:#HNA:7I6C7+Z@GEW[7&
MEV-K!8S->I\EVTD#&Y3Y9BXXKI** ,LZ'HIT;_A'#I&EGP]_9O\ 8W]@G3[0
MZ-_8_P!F^Q?V5_9?D_8?[-^Q_P"B?8?(^R_9OW'E>5\E<W;_  Q^&UK9ZEIU
MK\/? ]MI^LQVL6KV%OX3T&&SU6*PN1>6,>I6L>GK!?1V=V!=6J722K;W($\(
M24!J[BB@#/U+2=*UB&&WU?3-/U6WM[NUU"W@U*RMKZ&"_L9EN+*]ABNHY4BN
M[.=5FM;E%6:WF59(71P&%37O#7ASQ3:16'B?0-$\1V,%RE[!9:]I5CJ]I#>1
MQ301W<5MJ$%Q#'<I!<W$*3H@E6*XFC5PDLBMMT4 <)+\+?AE/:6=A-\.? DU
MCIS7;Z?9R^$/#\EI8OJ#Q2W[V=N^GF&V:]D@@DNV@1#<O#$\Q=HT(Z#2?#7A
MS0))Y="\/Z)HLMU::587,NDZ58:=)<6.A6AL-$LIWLX(6EM-'L2;/2K:0M#I
M]H3;VB0PDI6W10!QVK_#OX?Z_;:A9:[X%\':W9ZOJ4&LZK::OX8T34K;4]8M
M8S#;:KJ$%Y8S17NI6\+-%!?7*2W44;%(Y54D5:UOP3X,\2QZ?#XC\(^&-?BT
MF.6'2HM;T#2M5CTR*=;=)XM/2^M)ULXYEM+594MA&LBVUNK@B&,+T]% &1#X
M?T&VT0^&K?1-(@\.-93Z:V@0Z;91:(VG7221W-@=*2%;$V5Q'-+'/:F#R)DE
MD22-E=@2R\/Z#IMS'>:=HFD6%Y%I5GH<5U9:;96MS'HFG,[:?H\<\$,<J:58
MM)(UGIZN+2U:1S!"A9B=>B@#C)?AQ\/)]-LM&G\!^#)M(TVXGO-.TJ7POH<F
MFV%W='-S=65B]BUK:W%P>9YX(HY9C_K&:M^^T/1-3TP:)J6CZ5J&C 6:C2+[
M3[2[TP+I\T%Q8*+">&2U L;BVMI[,"+%M-;P2P['BC9=2B@#G/$G@[PCXRM[
M2T\7^%?#?BNUL+I+ZQMO$FAZ9KEO97L8Q'>6D.J6MU';W2#A+B%4F4<*XK1T
MS1='T5;U=&TG3-)74M1NM7U%=,L+6P6_U:^*&]U2]%K%$+K4;PQH;J]G$ES<
M%$,LKE1C2HH YRR\'>$=-?2I-.\+>'-/DT*34YM$>RT/3+5]&FUL$:S+I306
ML;:?)JX)&IR6AA:_!(NC+DU2O/AYX U#6#XAO_ W@^^U]KJUOFUR\\,Z+<ZP
M;VQ$"V5X=3FLGO3=6:VML+6X,_FVXMX!$Z"*/;V%% $5Q;P7<$]K=00W-M<P
MR6]S;7$:307$$R-'-!/#(K1RPRQLT<D<BLCHS*RE2145C8V6F65IINFV=KIV
MG6%O#9V-A8V\-I965I;QK%;VMI:VZ1P6]O!$BQPP0QI%%&JHBJH %JB@#GO#
M_A'PIX22_B\*^&/#WAF/5;Z34]4C\/Z+INC)J6I3 ";4+]--MK9;R^E  DN[
M@23N  TAIJ^#O"*>)9/&:>%O#B>,)K,:?+XK70],7Q++8*BQK8R:Z+4:H]FL
M:(@MFNC"$55";5 '1T4 84WA;PS<0:U;3^'="FMO$DHG\16\VD:?)!KTXBB@
M$VM1/;M'JDH@@@A$E\L[B*&*/.R-%&Q#!#;PQ6UO#%!;P1)!!;PQI%###$@C
MBABB0+''%&BJB1HH1$ 50  *EHH S=(T;2/#^GV^D:#I6FZ)I5IYOV73-(L;
M73=/MO/GDN9_L]E9Q0VT/G7,TUQ+Y<2^9/+)*^Z21F-+2/"GA;P]?:WJ>@>&
MM T/4O$UZNH^)-0TC1M.TV^\0:@IF*W^MW=E;07&JWJFXG*W5_)<3@SS$29E
M?=OT4 9\.DZ5;ZC>:Q;Z9I\&KZC!:VVH:I#96T6HW]M8^;]BM[R^2-;FZ@L_
M/G^RQ3RO';^=+Y*IYCYY[1_AU\/O#VH1ZMH'@7P;H>J0I-'%J6C^&-$TS4(D
MN%*3I'>65C!<(DZ$I,JR 2J2KA@2*[&B@#(U[P]H'BK2KO0?$^AZ/XCT._$2
MWVC:]IEEK&E7JPS1W$*W>G:A!<6=P(KB**>(30N(YHHY5PZ*P)?#V@3Z?I^D
MSZ'H\VE:3)ITNE:9+IEE)I^F2Z.T;:3)I]D\#6UE)I;0PMISVT<;6311FV,1
M1<:]% &;_8VC_P!L?\)#_9.F_P!O_P!F_P!C_P!N?8;7^V/[(^T_;?[*_M/R
MOMO]F_;/]+^P^?\ 9?M/[_RO-^>G7FDZ5J-QIUWJ&F:??76D7+7NDW-Y96US
M<:7>/#);/=Z=-/&\EE<O;RRV[3VS12M#+)$7*.RG0HH SH-(TFVO]1U6VTO3
MK?5-7CLXM6U*"RMHK_5(M/CEBL(M1O(XEN+V.QBGGCLTN9)5MHYI4A"+(X/.
MW?PX^'FH6.E:7?\ @/P9>Z;H4=U#HFG7?A?0[FQT:*^DBFO8M*M)K%[?3H[R
M6""6Z2TCA6XDAB>8.T:%>SHH R8] T*'13X:AT32(O#C6$VE-H$>FV<>BG3+
MB)X)]..E+"+$V$T$DD,UF8/L\D4CQO&R,P-2[\(^$]06P2_\,>'KU-*TZ]T?
M2TN]%TVY73=(U.R&FZCI=@LULXL].U#3E73[VQMQ';7=DHM9XI( (ZZ&B@#E
MM!\#>"O"MQ/=^&/!_A;PY=74(MKFYT'P_I.CW%Q;JXE6">;3[2WDEA60"012
M,R!P'"[@#6C9^'?#^G6^J6FGZ'H]C::W>7NH:U:V>F65M;ZO?ZE&D6HWVJ0P
M0)'?WE_%&D=[<W:RS74:(D[R*H V** .'L?AE\-M,6^33?A[X'T]-3TZ?1]2
M6Q\)Z#:+J&DW3PO=:7?+;V$8N].N7MX'GLK@26TSP0M)$QC0KN7'ACPU>36E
MQ=^'M#NI[#3KK2+&>XTFPGFLM)O8!;7NEVDDMNSV^G7=L!;W5E"R6UQ !%+$
M\8VUN44 <E8> / >E>'I_".F>"?".G>$[J62:Z\,6'AO1K/P]<S2RQSRRSZ+
M;V4>FS2R30Q32226S,\L4<C$NBD6] \(>$_"@NU\+>%_#OAI;\PM?#0-$TW1
MA>-;"46[78TZVMA<& 33"$S;S$)90FT2/GHJ* .=M?!_A*Q\17_B^R\+^';/
MQ9JMHNGZGXHM=$TRW\1:C8(T#I97^MQ6J:E>6B/;6SK;7%S)"K6\#! 8HRM.
M]^'_ (#U&TCL-0\$^$;^QAU"\U:&RO?#>C75I%JNH.TE_J<=M/920IJ%]([O
M>7JH+FY=V::1V8D]=10!D:AH&@ZMI#:!JNB:1J>@O%;0OHFH:;9WND-#920S
M6<+:;<PR6;16DUO;RVT9A*0200R1!&B0KBV7P[^'^FP+:Z=X&\'6%LNJ6&MK
M;V7AG1;6!=:TIB^EZNL,%C'&-4TUB6L+\*+NS8EK>6,G-=C10 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M\_G_  =!_P#*%7]JC_L9_P!F_P#]:6^$U?T!U_/Y_P '0?\ RA5_:H_[&?\
M9O\ _6EOA-05#XX_XE^9^T'[.W_)OWP*_P"R.?#'_P!0G1*]CKQS]G;_ )-^
M^!7_ &1SX8_^H3HE>QT">[]7^;"BBB@1_,%^RS_RM3_\%+O^S%/A)_Z9/V/*
M_I]K^8+]EG_E:G_X*7?]F*?"3_TR?L>5_3[27^?YLN>\?\$/R"BBBF0%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?S^?
M\'0?_*%7]JC_ +&?]F__ -:6^$U?T!U_/Y_P=!_\H5?VJ/\ L9_V;_\ UI;X
M34%0^./^)?F?M!^SM_R;]\"O^R.?#'_U"=$KV.O'/V=O^3?O@5_V1SX8_P#J
M$Z)7L= GN_5_FPHHHH$?S!?LL_\ *U/_ ,%+O^S%/A)_Z9/V/*_I]K^8+]EG
M_E:G_P""EW_9BGPD_P#3)^QY7]/M)?Y_FRY[Q_P0_(****9 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_/Y_P '0?\
MRA5_:H_[&?\ 9O\ _6EOA-7] =?S^?\ !T'_ ,H5?VJ/^QG_ &;_ /UI;X34
M%0^./^)?F?M!^SM_R;]\"O\ LCGPQ_\ 4)T2O8Z\<_9V_P"3?O@5_P!D<^&/
M_J$Z)7L= GN_5_FPHHHH$?S!?LL_\K4__!2[_LQ3X2?^F3]CROZ?:_F"_99_
MY6I_^"EW_9BGPD_],G['E?T^TE_G^;+GO'_!#\@HHHID!1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?S^?\ !T'_ ,H5?VJ/^QG_
M &;_ /UI;X35_0'7\_G_  =!_P#*%7]JC_L9_P!F_P#]:6^$U!4/CC_B7YG[
M0?L[?\F_? K_ +(Y\,?_ %"=$KV.O'/V=O\ DW[X%?\ 9'/AC_ZA.B5['0)[
MOU?YL****!'\P7[+/_*U/_P4N_[,4^$G_ID_8\K^GVOY@OV6?^5J?_@I=_V8
MI\)/_3)^QY7]/M)?Y_FRY[Q_P0_(****9 4444 %%%% !1110 4444 %%%%
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M&O%NB7TMAHGC"/PQI^LVHTWQ5'K&F K'VK1110 4444 %%%% !1110 4444
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MVD^#/VF_C!^RYXCT_0=0\0?#?X[:OX-^&OQ.C\!:#X(\.:7(FH+:ZMZ1X/\
M^">OQC\ _L8M^T)^SC\&OVA[7X]_LP_\%&_AS^V]^SY^S=\2O@K^S=^RGKGB
M?P_I6@_#OX9_M-?"WX/_  Z^"7C/QGX2^$?PB_:"^$NH^.4N_!MR?"%]K?Q.
M\)7&OCP-8VGB'2=?U?\ KHHH#F;W2WOVOWV[_AT/XS/C-_P2_P#VJ;;]GK_@
MGI\3?'_P1U;XN:EX@^+G[9O[8G_!2?X.^"/@]\"OVC/$5O\ M5_MO67AG7_
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M_:Q_Z3\_\%5?_#Y?&'_Y^M'_ !#]_M8_])^?^"JO_A\OC#_\_6@.6/\ .O\
MP&1_3C17\QW_ !#]_M8_])^?^"JO_A\OC#_\_6C_ (A^_P!K'_I/S_P55_\
M#Y?&'_Y^M <L?YU_X#(_IQHK^8[_ (A^_P!K'_I/S_P55_\ #Y?&'_Y^M'_$
M/W^UC_TGY_X*J_\ A\OC#_\ /UH#EC_.O_ 9'].-%?S'?\0_?[6/_2?G_@JK
M_P"'R^,/_P _6C_B'[_:Q_Z3\_\ !57_ ,/E\8?_ )^M <L?YU_X#(_IQHK^
M8[_B'[_:Q_Z3\_\ !57_ ,/E\8?_ )^M'_$/W^UC_P!)^?\ @JK_ .'R^,/_
M ,_6@.6/\Z_\!D?TXT5_,=_Q#]_M8_\ 2?G_ (*J_P#A\OC#_P#/UH_XA^_V
ML?\ I/S_ ,%5?_#Y?&'_ .?K0'+'^=?^ R/Z<:*_F._XA^_VL?\ I/S_ ,%5
M?_#Y?&'_ .?K1_Q#]_M8_P#2?G_@JK_X?+XP_P#S]: Y8_SK_P !D?TXT5_,
M=_Q#]_M8_P#2?G_@JK_X?+XP_P#S]:/^(?O]K'_I/S_P55_\/E\8?_GZT!RQ
M_G7_ (#(_IQHK^8[_B'[_:Q_Z3\_\%5?_#Y?&'_Y^M'_ !#]_M8_])^?^"JO
M_A\OC#_\_6@.6/\ .O\ P&1_3C17\QW_ !#]_M8_])^?^"JO_A\OC#_\_6C_
M (A^_P!K'_I/S_P55_\ #Y?&'_Y^M <L?YU_X#(_IQHK^8[_ (A^_P!K'_I/
MS_P55_\ #Y?&'_Y^M'_$/W^UC_TGY_X*J_\ A\OC#_\ /UH#EC_.O_ 9'].-
M%?S'?\0_?[6/_2?G_@JK_P"'R^,/_P _6C_B'[_:Q_Z3\_\ !57_ ,/E\8?_
M )^M <L?YU_X#(_IQHK^8[_B'[_:Q_Z3\_\ !57_ ,/E\8?_ )^M'_$/W^UC
M_P!)^?\ @JK_ .'R^,/_ ,_6@.6/\Z_\!D?TXT5_,=_Q#]_M8_\ 2?G_ (*J
M_P#A\OC#_P#/UH_XA^_VL?\ I/S_ ,%5?_#Y?&'_ .?K0'+'^=?^ R/Z<:*_
MF._XA^_VL?\ I/S_ ,%5?_#Y?&'_ .?K1_Q#]_M8_P#2?G_@JK_X?+XP_P#S
M]: Y8_SK_P !D?TXT5_,=_Q#]_M8_P#2?G_@JK_X?+XP_P#S]:/^(?O]K'_I
M/S_P55_\/E\8?_GZT!RQ_G7_ (#(_IQHK^8[_B'[_:Q_Z3\_\%5?_#Y?&'_Y
M^M'_ !#]_M8_])^?^"JO_A\OC#_\_6@.6/\ .O\ P&1_3C17\QW_ !#]_M8_
M])^?^"JO_A\OC#_\_6C_ (A^_P!K'_I/S_P55_\ #Y?&'_Y^M <L?YU_X#(_
MIQHK^8[_ (A^_P!K'_I/S_P55_\ #Y?&'_Y^M'_$/W^UC_TGY_X*J_\ A\OC
M#_\ /UH#EC_.O_ 9'].-%?S'?\0_?[6/_2?G_@JK_P"'R^,/_P _6C_B'[_:
MQ_Z3\_\ !57_ ,/E\8?_ )^M <L?YU_X#(_IQHK^8[_B'[_:Q_Z3\_\ !57_
M ,/E\8?_ )^M'_$/W^UC_P!)^?\ @JK_ .'R^,/_ ,_6@.6/\Z_\!D?TXT5_
M,=_Q#]_M8_\ 2?G_ (*J_P#A\OC#_P#/UH_XA^_VL?\ I/S_ ,%5?_#Y?&'_
M .?K0'+'^=?^ R/Z<:*_F._XA^_VL?\ I/S_ ,%5?_#Y?&'_ .?K1_Q#]_M8
M_P#2?G_@JK_X?+XP_P#S]: Y8_SK_P !D?TXT5_,=_Q#]_M8_P#2?G_@JK_X
M?+XP_P#S]:/^(?O]K'_I/S_P55_\/E\8?_GZT!RQ_G7_ (#(_IQHK^8[_B'[
M_:Q_Z3\_\%5?_#Y?&'_Y^M'_ !#]_M8_])^?^"JO_A\OC#_\_6@.6/\ .O\
MP&1_3C17\QW_ !#]_M8_])^?^"JO_A\OC#_\_6C_ (A^_P!K'_I/S_P55_\
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M74+R+3/"WA#4Y;FY@MY((]1NM$TAI!J6O:3;7?&_\0_?[6/_ $GY_P""JO\
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
